data_2lw3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lw3 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.7 mpt? . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -113.13 128.59 56.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.604 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.412 ' O ' ' CD1' ' A' ' 90' ' ' ILE . 39.1 tp -95.79 115.76 27.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.087 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.1 p -126.45 131.77 51.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 88' ' ' LEU . 26.1 p90 -119.77 148.88 42.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.832 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 57' ' ' ILE . 2.2 tm-20 -155.81 144.88 20.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.901 0.382 . . . . 0.0 110.919 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.436 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 31.4 mm -116.11 165.59 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.901 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.686 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -133.01 165.42 24.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.023 0.44 . . . . 0.0 110.952 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.76 170.56 37.33 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.588 ' O ' ' OG1' ' A' ' 63' ' ' THR . 17.9 Cg_endo -64.82 161.2 37.25 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.518 2.146 . . . . 0.0 112.016 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -72.51 119.52 6.17 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.868 2.379 . . . . 0.0 112.163 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.69 7.31 45.24 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.588 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -82.92 136.02 34.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.809 0.338 . . . . 0.0 110.653 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -114.53 122.63 69.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.615 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.61 151.53 44.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.503 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.497 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 9.2 p30 -96.24 116.0 28.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.635 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 mt -96.83 130.45 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.572 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.4 t -134.19 126.06 29.14 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.02 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.657 ' CZ ' ' O ' ' A' ' 70' ' ' PHE . 11.0 t80 -151.38 152.64 33.39 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.876 0.369 . . . . 0.0 110.63 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.657 ' O ' ' CZ ' ' A' ' 69' ' ' TYR . 49.7 t80 -84.75 121.53 27.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.494 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.52 151.18 27.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.627 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.5 t -64.72 -35.27 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.604 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -89.7 10.24 24.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.657 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 70.52 79.56 0.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.582 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -170.77 85.17 0.52 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.469 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -59.31 139.95 92.31 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.859 2.373 . . . . 0.0 112.197 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -106.04 132.67 51.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.56 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.1 mtm-85 -140.43 126.22 19.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.468 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.3 m -121.31 136.97 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.735 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -129.95 126.2 37.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.516 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.68 23.96 17.03 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.98 153.36 22.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 110.467 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -92.93 -39.82 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.615 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.608 ' CD1' ' CH2' ' A' ' 86' ' ' TRP . 0.2 OUTLIER -147.83 157.8 43.33 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.976 0.417 . . . . 0.0 110.628 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.73 162.49 39.45 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.87 2.38 . . . . 0.0 112.268 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.608 ' CH2' ' CD1' ' A' ' 84' ' ' LEU . 2.1 m95 -132.86 -156.49 0.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.332 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 96.7 p -130.49 161.22 31.92 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.946 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 55' ' ' TYR . 0.6 OUTLIER -132.47 155.42 48.59 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.405 178.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.533 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.2 OUTLIER -116.2 120.61 39.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.668 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.412 ' CD1' ' O ' ' A' ' 53' ' ' LEU . 3.8 mp -124.15 129.79 73.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.656 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.01 129.86 53.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.302 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.563 ' O ' ' O ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -125.79 157.97 36.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.659 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.563 ' O ' ' O ' ' A' ' 92' ' ' THR . 5.1 m120 -34.76 -100.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.618 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.8 72.59 0.33 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.587 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.45 ' O ' ' CG2' ' A' ' 97' ' ' VAL . . . -169.68 166.06 9.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.745 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.56 128.89 34.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.518 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 95' ' ' ALA . 0.7 OUTLIER -133.44 147.74 31.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.718 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.424 ' SD ' ' HB3' ' A' ' 122' ' ' ALA . 23.0 mtm -149.19 150.25 32.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.309 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.17 162.16 23.59 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -105.23 117.08 33.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.892 0.377 . . . . 0.0 110.589 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 tp -132.88 133.66 58.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.532 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.0 m -130.59 165.32 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.217 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -139.62 142.22 37.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.759 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -132.96 75.98 1.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.383 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -125.52 164.43 19.1 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.56 ' ND2' ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -78.02 48.86 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.108 0.48 . . . . 0.0 110.458 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.657 ' HG ' ' H ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -93.8 173.23 7.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.613 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.603 ' N ' ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -101.61 -17.07 16.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.418 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.657 ' H ' ' HG ' ' A' ' 107' ' ' SER . 40.9 t -146.54 115.98 7.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.0 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.424 ' O ' ' O ' ' A' ' 126' ' ' SER . 3.4 mt -137.64 125.96 32.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.834 0.35 . . . . 0.0 110.51 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -154.83 175.27 32.95 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -120.23 169.62 10.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.687 0.279 . . . . 0.0 110.519 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.94 144.99 13.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.81 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.4 mt -140.74 122.97 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.579 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.0 p -122.72 122.29 38.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.371 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.594 ' O ' ' N ' ' A' ' 118' ' ' GLY . 55.9 t -122.12 157.74 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.857 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.469 ' N ' ' CG1' ' A' ' 116' ' ' VAL . 80.9 m-20 39.22 20.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.807 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 116' ' ' VAL . . . 70.44 0.95 33.46 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 116' ' ' VAL . 4.6 tttp -113.65 143.46 44.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 110.57 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.4 p -71.56 124.23 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.784 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.454 ' HG2' ' NH1' ' A' ' 121' ' ' ARG . 26.9 mtt-85 -125.38 -41.4 2.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.175 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.424 ' HB3' ' SD ' ' A' ' 98' ' ' MET . . . -152.78 128.22 9.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.134 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -149.16 131.74 15.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.786 0.326 . . . . 0.0 111.026 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.0 119.06 28.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.351 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.506 ' CG1' ' O ' ' A' ' 125' ' ' VAL . 7.5 p -122.25 118.53 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.726 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.3 OUTLIER -115.35 127.16 55.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.538 179.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -95.6 133.15 39.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.714 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.573 ' O ' ' O ' ' A' ' 108' ' ' ASP . 9.6 mt-10 -148.97 130.51 14.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.355 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.01 -11.02 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.605 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -164.38 72.03 0.22 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.35 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.669 -179.768 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.9 ptp . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -116.22 119.27 35.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.512 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.3 tt -98.5 115.2 28.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.026 0.441 . . . . 0.0 110.703 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -127.51 129.71 47.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.052 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.413 ' HH ' HD21 ' A' ' 88' ' ' LEU . 12.5 p90 -119.96 148.54 43.4 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.732 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.74 ' HB2' ' HG ' ' A' ' 87' ' ' SER . 6.0 tt0 -156.8 131.93 9.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.705 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.516 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 4.6 mm -91.36 167.95 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.41 145.49 51.25 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.885 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.07 156.66 28.09 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -50.33 161.63 1.1 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.923 2.415 . . . . 0.0 111.987 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -76.95 133.74 14.02 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.953 2.435 . . . . 0.0 112.279 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.94 -9.92 67.37 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.6 m -81.68 130.23 34.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.841 0.353 . . . . 0.0 110.496 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.9 m -101.9 127.39 55.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.579 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.35 155.48 49.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.557 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.503 ' OD1' ' C ' ' A' ' 66' ' ' ASP . 44.2 t0 -103.18 129.15 50.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.555 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.497 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 2.9 mt -118.73 126.46 75.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.62 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 39.9 t -113.27 117.87 33.04 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.067 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.593 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 33.9 t80 -139.96 145.93 38.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.702 0.287 . . . . 0.0 110.538 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.593 ' O ' ' CE2' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -83.24 134.48 34.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.207 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 74' ' ' SER . 11.9 t0 -94.21 153.32 18.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.92 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.2 p -48.84 -39.09 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.635 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.514 ' O ' ' CB ' ' A' ' 74' ' ' SER . 0.3 OUTLIER -87.71 11.75 14.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.409 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.68 ' OG ' ' N ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER 82.15 -71.65 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.507 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.68 ' N ' ' OG ' ' A' ' 74' ' ' SER . 1.1 tp10 -26.12 88.75 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.701 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.588 ' N ' ' O ' ' A' ' 74' ' ' SER . 14.8 Cg_exo -65.08 144.57 82.39 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.932 2.421 . . . . 0.0 112.083 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -107.72 150.07 27.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.285 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -138.24 129.92 28.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.787 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.2 m -102.46 123.54 55.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.476 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 0.5 OUTLIER -120.97 108.74 14.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.686 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.69 29.03 7.56 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.45 132.86 34.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 0.0 110.578 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.08 -76.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.607 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.434 ' H ' ' CD1' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -118.17 156.73 50.25 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.588 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.516 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 25.6 Cg_endo -64.1 151.33 85.78 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.904 2.403 . . . . 0.0 112.339 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -114.31 -171.2 1.87 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.396 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.74 ' HG ' ' HB2' ' A' ' 56' ' ' GLU . 70.9 m -125.03 151.54 45.46 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.044 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.413 HD21 ' HH ' ' A' ' 55' ' ' TYR . 8.1 tp -130.73 154.6 47.8 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.863 0.363 . . . . 0.0 110.5 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -123.57 120.65 33.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.404 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.7 mt -130.9 132.09 64.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.571 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.77 126.03 51.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.569 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.507 ' O ' ' C ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -130.24 156.39 44.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.585 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.623 ' OD1' ' N ' ' A' ' 93' ' ' ASN . 0.4 OUTLIER -30.78 120.13 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.478 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -42.51 92.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.568 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 93' ' ' ASN . . . -175.03 -171.92 0.56 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.446 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.68 113.15 8.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.452 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 t -107.26 152.36 8.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.192 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.5 ttt -148.48 137.48 21.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 0.0 111.015 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.64 156.99 18.85 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -118.73 115.39 24.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.812 0.339 . . . . 0.0 110.794 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.9 140.5 49.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.609 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 89.1 t -127.19 147.64 32.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.465 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -139.41 140.37 37.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.746 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -139.05 78.89 1.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.587 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.56 163.8 23.63 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -78.77 52.13 1.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.8 0.333 . . . . 0.0 110.483 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 129' ' ' VAL . 70.9 m -100.49 175.05 5.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.554 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 109' ' ' SER . 6.9 t70 -104.59 128.52 52.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.505 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 108' ' ' ASP . 47.0 t 44.02 93.52 0.01 OUTLIER 'General case' 0 C--O 1.24 0.599 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.971 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.498 ' CG2' ' OD1' ' A' ' 127' ' ' ASN . 15.9 tt -124.56 127.1 72.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 120.793 0.33 . . . . 0.0 110.461 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 125' ' ' VAL . . . -147.22 172.09 27.73 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.675 ' SG ' ' N ' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -118.75 162.66 18.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.675 ' N ' ' SG ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -158.76 143.72 16.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.923 0.392 . . . . 0.0 110.887 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.9 mp -118.72 124.95 73.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.306 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.88 127.69 54.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.765 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.67 136.59 31.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.462 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.515 ' OD1' ' O ' ' A' ' 117' ' ' ASP . 57.7 t0 65.55 9.45 5.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.449 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.13 -5.98 57.77 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -101.13 139.3 37.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.812 0.339 . . . . 0.0 110.579 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 m -78.24 142.51 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.602 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -168.14 24.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.573 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -123.67 152.85 41.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.772 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.1 147.55 23.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.263 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.0 ptt85 -127.78 135.41 50.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.767 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.415 ' O ' ' CA ' ' A' ' 111' ' ' GLY . 2.1 t -103.08 134.64 43.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.165 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.644 ' C ' HD21 ' A' ' 127' ' ' ASN . 46.7 m -102.63 116.45 32.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.942 0.401 . . . . 0.0 110.901 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.69 ' N ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -128.34 135.19 49.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.449 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.642 ' C ' ' H ' ' A' ' 130' ' ' ASN . 1.1 pm0 -104.36 174.6 5.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.746 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.611 ' N ' ' O ' ' A' ' 107' ' ' SER . 1.8 p -55.35 1.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.752 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.642 ' H ' ' C ' ' A' ' 128' ' ' GLU . 25.3 m-80 -112.84 -5.5 13.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.59 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.454 179.945 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.458 ' N ' ' H ' ' A' ' 117' ' ' ASP . 9.2 mtt . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.644 ' HD1' ' H ' ' A' ' 52' ' ' HIS . 1.5 p-80 -109.36 125.81 52.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.308 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.502 ' CD2' ' C ' ' A' ' 53' ' ' LEU . 5.5 tt -96.1 115.87 28.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.785 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.7 p -126.28 130.12 50.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.496 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.554 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 1.8 p90 -122.69 149.94 43.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.517 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.424 ' HG2' ' N ' ' A' ' 57' ' ' ILE . 17.0 tt0 -155.36 148.09 24.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.956 0.408 . . . . 0.0 111.042 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.424 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 1.6 mm -112.88 163.59 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.971 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.5 156.71 44.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.905 0.384 . . . . 0.0 110.698 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.65 170.21 42.93 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -47.56 152.87 2.38 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.854 2.369 . . . . 0.0 112.229 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -67.04 119.66 6.69 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.825 2.35 . . . . 0.0 111.933 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.99 -0.03 62.22 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.4 t -74.85 144.06 43.59 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.878 0.371 . . . . 0.0 110.559 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.87 128.83 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.508 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.47 151.49 41.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.806 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.67 124.81 49.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.206 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.9 mt -111.17 133.64 56.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.017 0.437 . . . . 0.0 111.013 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.5 t -132.35 131.05 41.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.957 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.679 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 11.2 t80 -150.98 156.49 41.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.895 0.379 . . . . 0.0 110.986 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.679 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 10.0 t80 -83.76 119.63 25.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.282 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -89.42 146.08 24.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.841 0.353 . . . . 0.0 110.775 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.5 p -53.99 -24.2 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.605 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.461 ' O ' ' CB ' ' A' ' 74' ' ' SER . 2.9 m-20 -86.55 -3.87 59.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.64 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.3 m 78.55 34.21 0.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.526 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -135.87 104.27 9.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.408 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -77.74 140.14 18.37 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.284 1.99 . . . . 0.0 112.086 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -107.42 148.11 29.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.563 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 75.4 mtm-85 -139.26 131.62 28.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.622 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.3 m -114.21 118.98 60.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.608 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -112.6 145.74 39.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.481 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.32 5.81 44.48 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.15 137.75 58.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.809 0.338 . . . . 0.0 110.413 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.45 -44.24 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.54 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.55 155.27 45.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.109 0.48 . . . . 0.0 110.774 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.83 159.44 52.79 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 123.208 2.605 . . . . 0.0 112.533 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -129.13 -179.26 5.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.215 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 92.8 p -112.27 164.53 13.11 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.323 0.582 . . . . 0.0 111.004 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.88 145.8 33.46 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.937 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.508 ' CG ' ' O ' ' A' ' 89' ' ' HIS . 19.8 p80 -121.52 123.53 42.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 110.851 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.3 mt -128.51 121.3 54.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.513 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.4 m -104.14 122.47 45.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.548 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.553 ' O ' ' C ' ' A' ' 93' ' ' ASN . 1.9 m -129.19 158.33 39.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.536 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.553 ' C ' ' O ' ' A' ' 92' ' ' THR . 41.9 m-20 -25.54 91.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.713 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 94' ' ' ASP . 0.1 OUTLIER -31.47 124.98 0.24 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.566 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 94' ' ' ASP . . . 163.75 -71.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.595 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -156.25 120.42 4.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.447 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 t -127.81 147.26 32.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.711 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.6 ttm -151.51 159.42 44.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.517 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -153.46 156.26 26.65 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.536 HD22 ' NH2' ' A' ' 124' ' ' ARG . 0.8 OUTLIER -119.19 115.83 25.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.327 . . . . 0.0 110.611 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.9 tt -130.95 137.26 56.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.71 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.34 145.52 33.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.536 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -123.84 158.84 30.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.702 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -143.79 76.16 1.5 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.386 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -116.79 163.61 12.47 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.728 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -79.28 28.44 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.572 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 105' ' ' GLY . 2.0 p -73.05 -174.41 1.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.538 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' A' ' 128' ' ' GLU . 3.0 m-20 -113.25 -24.9 9.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.716 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 t -151.21 101.52 2.86 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.959 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.539 ' O ' ' O ' ' A' ' 126' ' ' SER . 15.6 tt -138.39 135.6 44.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.896 0.379 . . . . 0.0 110.577 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.73 173.1 35.67 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 1.4 p -124.93 162.31 24.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.821 0.343 . . . . 0.0 110.771 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -149.07 158.25 44.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.457 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.9 mm -126.56 127.68 70.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.634 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.57 132.4 53.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.567 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.455 ' C ' ' N ' ' A' ' 118' ' ' GLY . 7.6 p -143.14 149.65 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.571 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.458 ' H ' ' N ' ' A' ' 51' ' ' MET . 5.9 m-20 48.89 15.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.391 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.455 ' N ' ' C ' ' A' ' 116' ' ' VAL . . . 77.69 1.42 77.46 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -116.79 126.88 53.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.731 0.3 . . . . 0.0 110.607 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.0 t -74.88 136.51 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.475 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -129.13 -33.59 1.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.841 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.06 129.53 14.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.486 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -151.58 126.73 9.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.807 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.536 ' NH2' HD22 ' A' ' 100' ' ' ASN . 0.2 OUTLIER -113.6 115.73 28.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.238 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.7 m -114.97 133.21 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.696 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.5 OUTLIER -132.61 115.88 15.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.454 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -97.81 130.03 44.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.393 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.517 ' O ' ' O ' ' A' ' 108' ' ' ASP . 3.9 mm-40 -138.68 130.77 28.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.908 0.385 . . . . 0.0 110.806 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.9 m -73.4 -4.04 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.266 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.2 73.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.059 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.659 -179.711 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -112.57 126.16 55.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.558 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.455 HD12 ' N ' ' A' ' 54' ' ' THR . 11.6 tp -97.32 115.28 27.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.56 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.455 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -127.14 142.85 51.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.509 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -126.0 148.43 49.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.42 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.733 ' OE1' ' OG ' ' A' ' 87' ' ' SER . 11.7 tt0 -156.7 134.4 10.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.979 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.516 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 20.7 mm -101.98 170.57 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -132.19 173.04 11.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 111.085 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.21 151.51 6.15 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -40.16 139.16 1.07 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.586 2.191 . . . . 0.0 111.938 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.75 135.56 36.02 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.588 2.192 . . . . 0.0 112.22 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.6 -0.89 58.22 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.7 m -86.21 139.37 31.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.792 0.33 . . . . 0.0 110.645 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 p -111.55 123.4 67.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.384 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -137.45 156.71 47.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.537 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.15 115.17 27.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.331 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.7 mt -105.34 131.18 55.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.708 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.5 t -134.74 125.94 27.99 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.952 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.661 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 42.7 t80 -145.87 158.98 43.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.834 0.35 . . . . 0.0 110.647 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.661 ' O ' ' CE2' ' A' ' 69' ' ' TYR . 4.6 t80 -88.83 136.72 32.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.679 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.32 116.71 32.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.36 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.0 t -75.5 -5.81 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.758 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.92 -17.98 25.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.593 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.6 t -176.72 -127.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.714 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -94.52 150.95 38.89 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.515 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.37 139.69 90.91 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.53 2.153 . . . . 0.0 111.871 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.58 156.84 17.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.697 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.7 ttm-85 -141.52 125.12 16.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.515 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.31 118.44 58.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.513 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 0.9 OUTLIER -115.74 133.62 55.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.658 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.55 31.37 8.89 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.57 148.98 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.863 0.363 . . . . 0.0 110.455 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.5 t -81.62 -53.35 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.301 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.528 ' O ' ' NE1' ' A' ' 86' ' ' TRP . 0.2 OUTLIER -140.67 151.89 64.51 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.209 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.516 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 11.5 Cg_endo -57.15 158.17 18.84 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.8 2.333 . . . . 0.0 112.071 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.528 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 37.4 m95 -130.15 -160.6 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.485 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.733 ' OG ' ' OE1' ' A' ' 56' ' ' GLU . 71.2 m -132.86 144.98 50.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.016 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.48 144.1 51.09 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.695 ' CD2' ' H ' ' A' ' 89' ' ' HIS . 0.7 OUTLIER -108.29 124.87 50.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.919 0.39 . . . . 0.0 110.943 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.6 mt -130.58 128.58 63.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.087 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.26 122.54 47.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.858 0.361 . . . . 0.0 110.934 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.537 ' O ' ' C ' ' A' ' 93' ' ' ASN . 5.3 m -126.14 125.57 42.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.236 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.537 ' C ' ' O ' ' A' ' 92' ' ' THR . 1.2 m-20 28.77 -134.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.494 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.532 ' OD1' ' C ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -139.41 98.74 3.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.563 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 168.35 -171.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.573 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -91.24 135.96 33.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.62 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.92 159.42 36.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.452 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.03 146.55 51.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.746 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.77 151.54 18.35 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -112.12 114.99 28.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.723 0.297 . . . . 0.0 110.596 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -133.29 139.13 49.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.515 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.467 HG11 ' H ' ' A' ' 103' ' ' ALA . 2.3 t -131.96 165.14 32.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.519 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.467 ' H ' HG11 ' A' ' 102' ' ' VAL . . . -143.61 148.13 35.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.447 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.46 63.97 1.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.175 0.512 . . . . 0.0 110.359 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -118.16 163.53 12.93 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.43 52.42 2.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.733 0.301 . . . . 0.0 110.636 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.1 m -88.98 -167.82 2.0 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.388 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -112.26 -42.42 3.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.805 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.3 t -128.01 128.06 44.31 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.99 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.537 ' O ' ' O ' ' A' ' 126' ' ' SER . 7.5 mt -141.75 148.08 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.706 0.289 . . . . 0.0 110.307 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.44 ' N ' HG23 ' A' ' 110' ' ' ILE . . . 177.8 163.86 30.21 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -117.83 160.14 21.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 0.0 110.611 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -151.3 155.48 38.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.635 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.4 mt -138.32 114.93 10.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.424 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.9 p -117.24 126.81 53.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.619 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 t -125.46 134.62 66.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.27 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 52.0 23.25 2.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.476 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.6 8.37 87.16 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -119.06 126.18 51.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.631 0.253 . . . . 0.0 110.399 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.2 p -74.26 138.72 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.769 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -115.35 -68.22 0.94 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.278 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -142.79 126.98 17.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.276 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -148.28 129.23 14.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.89 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -95.36 127.44 41.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.374 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.45 ' CG1' ' O ' ' A' ' 125' ' ' VAL . 10.8 p -117.45 117.31 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.806 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.6 OUTLIER -126.82 115.97 20.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.377 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 128' ' ' GLU . 54.9 t-20 -96.98 130.21 44.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.642 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.416 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 14.5 mt-10 -141.72 130.45 22.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.36 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 130' ' ' ASN . 0.3 OUTLIER -82.74 92.56 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.655 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 129' ' ' VAL . 1.0 OUTLIER 83.3 62.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.529 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 121.08 0.467 . . . . 0.0 110.572 179.943 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.443 ' SD ' ' OD1' ' A' ' 117' ' ' ASP . 17.2 mmt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.95 117.65 33.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.439 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.57 114.85 26.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.39 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.575 ' OG1' ' O ' ' A' ' 88' ' ' LEU . 7.5 t -127.47 140.82 51.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.786 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -127.57 149.34 50.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.282 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.633 ' HB2' ' HG ' ' A' ' 87' ' ' SER . 2.4 tm-20 -155.66 154.75 32.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 0.0 110.931 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.595 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 4.9 mm -116.51 161.38 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.294 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.535 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 7.9 m-85 -134.96 158.6 43.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.709 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.37 167.95 36.41 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -46.65 148.77 3.4 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.737 2.291 . . . . 0.0 112.08 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -70.29 134.7 27.47 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.703 2.268 . . . . 0.0 112.091 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.61 1.39 71.26 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 95.9 m -81.25 135.53 35.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.908 0.385 . . . . 0.0 110.44 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.0 t -113.33 123.44 68.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.491 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.07 153.13 43.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.778 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.22 121.36 40.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.366 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.9 mp -98.81 131.2 46.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.766 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.3 t -129.62 119.2 23.18 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.019 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.6 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 2.6 p90 -142.23 171.34 14.19 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.631 0.253 . . . . 0.0 110.443 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.636 ' CD1' ' O ' ' A' ' 70' ' ' PHE . 0.6 OUTLIER -87.57 130.68 34.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.492 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 72' ' ' VAL . 33.3 t0 -88.83 139.1 30.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.519 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.557 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 6.2 p -54.56 -25.93 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.805 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.401 ' N ' HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -88.31 8.94 25.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.74 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.5 m 69.6 62.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.523 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -170.43 92.26 0.48 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.263 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -58.84 139.82 92.47 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.712 2.275 . . . . 0.0 112.342 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -108.23 155.61 20.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.732 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -137.37 125.58 23.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.265 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.5 m -106.69 120.91 58.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.844 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.69 129.05 53.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.385 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.07 13.8 58.47 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.79 128.03 34.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.742 0.306 . . . . 0.0 110.618 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.35 -96.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.307 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.427 ' CD1' ' H ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -90.0 158.42 44.44 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.924 0.392 . . . . 0.0 110.453 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.595 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 17.4 Cg_endo -60.41 154.87 50.28 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.992 2.462 . . . . 0.0 112.194 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.9 175.42 6.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.429 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.633 ' HG ' ' HB2' ' A' ' 56' ' ' GLU . 68.0 m -113.21 152.35 29.86 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.946 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.575 ' O ' ' OG1' ' A' ' 54' ' ' THR . 2.2 tp -129.67 151.72 49.96 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.041 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.657 ' H ' ' ND1' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -112.32 126.0 54.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 0.0 110.898 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.5 mt -131.09 132.46 63.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.48 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.85 129.3 56.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.541 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 p -122.61 140.62 52.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.627 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.546 ' O ' ' C ' ' A' ' 94' ' ' ASP . 3.3 p30 -74.89 108.61 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.801 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.546 ' C ' ' O ' ' A' ' 93' ' ' ASN . 1.4 t70 26.39 83.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.642 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 177.59 139.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.549 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.02 125.01 42.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.718 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.1 t -141.38 123.73 14.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.503 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.85 136.0 33.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.499 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.41 148.7 20.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -102.87 115.59 30.89 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.5 tt -130.18 142.07 44.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.892 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 103' ' ' ALA . 69.4 t -136.7 162.64 34.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.224 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.476 ' N ' ' CG1' ' A' ' 102' ' ' VAL . . . -142.98 144.83 32.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.698 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -120.52 42.75 2.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.401 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -96.32 157.82 21.53 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.408 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 4.9 p30 -79.3 26.79 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.743 0.306 . . . . 0.0 110.536 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.785 ' HG ' ' H ' ' A' ' 108' ' ' ASP . 12.3 t -63.97 -173.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.483 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.785 ' H ' ' HG ' ' A' ' 107' ' ' SER . 12.8 t0 -119.45 -58.85 1.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.778 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.2 t -99.96 98.25 9.03 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.987 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 6.9 mt -117.02 149.37 19.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.74 0.305 . . . . 0.0 110.341 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.9 161.59 26.83 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.592 ' SG ' ' N ' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -118.74 157.55 27.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 110.95 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.592 ' N ' ' SG ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -151.3 138.24 19.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.342 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.462 ' CD1' ' SG ' ' A' ' 112' ' ' CYS . 1.7 mp -125.7 125.71 68.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.719 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 p -123.54 129.23 50.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.38 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.2 p -126.53 126.04 68.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.594 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.443 ' OD1' ' SD ' ' A' ' 51' ' ' MET . 4.0 t70 65.13 12.23 7.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.559 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.73 -4.53 84.62 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -96.61 132.43 42.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.861 0.362 . . . . 0.0 110.46 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.69 125.09 40.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.566 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.9 mmt85 -127.28 -53.99 1.37 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.612 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -119.46 129.17 54.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.502 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -151.59 122.86 7.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.37 118.93 33.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.261 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.3 t -127.46 118.99 51.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.069 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -133.17 116.98 16.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.323 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.23 128.78 40.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.909 0.385 . . . . 0.0 110.859 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.604 ' C ' ' H ' ' A' ' 130' ' ' ASN . 0.8 OUTLIER -157.9 130.35 7.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.381 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.462 ' N ' ' OE1' ' A' ' 128' ' ' GLU . 74.0 t -63.17 6.27 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.034 0.445 . . . . 0.0 110.163 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.604 ' H ' ' C ' ' A' ' 128' ' ' GLU . 0.7 OUTLIER -167.31 66.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.161 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.751 -179.716 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.527 ' HD1' ' H ' ' A' ' 52' ' ' HIS . 9.7 p-80 -105.96 128.44 53.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.401 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.578 ' CD1' ' O ' ' A' ' 97' ' ' VAL . 1.6 tt -97.01 115.52 27.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.618 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.03 139.53 52.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.642 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.436 ' CE1' HG21 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -121.37 148.52 44.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.243 179.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -156.25 144.01 19.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.932 0.396 . . . . 0.0 111.087 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.569 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 6.1 mm -115.23 167.47 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.483 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.407 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -140.97 163.87 31.8 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.524 -0.471 . . . . 0.0 111.172 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.62 165.39 37.84 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.584 ' O ' ' OG1' ' A' ' 63' ' ' THR . 71.3 Cg_exo -41.71 166.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.882 2.388 . . . . 0.0 111.985 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -80.14 116.64 3.4 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.723 2.282 . . . . 0.0 112.283 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.08 12.9 62.89 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.584 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -86.22 148.84 25.46 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.46 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.406 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 11.4 m -112.32 122.69 67.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.549 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.21 143.56 32.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.463 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.75 126.97 40.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.535 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.414 HD11 ' N ' ' A' ' 67' ' ' ILE . 3.7 mp -107.81 126.57 64.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.503 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.4 t -130.71 125.49 34.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.921 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.774 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 31.2 p90 -146.42 169.97 17.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.727 0.299 . . . . 0.0 110.561 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -85.98 119.19 26.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.579 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 73' ' ' ASN . 4.2 t0 -90.97 105.9 18.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.507 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.6 t -59.1 -5.07 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.659 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.516 ' O ' ' CB ' ' A' ' 74' ' ' SER . 0.3 OUTLIER -77.58 -21.5 52.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.726 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.712 ' HG ' ' N ' ' A' ' 75' ' ' GLU . 1.7 t 159.56 -93.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.715 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.712 ' N ' ' HG ' ' A' ' 74' ' ' SER . 8.1 pt-20 -100.91 148.92 35.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.616 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.29 145.69 49.1 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.759 2.306 . . . . 0.0 112.339 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.774 ' NE2' ' CE1' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -107.69 154.76 21.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.599 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 -132.08 135.08 46.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.579 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 p -116.96 125.51 73.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.59 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -136.87 134.2 36.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.489 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.03 7.66 59.54 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.81 153.26 35.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.733 0.301 . . . . 0.0 110.604 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.0 p -90.86 -30.47 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.449 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.92 154.3 26.14 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 110.733 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.569 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 18.7 Cg_endo -61.64 158.47 36.97 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.873 2.382 . . . . 0.0 112.111 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -121.42 -160.13 0.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.54 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.1 t -136.3 138.24 41.52 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.969 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.21 143.45 51.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.728 0.299 . . . . 0.0 110.29 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.646 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -105.94 121.07 43.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.771 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.1 mp -121.47 130.63 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.567 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.9 p -112.69 131.61 55.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.495 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.426 ' H ' ' HG1' ' A' ' 92' ' ' THR . 0.7 OUTLIER -112.57 157.57 21.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.553 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -52.94 -16.37 1.02 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.418 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -103.37 -115.94 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.538 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -166.33 -56.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.698 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.31 121.77 37.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.576 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.578 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 39.9 t -150.69 160.92 3.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.537 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.527 ' N ' ' CG1' ' A' ' 97' ' ' VAL . 4.8 mtt -121.62 157.45 30.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.408 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -142.96 148.31 20.01 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -102.96 118.28 36.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.796 0.331 . . . . 0.0 110.479 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.436 HG21 ' CE1' ' A' ' 55' ' ' TYR . 14.9 tt -133.19 142.13 42.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.546 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.5 t -140.68 163.73 22.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.662 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -138.42 158.68 43.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.408 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -135.64 75.74 1.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.73 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.23 155.23 19.25 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.0 55.2 1.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 110.359 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.649 ' OG ' ' N ' ' A' ' 108' ' ' ASP . 6.3 t -85.48 -167.56 1.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.712 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.649 ' N ' ' OG ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -119.84 -14.21 9.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.594 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.9 t -159.24 125.39 4.44 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.971 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.577 ' O ' ' O ' ' A' ' 126' ' ' SER . 26.1 mt -138.03 158.16 32.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.728 0.299 . . . . 0.0 110.514 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.489 ' N ' ' CG2' ' A' ' 110' ' ' ILE . . . -177.2 156.74 20.93 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.532 ' O ' ' O ' ' A' ' 124' ' ' ARG . 3.8 p -122.57 151.73 41.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.659 0.266 . . . . 0.0 110.449 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -160.01 148.22 16.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.663 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.415 HG22 HD13 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -129.68 123.22 56.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.802 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 72.5 p -119.16 136.53 54.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.333 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.457 ' C ' ' H ' ' A' ' 118' ' ' GLY . 84.9 t -132.44 149.09 31.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.792 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 55.39 8.88 0.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.58 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 116' ' ' VAL . . . 79.81 11.02 85.07 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -116.8 135.24 53.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.769 0.319 . . . . 0.0 110.546 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 71.9 t -70.08 120.57 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.616 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.418 ' NH1' ' HB3' ' A' ' 121' ' ' ARG . 4.0 mtp-105 -116.53 -72.26 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.655 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.22 134.92 46.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.676 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -149.65 157.19 43.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.489 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.532 ' O ' ' O ' ' A' ' 112' ' ' CYS . 7.5 ttt85 -123.52 130.14 52.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.646 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 54.6 t -114.03 118.52 58.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.527 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.577 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.7 OUTLIER -132.77 121.93 23.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.509 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -106.34 129.63 54.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.7 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -157.35 133.88 9.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.496 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' A' ' 130' ' ' ASN . 4.2 m -82.64 135.88 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.433 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 107' ' ' SER . 1.7 m-80 36.26 53.36 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.443 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.722 -179.9 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 30.8 mtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -110.95 123.68 50.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.326 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.418 ' CD2' ' C ' ' A' ' 53' ' ' LEU . 6.9 tt -95.84 114.58 26.33 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.286 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.7 p -127.34 132.85 50.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.771 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 13.0 p90 -123.69 148.17 46.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.373 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.88 ' HB2' ' HG ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -156.53 149.48 23.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.658 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.555 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -109.19 175.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.104 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -139.96 147.67 40.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.724 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.32 157.97 29.64 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -42.19 161.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.88 2.386 . . . . 0.0 112.164 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.41 122.77 7.21 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.933 2.422 . . . . 0.0 112.293 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.43 11.18 59.85 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.5 m -83.28 130.81 35.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 0.0 110.549 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -113.94 121.73 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.577 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.42 155.73 44.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.661 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -95.44 115.8 27.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.105 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 mp -99.95 134.72 38.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.739 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.5 t -135.58 132.39 37.11 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.974 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 77' ' ' GLN . 24.1 p90 -145.31 164.7 30.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.766 0.317 . . . . 0.0 110.531 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.14 135.44 33.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.484 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -98.65 152.38 19.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.588 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 p -63.84 -31.23 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.549 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.629 ' O ' ' CB ' ' A' ' 74' ' ' SER . 18.3 m-20 -75.78 2.84 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.494 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.629 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.0 OUTLIER 91.34 -52.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.281 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -60.0 113.98 8.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.13 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -74.5 141.28 28.03 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.245 1.964 . . . . 0.0 112.25 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 69' ' ' TYR . 24.5 tt0 -107.14 145.61 32.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.621 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -139.4 130.45 26.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.536 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.8 t -105.05 123.22 59.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.549 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 81' ' ' GLY . 19.5 t0 -121.96 134.71 54.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.675 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.488 ' N ' ' OD1' ' A' ' 80' ' ' ASP . . . 94.17 18.35 36.93 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.31 128.53 35.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.761 0.315 . . . . 0.0 110.563 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 p -76.78 -14.63 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.519 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -159.72 155.96 23.69 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.562 179.664 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.555 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 11.7 Cg_endo -57.08 152.95 41.39 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.989 2.46 . . . . 0.0 112.273 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.64 162.17 18.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.413 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.88 ' HG ' ' HB2' ' A' ' 56' ' ' GLU . 72.6 m -110.29 139.13 45.77 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.988 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 tp -130.41 140.46 50.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.767 0.318 . . . . 0.0 110.438 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.529 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 1.0 OUTLIER -110.73 119.27 38.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.621 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 64.0 mt -129.07 130.02 68.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.324 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.61 123.66 47.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.864 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.659 ' C ' ' H ' ' A' ' 94' ' ' ASP . 0.2 OUTLIER -99.35 153.34 19.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.247 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -60.31 7.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.621 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.659 ' H ' ' C ' ' A' ' 92' ' ' THR . 11.1 t0 -123.26 -103.28 0.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.489 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.472 ' N ' ' OD1' ' A' ' 94' ' ' ASP . . . 168.81 -56.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.686 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -88.55 114.65 25.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.548 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 p -168.47 144.74 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.936 0.398 . . . . 0.0 110.835 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -121.13 143.21 49.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.354 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.564 ' C ' HD21 ' A' ' 100' ' ' ASN . . . -111.09 162.6 12.43 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.57 HD21 ' N ' ' A' ' 100' ' ' ASN . 1.0 OUTLIER -104.89 117.94 35.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.754 0.311 . . . . 0.0 110.519 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.2 tt -131.18 131.75 63.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.698 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 103' ' ' ALA . 5.8 t -123.15 147.61 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.483 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.424 ' N ' HG12 ' A' ' 102' ' ' VAL . . . -128.8 138.38 52.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.662 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -122.56 73.17 1.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.452 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.73 163.37 20.67 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.62 ' OD1' ' ND2' ' A' ' 130' ' ' ASN . 24.9 t30 -84.0 37.89 0.62 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.749 0.309 . . . . 0.0 110.767 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.519 ' HG ' ' CD1' ' A' ' 110' ' ' ILE . 4.5 p -70.23 -177.68 1.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.531 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.49 -40.13 5.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.632 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.5 t -137.0 115.91 12.28 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.981 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.519 ' CD1' ' HG ' ' A' ' 107' ' ' SER . 10.3 mt -117.55 159.82 17.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.844 0.354 . . . . 0.0 110.529 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.441 ' N ' ' CG2' ' A' ' 110' ' ' ILE . . . 174.8 149.24 7.08 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.524 ' O ' ' O ' ' A' ' 124' ' ' ARG . 11.7 p -117.92 151.88 36.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.735 0.302 . . . . 0.0 110.587 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -154.31 154.85 34.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.507 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.54 124.4 28.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.581 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.3 p -122.35 141.17 51.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.686 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 119' ' ' LYS . 15.6 m -146.0 149.27 16.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.521 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 t0 49.41 17.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.639 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.411 ' N ' ' C ' ' A' ' 116' ' ' VAL . . . 84.87 -9.59 65.32 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 116' ' ' VAL . 15.9 mttm -112.07 124.72 53.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 0.0 110.539 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.43 ' O ' ' CG1' ' A' ' 120' ' ' VAL . 6.1 p -82.24 124.65 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.575 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -94.27 -34.91 12.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.531 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -141.05 141.28 34.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.505 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -148.99 122.47 9.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.783 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.524 ' O ' ' O ' ' A' ' 112' ' ' CYS . 27.2 mtt85 -127.29 115.87 19.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.205 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.25 118.23 54.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.001 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.9 OUTLIER -120.1 118.57 30.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.153 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.491 ' O ' ' OE1' ' A' ' 128' ' ' GLU . 2.7 m120 -94.23 129.9 40.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.842 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.491 ' OE1' ' O ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER -151.21 136.55 17.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.383 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 52.2 t -95.98 128.61 47.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.779 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.62 ' ND2' ' OD1' ' A' ' 106' ' ' ASN . 7.8 m120 60.89 35.75 19.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.911 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.338 179.817 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -102.48 120.0 39.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.453 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.564 ' CD2' ' C ' ' A' ' 53' ' ' LEU . 5.9 tt -96.19 115.87 28.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.743 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 t -126.71 132.55 51.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.348 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -120.08 149.75 41.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.849 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.424 ' OE1' ' CD2' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -155.66 141.76 18.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.671 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.5 mp -112.12 157.76 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.188 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.656 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -133.07 170.83 14.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.98 0.419 . . . . 0.0 111.047 -179.606 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.24 179.97 39.99 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -47.44 158.66 0.58 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.648 2.232 . . . . 0.0 112.062 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.0 110.95 3.05 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.77 2.313 . . . . 0.0 112.159 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.51 8.91 57.1 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -85.2 141.19 30.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.742 0.306 . . . . 0.0 110.527 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.45 130.67 59.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.307 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -135.67 155.7 50.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.637 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.599 ' OD2' ' NE2' ' A' ' 104' ' ' GLN . 11.6 p-10 -97.96 127.6 44.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.445 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.4 mp -99.31 120.73 49.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.638 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.1 t -135.65 117.04 14.67 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.987 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -143.83 171.11 14.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.768 0.318 . . . . 0.0 110.431 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -83.96 128.25 34.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.551 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' A' ' 72' ' ' VAL . 15.3 t0 -91.3 142.9 27.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.607 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.567 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 1.0 OUTLIER -63.68 -25.03 37.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.554 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.36 11.43 34.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.454 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 70.26 15.75 7.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.345 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 71' ' ' ASP . 1.9 tt0 -118.52 93.03 44.99 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.295 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -77.43 139.64 18.59 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.463 2.109 . . . . 0.0 112.333 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.436 ' HG2' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -107.67 143.34 36.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.572 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.436 ' N ' ' HG2' ' A' ' 77' ' ' GLN . 14.4 mtp-105 -139.65 125.35 19.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.536 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.7 m -107.66 134.5 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.621 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.632 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -104.91 142.46 34.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.451 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.54 31.81 81.03 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.52 131.26 34.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.842 0.353 . . . . 0.0 110.524 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.8 p -87.05 113.5 24.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.514 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tp 60.51 118.34 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.462 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -55.24 160.96 7.62 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.953 1.769 . . . . 0.0 111.844 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.584 ' CD1' ' C ' ' A' ' 86' ' ' TRP . 0.1 OUTLIER -112.14 -172.69 2.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.655 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 92.1 p -111.19 155.46 22.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.449 ' HG ' ' N ' ' A' ' 89' ' ' HIS . 6.3 tp -140.25 143.77 36.13 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.495 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.573 ' N ' ' CD2' ' A' ' 89' ' ' HIS . 0.2 OUTLIER -107.6 128.1 54.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.765 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.5 mt -125.55 130.83 72.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.487 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -122.95 122.76 39.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.747 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.553 ' O ' ' C ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -117.58 156.82 27.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.465 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.553 ' C ' ' O ' ' A' ' 92' ' ' THR . 4.4 m-20 -24.15 -60.13 0.05 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.841 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.447 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 0.3 OUTLIER 165.51 92.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.546 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -175.33 133.94 0.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.53 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.55 116.17 15.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.614 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.5 p -139.26 138.26 40.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.426 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.42 165.26 12.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.684 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -127.45 144.24 14.96 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -103.46 119.77 39.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.75 0.31 . . . . 0.0 110.736 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.5 tt -133.02 136.63 55.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.698 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.0 t -127.85 149.34 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.308 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -120.8 148.63 43.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 0.0 110.76 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.599 ' NE2' ' OD2' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -119.32 51.38 1.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.576 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -112.16 159.47 13.7 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -81.95 62.23 5.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.771 0.319 . . . . 0.0 110.62 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.702 ' HG ' ' CD1' ' A' ' 110' ' ' ILE . 77.4 p -93.95 -172.84 2.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.504 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 109' ' ' SER . 26.6 m-20 -131.65 20.78 4.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.619 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 87.8 p 177.4 91.42 0.01 OUTLIER 'General case' 0 C--O 1.244 0.787 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.983 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.702 ' CD1' ' HG ' ' A' ' 107' ' ' SER . 12.0 mt -115.96 128.43 73.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 120.772 0.32 . . . . 0.0 110.325 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -152.48 173.34 31.56 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -119.9 165.14 15.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.713 0.292 . . . . 0.0 110.475 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.656 ' NH1' ' OE1' ' A' ' 123' ' ' GLU . 5.6 ttm-85 -154.46 139.49 17.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.588 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.4 mm -134.07 114.02 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.517 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.7 m -117.93 138.0 52.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.656 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' A' ' 119' ' ' LYS . 30.4 m -140.62 148.78 21.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.732 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.446 ' C ' ' H ' ' A' ' 119' ' ' LYS . 34.1 m-20 44.97 26.57 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.73 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.99 -9.66 5.04 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.446 ' H ' ' C ' ' A' ' 117' ' ' ASP . 14.1 mttp -106.28 127.37 53.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.751 0.31 . . . . 0.0 110.363 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.76 130.95 32.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.929 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -105.85 -67.78 0.91 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.419 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -150.47 132.33 15.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.364 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.656 ' OE1' ' NH1' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -150.67 146.88 26.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.585 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -109.74 121.77 45.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.576 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' A' ' 125' ' ' VAL . 16.3 m -114.54 118.24 58.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.546 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.567 ' O ' ' O ' ' A' ' 110' ' ' ILE . 24.3 p -124.37 117.62 24.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.513 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' A' ' 127' ' ' ASN . 0.8 OUTLIER -99.57 129.85 45.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.414 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.05 145.09 21.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.681 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 m -70.3 -17.8 21.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.625 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -167.55 98.57 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.407 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.422 -179.922 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 27.3 mmm . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -110.18 123.12 49.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.45 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.537 ' CD2' ' C ' ' A' ' 53' ' ' LEU . 5.8 tt -95.79 115.79 27.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.214 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.33 139.52 53.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.704 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -119.82 149.83 41.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.018 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 1.08 ' HB2' ' HG ' ' A' ' 87' ' ' SER . 0.3 OUTLIER -154.44 134.75 13.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.983 0.421 . . . . 0.0 110.954 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.5 mm -97.76 170.32 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.587 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.498 ' CD1' ' N ' ' A' ' 59' ' ' GLY . 4.9 t80 -142.6 154.38 44.36 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.782 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.498 ' N ' ' CD1' ' A' ' 58' ' ' PHE . . . -168.48 173.97 43.19 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.589 ' O ' ' OG1' ' A' ' 63' ' ' THR . 1.3 Cg_endo -47.02 167.79 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 122.793 2.328 . . . . 0.0 111.936 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.33 117.63 5.18 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.857 2.371 . . . . 0.0 112.265 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.2 18.21 67.52 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.589 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 4.0 m -72.31 132.0 43.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.807 0.337 . . . . 0.0 110.607 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.433 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 5.2 m -108.03 122.93 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.578 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -141.34 155.92 45.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.295 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.45 126.98 42.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.621 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.6 mp -108.3 136.68 43.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.582 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.4 t -134.33 116.84 15.71 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.973 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.533 ' CG ' ' N ' ' A' ' 70' ' ' PHE . 50.5 t80 -143.96 165.08 28.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.753 0.311 . . . . 0.0 110.508 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.533 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 29.4 t80 -84.89 120.37 26.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.608 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -84.69 135.5 34.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.559 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.7 p -70.04 -15.25 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.69 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.643 ' O ' ' CB ' ' A' ' 74' ' ' SER . 3.9 t30 -78.81 -21.99 46.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.698 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.643 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 2.0 t 149.79 -104.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.567 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.617 ' N ' ' OG ' ' A' ' 74' ' ' SER . 0.4 OUTLIER -62.78 152.92 81.09 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.756 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -72.09 145.41 44.39 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.877 2.385 . . . . 0.0 112.289 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -102.74 144.48 31.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.32 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -144.87 138.37 26.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.952 0.406 . . . . 0.0 110.963 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.8 m -115.39 131.86 66.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.209 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.67 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -121.45 149.31 43.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.922 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 61.69 -6.59 0.21 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.598 ' H ' ' C ' ' A' ' 80' ' ' ASP . . . -63.94 134.42 55.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 0.0 110.573 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.536 ' O ' ' C ' ' A' ' 84' ' ' LEU . 3.6 m -47.5 -176.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.55 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.536 ' C ' ' O ' ' A' ' 83' ' ' VAL . 1.8 pt? -28.46 148.04 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.62 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -56.15 146.51 70.47 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.757 2.305 . . . . 0.0 112.233 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -112.29 -166.52 1.09 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.556 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 1.08 ' HG ' ' HB2' ' A' ' 56' ' ' GLU . 59.2 m -117.85 165.1 14.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.959 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.79 155.19 50.74 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.627 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.4 m80 -114.12 124.34 51.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.598 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mm -129.57 124.72 60.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.445 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 p -119.38 128.46 54.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.562 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.66 133.59 48.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.585 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -61.06 -7.3 2.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.618 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -73.51 -95.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.656 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 177.07 -92.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.234 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.68 121.31 29.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.319 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.86 155.75 37.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.785 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.78 146.32 52.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.263 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -130.89 162.12 23.47 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.12 114.64 22.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.707 0.289 . . . . 0.0 110.356 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.1 tt -133.33 140.38 47.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.706 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.6 p -142.21 146.8 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.584 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -129.85 144.32 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.664 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -125.7 76.84 1.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.498 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.96 160.9 13.26 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.555 ' O ' ' O ' ' A' ' 107' ' ' SER . 1.4 m-20 -79.47 13.58 1.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.743 0.306 . . . . 0.0 110.494 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.555 ' O ' ' O ' ' A' ' 106' ' ' ASN . 25.3 p -48.54 -170.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.578 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -104.35 -15.03 15.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.553 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.0 t -168.78 122.36 0.84 Allowed 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.982 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 126' ' ' SER . 11.2 mt -125.93 138.62 53.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.724 0.297 . . . . 0.0 110.49 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.7 160.38 31.01 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 31.8 p -118.52 155.08 31.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 0.0 110.678 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.31 144.51 22.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.662 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.3 mt -138.31 114.95 10.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.389 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.71 140.78 49.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.723 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.7 p -145.76 150.09 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.476 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.6 10.99 2.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.483 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 83.64 -3.48 85.07 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.457 ' HB3' ' NH2' ' A' ' 121' ' ' ARG . 13.8 tptm -121.21 137.33 54.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.775 0.321 . . . . 0.0 110.569 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.2 m -73.96 143.77 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.508 ' HE ' ' CA ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -111.7 -60.09 1.9 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.383 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.5 126.94 5.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.249 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -151.69 129.33 11.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.83 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.455 ' HA ' ' HE ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -98.02 115.71 28.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.326 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 74.2 t -114.99 117.55 56.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.687 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 110' ' ' ILE . 16.6 m -131.88 132.61 43.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.621 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.28 138.17 32.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.24 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -150.21 130.76 13.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.934 0.397 . . . . 0.0 110.831 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -93.71 122.03 44.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.432 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.437 ' N ' ' OD1' ' A' ' 130' ' ' ASN . 0.4 OUTLIER 70.9 39.86 0.99 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.685 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.362 179.874 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.5 mtp . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.526 ' H ' ' ND1' ' A' ' 52' ' ' HIS . 2.1 p-80 -91.1 128.15 36.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.22 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.7 tp -97.5 114.9 26.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.814 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.4 t -127.78 133.41 49.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.533 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.572 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -121.8 149.47 43.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 0.0 110.461 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 1.014 ' HB2' ' HG ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -155.52 143.66 20.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.808 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.525 ' O ' ' OE1' ' A' ' 56' ' ' GLU . 42.9 mm -111.22 167.81 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.917 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.42 173.57 10.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.013 0.435 . . . . 0.0 110.989 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.42 ' HA2' ' HG ' ' A' ' 107' ' ' SER . . . 166.47 157.57 10.4 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -43.64 155.58 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.495 2.13 . . . . 0.0 112.034 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -66.94 117.9 5.14 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.844 2.363 . . . . 0.0 112.27 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.85 3.78 58.04 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.406 HG21 ' ND2' ' A' ' 106' ' ' ASN . 98.9 m -86.77 139.94 30.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 0.0 110.739 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.4 ' N ' HG22 ' A' ' 63' ' ' THR . 2.4 m -106.78 131.41 56.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.389 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.94 149.34 50.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.649 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 104' ' ' GLN . 0.0 OUTLIER -99.14 121.8 41.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.44 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 77' ' ' GLN . 2.1 mp -108.14 125.78 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.566 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.5 t -127.62 116.26 20.05 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.032 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -151.38 170.85 18.54 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.806 0.336 . . . . 0.0 110.636 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.486 ' CE1' ' O ' ' A' ' 71' ' ' ASP . 52.1 t80 -84.19 133.11 34.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.737 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.486 ' O ' ' CE1' ' A' ' 70' ' ' PHE . 21.1 t0 -104.44 149.6 25.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.555 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.82 -33.76 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.684 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -80.47 11.35 3.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.632 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.58 47.55 10.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.503 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -149.38 96.8 3.62 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.45 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.25 139.61 90.89 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.453 2.102 . . . . 0.0 111.893 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 67' ' ' ILE . 11.9 mt-30 -107.84 132.09 53.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.755 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 -131.84 129.39 40.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.345 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.7 m -120.3 136.64 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.857 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.9 143.62 51.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.343 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 58.95 13.61 20.07 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.21 147.53 31.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.758 0.314 . . . . 0.0 110.642 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.565 ' O ' ' O ' ' A' ' 84' ' ' LEU . 4.1 p -52.25 165.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.424 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.565 ' O ' ' O ' ' A' ' 83' ' ' VAL . 0.3 OUTLIER -27.49 149.46 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.941 0.4 . . . . 0.0 110.813 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.59 141.01 94.11 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.902 2.401 . . . . 0.0 112.251 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -113.17 -168.88 1.39 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.547 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 1.014 ' HG ' ' HB2' ' A' ' 56' ' ' GLU . 59.6 m -115.34 155.44 27.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.008 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.405 ' C ' ' ND1' ' A' ' 89' ' ' HIS . 0.7 OUTLIER -135.21 151.24 50.44 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.22 178.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.759 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -125.61 127.35 46.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.006 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mt -130.81 134.58 61.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.343 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 m -120.96 131.5 54.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.498 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.542 ' O ' ' C ' ' A' ' 93' ' ' ASN . 91.8 m -117.14 135.06 54.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.529 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.542 ' C ' ' O ' ' A' ' 92' ' ' THR . 73.0 m-80 28.05 -93.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.641 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 92' ' ' THR . 11.1 t70 -172.33 76.25 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.688 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -171.62 167.09 6.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.6 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.67 151.1 46.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.293 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 93.0 t -153.12 151.21 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.0 0.428 . . . . 0.0 110.937 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -120.05 173.25 7.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.891 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.4 142.76 8.55 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.587 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -104.11 116.38 32.11 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.28 140.29 48.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.98 0.419 . . . . 0.0 111.039 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.1 148.99 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.263 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -135.83 135.02 39.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 110.696 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.418 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 7.6 mt-30 -127.77 83.95 2.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.608 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.62 163.91 14.92 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.59 ' C ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -78.71 49.6 0.91 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.854 0.359 . . . . 0.0 110.418 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.48 ' OG ' ' N ' ' A' ' 108' ' ' ASP . 28.9 t -92.94 -172.37 2.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.515 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.48 ' N ' ' OG ' ' A' ' 107' ' ' SER . 4.8 m-20 -97.62 -38.35 9.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.535 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.535 ' HB2' HD22 ' A' ' 127' ' ' ASN . 44.2 t -141.01 112.04 7.2 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.987 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 126' ' ' SER . 5.4 mt -112.63 123.02 67.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.856 0.36 . . . . 0.0 110.677 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -150.51 173.5 30.1 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 11.8 p -127.9 165.98 19.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.743 0.306 . . . . 0.0 110.494 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 18.4 mtm-85 -151.32 144.04 24.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.489 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.4 mm -127.79 115.97 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.568 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 81.8 p -122.0 122.01 38.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.465 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.65 150.86 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.764 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.9 t70 58.54 16.86 4.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.647 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.91 -1.6 10.03 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -117.52 137.86 52.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.596 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.413 ' O ' ' CG1' ' A' ' 120' ' ' VAL . 2.0 p -78.75 132.28 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.615 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.4 mtm-85 -123.46 -47.03 2.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.711 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -145.09 128.82 17.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.783 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -149.73 128.39 12.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.414 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.442 ' HG2' HH11 ' A' ' 124' ' ' ARG . 5.3 tpp85 -116.24 116.29 27.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.71 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.2 122.53 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.358 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 110' ' ' ILE . 65.6 m -126.53 124.63 40.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.733 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.535 HD22 ' HB2' ' A' ' 109' ' ' SER . 0.1 OUTLIER -95.65 131.61 41.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.465 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 108' ' ' ASP . 78.2 tt0 -153.73 134.2 13.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.572 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.4 t -93.13 123.39 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.549 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.72 44.77 10.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.46 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.463 -179.903 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.2 mmt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -114.91 125.33 53.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.546 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.66 117.24 34.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.397 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 t -126.2 142.13 51.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.009 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.63 148.49 43.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.023 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.474 ' C ' ' CD ' ' A' ' 56' ' ' GLU . 8.0 tm-20 -156.48 134.42 11.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.868 0.366 . . . . 0.0 111.047 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.63 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 9.7 tt -116.53 139.07 44.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.943 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.88 172.3 10.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.748 0.308 . . . . 0.0 110.766 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.41 -81.97 0.2 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.51 ' CB ' ' HG1' ' A' ' 63' ' ' THR . 10.0 Cg_endo -56.46 109.34 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.896 2.397 . . . . 0.0 111.97 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.8 96.39 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.531 2.154 . . . . 0.0 111.896 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.28 -16.7 16.02 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.51 ' HG1' ' CB ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -68.05 152.0 46.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.766 0.317 . . . . 0.0 110.401 179.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.0 m -101.21 123.58 54.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.818 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.21 155.54 46.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.335 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -95.29 121.9 37.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.75 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.52 138.0 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.333 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.2 t -134.15 125.96 29.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.965 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.601 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 12.6 t80 -137.45 152.74 49.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.848 0.356 . . . . 0.0 110.603 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.601 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 83.9 t80 -83.58 126.5 32.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.649 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.09 154.06 22.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.536 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.0 p -72.34 -32.03 40.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.799 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.58 ' O ' ' CB ' ' A' ' 74' ' ' SER . 1.8 p-10 -81.63 -7.4 59.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.945 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.58 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.5 t 86.58 86.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.822 0.344 . . . . 0.0 110.373 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 171.24 92.55 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.323 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -59.4 139.97 92.1 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.716 2.277 . . . . 0.0 112.147 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -106.06 140.56 38.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.417 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.8 ttp-105 -141.48 132.49 26.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.679 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.1 m -123.26 129.17 75.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.469 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -119.62 127.74 53.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.736 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.55 13.05 79.22 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.7 137.02 33.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 0.0 110.608 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.584 ' O ' ' O ' ' A' ' 84' ' ' LEU . 4.2 m -59.48 -167.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.442 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.584 ' O ' ' O ' ' A' ' 83' ' ' VAL . 0.3 OUTLIER -32.22 156.94 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.533 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.63 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 10.7 Cg_endo -56.84 159.43 14.38 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 123.006 2.471 . . . . 0.0 112.301 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -125.09 -164.23 1.27 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.531 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 99.1 p -135.43 153.78 51.67 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.962 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.2 mp -129.7 155.43 45.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.715 0.293 . . . . 0.0 110.583 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -109.84 120.23 41.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.636 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.6 mt -128.75 133.64 65.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.526 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.8 p -118.21 124.34 47.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.463 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.484 ' C ' ' H ' ' A' ' 94' ' ' ASP . 3.1 m -116.25 135.19 54.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.628 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -72.64 39.83 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.58 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.484 ' H ' ' C ' ' A' ' 92' ' ' THR . 33.2 t0 -122.16 -97.15 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.616 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 176.28 -78.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.582 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -102.14 125.57 48.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.404 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.44 HG11 ' N ' ' A' ' 98' ' ' MET . 93.5 t -148.63 155.58 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.419 . . . . 0.0 110.827 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.44 ' N ' HG11 ' A' ' 97' ' ' VAL . 7.8 mtt -127.59 179.25 5.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.315 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -158.87 153.79 24.9 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -113.07 121.84 45.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.748 0.309 . . . . 0.0 110.355 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 101' ' ' ILE . 9.7 tt -133.13 128.93 56.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.711 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.9 t -127.15 145.22 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.41 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -127.74 156.74 41.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.704 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -119.43 66.45 0.8 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.579 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 131' ' ' ALA . . . -119.1 157.93 15.12 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -93.45 83.01 4.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.808 0.337 . . . . 0.0 110.595 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.7 p -115.56 -166.93 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.406 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -124.55 10.2 8.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.593 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.5 p -170.72 105.0 0.26 Allowed 'General case' 0 C--O 1.242 0.71 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.867 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.55 ' O ' ' O ' ' A' ' 126' ' ' SER . 5.4 tt -132.09 136.63 56.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 120.683 0.278 . . . . 0.0 110.378 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.55 176.77 41.03 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 32.0 m -120.46 149.55 42.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.793 0.33 . . . . 0.0 110.391 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.2 mtp-105 -144.37 146.19 32.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.754 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.41 122.97 58.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.236 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.1 t -118.36 126.12 51.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.954 0.407 . . . . 0.0 110.787 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.9 p -136.48 138.99 46.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.333 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.431 ' C ' ' H ' ' A' ' 119' ' ' LYS . 14.2 t0 48.1 22.99 0.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.525 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.9 -7.42 9.53 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 117' ' ' ASP . 22.6 mttp -99.84 133.08 44.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.871 0.367 . . . . 0.0 110.651 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 p -67.36 141.34 17.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.418 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -118.02 -75.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.588 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -150.67 128.55 11.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.481 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -150.95 160.17 44.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.611 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -121.05 124.67 45.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.561 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.33 117.28 52.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.57 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.55 ' O ' ' O ' ' A' ' 110' ' ' ILE . 48.1 p -132.22 120.94 22.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.583 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.765 HD21 ' H ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -100.18 129.88 46.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.505 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.45 162.12 31.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.463 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.6 p -102.31 -8.49 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.561 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 130' ' ' ASN . 21.8 p30 -164.83 63.24 0.13 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.499 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 105' ' ' GLY . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.528 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.437 ' N ' ' HA ' ' A' ' 117' ' ' ASP . 4.6 ttt . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.92 128.82 56.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.293 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.583 ' CD1' ' C ' ' A' ' 53' ' ' LEU . 3.1 tm? -95.72 115.27 27.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 0.0 110.203 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.6 p -127.33 131.99 50.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.583 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -125.84 149.48 48.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.218 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -155.5 142.42 19.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.918 0.39 . . . . 0.0 110.845 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.437 HG22 ' N ' ' A' ' 58' ' ' PHE . 48.1 mm -109.6 165.78 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.187 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.69 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -143.77 149.34 36.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.9 0.381 . . . . 0.0 110.349 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.45 163.34 33.94 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -41.68 145.82 0.62 Allowed 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.685 2.257 . . . . 0.0 111.724 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.53 115.96 3.99 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.636 2.224 . . . . 0.0 112.294 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.35 2.66 50.84 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.56 ' O ' ' O ' ' A' ' 83' ' ' VAL . 7.9 m -86.54 141.21 29.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.788 0.327 . . . . 0.0 110.949 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.2 m -104.25 127.16 58.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.202 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.67 154.7 48.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.913 0.387 . . . . 0.0 110.889 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -107.81 121.54 44.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.7 mt -108.52 131.59 58.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.744 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.3 t -134.75 119.72 18.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.026 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.464 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 69.6 t80 -132.19 162.17 31.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.831 0.348 . . . . 0.0 110.724 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.464 ' O ' ' CE2' ' A' ' 69' ' ' TYR . 51.2 t80 -88.89 126.4 35.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.662 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -84.46 141.29 30.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.44 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.19 -23.94 29.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.712 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.629 ' O ' ' CB ' ' A' ' 74' ' ' SER . 7.2 t-20 -85.0 -13.35 50.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.762 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.629 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 6.0 p 92.18 15.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.64 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -125.08 78.89 66.18 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.411 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.3 139.06 20.67 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.507 2.138 . . . . 0.0 112.454 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -108.46 158.61 17.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.146 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -130.36 136.97 49.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.869 0.366 . . . . 0.0 110.83 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.405 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 14.7 p -119.28 118.13 56.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.18 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.16 136.16 54.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.585 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.44 7.95 61.5 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.87 139.0 55.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.748 0.308 . . . . 0.0 110.562 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.56 ' O ' ' O ' ' A' ' 63' ' ' THR . 2.1 t -70.94 -53.1 22.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.293 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.87 154.13 80.25 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.609 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -66.24 155.08 71.59 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 122.91 2.407 . . . . 0.0 112.101 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.553 ' CG ' ' N ' ' A' ' 87' ' ' SER . 43.1 t-105 -123.54 -161.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.265 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.553 ' N ' ' CG ' ' A' ' 86' ' ' TRP . 99.7 p -139.69 150.82 45.33 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 120.604 0.24 . . . . 0.0 110.993 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.5 tp -128.16 147.06 50.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.219 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.484 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -108.62 120.26 41.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.804 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.0 mt -130.53 128.93 64.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.6 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.5 m -111.06 122.87 48.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.283 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.538 ' O ' ' C ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -124.7 130.62 52.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.816 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.538 ' C ' ' O ' ' A' ' 92' ' ' THR . 1.3 p30 24.31 -120.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.89 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -163.36 88.41 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.469 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -174.44 -159.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.549 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.57 119.56 24.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.374 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.2 t -114.39 142.19 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.796 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.4 ptp -128.29 166.02 19.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.005 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.94 145.77 12.62 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -116.08 115.11 25.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.349 . . . . 0.0 110.261 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.9 tt -132.41 135.28 58.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.61 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 93.7 t -128.03 150.24 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.463 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -122.81 140.93 52.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.39 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -118.93 77.74 1.21 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.667 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.01 159.66 23.1 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -82.16 46.6 1.04 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.85 0.357 . . . . 0.0 110.497 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 72.4 p -80.01 -174.66 4.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.577 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -124.77 9.97 8.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.59 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.1 t -171.09 122.48 0.57 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.936 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.583 ' O ' ' O ' ' A' ' 126' ' ' SER . 15.6 mt -142.23 152.47 18.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 120.824 0.345 . . . . 0.0 110.404 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.402 ' N ' ' CG2' ' A' ' 110' ' ' ILE . . . -176.59 158.68 25.01 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.654 ' SG ' ' O ' ' A' ' 124' ' ' ARG . 0.5 OUTLIER -118.03 167.76 11.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 0.0 110.674 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -159.39 123.95 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.312 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.3 mm -125.37 112.61 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.926 0.393 . . . . 0.0 110.782 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.78 135.62 55.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.458 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 t -118.79 150.8 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.559 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.437 ' HA ' ' N ' ' A' ' 51' ' ' MET . 37.4 t70 51.88 24.21 2.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.585 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.27 4.99 39.76 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -110.4 138.84 46.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.875 0.369 . . . . 0.0 110.69 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.4 p -86.17 119.34 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.502 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.5 -35.85 2.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.304 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.81 127.04 5.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.499 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -151.56 145.66 25.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.439 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.654 ' O ' ' SG ' ' A' ' 112' ' ' CYS . 1.8 ttt180 -116.36 123.44 47.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.699 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.0 p -138.95 116.25 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.619 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.583 ' O ' ' O ' ' A' ' 110' ' ' ILE . 51.4 m -133.81 121.74 22.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.443 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.95 137.32 36.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 110.773 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -155.01 134.02 12.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.333 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.2 t -68.1 129.52 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.559 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 40.32 69.78 0.29 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.402 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.488 -179.919 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 12.4 mtm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -96.86 127.62 43.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.407 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.1 tt -96.84 115.79 28.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.594 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.93 137.23 53.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.674 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.454 ' OH ' ' CD2' ' A' ' 69' ' ' TYR . 23.8 p90 -120.07 149.56 42.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.979 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.473 ' CG ' ' N ' ' A' ' 57' ' ' ILE . 26.0 tt0 -155.59 156.03 34.35 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.34 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.485 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -115.85 175.74 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.956 179.296 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.63 145.61 36.85 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.028 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -168.66 160.45 33.95 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -43.48 155.59 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.707 2.272 . . . . 0.0 112.147 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.0 114.51 3.41 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.729 2.286 . . . . 0.0 112.053 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.02 15.49 30.72 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.3 m -79.31 139.06 37.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.829 0.347 . . . . 0.0 110.638 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.2 m -109.76 123.06 65.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.447 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.46 154.22 44.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.786 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.28 115.59 27.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.374 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.3 mm -102.05 121.59 53.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.587 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.3 t -135.59 120.3 18.36 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.916 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.454 ' CD2' ' OH ' ' A' ' 55' ' ' TYR . 22.7 p90 -141.26 158.05 44.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.869 0.366 . . . . 0.0 110.7 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -83.5 136.57 34.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.27 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.18 137.71 41.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.579 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.8 t -62.34 -18.69 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.4 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.554 ' O ' ' OG ' ' A' ' 74' ' ' SER . 3.0 m-20 -89.31 -0.19 57.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.696 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.554 ' OG ' ' O ' ' A' ' 73' ' ' ASN . 7.9 p 73.44 40.82 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.573 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -154.05 91.35 3.17 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.48 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.94 141.55 15.06 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.749 2.299 . . . . 0.0 112.315 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -107.24 147.97 29.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.478 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.431 ' NH1' ' HG3' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -135.91 133.09 37.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.676 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.7 t -112.88 118.87 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.66 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.1 116.61 32.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.376 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.27 20.87 16.56 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.43 153.86 25.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.368 . . . . 0.0 110.617 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.18 -39.49 8.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.374 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.63 152.48 28.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.5 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.485 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 19.8 Cg_endo -61.42 150.45 85.0 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.943 2.429 . . . . 0.0 112.363 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -128.75 -172.45 2.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.458 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 97.3 p -127.81 155.04 44.72 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.041 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.8 mp -130.99 148.19 52.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.859 0.361 . . . . 0.0 110.942 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.571 ' O ' ' CG ' ' A' ' 89' ' ' HIS . 6.5 p80 -110.16 124.23 51.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.017 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.9 mt -129.01 134.79 63.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.926 0.394 . . . . 0.0 110.932 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.17 122.95 46.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.322 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.591 ' O ' ' N ' ' A' ' 94' ' ' ASP . 2.2 m -126.96 128.16 45.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.768 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.526 ' C ' ' O ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -29.2 -37.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.555 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 92' ' ' THR . 1.6 m-20 -66.03 -135.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.684 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.45 -35.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.385 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.72 137.45 52.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.558 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.0 t -150.09 124.28 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.581 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 5.5 mtt -96.55 131.31 43.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.605 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.23 146.79 18.88 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.505 ' O ' ' CG ' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -102.79 116.51 32.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.791 0.329 . . . . 0.0 110.453 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.0 tt -133.12 136.89 54.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.641 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.7 t -139.75 149.29 22.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.433 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -126.77 148.22 49.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.639 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -133.51 46.16 2.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.537 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -99.3 163.81 20.1 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.87 36.58 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.745 0.307 . . . . 0.0 110.535 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.431 ' H ' ' C ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -65.25 -167.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.646 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -122.78 -25.15 4.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.582 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.8 t -144.5 88.26 1.92 Allowed 'General case' 0 C--O 1.243 0.752 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.026 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 6.1 mt -100.6 149.2 6.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 120.833 0.349 . . . . 0.0 110.486 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.84 164.32 29.98 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 9.3 p -125.82 152.87 44.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.78 0.324 . . . . 0.0 110.698 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.06 141.11 24.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.491 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.9 mm -115.76 133.01 63.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.717 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.3 p -122.67 121.08 35.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.471 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.97 129.05 75.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.666 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.24 17.29 1.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.404 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 88.1 -8.57 77.87 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -101.45 147.5 26.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.322 . . . . 0.0 110.68 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.29 128.5 37.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.624 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.44 ' HB3' HH11 ' A' ' 121' ' ' ARG . 0.0 OUTLIER -107.66 -65.53 1.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.401 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -149.34 127.28 11.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.042 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.31 130.27 12.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.036 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -111.97 115.6 29.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.918 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.58 124.93 72.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.054 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.4 m -127.6 126.28 41.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.04 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.09 129.22 40.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.008 0.432 . . . . 0.0 110.837 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -157.32 130.57 7.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.231 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.49 116.3 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.452 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.508 ' O ' ' CG ' ' A' ' 130' ' ' ASN . 4.7 t30 59.94 69.72 0.68 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.417 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.596 -179.817 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -116.0 128.79 56.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.341 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.493 ' CD1' ' O ' ' A' ' 53' ' ' LEU . 3.3 pp -96.27 120.51 36.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.928 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.58 133.95 50.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.68 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -120.86 149.59 42.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.378 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 1.072 ' HB2' ' HG ' ' A' ' 87' ' ' SER . 1.8 tm-20 -155.4 144.68 20.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.97 0.414 . . . . 0.0 110.923 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.461 HG22 HD13 ' A' ' 57' ' ' ILE . 34.6 mm -116.11 153.39 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.11 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.528 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -140.22 163.68 32.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.05 0.452 . . . . 0.0 111.04 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.34 171.23 43.49 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.505 ' O ' ' OG1' ' A' ' 63' ' ' THR . 53.9 Cg_exo -46.91 153.43 1.4 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.654 2.236 . . . . 0.0 111.985 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -64.68 119.59 6.66 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.721 2.281 . . . . 0.0 112.039 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.24 5.34 62.21 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 33.0 m -69.37 144.66 53.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 0.0 110.604 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 p -119.49 122.1 68.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.48 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.11 155.31 44.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.705 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.72 115.22 30.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.115 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 mp -90.36 127.7 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.829 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.4 t -128.13 116.06 19.36 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.021 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.512 ' CZ ' ' OD1' ' A' ' 71' ' ' ASP . 2.9 p90 -146.04 148.8 33.07 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.236 0.335 . . . . 0.0 110.413 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -88.13 121.37 30.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.379 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.512 ' OD1' ' CZ ' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -82.93 144.81 29.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.541 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.5 p -55.47 -11.02 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.95 0.405 . . . . 0.0 110.177 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 74' ' ' SER . 35.4 t30 -92.54 -8.97 42.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.417 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.563 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.5 p 85.24 3.74 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.423 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -114.29 95.82 40.51 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.52 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -79.38 139.54 14.68 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.552 2.168 . . . . 0.0 112.072 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -107.93 151.06 26.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -128.82 134.03 48.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.467 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.0 m -105.96 129.43 59.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.587 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 5.8 p-10 -111.98 132.88 54.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.697 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.16 28.65 63.82 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.51 147.63 52.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.799 0.333 . . . . 0.0 110.673 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.421 HG11 ' N ' ' A' ' 84' ' ' LEU . 10.0 p -100.3 -30.8 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.503 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.421 ' N ' HG11 ' A' ' 83' ' ' VAL . 2.6 tp -170.26 114.76 0.48 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.415 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -55.75 162.25 6.97 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.095 1.863 . . . . 0.0 111.895 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.465 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 7.1 m-90 -126.09 -150.7 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.558 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 1.072 ' HG ' ' HB2' ' A' ' 56' ' ' GLU . 59.1 m -121.87 165.5 15.81 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.004 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.78 150.18 35.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.783 0.325 . . . . 0.0 110.821 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -110.16 119.54 39.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.375 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.1 mt -126.57 135.53 63.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.627 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.41 123.41 48.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.598 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.55 ' O ' ' C ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -132.3 155.58 48.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.399 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.55 ' C ' ' O ' ' A' ' 92' ' ' THR . 3.4 p30 -26.73 124.06 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.668 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 93' ' ' ASN . 0.3 OUTLIER -32.08 98.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.449 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 93' ' ' ASN . . . 167.35 143.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.361 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.4 126.38 29.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.703 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.98 131.57 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.416 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.569 ' SD ' ' CB ' ' A' ' 122' ' ' ALA . 6.3 mtm -96.37 137.17 35.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.651 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.29 162.45 19.91 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -111.63 115.81 29.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.312 . . . . 0.0 110.64 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.1 tt -132.82 141.41 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.445 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.2 155.97 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 110.753 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -136.52 146.46 46.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.322 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -120.31 31.99 6.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.738 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.59 156.6 26.89 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -85.89 78.58 9.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.773 0.321 . . . . 0.0 110.405 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.6 m -107.5 179.18 4.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.637 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.56 -12.03 15.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.685 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.9 p -167.55 100.0 0.49 Allowed 'General case' 0 C--O 1.243 0.721 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.005 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' A' ' 110' ' ' ILE . 12.5 tt -132.36 132.27 60.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.846 0.355 . . . . 0.0 110.696 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -153.29 175.89 31.54 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 1.7 p -124.32 156.75 36.44 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.725 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -160.95 139.58 10.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.428 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.5 mp -126.94 118.0 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.906 0.384 . . . . 0.0 110.765 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.7 t -116.83 128.3 55.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.3 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.9 t -121.0 155.81 24.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.818 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 58.44 14.34 2.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.597 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.5 9.47 78.03 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -116.51 140.07 49.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.774 0.321 . . . . 0.0 110.56 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.89 132.41 33.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.43 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -129.33 -74.94 0.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.573 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.569 ' CB ' ' SD ' ' A' ' 98' ' ' MET . . . -125.47 129.0 48.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.679 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -149.49 133.06 16.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.637 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.9 mmt-85 -105.97 119.93 40.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.481 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 84.9 t -113.05 116.24 52.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.73 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.7 m -133.94 117.04 16.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.144 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.437 ' ND2' ' N ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -114.53 129.55 56.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.838 0.352 . . . . 0.0 110.877 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -154.97 130.62 9.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.42 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.7 t -85.56 139.26 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.756 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 60.76 42.52 13.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.697 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.491 179.8 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.404 ' H2 ' ' CG2' ' A' ' 116' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -97.41 118.24 33.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.214 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.484 ' C ' ' CD1' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -96.0 115.2 27.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.767 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.444 ' N ' HD13 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -127.32 130.48 49.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.493 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.5 ' OH ' ' CZ ' ' A' ' 69' ' ' TYR . 33.0 p90 -119.97 148.71 43.2 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.274 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.847 ' HB2' ' HG ' ' A' ' 87' ' ' SER . 1.7 tm-20 -156.05 136.43 13.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.9 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.513 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 4.2 mp -99.15 167.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.745 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.404 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -132.79 163.65 28.59 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.145 -179.576 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.98 142.65 4.98 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -41.79 155.92 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.513 2.142 . . . . 0.0 112.202 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.07 134.77 28.1 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.76 2.306 . . . . 0.0 112.188 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.84 -4.16 71.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.56 ' O ' ' O ' ' A' ' 83' ' ' VAL . 15.7 m -86.64 130.84 34.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.0 110.723 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.36 126.11 60.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.428 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -136.72 152.85 50.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.661 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -106.45 116.56 32.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.361 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 mp -96.3 131.7 42.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.5 t -134.69 123.84 24.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.003 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.5 ' CZ ' ' OH ' ' A' ' 55' ' ' TYR . 37.3 p90 -151.48 170.76 18.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.909 0.385 . . . . 0.0 110.624 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.64 ' CE1' ' O ' ' A' ' 74' ' ' SER . 27.3 t80 -88.74 134.55 33.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.29 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 73' ' ' ASN . 0.9 OUTLIER -109.48 141.57 41.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.831 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.443 ' O ' ' CG1' ' A' ' 72' ' ' VAL . 17.2 t -52.73 -11.44 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.328 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.629 ' O ' ' CB ' ' A' ' 74' ' ' SER . 49.8 m-80 -83.86 1.26 44.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.461 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.64 ' O ' ' CE1' ' A' ' 70' ' ' PHE . 0.9 OUTLIER 92.27 -75.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.763 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.85 135.34 86.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.583 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.15 143.57 28.75 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.554 2.169 . . . . 0.0 112.133 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -104.12 135.97 44.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.392 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.8 125.93 24.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.861 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.2 m -109.07 127.14 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.425 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.664 ' OD1' ' N ' ' A' ' 81' ' ' GLY . 13.1 t0 -126.39 150.35 48.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.866 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.664 ' N ' ' OD1' ' A' ' 80' ' ' ASP . . . 85.21 12.19 74.08 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.37 140.63 30.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.746 0.308 . . . . 0.0 110.632 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.56 ' O ' ' O ' ' A' ' 63' ' ' THR . 1.5 p -81.66 -33.77 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.473 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.25 152.51 64.53 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.479 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.513 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 20.5 Cg_endo -62.41 160.48 31.35 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.888 2.392 . . . . 0.0 112.066 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.573 ' CD1' ' N ' ' A' ' 86' ' ' TRP . 10.5 m95 -123.6 172.65 8.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.395 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.847 ' HG ' ' HB2' ' A' ' 56' ' ' GLU . 70.5 m -114.83 144.8 42.94 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.032 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 89' ' ' HIS . 0.6 OUTLIER -131.35 141.02 49.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.853 0.358 . . . . 0.0 110.778 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.608 ' N ' ' CD2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -108.59 123.29 48.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.305 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.3 mt -129.35 124.17 59.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.932 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.506 ' H ' ' HG1' ' A' ' 91' ' ' THR . 0.1 OUTLIER -111.21 123.27 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.212 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.6 m -126.38 133.67 51.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 110.98 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.558 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 26.0 t-20 39.69 32.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.983 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.536 ' C ' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER 28.8 59.68 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.612 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.45 -146.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.385 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -119.47 123.29 43.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.5 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.2 p -159.71 139.7 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.645 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.51 177.66 5.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.649 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -138.14 162.73 25.68 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.527 ' N ' ' ND2' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -118.81 116.51 26.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.699 0.285 . . . . 0.0 110.561 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -133.33 142.54 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.805 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 98.5 t -121.97 146.66 26.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.206 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -140.08 138.86 35.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.959 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -131.39 102.28 5.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.208 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -131.04 163.83 23.42 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -78.97 19.69 0.52 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.853 0.359 . . . . 0.0 110.274 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.444 ' H ' ' C ' ' A' ' 105' ' ' GLY . 6.1 p -69.04 -171.72 0.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.64 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.83 8.23 12.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.675 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.0 p -172.79 104.84 0.15 Allowed 'General case' 0 C--O 1.242 0.686 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 126' ' ' SER . 2.9 mt -126.55 136.93 59.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 120.807 0.337 . . . . 0.0 110.341 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.54 175.98 41.8 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -126.18 167.54 15.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.762 0.315 . . . . 0.0 110.603 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -157.43 140.36 15.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.437 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.455 HD11 ' N ' ' A' ' 114' ' ' ILE . 3.6 mp -124.42 114.99 43.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.689 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.54 123.88 41.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.429 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.619 ' C ' ' H ' ' A' ' 118' ' ' GLY . 10.8 p -135.15 151.22 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.706 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 117' ' ' ASP . 13.2 t70 53.03 2.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.579 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.619 ' H ' ' C ' ' A' ' 116' ' ' VAL . . . 88.53 9.37 69.29 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -123.77 127.92 48.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.723 0.297 . . . . 0.0 110.629 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.5 p -80.03 136.47 23.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.425 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.38 -52.91 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.877 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -150.86 128.31 11.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.602 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.74 126.79 9.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.806 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -96.0 118.87 33.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.406 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.0 t -121.0 116.59 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.83 0.348 . . . . 0.0 110.885 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.57 ' C ' HD21 ' A' ' 127' ' ' ASN . 0.3 OUTLIER -134.03 116.09 15.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.456 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.768 ' N ' HD21 ' A' ' 127' ' ' ASN . 0.6 OUTLIER -100.16 132.51 45.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.569 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -136.25 138.66 42.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.502 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 26.4 m -68.22 -6.14 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.588 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -161.6 92.64 0.88 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.615 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.489 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.6 mtt . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -92.76 129.03 38.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.461 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 tt -95.63 118.02 31.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.513 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.3 135.08 51.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.596 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.538 ' HH ' ' CD2' ' A' ' 88' ' ' LEU . 1.2 p90 -120.34 148.62 43.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.409 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.776 ' HB2' ' HG ' ' A' ' 87' ' ' SER . 0.3 OUTLIER -156.38 138.58 14.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.8 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.449 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 1.3 mm -105.95 174.73 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.905 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -133.36 171.94 13.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.991 0.424 . . . . 0.0 110.963 -179.591 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.86 147.13 5.07 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -39.16 152.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.758 2.306 . . . . 0.0 112.171 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -67.18 123.86 11.43 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.781 2.321 . . . . 0.0 112.151 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.87 -7.76 60.99 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -69.99 134.89 48.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.743 0.306 . . . . 0.0 110.493 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.9 t -111.7 125.71 69.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.632 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -141.13 155.37 46.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.371 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -98.9 123.15 42.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.717 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 52.2 mt -102.74 124.15 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.433 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 42.1 t -122.32 117.51 26.26 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.059 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.597 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 35.9 t80 -143.35 158.31 43.75 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.79 0.329 . . . . 0.0 110.489 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.597 ' O ' ' CE2' ' A' ' 69' ' ' TYR . 68.1 t80 -85.31 134.68 34.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.572 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' A' ' 73' ' ' ASN . 27.9 t0 -103.94 126.12 50.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.611 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.5 t -62.29 -5.49 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.687 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.647 ' O ' ' CB ' ' A' ' 74' ' ' SER . 63.3 m-20 -85.72 -22.32 27.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.615 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.647 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 2.3 p 146.24 -99.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.547 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.99 147.64 98.35 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.65 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.58 154.9 50.06 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.719 2.28 . . . . 0.0 112.152 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -90.25 149.37 22.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.396 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ttp85 -152.59 133.17 13.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.737 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.05 136.66 52.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.414 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.537 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 1.0 OUTLIER -127.36 121.62 31.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.709 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.36 26.78 32.26 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.33 128.31 34.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.752 0.311 . . . . 0.0 110.626 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.4 t -67.87 -31.56 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.496 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -161.54 156.5 20.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.491 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.449 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 11.6 Cg_endo -57.01 149.17 63.93 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.893 2.396 . . . . 0.0 112.282 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -120.6 -178.0 3.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.29 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.776 ' HG ' ' HB2' ' A' ' 56' ' ' GLU . 74.9 m -120.49 141.7 49.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.005 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.538 ' CD2' ' HH ' ' A' ' 55' ' ' TYR . 0.4 OUTLIER -128.37 139.61 52.29 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.596 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.659 ' H ' ' ND1' ' A' ' 89' ' ' HIS . 2.1 p-80 -114.83 127.79 55.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 0.0 110.963 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.405 HD12 HG21 ' A' ' 90' ' ' ILE . 96.4 mt -127.62 134.48 65.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.155 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -103.69 122.74 45.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.601 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.649 ' C ' ' H ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER -127.83 135.12 49.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.665 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 93' ' ' ASN . 0.5 OUTLIER -67.94 24.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.296 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.649 ' H ' ' C ' ' A' ' 92' ' ' THR . 2.2 t70 -114.07 0.87 14.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.536 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 60.7 -84.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.632 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.03 113.5 21.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.501 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.61 160.59 24.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.679 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.443 ' CG ' ' N ' ' A' ' 99' ' ' GLY . 4.3 ttt -130.15 158.21 40.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.381 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.443 ' N ' ' CG ' ' A' ' 98' ' ' MET . . . -156.38 152.3 23.7 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -110.47 117.46 33.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.864 0.364 . . . . 0.0 110.445 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.9 tt -132.08 137.48 54.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.535 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.2 t -138.05 149.93 24.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.554 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -120.79 150.24 41.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.58 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -135.59 79.46 1.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.646 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -131.64 161.24 23.69 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.582 ' N ' ' ND2' ' A' ' 106' ' ' ASN . 0.4 OUTLIER -79.07 28.57 0.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.84 0.352 . . . . 0.0 110.405 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.46 ' H ' ' HG ' ' A' ' 107' ' ' SER . 0.0 OUTLIER -62.96 -166.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.598 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 108' ' ' ASP . 1.4 m-20 -114.75 -28.25 7.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.668 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.4 t -141.74 126.68 18.26 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.898 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.509 ' O ' ' O ' ' A' ' 126' ' ' SER . 23.0 mt -135.67 154.1 34.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.412 ' N ' ' CG2' ' A' ' 110' ' ' ILE . . . 174.69 159.23 20.59 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 124' ' ' ARG . 5.7 p -117.93 161.46 19.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.766 0.317 . . . . 0.0 110.339 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -161.3 136.87 7.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.664 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.1 mt -127.5 122.77 60.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.416 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.45 139.6 51.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.53 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.6 m -133.06 135.27 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.682 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 53.23 30.65 10.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.67 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.98 -1.58 23.22 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -109.31 136.01 49.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.331 . . . . 0.0 110.556 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.9 t -77.54 128.7 38.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.779 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.95 -63.91 1.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.379 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.93 127.21 45.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -149.38 131.83 15.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.993 0.425 . . . . 0.0 111.066 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.475 ' O ' ' SG ' ' A' ' 112' ' ' CYS . 3.0 ttp180 -121.48 115.52 23.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.897 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.524 ' O ' ' CG2' ' A' ' 125' ' ' VAL . 1.1 m -111.16 125.59 68.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.907 0.384 . . . . 0.0 111.025 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.7 OUTLIER -131.46 115.93 16.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.016 179.473 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -101.81 131.01 48.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.885 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -156.63 136.64 12.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.613 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 20.4 t -88.99 140.95 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.568 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 46.02 53.75 8.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.272 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.631 -179.935 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.3 mtm . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -114.88 128.74 56.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.465 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.444 ' CD2' ' O ' ' A' ' 97' ' ' VAL . 14.5 tp -96.13 114.86 26.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.449 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.5 p -127.78 129.95 47.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.563 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.456 ' CD1' ' C ' ' A' ' 55' ' ' TYR . 26.0 p90 -123.47 148.33 46.31 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.474 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.748 ' HB2' ' HG ' ' A' ' 87' ' ' SER . 10.4 tt0 -156.65 133.53 10.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.777 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.563 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 1.9 mp -98.76 158.31 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.854 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.49 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -132.3 166.26 22.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.912 0.387 . . . . 0.0 110.781 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.66 163.16 19.88 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.06 109.61 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.655 2.237 . . . . 0.0 112.119 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -45.79 141.87 8.17 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.517 2.145 . . . . 0.0 112.008 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.53 -13.31 56.75 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.6 p -83.03 137.76 34.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.716 0.293 . . . . 0.0 110.56 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.9 m -103.31 132.37 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.739 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.49 153.83 43.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.306 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -97.27 114.88 26.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.623 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.456 ' N ' HD13 ' A' ' 67' ' ' ILE . 1.8 mp -87.71 122.67 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.583 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.4 t -130.26 116.28 18.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.98 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.61 ' CZ ' ' O ' ' A' ' 70' ' ' PHE . 16.3 t80 -149.86 149.43 30.47 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.822 0.344 . . . . 0.0 110.575 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.61 ' O ' ' CZ ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -84.71 130.53 34.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.389 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.67 ' OD1' ' N ' ' A' ' 72' ' ' VAL . 67.9 t0 -93.87 146.38 23.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.802 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.67 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 89.7 t -69.59 -34.3 60.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.46 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -81.01 11.76 3.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.761 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.9 m 61.49 71.4 0.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.61 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.461 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 3.2 tt0 -178.66 77.73 0.22 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.379 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.66 144.25 99.47 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.96 2.44 . . . . 0.0 112.177 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -107.66 134.85 50.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.382 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 mtm-85 -134.08 126.92 31.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.922 0.391 . . . . 0.0 110.656 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 t -115.94 119.77 62.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.513 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -108.51 121.6 45.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.566 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.21 15.38 38.68 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.72 130.59 43.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 0.0 110.648 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.3 t -73.47 -35.17 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.294 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.407 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -149.76 157.36 38.35 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.507 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.563 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 18.6 Cg_endo -61.33 157.08 42.3 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.989 2.459 . . . . 0.0 112.107 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -129.26 176.93 7.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.356 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.748 ' HG ' ' HB2' ' A' ' 56' ' ' GLU . 59.7 m -114.19 161.58 17.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.98 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.0 tp -147.98 134.97 20.24 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.244 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -109.15 126.36 53.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.841 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.415 HD11 ' N ' ' A' ' 90' ' ' ILE . 4.6 mp -130.46 136.79 57.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.388 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.6 p -122.63 130.03 52.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.524 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.676 ' O ' ' N ' ' A' ' 94' ' ' ASP . 2.0 m -113.3 156.11 23.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.696 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.551 ' O ' ' C ' ' A' ' 94' ' ' ASP . 11.2 t30 -28.59 84.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.786 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.676 ' N ' ' O ' ' A' ' 92' ' ' THR . 10.3 m-20 23.6 92.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.707 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 172.06 140.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.652 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.5 140.01 33.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.234 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.444 ' O ' ' CD2' ' A' ' 53' ' ' LEU . 9.2 p -150.86 142.97 16.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 110.888 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.547 ' N ' ' SD ' ' A' ' 98' ' ' MET . 3.1 mmt -93.31 161.13 14.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.129 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.43 154.7 20.99 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.383 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.433 HD21 ' N ' ' A' ' 100' ' ' ASN . 1.5 m-80 -109.92 115.38 29.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.681 0.277 . . . . 0.0 110.263 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.4 tt -131.96 142.38 43.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.957 0.408 . . . . 0.0 110.981 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.0 t -139.98 145.82 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.357 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -143.51 151.73 40.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.763 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.46 103.89 7.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.529 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.58 161.71 23.7 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.521 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.8 OUTLIER -82.87 54.92 2.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 0.0 110.574 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.27 -167.13 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.45 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -118.24 -10.94 10.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.618 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 t -154.84 102.41 2.35 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.56 ' O ' ' O ' ' A' ' 126' ' ' SER . 3.7 mt -127.23 127.06 68.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.854 0.359 . . . . 0.0 110.3 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.04 172.26 33.95 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.564 ' O ' ' O ' ' A' ' 124' ' ' ARG . 31.6 p -125.08 161.53 26.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.768 0.318 . . . . 0.0 110.694 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -156.41 147.04 21.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.496 179.799 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.8 mp -121.57 117.18 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 110.82 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.78 129.4 51.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.284 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.531 ' C ' ' H ' ' A' ' 118' ' ' GLY . 27.3 m -136.5 144.49 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.917 0.389 . . . . 0.0 110.969 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' A' ' 117' ' ' ASP . 21.7 t0 44.93 13.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.84 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 116' ' ' VAL . . . 83.64 -2.25 87.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 116' ' ' VAL . 4.6 ttmt -102.99 126.07 50.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.387 . . . . 0.0 110.396 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 20.9 t -80.86 140.33 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.631 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.415 ' NH1' ' HG3' ' A' ' 121' ' ' ARG . 1.7 mmm-85 -128.87 -48.94 1.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.497 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.91 135.99 9.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.535 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -149.54 155.9 41.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.502 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.564 ' O ' ' O ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -124.61 116.13 21.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.517 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.5 t -121.26 117.25 52.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.567 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.56 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.6 OUTLIER -130.54 121.75 26.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.588 -179.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.477 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -94.53 129.84 41.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.241 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -132.25 139.98 48.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.812 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.25 -8.98 12.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.413 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 178.93 82.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.41 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.675 -179.799 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.616 ' SD ' ' OD1' ' A' ' 117' ' ' ASP . 41.7 mtm . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.17 129.14 55.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.453 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.444 ' CD2' ' C ' ' A' ' 53' ' ' LEU . 7.0 tt -95.52 114.79 26.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.962 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.33 135.76 50.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 55' ' ' TYR . 26.8 p90 -130.13 149.3 51.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.096 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.981 ' OE1' ' OG ' ' A' ' 87' ' ' SER . 15.5 tt0 -155.64 150.72 26.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.963 0.411 . . . . 0.0 111.079 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.408 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 7.1 tt -112.1 163.21 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.887 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.642 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -139.96 165.08 28.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 110.993 -179.469 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.6 171.37 44.33 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -47.85 112.74 0.61 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.716 2.277 . . . . 0.0 111.976 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -44.62 146.79 2.01 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.431 2.087 . . . . 0.0 112.267 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.78 -10.7 59.2 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.411 HG21 ' N ' ' A' ' 64' ' ' VAL . 24.1 m -79.37 139.18 37.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 110.661 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.411 ' N ' HG21 ' A' ' 63' ' ' THR . 9.7 t -102.48 122.95 55.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.496 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.87 140.96 36.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.695 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -101.04 116.07 31.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.31 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.9 tt -102.06 138.4 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.81 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.2 t -124.48 118.67 27.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.949 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -128.19 167.12 17.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.756 0.312 . . . . 0.0 110.55 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -99.62 134.83 41.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.313 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -95.75 139.14 32.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.68 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -54.91 -29.77 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.549 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.577 ' N ' HD21 ' A' ' 73' ' ' ASN . 1.6 m120 -84.19 2.93 37.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.523 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.563 ' HG ' ' C ' ' A' ' 73' ' ' ASN . 0.7 OUTLIER 76.99 10.1 2.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.508 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -110.43 91.39 11.78 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.401 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.92 139.83 17.73 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.624 2.216 . . . . 0.0 112.309 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -107.83 158.35 17.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.592 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -145.58 126.35 14.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.624 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.0 m -108.21 135.57 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.499 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -128.96 132.96 47.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.74 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.31 17.65 42.02 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.87 149.44 36.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.837 0.351 . . . . 0.0 110.754 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.35 -42.43 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.302 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.49 154.07 56.1 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.187 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.28 147.37 47.39 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 122.96 2.44 . . . . 0.0 112.266 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.534 ' CD1' ' N ' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -114.23 -162.75 0.83 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.256 179.709 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.981 ' OG ' ' OE1' ' A' ' 56' ' ' GLU . 70.3 m -116.59 153.53 32.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.986 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 mt -128.23 141.74 51.37 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.737 0.303 . . . . 0.0 110.506 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.34 119.92 40.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.509 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.45 HG23 HD11 ' A' ' 90' ' ' ILE . 26.2 mm -126.7 121.55 58.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.75 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 p -105.38 122.48 46.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.344 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.2 m -122.08 149.25 43.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.716 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -86.83 31.31 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.454 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.575 ' C ' ' H ' ' A' ' 96' ' ' ALA . 32.8 m-20 -114.52 -4.07 12.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.548 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 70.77 -28.52 0.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.713 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.575 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -156.62 138.15 14.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.701 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.3 p -174.9 144.7 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.429 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -104.3 154.3 19.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.777 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -122.02 159.03 16.7 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.25 122.13 46.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.719 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.8 pt -132.53 139.52 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.531 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 103' ' ' ALA . 75.0 t -123.43 159.31 28.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.349 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.439 ' N ' ' CG1' ' A' ' 102' ' ' VAL . . . -131.05 152.08 50.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.982 0.42 . . . . 0.0 110.612 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.91 64.05 1.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.328 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.455 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -130.97 163.99 23.35 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.7 20.39 0.45 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 0.0 110.558 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.603 ' OG ' ' N ' ' A' ' 108' ' ' ASP . 6.0 t -53.47 -173.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.626 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.603 ' N ' ' OG ' ' A' ' 107' ' ' SER . 37.4 t0 -119.61 -73.44 0.64 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.615 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.691 ' OG ' ' ND2' ' A' ' 127' ' ' ASN . 30.1 t -89.21 122.12 32.18 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.975 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 126' ' ' SER . 12.7 mt -130.46 139.44 51.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.828 0.347 . . . . 0.0 110.5 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.17 144.36 7.98 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 10.7 p -117.96 156.91 27.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.73 0.3 . . . . 0.0 110.476 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -159.96 146.04 15.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.899 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.493 ' CD1' ' N ' ' A' ' 114' ' ' ILE . 3.8 mp -131.83 122.05 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.368 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.0 t -118.68 140.94 49.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.679 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.494 ' C ' ' H ' ' A' ' 118' ' ' GLY . 31.1 m -124.17 144.72 32.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.559 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.616 ' OD1' ' SD ' ' A' ' 51' ' ' MET . 0.5 OUTLIER 52.94 9.77 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.575 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 116' ' ' VAL . . . 88.02 5.6 76.75 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.6 mtmt -106.44 127.33 53.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.748 0.309 . . . . 0.0 110.512 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.5 m -70.9 118.84 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.74 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -103.44 -72.94 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.479 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -135.31 128.09 31.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.315 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -146.9 123.85 11.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.0 mtt-85 -100.61 115.46 30.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.286 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.9 t -123.98 117.25 50.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.61 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.2 OUTLIER -132.99 122.67 24.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.406 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.691 ' ND2' ' OG ' ' A' ' 109' ' ' SER . 11.3 m120 -94.2 129.74 40.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.342 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -152.85 130.74 11.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.718 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 129' ' ' VAL . 13.7 p -65.06 104.36 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.554 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.576 ' N ' HD21 ' A' ' 130' ' ' ASN . 1.0 OUTLIER 66.79 81.76 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.56 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.606 -179.882 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -114.24 128.0 56.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.445 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.404 ' O ' ' CG ' ' A' ' 53' ' ' LEU . 2.2 pp -95.9 116.06 28.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.334 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.9 t -123.76 144.8 49.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.77 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.438 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -119.48 149.41 41.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.013 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.573 ' HB2' ' HG ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -155.76 136.88 13.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.946 0.403 . . . . 0.0 111.087 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.492 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 21.0 mt -116.31 161.81 14.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.002 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.474 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -141.32 151.02 43.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.018 0.437 . . . . 0.0 110.662 -179.878 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -165.93 168.83 39.93 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -46.11 144.72 6.06 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.651 2.234 . . . . 0.0 111.781 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -64.29 120.48 7.82 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.592 2.195 . . . . 0.0 112.17 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.09 2.94 59.13 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.579 ' O ' ' O ' ' A' ' 83' ' ' VAL . 6.7 t -78.71 141.48 37.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.861 0.363 . . . . 0.0 110.665 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.8 m -101.79 128.2 54.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.621 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.35 144.73 33.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.839 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.45 116.32 32.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.247 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.7 mt -101.03 124.71 54.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.023 0.439 . . . . 0.0 111.006 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.5 t -135.63 124.35 23.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.992 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' A' ' 69' ' ' TYR . 23.9 p90 -147.94 169.01 20.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.909 0.385 . . . . 0.0 110.965 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -87.35 125.7 34.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.455 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -90.95 155.07 19.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.632 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 73' ' ' ASN . 5.3 p -51.77 -37.07 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.495 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 74' ' ' SER . 0.9 OUTLIER -85.16 11.75 9.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.473 179.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.516 ' O ' ' C ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER 81.19 -68.03 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.313 -179.729 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.516 ' C ' ' O ' ' A' ' 74' ' ' SER . 5.6 tt0 -31.91 104.14 0.22 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.136 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -76.7 139.86 20.43 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.317 2.011 . . . . 0.0 112.318 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.79 147.66 24.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.498 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -144.73 130.01 18.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.465 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.9 m -109.8 124.5 66.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.411 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.01 117.99 31.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.73 16.73 27.93 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.86 135.66 48.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.774 0.321 . . . . 0.0 110.5 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.579 ' O ' ' O ' ' A' ' 63' ' ' THR . 0.5 OUTLIER -81.17 -38.68 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.659 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.16 157.06 43.24 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.119 0.485 . . . . 0.0 110.578 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.492 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 38.0 Cg_endo -68.82 160.31 50.19 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.867 2.378 . . . . 0.0 112.227 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.93 -169.65 2.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.498 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.573 ' HG ' ' HB2' ' A' ' 56' ' ' GLU . 70.5 m -133.83 144.98 49.3 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.952 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.3 tp -138.32 155.64 48.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.627 0.251 . . . . 0.0 110.398 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -115.82 135.37 54.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 110.984 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.7 mt -129.23 130.32 67.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.249 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.4 t -115.35 129.21 56.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.771 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.557 ' O ' ' C ' ' A' ' 93' ' ' ASN . 14.0 m -129.97 125.42 35.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.226 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.557 ' C ' ' O ' ' A' ' 92' ' ' THR . 1.9 m120 26.26 -104.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.544 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 94' ' ' ASP . 4.8 p-10 -160.05 81.23 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.484 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -167.43 147.41 5.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.664 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.36 127.21 33.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.361 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -140.56 150.07 21.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -102.39 172.59 6.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.208 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -138.44 161.8 25.72 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.534 ' OD1' ' C ' ' A' ' 100' ' ' ASN . 16.2 t-20 -114.96 115.22 26.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 0.0 110.498 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.7 tt -130.98 141.42 46.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.505 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.42 HG13 ' H ' ' A' ' 103' ' ' ALA . 77.8 t -129.36 155.43 41.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.879 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.42 ' H ' HG13 ' A' ' 102' ' ' VAL . . . -121.31 147.24 45.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.562 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.49 54.26 1.95 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.812 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.65 162.97 20.72 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.98 89.83 4.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.853 0.359 . . . . 0.0 110.448 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.2 p -117.82 177.7 4.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.774 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -116.91 -0.01 12.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.439 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.1 p -170.46 84.52 0.11 Allowed 'General case' 0 C--O 1.245 0.853 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.047 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.468 ' O ' ' CG2' ' A' ' 110' ' ' ILE . 0.4 OUTLIER -109.96 128.97 65.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 120.9 0.381 . . . . 0.0 110.774 -179.752 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -152.86 164.41 30.78 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 20.3 m -125.0 153.24 43.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.928 0.394 . . . . 0.0 110.727 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -159.87 144.89 15.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.309 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.438 HD13 ' CE2' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -126.56 133.67 68.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.833 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.8 m -122.79 124.02 42.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.432 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.454 ' C ' ' H ' ' A' ' 118' ' ' GLY . 0.5 OUTLIER -131.84 148.78 32.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.556 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.0 t0 49.87 13.46 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.691 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 116' ' ' VAL . . . 84.64 -0.14 89.22 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.62 138.34 50.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.717 0.294 . . . . 0.0 110.586 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.3 t -85.41 118.67 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.53 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -90.37 -62.09 1.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.5 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -114.7 131.75 56.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.449 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -129.52 121.75 27.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.773 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.457 ' O ' ' CG ' ' A' ' 124' ' ' ARG . 11.8 ptm180 -128.49 123.19 32.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.293 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.8 t -122.5 120.25 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.63 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.42 115.94 18.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.637 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -95.08 130.18 41.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.211 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -150.4 130.57 13.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.761 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.07 18.34 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.993 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 130' ' ' ASN . 2.4 t-20 -179.09 65.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.409 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.627 -179.889 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.66 127.85 54.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.481 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.453 ' CD1' ' O ' ' A' ' 97' ' ' VAL . 1.5 tt -96.12 115.72 27.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.416 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.62 130.95 51.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.667 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -119.98 149.01 42.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.2 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.578 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 2.6 tm-20 -156.03 146.76 21.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.984 0.421 . . . . 0.0 111.002 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.462 HG22 HD12 ' A' ' 57' ' ' ILE . 74.7 mt -114.73 159.96 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.761 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 59' ' ' GLY . 11.8 t80 -140.28 156.86 46.3 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.245 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.589 ' N ' ' CD1' ' A' ' 58' ' ' PHE . . . -160.72 175.04 37.45 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.478 ' O ' ' OG1' ' A' ' 63' ' ' THR . 50.0 Cg_exo -50.93 157.98 3.44 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.623 2.216 . . . . 0.0 111.979 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -75.27 118.66 5.27 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.803 2.335 . . . . 0.0 112.187 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.03 9.9 55.5 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -83.77 150.67 25.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.785 0.326 . . . . 0.0 110.442 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.06 121.98 60.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.569 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.38 153.55 42.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.529 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.92 115.71 27.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.401 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.1 mm -93.24 132.73 36.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.853 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.5 t -135.8 127.54 29.15 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.909 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.454 ' CG ' ' N ' ' A' ' 70' ' ' PHE . 40.1 t80 -150.46 157.34 42.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.801 0.334 . . . . 0.0 110.678 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 12.9 t80 -87.44 124.35 33.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.439 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.83 156.81 22.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.483 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.454 HG11 ' N ' ' A' ' 73' ' ' ASN . 4.7 p -59.29 -30.84 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.473 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 74' ' ' SER . 34.9 m120 -95.72 11.6 32.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.31 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.63 ' OG ' ' N ' ' A' ' 75' ' ' GLU . 1.1 p 85.19 -69.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.379 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.63 ' N ' ' OG ' ' A' ' 74' ' ' SER . 11.4 pt-20 -29.63 94.86 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.495 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.498 ' N ' ' O ' ' A' ' 74' ' ' SER . 51.3 Cg_endo -77.01 141.6 21.2 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.506 2.137 . . . . 0.0 111.978 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.452 ' HG2' ' N ' ' A' ' 78' ' ' ARG . 1.4 tt0 -107.58 140.83 39.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.987 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.452 ' N ' ' HG2' ' A' ' 77' ' ' GLN . 4.4 mtt-85 -135.9 133.5 37.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.165 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 m -99.35 136.56 29.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.72 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -113.09 103.67 11.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.64 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.32 33.46 5.4 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.31 148.11 50.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.789 0.328 . . . . 0.0 110.559 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.5 m -107.56 -20.03 6.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.395 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.442 ' CD2' ' O ' ' A' ' 85' ' ' PRO . 5.3 tt -174.99 115.17 0.29 Allowed Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.222 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.442 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 27.4 Cg_exo -55.63 144.19 76.08 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.897 1.731 . . . . 0.0 111.803 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.526 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 4.4 m-90 -111.5 -144.54 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.528 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.578 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . 97.0 p -134.17 155.21 50.52 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.977 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -129.1 151.84 49.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.786 0.327 . . . . 0.0 110.492 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.594 ' N ' ' CD2' ' A' ' 89' ' ' HIS . 0.4 OUTLIER -105.86 119.05 38.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.629 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.433 HG23 HD13 ' A' ' 90' ' ' ILE . 50.3 mm -126.41 138.25 55.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.456 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 t -103.76 130.44 51.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.649 ' O ' ' N ' ' A' ' 94' ' ' ASP . 17.4 p -116.75 140.34 49.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.737 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.524 ' CG ' ' O ' ' A' ' 93' ' ' ASN . 1.8 t30 -49.5 79.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.59 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 92' ' ' THR . 21.9 m-20 34.08 79.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.55 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -169.41 145.79 3.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.508 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.5 113.6 26.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.439 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.453 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 7.7 p -133.91 156.78 41.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.674 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.43 ' HE3' ' NH2' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -108.07 117.26 33.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.533 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.38 161.87 54.39 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -112.9 115.39 28.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 0.0 110.595 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.4 tt -131.08 139.25 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.643 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 103' ' ' ALA . 8.2 t -130.39 155.16 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.397 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.451 ' N ' ' CG1' ' A' ' 102' ' ' VAL . . . -140.72 157.16 45.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.737 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -136.83 73.71 1.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.586 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -128.8 163.51 22.18 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -79.18 106.74 11.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.868 0.366 . . . . 0.0 110.516 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.0 p -140.9 -170.83 3.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.622 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 108' ' ' ASP . 2.3 t70 -134.15 4.93 3.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.5 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.8 p -174.73 62.46 0.02 OUTLIER 'General case' 0 C--O 1.245 0.847 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.959 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.504 ' O ' ' O ' ' A' ' 126' ' ' SER . 4.2 tt -98.99 129.52 49.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 O-C-N 123.16 0.288 . . . . 0.0 110.424 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -149.42 172.4 29.45 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.569 ' O ' ' O ' ' A' ' 124' ' ' ARG . 0.9 OUTLIER -118.99 157.32 27.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.765 0.317 . . . . 0.0 110.28 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.511 ' NH2' ' OE1' ' A' ' 56' ' ' GLU . 15.1 ptt-85 -161.41 141.78 10.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.642 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.1 mm -117.71 131.37 70.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.615 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.1 p -110.3 132.88 53.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.429 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.5 t -142.05 150.08 19.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.598 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 50.99 19.24 0.63 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.653 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.38 -4.73 24.9 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -120.94 132.03 54.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.797 0.332 . . . . 0.0 110.557 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.3 t -74.63 134.53 29.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.46 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.03 -46.82 2.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.789 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.64 129.73 14.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.69 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -150.19 155.73 40.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.576 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.569 ' O ' ' O ' ' A' ' 112' ' ' CYS . 25.8 mtt-85 -116.22 116.0 27.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.608 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.7 p -124.31 128.82 74.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.527 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 110' ' ' ILE . 4.7 m -128.71 130.46 47.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.534 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -99.41 137.92 37.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.517 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -145.64 166.47 25.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.459 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.424 ' C ' ' CG ' ' A' ' 130' ' ' ASN . 5.2 t -97.59 -3.37 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.443 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.424 ' CG ' ' C ' ' A' ' 129' ' ' VAL . 0.1 OUTLIER 172.33 79.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.354 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.513 -179.83 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.7 mpt? . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -113.13 128.59 56.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.604 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.412 ' O ' ' CD1' ' A' ' 90' ' ' ILE . 39.1 tp -95.79 115.76 27.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.087 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.1 p -126.45 131.77 51.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 88' ' ' LEU . 26.1 p90 -119.77 148.88 42.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.832 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 57' ' ' ILE . 2.2 tm-20 -155.81 144.88 20.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.901 0.382 . . . . 0.0 110.919 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.436 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 31.4 mm -116.11 165.59 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.901 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.686 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -133.01 165.42 24.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.023 0.44 . . . . 0.0 110.952 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.76 170.56 37.33 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.588 ' O ' ' OG1' ' A' ' 63' ' ' THR . 17.9 Cg_endo -64.82 161.2 37.25 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.518 2.146 . . . . 0.0 112.016 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -72.51 119.52 6.17 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.868 2.379 . . . . 0.0 112.163 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.69 7.31 45.24 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.588 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -82.92 136.02 34.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.809 0.338 . . . . 0.0 110.653 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -114.53 122.63 69.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.615 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.61 151.53 44.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.503 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.497 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 9.2 p30 -96.24 116.0 28.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.635 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 mt -96.83 130.45 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.572 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.4 t -134.19 126.06 29.14 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.02 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.657 ' CZ ' ' O ' ' A' ' 70' ' ' PHE . 11.0 t80 -151.38 152.64 33.39 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.876 0.369 . . . . 0.0 110.63 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.657 ' O ' ' CZ ' ' A' ' 69' ' ' TYR . 49.7 t80 -84.75 121.53 27.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.494 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.52 151.18 27.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.627 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.5 t -64.72 -35.27 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.604 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -89.7 10.24 24.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.657 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 70.52 79.56 0.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.582 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -170.77 85.17 0.52 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.469 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -59.31 139.95 92.31 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.859 2.373 . . . . 0.0 112.197 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -106.04 132.67 51.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.56 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.1 mtm-85 -140.43 126.22 19.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.468 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.3 m -121.31 136.97 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.735 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -129.95 126.2 37.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.516 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.68 23.96 17.03 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.98 153.36 22.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 110.467 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -92.93 -39.82 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.615 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.608 ' CD1' ' CH2' ' A' ' 86' ' ' TRP . 0.2 OUTLIER -147.83 157.8 43.33 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.976 0.417 . . . . 0.0 110.628 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.73 162.49 39.45 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.87 2.38 . . . . 0.0 112.268 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.608 ' CH2' ' CD1' ' A' ' 84' ' ' LEU . 2.1 m95 -132.86 -156.49 0.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.332 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 96.7 p -130.49 161.22 31.92 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.946 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 55' ' ' TYR . 0.6 OUTLIER -132.47 155.42 48.59 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.405 178.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.533 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.2 OUTLIER -116.2 120.61 39.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.668 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.412 ' CD1' ' O ' ' A' ' 53' ' ' LEU . 3.8 mp -124.15 129.79 73.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.656 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.01 129.86 53.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.302 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.563 ' O ' ' O ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -125.79 157.97 36.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.659 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.563 ' O ' ' O ' ' A' ' 92' ' ' THR . 5.1 m120 -34.76 -100.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.618 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.8 72.59 0.33 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.587 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.45 ' O ' ' CG2' ' A' ' 97' ' ' VAL . . . -169.68 166.06 9.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.745 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.56 128.89 34.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.518 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 95' ' ' ALA . 0.7 OUTLIER -133.44 147.74 31.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.718 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.424 ' SD ' ' HB3' ' A' ' 122' ' ' ALA . 23.0 mtm -149.19 150.25 32.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.309 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.17 162.16 23.59 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -105.23 117.08 33.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.892 0.377 . . . . 0.0 110.589 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 tp -132.88 133.66 58.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.532 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.0 m -130.59 165.32 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.217 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -139.62 142.22 37.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.759 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -132.96 75.98 1.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.383 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -125.52 164.43 19.1 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.56 ' ND2' ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -78.02 48.86 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.108 0.48 . . . . 0.0 110.458 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.657 ' HG ' ' H ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -93.8 173.23 7.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.613 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.603 ' N ' ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -101.61 -17.07 16.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.418 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.657 ' H ' ' HG ' ' A' ' 107' ' ' SER . 40.9 t -146.54 115.98 7.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.0 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.424 ' O ' ' O ' ' A' ' 126' ' ' SER . 3.4 mt -137.64 125.96 32.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.834 0.35 . . . . 0.0 110.51 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -154.83 175.27 32.95 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -120.23 169.62 10.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.687 0.279 . . . . 0.0 110.519 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.94 144.99 13.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.81 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.4 mt -140.74 122.97 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.579 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.0 p -122.72 122.29 38.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.371 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.594 ' O ' ' N ' ' A' ' 118' ' ' GLY . 55.9 t -122.12 157.74 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.857 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.469 ' N ' ' CG1' ' A' ' 116' ' ' VAL . 80.9 m-20 39.22 20.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.807 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 116' ' ' VAL . . . 70.44 0.95 33.46 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 116' ' ' VAL . 4.6 tttp -113.65 143.46 44.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 110.57 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.4 p -71.56 124.23 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.784 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.454 ' HG2' ' NH1' ' A' ' 121' ' ' ARG . 26.9 mtt-85 -125.38 -41.4 2.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.175 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.424 ' HB3' ' SD ' ' A' ' 98' ' ' MET . . . -152.78 128.22 9.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.134 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -149.16 131.74 15.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.786 0.326 . . . . 0.0 111.026 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.0 119.06 28.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.351 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.506 ' CG1' ' O ' ' A' ' 125' ' ' VAL . 7.5 p -122.25 118.53 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.726 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.3 OUTLIER -115.35 127.16 55.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.538 179.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -95.6 133.15 39.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.714 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.573 ' O ' ' O ' ' A' ' 108' ' ' ASP . 9.6 mt-10 -148.97 130.51 14.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.355 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.01 -11.02 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.605 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -164.38 72.03 0.22 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.35 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.49 71.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.669 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.56 ' O ' ' CE1' ' A' ' 134' ' ' TYR . 38.3 t80 -157.99 6.18 0.13 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.447 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.63 ' C ' ' H ' ' A' ' 135' ' ' CYS . 68.1 p -90.39 -16.66 28.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.621 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 134' ' ' TYR . 0.4 OUTLIER 67.8 -33.79 0.23 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.466 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . 0.63 ' H ' ' C ' ' A' ' 133' ' ' THR . 0.5 OUTLIER 178.23 98.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.474 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.3 tp -156.64 90.3 1.15 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.716 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.545 ' O ' ' C ' ' A' ' 138' ' ' LYS . 16.9 t -84.4 124.45 39.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.416 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.545 ' C ' ' O ' ' A' ' 137' ' ' VAL . 3.5 tppt? -27.32 128.29 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.815 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.84 -16.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.575 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.617 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.9 ptp . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -116.22 119.27 35.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.512 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.3 tt -98.5 115.2 28.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.026 0.441 . . . . 0.0 110.703 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -127.51 129.71 47.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.052 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.413 ' HH ' HD21 ' A' ' 88' ' ' LEU . 12.5 p90 -119.96 148.54 43.4 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.732 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.74 ' HB2' ' HG ' ' A' ' 87' ' ' SER . 6.0 tt0 -156.8 131.93 9.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.705 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.516 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 4.6 mm -91.36 167.95 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.41 145.49 51.25 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.885 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.07 156.66 28.09 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -50.33 161.63 1.1 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.923 2.415 . . . . 0.0 111.987 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -76.95 133.74 14.02 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.953 2.435 . . . . 0.0 112.279 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.94 -9.92 67.37 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.6 m -81.68 130.23 34.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.841 0.353 . . . . 0.0 110.496 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.9 m -101.9 127.39 55.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.579 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.35 155.48 49.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.557 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.503 ' OD1' ' C ' ' A' ' 66' ' ' ASP . 44.2 t0 -103.18 129.15 50.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.555 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.497 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 2.9 mt -118.73 126.46 75.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.62 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 39.9 t -113.27 117.87 33.04 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.067 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.593 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 33.9 t80 -139.96 145.93 38.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.702 0.287 . . . . 0.0 110.538 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.593 ' O ' ' CE2' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -83.24 134.48 34.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.207 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 74' ' ' SER . 11.9 t0 -94.21 153.32 18.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.92 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.2 p -48.84 -39.09 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.635 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.514 ' O ' ' CB ' ' A' ' 74' ' ' SER . 0.3 OUTLIER -87.71 11.75 14.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.409 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.68 ' OG ' ' N ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER 82.15 -71.65 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.507 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.68 ' N ' ' OG ' ' A' ' 74' ' ' SER . 1.1 tp10 -26.12 88.75 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.701 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.588 ' N ' ' O ' ' A' ' 74' ' ' SER . 14.8 Cg_exo -65.08 144.57 82.39 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.932 2.421 . . . . 0.0 112.083 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -107.72 150.07 27.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.285 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -138.24 129.92 28.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.787 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.2 m -102.46 123.54 55.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.476 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 0.5 OUTLIER -120.97 108.74 14.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.686 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.69 29.03 7.56 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.45 132.86 34.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 0.0 110.578 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.08 -76.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.607 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.434 ' H ' ' CD1' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -118.17 156.73 50.25 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.588 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.516 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 25.6 Cg_endo -64.1 151.33 85.78 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.904 2.403 . . . . 0.0 112.339 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -114.31 -171.2 1.87 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.396 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.74 ' HG ' ' HB2' ' A' ' 56' ' ' GLU . 70.9 m -125.03 151.54 45.46 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.044 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.413 HD21 ' HH ' ' A' ' 55' ' ' TYR . 8.1 tp -130.73 154.6 47.8 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.863 0.363 . . . . 0.0 110.5 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -123.57 120.65 33.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.404 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.7 mt -130.9 132.09 64.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.571 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.77 126.03 51.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.569 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.507 ' O ' ' C ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -130.24 156.39 44.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.585 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.623 ' OD1' ' N ' ' A' ' 93' ' ' ASN . 0.4 OUTLIER -30.78 120.13 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.478 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -42.51 92.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.568 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 93' ' ' ASN . . . -175.03 -171.92 0.56 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.446 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.68 113.15 8.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.452 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 t -107.26 152.36 8.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.192 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.5 ttt -148.48 137.48 21.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 0.0 111.015 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.64 156.99 18.85 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -118.73 115.39 24.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.812 0.339 . . . . 0.0 110.794 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.9 140.5 49.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.609 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 89.1 t -127.19 147.64 32.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.465 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -139.41 140.37 37.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.746 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -139.05 78.89 1.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.587 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.56 163.8 23.63 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -78.77 52.13 1.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.8 0.333 . . . . 0.0 110.483 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 129' ' ' VAL . 70.9 m -100.49 175.05 5.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.554 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 109' ' ' SER . 6.9 t70 -104.59 128.52 52.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.505 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 108' ' ' ASP . 47.0 t 44.02 93.52 0.01 OUTLIER 'General case' 0 C--O 1.24 0.599 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.971 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.498 ' CG2' ' OD1' ' A' ' 127' ' ' ASN . 15.9 tt -124.56 127.1 72.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 120.793 0.33 . . . . 0.0 110.461 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 125' ' ' VAL . . . -147.22 172.09 27.73 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.675 ' SG ' ' N ' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -118.75 162.66 18.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.675 ' N ' ' SG ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -158.76 143.72 16.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.923 0.392 . . . . 0.0 110.887 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.9 mp -118.72 124.95 73.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.306 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.88 127.69 54.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.765 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.67 136.59 31.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.462 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.515 ' OD1' ' O ' ' A' ' 117' ' ' ASP . 57.7 t0 65.55 9.45 5.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.449 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.13 -5.98 57.77 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -101.13 139.3 37.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.812 0.339 . . . . 0.0 110.579 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 m -78.24 142.51 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.602 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -168.14 24.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.573 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -123.67 152.85 41.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.772 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.1 147.55 23.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.263 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.0 ptt85 -127.78 135.41 50.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.767 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.415 ' O ' ' CA ' ' A' ' 111' ' ' GLY . 2.1 t -103.08 134.64 43.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.165 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.644 ' C ' HD21 ' A' ' 127' ' ' ASN . 46.7 m -102.63 116.45 32.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.942 0.401 . . . . 0.0 110.901 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.69 ' N ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -128.34 135.19 49.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.449 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.642 ' C ' ' H ' ' A' ' 130' ' ' ASN . 1.1 pm0 -104.36 174.6 5.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.746 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.611 ' N ' ' O ' ' A' ' 107' ' ' SER . 1.8 p -55.35 1.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.752 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.642 ' H ' ' C ' ' A' ' 128' ' ' GLU . 25.3 m-80 -112.84 -5.5 13.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.59 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.41 73.98 6.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.454 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -128.55 -171.3 2.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.509 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.421 ' H ' ' HG1' ' A' ' 133' ' ' THR . 4.4 m -59.14 97.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.57 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -174.41 102.88 0.1 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.682 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 1.3 m -109.37 121.23 44.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.451 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.481 ' O ' ' C ' ' A' ' 137' ' ' VAL . 3.5 mt -80.05 -91.14 0.05 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.79 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.481 ' C ' ' O ' ' A' ' 136' ' ' LEU . 41.2 t -33.42 95.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.695 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -75.07 -27.99 60.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.559 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.42 ' N ' ' HG2' ' A' ' 138' ' ' LYS . 1.2 m -63.19 147.99 49.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.585 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.564 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.458 ' N ' ' H ' ' A' ' 117' ' ' ASP . 9.2 mtt . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.644 ' HD1' ' H ' ' A' ' 52' ' ' HIS . 1.5 p-80 -109.36 125.81 52.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.308 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.502 ' CD2' ' C ' ' A' ' 53' ' ' LEU . 5.5 tt -96.1 115.87 28.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.785 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.7 p -126.28 130.12 50.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.496 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.554 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 1.8 p90 -122.69 149.94 43.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.517 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.424 ' HG2' ' N ' ' A' ' 57' ' ' ILE . 17.0 tt0 -155.36 148.09 24.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.956 0.408 . . . . 0.0 111.042 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.424 ' N ' ' HG2' ' A' ' 56' ' ' GLU . 1.6 mm -112.88 163.59 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.971 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.5 156.71 44.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.905 0.384 . . . . 0.0 110.698 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.65 170.21 42.93 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -47.56 152.87 2.38 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.854 2.369 . . . . 0.0 112.229 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -67.04 119.66 6.69 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.825 2.35 . . . . 0.0 111.933 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.99 -0.03 62.22 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.4 t -74.85 144.06 43.59 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.878 0.371 . . . . 0.0 110.559 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.87 128.83 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.508 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.47 151.49 41.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.806 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.67 124.81 49.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.206 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.9 mt -111.17 133.64 56.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.017 0.437 . . . . 0.0 111.013 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.5 t -132.35 131.05 41.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.957 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.679 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 11.2 t80 -150.98 156.49 41.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.895 0.379 . . . . 0.0 110.986 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.679 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 10.0 t80 -83.76 119.63 25.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.282 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -89.42 146.08 24.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.841 0.353 . . . . 0.0 110.775 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.5 p -53.99 -24.2 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.605 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.461 ' O ' ' CB ' ' A' ' 74' ' ' SER . 2.9 m-20 -86.55 -3.87 59.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.64 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.3 m 78.55 34.21 0.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.526 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -135.87 104.27 9.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.408 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -77.74 140.14 18.37 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.284 1.99 . . . . 0.0 112.086 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -107.42 148.11 29.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.563 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 75.4 mtm-85 -139.26 131.62 28.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.622 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.3 m -114.21 118.98 60.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.608 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -112.6 145.74 39.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.481 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.32 5.81 44.48 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.15 137.75 58.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.809 0.338 . . . . 0.0 110.413 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.45 -44.24 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.54 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.55 155.27 45.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.109 0.48 . . . . 0.0 110.774 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.83 159.44 52.79 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 123.208 2.605 . . . . 0.0 112.533 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -129.13 -179.26 5.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.215 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 92.8 p -112.27 164.53 13.11 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.323 0.582 . . . . 0.0 111.004 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.88 145.8 33.46 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.937 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.508 ' CG ' ' O ' ' A' ' 89' ' ' HIS . 19.8 p80 -121.52 123.53 42.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 110.851 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.3 mt -128.51 121.3 54.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.513 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.4 m -104.14 122.47 45.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.548 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.553 ' O ' ' C ' ' A' ' 93' ' ' ASN . 1.9 m -129.19 158.33 39.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.536 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.553 ' C ' ' O ' ' A' ' 92' ' ' THR . 41.9 m-20 -25.54 91.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.713 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 94' ' ' ASP . 0.1 OUTLIER -31.47 124.98 0.24 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.566 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 94' ' ' ASP . . . 163.75 -71.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.595 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -156.25 120.42 4.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.447 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 t -127.81 147.26 32.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.711 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.6 ttm -151.51 159.42 44.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.517 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -153.46 156.26 26.65 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.536 HD22 ' NH2' ' A' ' 124' ' ' ARG . 0.8 OUTLIER -119.19 115.83 25.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.327 . . . . 0.0 110.611 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.9 tt -130.95 137.26 56.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.71 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.34 145.52 33.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.536 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -123.84 158.84 30.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.702 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -143.79 76.16 1.5 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.386 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -116.79 163.61 12.47 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.728 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -79.28 28.44 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.572 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 105' ' ' GLY . 2.0 p -73.05 -174.41 1.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.538 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' A' ' 128' ' ' GLU . 3.0 m-20 -113.25 -24.9 9.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.716 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 t -151.21 101.52 2.86 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.959 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.539 ' O ' ' O ' ' A' ' 126' ' ' SER . 15.6 tt -138.39 135.6 44.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.896 0.379 . . . . 0.0 110.577 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.73 173.1 35.67 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 1.4 p -124.93 162.31 24.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.821 0.343 . . . . 0.0 110.771 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -149.07 158.25 44.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.457 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.9 mm -126.56 127.68 70.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.634 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.57 132.4 53.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.567 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.455 ' C ' ' N ' ' A' ' 118' ' ' GLY . 7.6 p -143.14 149.65 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.571 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.458 ' H ' ' N ' ' A' ' 51' ' ' MET . 5.9 m-20 48.89 15.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.391 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.455 ' N ' ' C ' ' A' ' 116' ' ' VAL . . . 77.69 1.42 77.46 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -116.79 126.88 53.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.731 0.3 . . . . 0.0 110.607 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.0 t -74.88 136.51 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.475 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -129.13 -33.59 1.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.841 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.06 129.53 14.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.486 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -151.58 126.73 9.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.807 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.536 ' NH2' HD22 ' A' ' 100' ' ' ASN . 0.2 OUTLIER -113.6 115.73 28.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.238 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.7 m -114.97 133.21 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.696 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.5 OUTLIER -132.61 115.88 15.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.454 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -97.81 130.03 44.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.393 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.517 ' O ' ' O ' ' A' ' 108' ' ' ASP . 3.9 mm-40 -138.68 130.77 28.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.908 0.385 . . . . 0.0 110.806 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.9 m -73.4 -4.04 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.266 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.2 73.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.059 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -73.31 100.86 3.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.659 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -138.34 22.64 2.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.445 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.4 p -58.22 174.43 0.29 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.644 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.57 ' O ' ' O ' ' A' ' 135' ' ' CYS . 1.2 m-85 -118.83 40.44 3.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.676 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . 0.57 ' O ' ' O ' ' A' ' 134' ' ' TYR . 0.1 OUTLIER 34.34 101.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.815 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.9 mt -49.5 131.38 20.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.506 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 138' ' ' LYS . 7.7 p -177.21 -26.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.816 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.401 ' N ' HG13 ' A' ' 137' ' ' VAL . 4.9 ttmm -82.77 141.73 32.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.529 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.457 ' H ' ' HG ' ' A' ' 139' ' ' SER . 0.7 OUTLIER -64.76 -38.66 91.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.514 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.584 179.983 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -112.57 126.16 55.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.558 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.455 HD12 ' N ' ' A' ' 54' ' ' THR . 11.6 tp -97.32 115.28 27.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.56 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.455 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -127.14 142.85 51.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.509 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -126.0 148.43 49.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.42 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.733 ' OE1' ' OG ' ' A' ' 87' ' ' SER . 11.7 tt0 -156.7 134.4 10.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.979 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.516 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 20.7 mm -101.98 170.57 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -132.19 173.04 11.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 111.085 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.21 151.51 6.15 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -40.16 139.16 1.07 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.586 2.191 . . . . 0.0 111.938 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.75 135.56 36.02 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.588 2.192 . . . . 0.0 112.22 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.6 -0.89 58.22 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.7 m -86.21 139.37 31.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.792 0.33 . . . . 0.0 110.645 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 p -111.55 123.4 67.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.384 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -137.45 156.71 47.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.537 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.15 115.17 27.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.331 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.7 mt -105.34 131.18 55.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.708 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.5 t -134.74 125.94 27.99 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.952 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.661 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 42.7 t80 -145.87 158.98 43.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.834 0.35 . . . . 0.0 110.647 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.661 ' O ' ' CE2' ' A' ' 69' ' ' TYR . 4.6 t80 -88.83 136.72 32.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.679 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.32 116.71 32.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.36 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.0 t -75.5 -5.81 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.758 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.92 -17.98 25.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.593 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.6 t -176.72 -127.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.714 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -94.52 150.95 38.89 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.515 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.37 139.69 90.91 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.53 2.153 . . . . 0.0 111.871 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.58 156.84 17.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.697 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.7 ttm-85 -141.52 125.12 16.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.515 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.31 118.44 58.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.513 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 0.9 OUTLIER -115.74 133.62 55.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.658 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.55 31.37 8.89 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.57 148.98 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.863 0.363 . . . . 0.0 110.455 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.5 t -81.62 -53.35 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.301 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.528 ' O ' ' NE1' ' A' ' 86' ' ' TRP . 0.2 OUTLIER -140.67 151.89 64.51 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.209 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.516 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 11.5 Cg_endo -57.15 158.17 18.84 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.8 2.333 . . . . 0.0 112.071 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.528 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 37.4 m95 -130.15 -160.6 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.485 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.733 ' OG ' ' OE1' ' A' ' 56' ' ' GLU . 71.2 m -132.86 144.98 50.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.016 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.48 144.1 51.09 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.695 ' H ' ' CD2' ' A' ' 89' ' ' HIS . 0.7 OUTLIER -108.29 124.87 50.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.919 0.39 . . . . 0.0 110.943 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.6 mt -130.58 128.58 63.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.087 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.26 122.54 47.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.858 0.361 . . . . 0.0 110.934 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.537 ' O ' ' C ' ' A' ' 93' ' ' ASN . 5.3 m -126.14 125.57 42.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.236 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.537 ' C ' ' O ' ' A' ' 92' ' ' THR . 1.2 m-20 28.77 -134.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.494 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.532 ' OD1' ' C ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -139.41 98.74 3.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.563 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 168.35 -171.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.573 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -91.24 135.96 33.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.62 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.92 159.42 36.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.452 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.03 146.55 51.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.746 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.77 151.54 18.35 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -112.12 114.99 28.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.723 0.297 . . . . 0.0 110.596 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -133.29 139.13 49.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.515 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.467 HG11 ' H ' ' A' ' 103' ' ' ALA . 2.3 t -131.96 165.14 32.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.519 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.467 ' H ' HG11 ' A' ' 102' ' ' VAL . . . -143.61 148.13 35.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.447 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.46 63.97 1.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.175 0.512 . . . . 0.0 110.359 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -118.16 163.53 12.93 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.43 52.42 2.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.733 0.301 . . . . 0.0 110.636 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.1 m -88.98 -167.82 2.0 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.388 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -112.26 -42.42 3.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.805 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.3 t -128.01 128.06 44.31 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.99 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.537 ' O ' ' O ' ' A' ' 126' ' ' SER . 7.5 mt -141.75 148.08 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.706 0.289 . . . . 0.0 110.307 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.44 ' N ' HG23 ' A' ' 110' ' ' ILE . . . 177.8 163.86 30.21 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -117.83 160.14 21.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 0.0 110.611 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -151.3 155.48 38.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.635 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.4 mt -138.32 114.93 10.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.424 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.9 p -117.24 126.81 53.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.619 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 t -125.46 134.62 66.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.27 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 52.0 23.25 2.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.476 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.6 8.37 87.16 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -119.06 126.18 51.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.631 0.253 . . . . 0.0 110.399 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.2 p -74.26 138.72 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.769 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -115.35 -68.22 0.94 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.278 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -142.79 126.98 17.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.276 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -148.28 129.23 14.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.89 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -95.36 127.44 41.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.374 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.45 ' CG1' ' O ' ' A' ' 125' ' ' VAL . 10.8 p -117.45 117.31 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.806 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.6 OUTLIER -126.82 115.97 20.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.377 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 128' ' ' GLU . 54.9 t-20 -96.98 130.21 44.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.642 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.416 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 14.5 mt-10 -141.72 130.45 22.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.36 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 130' ' ' ASN . 0.3 OUTLIER -82.74 92.56 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.655 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.569 ' O ' ' N ' ' A' ' 132' ' ' TYR . 1.0 OUTLIER 83.3 62.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.529 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.3 71.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.08 0.467 . . . . 0.0 110.572 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.569 ' N ' ' O ' ' A' ' 130' ' ' ASN . 3.8 t80 -126.03 42.64 3.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.41 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.558 ' O ' ' O ' ' A' ' 132' ' ' TYR . 0.7 OUTLIER -39.58 171.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.91 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.454 ' O ' ' SG ' ' A' ' 135' ' ' CYS . 41.7 t80 62.08 146.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.676 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 134' ' ' TYR . 1.4 m -168.86 144.53 3.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.463 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 81.6 mt -100.53 102.53 13.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.507 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.544 ' O ' ' O ' ' A' ' 138' ' ' LYS . 14.6 p -147.14 -0.22 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.74 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.544 ' O ' ' O ' ' A' ' 137' ' ' VAL . 17.7 tttt 46.97 106.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.598 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 140' ' ' ALA . 5.4 m -77.81 -66.81 0.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.732 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 139' ' ' SER . . . . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.514 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.443 ' SD ' ' OD1' ' A' ' 117' ' ' ASP . 17.2 mmt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.95 117.65 33.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.439 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.57 114.85 26.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.39 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.575 ' OG1' ' O ' ' A' ' 88' ' ' LEU . 7.5 t -127.47 140.82 51.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.786 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -127.57 149.34 50.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.282 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.633 ' HB2' ' HG ' ' A' ' 87' ' ' SER . 2.4 tm-20 -155.66 154.75 32.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 0.0 110.931 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.595 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 4.9 mm -116.51 161.38 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.294 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.535 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 7.9 m-85 -134.96 158.6 43.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.709 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.37 167.95 36.41 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -46.65 148.77 3.4 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.737 2.291 . . . . 0.0 112.08 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -70.29 134.7 27.47 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.703 2.268 . . . . 0.0 112.091 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.61 1.39 71.26 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 95.9 m -81.25 135.53 35.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.908 0.385 . . . . 0.0 110.44 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.0 t -113.33 123.44 68.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.491 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.07 153.13 43.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.778 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.22 121.36 40.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.366 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.9 mp -98.81 131.2 46.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.766 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.3 t -129.62 119.2 23.18 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.019 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.6 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 2.6 p90 -142.23 171.34 14.19 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.631 0.253 . . . . 0.0 110.443 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.636 ' CD1' ' O ' ' A' ' 70' ' ' PHE . 0.6 OUTLIER -87.57 130.68 34.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.492 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 72' ' ' VAL . 33.3 t0 -88.83 139.1 30.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.519 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.557 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 6.2 p -54.56 -25.93 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.805 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.401 ' N ' HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -88.31 8.94 25.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.74 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.5 m 69.6 62.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.523 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -170.43 92.26 0.48 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.263 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -58.84 139.82 92.47 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.712 2.275 . . . . 0.0 112.342 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -108.23 155.61 20.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.732 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -137.37 125.58 23.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.265 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.5 m -106.69 120.91 58.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.844 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.69 129.05 53.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.385 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.07 13.8 58.47 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.79 128.03 34.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.742 0.306 . . . . 0.0 110.618 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.35 -96.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.307 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.427 ' CD1' ' H ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -90.0 158.42 44.44 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.924 0.392 . . . . 0.0 110.453 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.595 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 17.4 Cg_endo -60.41 154.87 50.28 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.992 2.462 . . . . 0.0 112.194 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.9 175.42 6.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.429 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.633 ' HG ' ' HB2' ' A' ' 56' ' ' GLU . 68.0 m -113.21 152.35 29.86 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.946 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.575 ' O ' ' OG1' ' A' ' 54' ' ' THR . 2.2 tp -129.67 151.72 49.96 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.041 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.657 ' H ' ' ND1' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -112.32 126.0 54.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 0.0 110.898 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.5 mt -131.09 132.46 63.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.48 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.85 129.3 56.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.541 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 p -122.61 140.62 52.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.627 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.546 ' O ' ' C ' ' A' ' 94' ' ' ASP . 3.3 p30 -74.89 108.61 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.801 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.546 ' C ' ' O ' ' A' ' 93' ' ' ASN . 1.4 t70 26.39 83.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.642 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 177.59 139.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.549 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.02 125.01 42.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.718 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.1 t -141.38 123.73 14.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.503 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.85 136.0 33.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.499 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.41 148.7 20.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -102.87 115.59 30.89 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.5 tt -130.18 142.07 44.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.892 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 103' ' ' ALA . 69.4 t -136.7 162.64 34.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.224 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.476 ' N ' ' CG1' ' A' ' 102' ' ' VAL . . . -142.98 144.83 32.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.698 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.602 ' OE1' ' CZ ' ' A' ' 132' ' ' TYR . 3.2 mt-30 -120.52 42.75 2.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.401 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -96.32 157.82 21.53 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.408 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 4.9 p30 -79.3 26.79 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.743 0.306 . . . . 0.0 110.536 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.785 ' HG ' ' H ' ' A' ' 108' ' ' ASP . 12.3 t -63.97 -173.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.483 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.785 ' H ' ' HG ' ' A' ' 107' ' ' SER . 12.8 t0 -119.45 -58.85 1.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.778 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.2 t -99.96 98.25 9.03 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.987 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 6.9 mt -117.02 149.37 19.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.74 0.305 . . . . 0.0 110.341 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.9 161.59 26.83 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.592 ' SG ' ' N ' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -118.74 157.55 27.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 110.95 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.592 ' N ' ' SG ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -151.3 138.24 19.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.342 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.462 ' CD1' ' SG ' ' A' ' 112' ' ' CYS . 1.7 mp -125.7 125.71 68.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.719 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 p -123.54 129.23 50.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.38 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.2 p -126.53 126.04 68.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.594 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.443 ' OD1' ' SD ' ' A' ' 51' ' ' MET . 4.0 t70 65.13 12.23 7.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.559 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.73 -4.53 84.62 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -96.61 132.43 42.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.861 0.362 . . . . 0.0 110.46 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.69 125.09 40.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.566 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.9 mmt85 -127.28 -53.99 1.37 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.612 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -119.46 129.17 54.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.502 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -151.59 122.86 7.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.37 118.93 33.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.261 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.3 t -127.46 118.99 51.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.069 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -133.17 116.98 16.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.323 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.23 128.78 40.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.909 0.385 . . . . 0.0 110.859 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.604 ' C ' ' H ' ' A' ' 130' ' ' ASN . 0.8 OUTLIER -157.9 130.35 7.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.381 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.462 ' N ' ' OE1' ' A' ' 128' ' ' GLU . 74.0 t -63.17 6.27 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.034 0.445 . . . . 0.0 110.163 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.604 ' H ' ' C ' ' A' ' 128' ' ' GLU . 0.7 OUTLIER -167.31 66.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.161 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.68 38.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.751 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.602 ' CZ ' ' OE1' ' A' ' 104' ' ' GLN . 28.0 t80 -177.15 111.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.529 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.558 ' O ' ' C ' ' A' ' 134' ' ' TYR . 0.2 OUTLIER -116.94 95.99 5.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.806 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.558 ' C ' ' O ' ' A' ' 133' ' ' THR . 2.0 m-85 23.38 -138.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.093 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -168.03 111.62 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.523 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.414 HD11 ' H ' ' A' ' 137' ' ' VAL . 2.0 mm? -55.92 -178.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.636 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.414 ' H ' HD11 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -141.52 105.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.514 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -125.03 -61.56 1.29 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.49 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.06 83.58 0.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.477 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.534 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.682 -179.895 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.527 ' HD1' ' H ' ' A' ' 52' ' ' HIS . 9.7 p-80 -105.96 128.44 53.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.401 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.578 ' CD1' ' O ' ' A' ' 97' ' ' VAL . 1.6 tt -97.01 115.52 27.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.618 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.03 139.53 52.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.642 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.436 ' CE1' HG21 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -121.37 148.52 44.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.243 179.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -156.25 144.01 19.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.932 0.396 . . . . 0.0 111.087 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.569 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 6.1 mm -115.23 167.47 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.483 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.407 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -140.97 163.87 31.8 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.524 -0.471 . . . . 0.0 111.172 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.62 165.39 37.84 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.584 ' O ' ' OG1' ' A' ' 63' ' ' THR . 71.3 Cg_exo -41.71 166.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.882 2.388 . . . . 0.0 111.985 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -80.14 116.64 3.4 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.723 2.282 . . . . 0.0 112.283 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.08 12.9 62.89 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.584 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -86.22 148.84 25.46 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.46 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.406 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 11.4 m -112.32 122.69 67.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.549 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.21 143.56 32.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.463 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.75 126.97 40.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.535 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.414 HD11 ' N ' ' A' ' 67' ' ' ILE . 3.7 mp -107.81 126.57 64.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.503 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.4 t -130.71 125.49 34.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.921 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.774 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 31.2 p90 -146.42 169.97 17.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.727 0.299 . . . . 0.0 110.561 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -85.98 119.19 26.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.579 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 73' ' ' ASN . 4.2 t0 -90.97 105.9 18.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.507 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.6 t -59.1 -5.07 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.659 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.516 ' O ' ' CB ' ' A' ' 74' ' ' SER . 0.3 OUTLIER -77.58 -21.5 52.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.726 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.712 ' HG ' ' N ' ' A' ' 75' ' ' GLU . 1.7 t 159.56 -93.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.715 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.712 ' N ' ' HG ' ' A' ' 74' ' ' SER . 8.1 pt-20 -100.91 148.92 35.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.616 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.29 145.69 49.1 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.759 2.306 . . . . 0.0 112.339 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.774 ' NE2' ' CE1' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -107.69 154.76 21.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.599 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 -132.08 135.08 46.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.579 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 p -116.96 125.51 73.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.59 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -136.87 134.2 36.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.489 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.03 7.66 59.54 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.81 153.26 35.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.733 0.301 . . . . 0.0 110.604 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.0 p -90.86 -30.47 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.449 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.92 154.3 26.14 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 110.733 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.569 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 18.7 Cg_endo -61.64 158.47 36.97 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.873 2.382 . . . . 0.0 112.111 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -121.42 -160.13 0.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.54 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.1 t -136.3 138.24 41.52 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.969 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.21 143.45 51.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.728 0.299 . . . . 0.0 110.29 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.646 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -105.94 121.07 43.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.771 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.1 mp -121.47 130.63 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.567 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.9 p -112.69 131.61 55.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.495 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.426 ' H ' ' HG1' ' A' ' 92' ' ' THR . 0.7 OUTLIER -112.57 157.57 21.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.553 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -52.94 -16.37 1.02 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.418 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -103.37 -115.94 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.538 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -166.33 -56.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.698 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.31 121.77 37.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.576 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.578 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 39.9 t -150.69 160.92 3.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.537 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.527 ' N ' ' CG1' ' A' ' 97' ' ' VAL . 4.8 mtt -121.62 157.45 30.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.408 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -142.96 148.31 20.01 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -102.96 118.28 36.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.796 0.331 . . . . 0.0 110.479 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.436 HG21 ' CE1' ' A' ' 55' ' ' TYR . 14.9 tt -133.19 142.13 42.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.546 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.5 t -140.68 163.73 22.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.662 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -138.42 158.68 43.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.408 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -135.64 75.74 1.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.73 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.23 155.23 19.25 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.0 55.2 1.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 110.359 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.649 ' OG ' ' N ' ' A' ' 108' ' ' ASP . 6.3 t -85.48 -167.56 1.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.712 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.649 ' N ' ' OG ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -119.84 -14.21 9.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.594 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.9 t -159.24 125.39 4.44 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.971 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.577 ' O ' ' O ' ' A' ' 126' ' ' SER . 26.1 mt -138.03 158.16 32.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.728 0.299 . . . . 0.0 110.514 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.489 ' N ' ' CG2' ' A' ' 110' ' ' ILE . . . -177.2 156.74 20.93 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.532 ' O ' ' O ' ' A' ' 124' ' ' ARG . 3.8 p -122.57 151.73 41.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.659 0.266 . . . . 0.0 110.449 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -160.01 148.22 16.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.663 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.415 HG22 HD13 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -129.68 123.22 56.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.802 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 72.5 p -119.16 136.53 54.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.333 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.457 ' C ' ' H ' ' A' ' 118' ' ' GLY . 84.9 t -132.44 149.09 31.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.792 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 55.39 8.88 0.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.58 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 116' ' ' VAL . . . 79.81 11.02 85.07 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -116.8 135.24 53.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.769 0.319 . . . . 0.0 110.546 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 71.9 t -70.08 120.57 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.616 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.418 ' NH1' ' HB3' ' A' ' 121' ' ' ARG . 4.0 mtp-105 -116.53 -72.26 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.655 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.22 134.92 46.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.676 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -149.65 157.19 43.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.489 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.532 ' O ' ' O ' ' A' ' 112' ' ' CYS . 7.5 ttt85 -123.52 130.14 52.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.646 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 54.6 t -114.03 118.52 58.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.527 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.577 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.7 OUTLIER -132.77 121.93 23.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.509 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -106.34 129.63 54.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.7 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -157.35 133.88 9.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.496 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' A' ' 130' ' ' ASN . 4.2 m -82.64 135.88 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.433 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 107' ' ' SER . 1.7 m-80 36.26 53.36 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.443 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.34 95.08 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.722 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.513 ' O ' ' CG ' ' A' ' 132' ' ' TYR . 1.9 p90 -131.79 22.26 4.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.319 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 69.9 p -67.01 117.79 9.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.682 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.45 ' O ' ' CB ' ' A' ' 135' ' ' CYS . 2.7 t80 -100.39 66.31 1.26 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.642 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . 0.45 ' CB ' ' O ' ' A' ' 134' ' ' TYR . 0.1 OUTLIER 77.71 25.73 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.595 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.443 ' N ' ' CD2' ' A' ' 136' ' ' LEU . 3.8 mm? -73.12 128.87 36.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.613 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.612 ' CG2' ' H ' ' A' ' 138' ' ' LYS . 16.1 m -130.82 -65.06 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.78 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.612 ' H ' ' CG2' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -53.56 -60.41 3.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.614 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.0 t 70.11 -76.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.606 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.373 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.55 179.975 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 30.8 mtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -110.95 123.68 50.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.326 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.418 ' CD2' ' C ' ' A' ' 53' ' ' LEU . 6.9 tt -95.84 114.58 26.33 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.286 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.7 p -127.34 132.85 50.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.771 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 13.0 p90 -123.69 148.17 46.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.373 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.88 ' HB2' ' HG ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -156.53 149.48 23.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.658 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.555 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -109.19 175.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.104 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -139.96 147.67 40.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.724 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.32 157.97 29.64 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -42.19 161.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.88 2.386 . . . . 0.0 112.164 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.41 122.77 7.21 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.933 2.422 . . . . 0.0 112.293 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.43 11.18 59.85 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.5 m -83.28 130.81 35.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 0.0 110.549 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -113.94 121.73 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.577 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.42 155.73 44.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.661 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -95.44 115.8 27.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.105 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 mp -99.95 134.72 38.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.739 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.5 t -135.58 132.39 37.11 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.974 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 77' ' ' GLN . 24.1 p90 -145.31 164.7 30.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.766 0.317 . . . . 0.0 110.531 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.14 135.44 33.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.484 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -98.65 152.38 19.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.588 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 p -63.84 -31.23 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.549 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.629 ' O ' ' CB ' ' A' ' 74' ' ' SER . 18.3 m-20 -75.78 2.84 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.494 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.629 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.0 OUTLIER 91.34 -52.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.281 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -60.0 113.98 8.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.13 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -74.5 141.28 28.03 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.245 1.964 . . . . 0.0 112.25 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 69' ' ' TYR . 24.5 tt0 -107.14 145.61 32.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.621 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -139.4 130.45 26.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.536 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.8 t -105.05 123.22 59.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.549 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 81' ' ' GLY . 19.5 t0 -121.96 134.71 54.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.675 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.488 ' N ' ' OD1' ' A' ' 80' ' ' ASP . . . 94.17 18.35 36.93 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.31 128.53 35.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.761 0.315 . . . . 0.0 110.563 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 p -76.78 -14.63 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.519 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -159.72 155.96 23.69 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.562 179.664 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.555 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 11.7 Cg_endo -57.08 152.95 41.39 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.989 2.46 . . . . 0.0 112.273 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.64 162.17 18.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.413 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.88 ' HG ' ' HB2' ' A' ' 56' ' ' GLU . 72.6 m -110.29 139.13 45.77 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.988 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 tp -130.41 140.46 50.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.767 0.318 . . . . 0.0 110.438 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.529 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 1.0 OUTLIER -110.73 119.27 38.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.621 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 64.0 mt -129.07 130.02 68.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.324 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.61 123.66 47.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.864 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.659 ' C ' ' H ' ' A' ' 94' ' ' ASP . 0.2 OUTLIER -99.35 153.34 19.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.247 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -60.31 7.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.621 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.659 ' H ' ' C ' ' A' ' 92' ' ' THR . 11.1 t0 -123.26 -103.28 0.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.489 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.472 ' N ' ' OD1' ' A' ' 94' ' ' ASP . . . 168.81 -56.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.686 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -88.55 114.65 25.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.548 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 p -168.47 144.74 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.936 0.398 . . . . 0.0 110.835 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -121.13 143.21 49.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.354 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.564 ' C ' HD21 ' A' ' 100' ' ' ASN . . . -111.09 162.6 12.43 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.57 HD21 ' N ' ' A' ' 100' ' ' ASN . 1.0 OUTLIER -104.89 117.94 35.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.754 0.311 . . . . 0.0 110.519 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.2 tt -131.18 131.75 63.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.698 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 103' ' ' ALA . 5.8 t -123.15 147.61 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.483 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.424 ' N ' HG12 ' A' ' 102' ' ' VAL . . . -128.8 138.38 52.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.662 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.638 ' NE2' ' OG1' ' A' ' 133' ' ' THR . 10.5 mm100 -122.56 73.17 1.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.452 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.73 163.37 20.67 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.62 ' OD1' ' ND2' ' A' ' 130' ' ' ASN . 24.9 t30 -84.0 37.89 0.62 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.749 0.309 . . . . 0.0 110.767 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.519 ' HG ' ' CD1' ' A' ' 110' ' ' ILE . 4.5 p -70.23 -177.68 1.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.531 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.49 -40.13 5.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.632 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.5 t -137.0 115.91 12.28 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.981 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.519 ' CD1' ' HG ' ' A' ' 107' ' ' SER . 10.3 mt -117.55 159.82 17.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.844 0.354 . . . . 0.0 110.529 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.441 ' N ' ' CG2' ' A' ' 110' ' ' ILE . . . 174.8 149.24 7.08 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.524 ' O ' ' O ' ' A' ' 124' ' ' ARG . 11.7 p -117.92 151.88 36.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.735 0.302 . . . . 0.0 110.587 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -154.31 154.85 34.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.507 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.54 124.4 28.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.581 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.3 p -122.35 141.17 51.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.686 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 119' ' ' LYS . 15.6 m -146.0 149.27 16.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.521 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 t0 49.41 17.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.639 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.411 ' N ' ' C ' ' A' ' 116' ' ' VAL . . . 84.87 -9.59 65.32 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 116' ' ' VAL . 15.9 mttm -112.07 124.72 53.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 0.0 110.539 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.43 ' O ' ' CG1' ' A' ' 120' ' ' VAL . 6.1 p -82.24 124.65 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.575 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -94.27 -34.91 12.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.531 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -141.05 141.28 34.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.505 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -148.99 122.47 9.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.783 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.524 ' O ' ' O ' ' A' ' 112' ' ' CYS . 27.2 mtt85 -127.29 115.87 19.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.205 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.25 118.23 54.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.001 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.9 OUTLIER -120.1 118.57 30.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.153 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.491 ' O ' ' OE1' ' A' ' 128' ' ' GLU . 2.7 m120 -94.23 129.9 40.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.842 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.491 ' OE1' ' O ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER -151.21 136.55 17.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.383 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 52.2 t -95.98 128.61 47.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.779 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.62 ' ND2' ' OD1' ' A' ' 106' ' ' ASN . 7.8 m120 60.89 35.75 19.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.911 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.11 124.16 20.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.338 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.647 ' O ' ' CD2' ' A' ' 132' ' ' TYR . 88.9 t80 -154.85 22.89 0.45 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.695 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.638 ' OG1' ' NE2' ' A' ' 104' ' ' GLN . 0.2 OUTLIER 81.39 115.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.571 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -72.46 -134.21 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.623 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . 0.511 ' O ' ' N ' ' A' ' 137' ' ' VAL . 7.6 t -148.01 -80.91 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.425 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.577 ' CD2' ' N ' ' A' ' 136' ' ' LEU . 3.5 mm? 33.7 -94.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.435 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.538 ' O ' ' C ' ' A' ' 138' ' ' LYS . 14.8 m -62.98 145.94 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.586 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.573 ' O ' ' O ' ' A' ' 139' ' ' SER . 15.4 pttt 27.81 -124.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.526 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.805 ' HG ' ' H ' ' A' ' 140' ' ' ALA . 46.1 t 47.0 173.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.43 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.805 ' H ' ' HG ' ' A' ' 139' ' ' SER . . . . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.597 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -102.48 120.0 39.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.453 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.564 ' CD2' ' C ' ' A' ' 53' ' ' LEU . 5.9 tt -96.19 115.87 28.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.743 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 t -126.71 132.55 51.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.348 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -120.08 149.75 41.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.849 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.424 ' OE1' ' CD2' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -155.66 141.76 18.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.671 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.5 mp -112.12 157.76 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.188 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.656 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -133.07 170.83 14.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.98 0.419 . . . . 0.0 111.047 -179.606 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.24 179.97 39.99 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -47.44 158.66 0.58 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.648 2.232 . . . . 0.0 112.062 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.0 110.95 3.05 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.77 2.313 . . . . 0.0 112.159 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.51 8.91 57.1 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -85.2 141.19 30.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.742 0.306 . . . . 0.0 110.527 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.45 130.67 59.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.307 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -135.67 155.7 50.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.637 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.599 ' OD2' ' NE2' ' A' ' 104' ' ' GLN . 11.6 p-10 -97.96 127.6 44.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.445 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.4 mp -99.31 120.73 49.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.638 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.1 t -135.65 117.04 14.67 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.987 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -143.83 171.11 14.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.768 0.318 . . . . 0.0 110.431 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -83.96 128.25 34.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.551 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' A' ' 72' ' ' VAL . 15.3 t0 -91.3 142.9 27.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.607 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.567 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 1.0 OUTLIER -63.68 -25.03 37.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.554 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.36 11.43 34.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.454 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 70.26 15.75 7.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.345 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 71' ' ' ASP . 1.9 tt0 -118.52 93.03 44.99 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.295 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -77.43 139.64 18.59 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.463 2.109 . . . . 0.0 112.333 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.436 ' HG2' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -107.67 143.34 36.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.572 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.436 ' N ' ' HG2' ' A' ' 77' ' ' GLN . 14.4 mtp-105 -139.65 125.35 19.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.536 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.7 m -107.66 134.5 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.621 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.632 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -104.91 142.46 34.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.451 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.54 31.81 81.03 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.52 131.26 34.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.842 0.353 . . . . 0.0 110.524 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.8 p -87.05 113.5 24.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.514 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tp 60.51 118.34 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.462 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -55.24 160.96 7.62 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.953 1.769 . . . . 0.0 111.844 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.584 ' CD1' ' C ' ' A' ' 86' ' ' TRP . 0.1 OUTLIER -112.14 -172.69 2.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.655 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 92.1 p -111.19 155.46 22.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.449 ' HG ' ' N ' ' A' ' 89' ' ' HIS . 6.3 tp -140.25 143.77 36.13 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.495 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.573 ' N ' ' CD2' ' A' ' 89' ' ' HIS . 0.2 OUTLIER -107.6 128.1 54.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.765 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.5 mt -125.55 130.83 72.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.487 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -122.95 122.76 39.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.747 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.553 ' O ' ' C ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -117.58 156.82 27.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.465 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.553 ' C ' ' O ' ' A' ' 92' ' ' THR . 4.4 m-20 -24.15 -60.13 0.05 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.841 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.447 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 0.3 OUTLIER 165.51 92.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.546 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -175.33 133.94 0.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.53 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.55 116.17 15.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.614 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.5 p -139.26 138.26 40.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.426 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.42 165.26 12.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.684 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -127.45 144.24 14.96 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -103.46 119.77 39.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.75 0.31 . . . . 0.0 110.736 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.5 tt -133.02 136.63 55.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.698 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.0 t -127.85 149.34 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.308 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -120.8 148.63 43.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 0.0 110.76 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.599 ' NE2' ' OD2' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -119.32 51.38 1.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.576 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -112.16 159.47 13.7 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -81.95 62.23 5.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.771 0.319 . . . . 0.0 110.62 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.702 ' HG ' ' CD1' ' A' ' 110' ' ' ILE . 77.4 p -93.95 -172.84 2.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.504 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 109' ' ' SER . 26.6 m-20 -131.65 20.78 4.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.619 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 87.8 p 177.4 91.42 0.01 OUTLIER 'General case' 0 C--O 1.244 0.787 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.983 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.702 ' CD1' ' HG ' ' A' ' 107' ' ' SER . 12.0 mt -115.96 128.43 73.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 120.772 0.32 . . . . 0.0 110.325 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -152.48 173.34 31.56 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -119.9 165.14 15.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.713 0.292 . . . . 0.0 110.475 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.656 ' NH1' ' OE1' ' A' ' 123' ' ' GLU . 5.6 ttm-85 -154.46 139.49 17.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.588 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.4 mm -134.07 114.02 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.517 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.7 m -117.93 138.0 52.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.656 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' A' ' 119' ' ' LYS . 30.4 m -140.62 148.78 21.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.732 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.446 ' C ' ' H ' ' A' ' 119' ' ' LYS . 34.1 m-20 44.97 26.57 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.73 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.99 -9.66 5.04 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.446 ' H ' ' C ' ' A' ' 117' ' ' ASP . 14.1 mttp -106.28 127.37 53.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.751 0.31 . . . . 0.0 110.363 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.76 130.95 32.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.929 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -105.85 -67.78 0.91 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.419 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -150.47 132.33 15.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.364 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.656 ' OE1' ' NH1' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -150.67 146.88 26.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.585 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -109.74 121.77 45.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.576 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' A' ' 125' ' ' VAL . 16.3 m -114.54 118.24 58.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.546 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.567 ' O ' ' O ' ' A' ' 110' ' ' ILE . 24.3 p -124.37 117.62 24.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.513 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' A' ' 127' ' ' ASN . 0.8 OUTLIER -99.57 129.85 45.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.414 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.05 145.09 21.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.681 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 m -70.3 -17.8 21.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.625 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.506 ' OD1' ' OG1' ' A' ' 133' ' ' THR . 0.7 OUTLIER -167.55 98.57 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.407 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.78 166.79 23.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.422 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 30.1 t80 66.26 69.47 0.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.463 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.506 ' OG1' ' OD1' ' A' ' 130' ' ' ASN . 3.7 m -160.91 -19.84 0.05 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.559 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -51.09 111.01 0.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.543 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . 0.568 ' SG ' ' N ' ' A' ' 136' ' ' LEU . 2.8 t -136.93 158.04 45.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.459 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.568 ' N ' ' SG ' ' A' ' 135' ' ' CYS . 1.8 mp -99.45 -122.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.592 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.13 34.29 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.526 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -144.71 175.02 10.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.681 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 m -101.86 -9.72 20.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.544 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.064 -0.969 . . . . 0.0 110.547 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 27.3 mmm . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -110.18 123.12 49.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.45 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.537 ' CD2' ' C ' ' A' ' 53' ' ' LEU . 5.8 tt -95.79 115.79 27.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.214 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.33 139.52 53.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.704 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -119.82 149.83 41.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.018 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 1.08 ' HB2' ' HG ' ' A' ' 87' ' ' SER . 0.3 OUTLIER -154.44 134.75 13.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.983 0.421 . . . . 0.0 110.954 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.5 mm -97.76 170.32 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.587 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.498 ' CD1' ' N ' ' A' ' 59' ' ' GLY . 4.9 t80 -142.6 154.38 44.36 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.782 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.498 ' N ' ' CD1' ' A' ' 58' ' ' PHE . . . -168.48 173.97 43.19 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.589 ' O ' ' OG1' ' A' ' 63' ' ' THR . 1.3 Cg_endo -47.02 167.79 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 122.793 2.328 . . . . 0.0 111.936 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.33 117.63 5.18 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.857 2.371 . . . . 0.0 112.265 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.2 18.21 67.52 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.589 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 4.0 m -72.31 132.0 43.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.807 0.337 . . . . 0.0 110.607 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.433 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 5.2 m -108.03 122.93 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.578 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -141.34 155.92 45.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.295 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.45 126.98 42.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.621 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.6 mp -108.3 136.68 43.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.582 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.4 t -134.33 116.84 15.71 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.973 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.533 ' CG ' ' N ' ' A' ' 70' ' ' PHE . 50.5 t80 -143.96 165.08 28.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.753 0.311 . . . . 0.0 110.508 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.533 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 29.4 t80 -84.89 120.37 26.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.608 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -84.69 135.5 34.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.559 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.7 p -70.04 -15.25 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.69 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.643 ' O ' ' CB ' ' A' ' 74' ' ' SER . 3.9 t30 -78.81 -21.99 46.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.698 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.643 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 2.0 t 149.79 -104.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.567 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.617 ' N ' ' OG ' ' A' ' 74' ' ' SER . 0.4 OUTLIER -62.78 152.92 81.09 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.756 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -72.09 145.41 44.39 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.877 2.385 . . . . 0.0 112.289 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -102.74 144.48 31.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.32 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -144.87 138.37 26.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.952 0.406 . . . . 0.0 110.963 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.8 m -115.39 131.86 66.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.209 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.67 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -121.45 149.31 43.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.922 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 61.69 -6.59 0.21 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.598 ' H ' ' C ' ' A' ' 80' ' ' ASP . . . -63.94 134.42 55.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 0.0 110.573 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.536 ' O ' ' C ' ' A' ' 84' ' ' LEU . 3.6 m -47.5 -176.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.55 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.536 ' C ' ' O ' ' A' ' 83' ' ' VAL . 1.8 pt? -28.46 148.04 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.62 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -56.15 146.51 70.47 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.757 2.305 . . . . 0.0 112.233 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -112.29 -166.52 1.09 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.556 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 1.08 ' HG ' ' HB2' ' A' ' 56' ' ' GLU . 59.2 m -117.85 165.1 14.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.959 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.79 155.19 50.74 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.627 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.4 m80 -114.12 124.34 51.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.598 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mm -129.57 124.72 60.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.445 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 p -119.38 128.46 54.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.562 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.66 133.59 48.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.585 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -61.06 -7.3 2.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.618 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -73.51 -95.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.656 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 177.07 -92.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.234 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.68 121.31 29.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.319 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.86 155.75 37.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.785 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.78 146.32 52.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.263 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -130.89 162.12 23.47 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.12 114.64 22.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.707 0.289 . . . . 0.0 110.356 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.1 tt -133.33 140.38 47.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.706 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.6 p -142.21 146.8 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.584 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -129.85 144.32 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.664 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -125.7 76.84 1.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.498 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.96 160.9 13.26 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.555 ' O ' ' O ' ' A' ' 107' ' ' SER . 1.4 m-20 -79.47 13.58 1.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.743 0.306 . . . . 0.0 110.494 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.555 ' O ' ' O ' ' A' ' 106' ' ' ASN . 25.3 p -48.54 -170.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.578 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -104.35 -15.03 15.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.553 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.0 t -168.78 122.36 0.84 Allowed 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.982 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 126' ' ' SER . 11.2 mt -125.93 138.62 53.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.724 0.297 . . . . 0.0 110.49 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.7 160.38 31.01 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 31.8 p -118.52 155.08 31.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 0.0 110.678 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.31 144.51 22.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.662 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.3 mt -138.31 114.95 10.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.389 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.71 140.78 49.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.723 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.7 p -145.76 150.09 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.476 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.6 10.99 2.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.483 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 83.64 -3.48 85.07 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.457 ' HB3' ' NH2' ' A' ' 121' ' ' ARG . 13.8 tptm -121.21 137.33 54.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.775 0.321 . . . . 0.0 110.569 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.2 m -73.96 143.77 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.508 ' HE ' ' CA ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -111.7 -60.09 1.9 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.383 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.5 126.94 5.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.249 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -151.69 129.33 11.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.83 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.455 ' HA ' ' HE ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -98.02 115.71 28.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.326 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 74.2 t -114.99 117.55 56.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.687 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 110' ' ' ILE . 16.6 m -131.88 132.61 43.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.621 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.28 138.17 32.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.24 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -150.21 130.76 13.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.934 0.397 . . . . 0.0 110.831 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -93.71 122.03 44.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.432 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 132' ' ' TYR . 0.4 OUTLIER 70.9 39.86 0.99 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.685 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.14 67.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.362 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.678 ' CG ' ' O ' ' A' ' 132' ' ' TYR . 37.1 t80 -139.91 21.53 2.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.539 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 73.4 p -152.73 -124.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.654 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -110.91 80.4 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.588 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 1.5 t -51.74 104.36 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.537 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 60.2 mt -76.21 100.83 5.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.595 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -113.16 23.09 5.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.471 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 29.1 mttm -77.88 76.58 4.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.615 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.573 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -63.83 112.95 3.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.498 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.573 ' O ' ' O ' ' A' ' 139' ' ' SER . . . . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.604 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.5 mtp . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.526 ' H ' ' ND1' ' A' ' 52' ' ' HIS . 2.1 p-80 -91.1 128.15 36.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.22 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.7 tp -97.5 114.9 26.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.814 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.4 t -127.78 133.41 49.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.533 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.572 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -121.8 149.47 43.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 0.0 110.461 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 1.014 ' HB2' ' HG ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -155.52 143.66 20.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.808 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.525 ' O ' ' OE1' ' A' ' 56' ' ' GLU . 42.9 mm -111.22 167.81 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.917 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.42 173.57 10.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.013 0.435 . . . . 0.0 110.989 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.42 ' HA2' ' HG ' ' A' ' 107' ' ' SER . . . 166.47 157.57 10.4 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -43.64 155.58 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.495 2.13 . . . . 0.0 112.034 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -66.94 117.9 5.14 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.844 2.363 . . . . 0.0 112.27 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.85 3.78 58.04 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.406 HG21 ' ND2' ' A' ' 106' ' ' ASN . 98.9 m -86.77 139.94 30.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 0.0 110.739 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.4 ' N ' HG22 ' A' ' 63' ' ' THR . 2.4 m -106.78 131.41 56.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.389 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.94 149.34 50.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.649 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 104' ' ' GLN . 0.0 OUTLIER -99.14 121.8 41.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.44 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 77' ' ' GLN . 2.1 mp -108.14 125.78 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.566 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.5 t -127.62 116.26 20.05 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.032 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -151.38 170.85 18.54 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.806 0.336 . . . . 0.0 110.636 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.486 ' CE1' ' O ' ' A' ' 71' ' ' ASP . 52.1 t80 -84.19 133.11 34.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.737 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.486 ' O ' ' CE1' ' A' ' 70' ' ' PHE . 21.1 t0 -104.44 149.6 25.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.555 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.82 -33.76 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.684 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -80.47 11.35 3.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.632 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.58 47.55 10.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.503 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -149.38 96.8 3.62 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.45 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.25 139.61 90.89 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.453 2.102 . . . . 0.0 111.893 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 67' ' ' ILE . 11.9 mt-30 -107.84 132.09 53.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.755 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 -131.84 129.39 40.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.345 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.7 m -120.3 136.64 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.857 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.9 143.62 51.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.343 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 58.95 13.61 20.07 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.21 147.53 31.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.758 0.314 . . . . 0.0 110.642 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.565 ' O ' ' O ' ' A' ' 84' ' ' LEU . 4.1 p -52.25 165.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.424 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.565 ' O ' ' O ' ' A' ' 83' ' ' VAL . 0.3 OUTLIER -27.49 149.46 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.941 0.4 . . . . 0.0 110.813 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.59 141.01 94.11 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.902 2.401 . . . . 0.0 112.251 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -113.17 -168.88 1.39 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.547 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 1.014 ' HG ' ' HB2' ' A' ' 56' ' ' GLU . 59.6 m -115.34 155.44 27.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.008 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.405 ' C ' ' ND1' ' A' ' 89' ' ' HIS . 0.7 OUTLIER -135.21 151.24 50.44 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.22 178.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.759 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -125.61 127.35 46.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.006 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mt -130.81 134.58 61.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.343 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 m -120.96 131.5 54.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.498 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.542 ' O ' ' C ' ' A' ' 93' ' ' ASN . 91.8 m -117.14 135.06 54.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.529 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.542 ' C ' ' O ' ' A' ' 92' ' ' THR . 73.0 m-80 28.05 -93.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.641 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 92' ' ' THR . 11.1 t70 -172.33 76.25 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.688 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -171.62 167.09 6.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.6 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.67 151.1 46.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.293 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 93.0 t -153.12 151.21 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.0 0.428 . . . . 0.0 110.937 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -120.05 173.25 7.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.891 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.4 142.76 8.55 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.587 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -104.11 116.38 32.11 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.28 140.29 48.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.98 0.419 . . . . 0.0 111.039 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.1 148.99 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.263 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -135.83 135.02 39.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 110.696 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.418 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 7.6 mt-30 -127.77 83.95 2.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.608 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.62 163.91 14.92 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.59 ' C ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -78.71 49.6 0.91 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.854 0.359 . . . . 0.0 110.418 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.48 ' OG ' ' N ' ' A' ' 108' ' ' ASP . 28.9 t -92.94 -172.37 2.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.515 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.48 ' N ' ' OG ' ' A' ' 107' ' ' SER . 4.8 m-20 -97.62 -38.35 9.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.535 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.535 ' HB2' HD22 ' A' ' 127' ' ' ASN . 44.2 t -141.01 112.04 7.2 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.987 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 126' ' ' SER . 5.4 mt -112.63 123.02 67.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.856 0.36 . . . . 0.0 110.677 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -150.51 173.5 30.1 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 11.8 p -127.9 165.98 19.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.743 0.306 . . . . 0.0 110.494 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 18.4 mtm-85 -151.32 144.04 24.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.489 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.4 mm -127.79 115.97 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.568 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 81.8 p -122.0 122.01 38.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.465 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.65 150.86 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.764 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.9 t70 58.54 16.86 4.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.647 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.91 -1.6 10.03 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -117.52 137.86 52.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.596 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.413 ' O ' ' CG1' ' A' ' 120' ' ' VAL . 2.0 p -78.75 132.28 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.615 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.4 mtm-85 -123.46 -47.03 2.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.711 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -145.09 128.82 17.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.783 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -149.73 128.39 12.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.414 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.442 ' HG2' HH11 ' A' ' 124' ' ' ARG . 5.3 tpp85 -116.24 116.29 27.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.71 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.2 122.53 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.358 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 110' ' ' ILE . 65.6 m -126.53 124.63 40.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.733 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.535 HD22 ' HB2' ' A' ' 109' ' ' SER . 0.1 OUTLIER -95.65 131.61 41.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.465 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 108' ' ' ASP . 78.2 tt0 -153.73 134.2 13.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.572 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.4 t -93.13 123.39 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.549 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 132' ' ' TYR . 0.8 OUTLIER 60.72 44.77 10.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.46 -179.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.35 71.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.463 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.573 ' N ' ' O ' ' A' ' 130' ' ' ASN . 57.6 t80 -88.77 127.29 35.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.403 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.546 ' C ' ' O ' ' A' ' 132' ' ' TYR . 29.6 p -26.28 111.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.832 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -86.48 172.39 10.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.576 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -57.94 167.81 1.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.467 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 137' ' ' VAL . 87.3 mt -120.65 -2.04 9.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.664 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.502 ' O ' ' O ' ' A' ' 136' ' ' LEU . 62.5 t 57.26 145.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.479 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.496 ' CG ' ' H ' ' A' ' 139' ' ' SER . 9.5 pttm -91.73 -108.15 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.673 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.496 ' H ' ' CG ' ' A' ' 138' ' ' LYS . 2.5 t 179.7 -78.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.601 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.442 179.986 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.2 mmt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -114.91 125.33 53.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.546 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.66 117.24 34.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.397 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 t -126.2 142.13 51.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.009 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.63 148.49 43.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.023 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.474 ' C ' ' CD ' ' A' ' 56' ' ' GLU . 8.0 tm-20 -156.48 134.42 11.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.868 0.366 . . . . 0.0 111.047 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.63 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 9.7 tt -116.53 139.07 44.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.943 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.88 172.3 10.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.748 0.308 . . . . 0.0 110.766 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.41 -81.97 0.2 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.51 ' CB ' ' HG1' ' A' ' 63' ' ' THR . 10.0 Cg_endo -56.46 109.34 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.896 2.397 . . . . 0.0 111.97 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.8 96.39 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.531 2.154 . . . . 0.0 111.896 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.28 -16.7 16.02 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.51 ' HG1' ' CB ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -68.05 152.0 46.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.766 0.317 . . . . 0.0 110.401 179.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.0 m -101.21 123.58 54.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.818 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.21 155.54 46.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.335 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -95.29 121.9 37.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.75 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.52 138.0 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.333 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.2 t -134.15 125.96 29.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.965 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.601 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 12.6 t80 -137.45 152.74 49.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.848 0.356 . . . . 0.0 110.603 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.601 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 83.9 t80 -83.58 126.5 32.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.649 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.09 154.06 22.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.536 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.0 p -72.34 -32.03 40.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.799 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.58 ' O ' ' CB ' ' A' ' 74' ' ' SER . 1.8 p-10 -81.63 -7.4 59.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.945 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.58 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.5 t 86.58 86.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.822 0.344 . . . . 0.0 110.373 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 171.24 92.55 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.323 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -59.4 139.97 92.1 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.716 2.277 . . . . 0.0 112.147 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -106.06 140.56 38.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.417 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.8 ttp-105 -141.48 132.49 26.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.679 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.1 m -123.26 129.17 75.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.469 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -119.62 127.74 53.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.736 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.55 13.05 79.22 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.7 137.02 33.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 0.0 110.608 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.584 ' O ' ' O ' ' A' ' 84' ' ' LEU . 4.2 m -59.48 -167.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.442 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.584 ' O ' ' O ' ' A' ' 83' ' ' VAL . 0.3 OUTLIER -32.22 156.94 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.533 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.63 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 10.7 Cg_endo -56.84 159.43 14.38 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 123.006 2.471 . . . . 0.0 112.301 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -125.09 -164.23 1.27 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.531 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 99.1 p -135.43 153.78 51.67 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.962 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.2 mp -129.7 155.43 45.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.715 0.293 . . . . 0.0 110.583 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -109.84 120.23 41.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.636 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.6 mt -128.75 133.64 65.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.526 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.8 p -118.21 124.34 47.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.463 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.484 ' C ' ' H ' ' A' ' 94' ' ' ASP . 3.1 m -116.25 135.19 54.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.628 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -72.64 39.83 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.58 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.484 ' H ' ' C ' ' A' ' 92' ' ' THR . 33.2 t0 -122.16 -97.15 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.616 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 176.28 -78.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.582 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -102.14 125.57 48.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.404 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.44 HG11 ' N ' ' A' ' 98' ' ' MET . 93.5 t -148.63 155.58 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.419 . . . . 0.0 110.827 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.44 ' N ' HG11 ' A' ' 97' ' ' VAL . 7.8 mtt -127.59 179.25 5.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.315 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -158.87 153.79 24.9 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -113.07 121.84 45.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.748 0.309 . . . . 0.0 110.355 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 101' ' ' ILE . 9.7 tt -133.13 128.93 56.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.711 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.9 t -127.15 145.22 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.41 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -127.74 156.74 41.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.704 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -119.43 66.45 0.8 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.579 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 131' ' ' ALA . . . -119.1 157.93 15.12 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -93.45 83.01 4.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.808 0.337 . . . . 0.0 110.595 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.7 p -115.56 -166.93 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.406 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -124.55 10.2 8.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.593 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.5 p -170.72 105.0 0.26 Allowed 'General case' 0 C--O 1.242 0.71 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.867 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.55 ' O ' ' O ' ' A' ' 126' ' ' SER . 5.4 tt -132.09 136.63 56.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 120.683 0.278 . . . . 0.0 110.378 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.55 176.77 41.03 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 32.0 m -120.46 149.55 42.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.793 0.33 . . . . 0.0 110.391 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.2 mtp-105 -144.37 146.19 32.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.754 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.41 122.97 58.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.236 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.1 t -118.36 126.12 51.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.954 0.407 . . . . 0.0 110.787 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.9 p -136.48 138.99 46.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.333 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.431 ' C ' ' H ' ' A' ' 119' ' ' LYS . 14.2 t0 48.1 22.99 0.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.525 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.9 -7.42 9.53 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 117' ' ' ASP . 22.6 mttp -99.84 133.08 44.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.871 0.367 . . . . 0.0 110.651 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 p -67.36 141.34 17.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.418 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -118.02 -75.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.588 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -150.67 128.55 11.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.481 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -150.95 160.17 44.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.611 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -121.05 124.67 45.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.561 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.33 117.28 52.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.57 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.55 ' O ' ' O ' ' A' ' 110' ' ' ILE . 48.1 p -132.22 120.94 22.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.583 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.765 HD21 ' H ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -100.18 129.88 46.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.505 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.45 162.12 31.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.463 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.6 p -102.31 -8.49 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.561 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 130' ' ' ASN . 21.8 p30 -164.83 63.24 0.13 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.499 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 105' ' ' GLY . . . -61.3 98.24 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.528 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -161.24 -20.66 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.43 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.5 m -73.31 78.71 1.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.42 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -44.21 -69.91 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.632 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 72.3 m -93.65 130.4 39.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.69 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.1 96.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.537 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.427 HG21 ' N ' ' A' ' 138' ' ' LYS . 6.8 p -171.76 149.51 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.646 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.482 ' O ' ' C ' ' A' ' 139' ' ' SER . 3.7 ptpt -151.17 -174.44 4.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.479 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.514 ' O ' ' C ' ' A' ' 140' ' ' ALA . 10.8 p 32.76 63.49 0.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.557 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.514 ' C ' ' O ' ' A' ' 139' ' ' SER . . . . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.659 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.437 ' N ' ' HA ' ' A' ' 117' ' ' ASP . 4.6 ttt . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.92 128.82 56.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.293 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.583 ' CD1' ' C ' ' A' ' 53' ' ' LEU . 3.1 tm? -95.72 115.27 27.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 0.0 110.203 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.6 p -127.33 131.99 50.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.583 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -125.84 149.48 48.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.218 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -155.5 142.42 19.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.918 0.39 . . . . 0.0 110.845 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.437 HG22 ' N ' ' A' ' 58' ' ' PHE . 48.1 mm -109.6 165.78 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.187 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.69 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -143.77 149.34 36.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.9 0.381 . . . . 0.0 110.349 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.45 163.34 33.94 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -41.68 145.82 0.62 Allowed 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.685 2.257 . . . . 0.0 111.724 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.53 115.96 3.99 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.636 2.224 . . . . 0.0 112.294 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.35 2.66 50.84 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.56 ' O ' ' O ' ' A' ' 83' ' ' VAL . 7.9 m -86.54 141.21 29.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.788 0.327 . . . . 0.0 110.949 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.2 m -104.25 127.16 58.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.202 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.67 154.7 48.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.913 0.387 . . . . 0.0 110.889 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -107.81 121.54 44.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.7 mt -108.52 131.59 58.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.744 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.3 t -134.75 119.72 18.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.026 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.464 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 69.6 t80 -132.19 162.17 31.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.831 0.348 . . . . 0.0 110.724 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.464 ' O ' ' CE2' ' A' ' 69' ' ' TYR . 51.2 t80 -88.89 126.4 35.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.662 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -84.46 141.29 30.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.44 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.19 -23.94 29.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.712 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.629 ' O ' ' CB ' ' A' ' 74' ' ' SER . 7.2 t-20 -85.0 -13.35 50.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.762 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.629 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 6.0 p 92.18 15.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.64 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -125.08 78.89 66.18 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.411 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.3 139.06 20.67 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.507 2.138 . . . . 0.0 112.454 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -108.46 158.61 17.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.146 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -130.36 136.97 49.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.869 0.366 . . . . 0.0 110.83 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.405 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 14.7 p -119.28 118.13 56.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.18 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.16 136.16 54.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.585 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.44 7.95 61.5 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.87 139.0 55.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.748 0.308 . . . . 0.0 110.562 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.56 ' O ' ' O ' ' A' ' 63' ' ' THR . 2.1 t -70.94 -53.1 22.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.293 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.87 154.13 80.25 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.609 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -66.24 155.08 71.59 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 122.91 2.407 . . . . 0.0 112.101 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.553 ' CG ' ' N ' ' A' ' 87' ' ' SER . 43.1 t-105 -123.54 -161.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.265 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.553 ' N ' ' CG ' ' A' ' 86' ' ' TRP . 99.7 p -139.69 150.82 45.33 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 120.604 0.24 . . . . 0.0 110.993 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.5 tp -128.16 147.06 50.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.219 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.484 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -108.62 120.26 41.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.804 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.0 mt -130.53 128.93 64.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.6 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.5 m -111.06 122.87 48.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.283 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.538 ' O ' ' C ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -124.7 130.62 52.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.816 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.538 ' C ' ' O ' ' A' ' 92' ' ' THR . 1.3 p30 24.31 -120.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.89 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -163.36 88.41 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.469 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -174.44 -159.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.549 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.57 119.56 24.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.374 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.2 t -114.39 142.19 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.796 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.4 ptp -128.29 166.02 19.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.005 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.94 145.77 12.62 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -116.08 115.11 25.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.349 . . . . 0.0 110.261 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.9 tt -132.41 135.28 58.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.61 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 93.7 t -128.03 150.24 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.463 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -122.81 140.93 52.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.39 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -118.93 77.74 1.21 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.667 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.01 159.66 23.1 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -82.16 46.6 1.04 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.85 0.357 . . . . 0.0 110.497 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 72.4 p -80.01 -174.66 4.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.577 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -124.77 9.97 8.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.59 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.1 t -171.09 122.48 0.57 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.936 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.583 ' O ' ' O ' ' A' ' 126' ' ' SER . 15.6 mt -142.23 152.47 18.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 120.824 0.345 . . . . 0.0 110.404 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.402 ' N ' ' CG2' ' A' ' 110' ' ' ILE . . . -176.59 158.68 25.01 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.654 ' SG ' ' O ' ' A' ' 124' ' ' ARG . 0.5 OUTLIER -118.03 167.76 11.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 0.0 110.674 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -159.39 123.95 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.312 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.3 mm -125.37 112.61 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.926 0.393 . . . . 0.0 110.782 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.78 135.62 55.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.458 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 t -118.79 150.8 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.559 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.437 ' HA ' ' N ' ' A' ' 51' ' ' MET . 37.4 t70 51.88 24.21 2.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.585 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.27 4.99 39.76 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -110.4 138.84 46.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.875 0.369 . . . . 0.0 110.69 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.4 p -86.17 119.34 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.502 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.5 -35.85 2.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.304 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.81 127.04 5.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.499 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -151.56 145.66 25.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.439 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.654 ' O ' ' SG ' ' A' ' 112' ' ' CYS . 1.8 ttt180 -116.36 123.44 47.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.699 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.0 p -138.95 116.25 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.619 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.583 ' O ' ' O ' ' A' ' 110' ' ' ILE . 51.4 m -133.81 121.74 22.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.443 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.95 137.32 36.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 110.773 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -155.01 134.02 12.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.333 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.2 t -68.1 129.52 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.559 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 40.32 69.78 0.29 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.402 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.21 89.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.488 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.65 93.8 1.51 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.737 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.502 ' O ' ' CG2' ' A' ' 133' ' ' THR . 89.6 m 58.61 52.3 7.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.958 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.422 ' CB ' ' O ' ' A' ' 133' ' ' THR . 1.4 t80 74.47 -167.86 0.1 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.889 0.376 . . . . 0.0 110.741 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . 0.647 ' O ' ' N ' ' A' ' 137' ' ' VAL . 0.8 OUTLIER -148.63 -58.1 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.501 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 54.53 -73.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.412 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.647 ' N ' ' O ' ' A' ' 135' ' ' CYS . 14.8 t 41.3 60.39 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.683 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -123.42 -10.42 7.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.474 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.7 p -46.7 97.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.561 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.544 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.445 179.936 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 12.4 mtm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -96.86 127.62 43.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.407 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.1 tt -96.84 115.79 28.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.594 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.93 137.23 53.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.674 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.454 ' OH ' ' CD2' ' A' ' 69' ' ' TYR . 23.8 p90 -120.07 149.56 42.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.979 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.473 ' CG ' ' N ' ' A' ' 57' ' ' ILE . 26.0 tt0 -155.59 156.03 34.35 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.34 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.485 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -115.85 175.74 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.956 179.296 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.63 145.61 36.85 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.028 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -168.66 160.45 33.95 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -43.48 155.59 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.707 2.272 . . . . 0.0 112.147 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.0 114.51 3.41 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.729 2.286 . . . . 0.0 112.053 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.02 15.49 30.72 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.3 m -79.31 139.06 37.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.829 0.347 . . . . 0.0 110.638 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.2 m -109.76 123.06 65.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.447 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.46 154.22 44.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.786 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.28 115.59 27.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.374 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.3 mm -102.05 121.59 53.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.587 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.3 t -135.59 120.3 18.36 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.916 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.454 ' CD2' ' OH ' ' A' ' 55' ' ' TYR . 22.7 p90 -141.26 158.05 44.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.869 0.366 . . . . 0.0 110.7 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -83.5 136.57 34.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.27 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.18 137.71 41.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.579 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.8 t -62.34 -18.69 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.4 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.554 ' O ' ' OG ' ' A' ' 74' ' ' SER . 3.0 m-20 -89.31 -0.19 57.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.696 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.554 ' OG ' ' O ' ' A' ' 73' ' ' ASN . 7.9 p 73.44 40.82 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.573 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -154.05 91.35 3.17 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.48 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.94 141.55 15.06 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.749 2.299 . . . . 0.0 112.315 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -107.24 147.97 29.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.478 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.431 ' NH1' ' HG3' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -135.91 133.09 37.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.676 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.7 t -112.88 118.87 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.66 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.1 116.61 32.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.376 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.27 20.87 16.56 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.43 153.86 25.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.368 . . . . 0.0 110.617 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.18 -39.49 8.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.374 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.63 152.48 28.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.5 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.485 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 19.8 Cg_endo -61.42 150.45 85.0 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.943 2.429 . . . . 0.0 112.363 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -128.75 -172.45 2.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.458 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 97.3 p -127.81 155.04 44.72 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.041 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.8 mp -130.99 148.19 52.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.859 0.361 . . . . 0.0 110.942 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' A' ' 89' ' ' HIS . 6.5 p80 -110.16 124.23 51.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.017 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.9 mt -129.01 134.79 63.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.926 0.394 . . . . 0.0 110.932 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.17 122.95 46.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.322 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.591 ' O ' ' N ' ' A' ' 94' ' ' ASP . 2.2 m -126.96 128.16 45.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.768 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.526 ' C ' ' O ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -29.2 -37.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.555 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 92' ' ' THR . 1.6 m-20 -66.03 -135.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.684 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.45 -35.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.385 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.72 137.45 52.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.558 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.0 t -150.09 124.28 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.581 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 5.5 mtt -96.55 131.31 43.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.605 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.23 146.79 18.88 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.505 ' O ' ' CG ' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -102.79 116.51 32.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.791 0.329 . . . . 0.0 110.453 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.0 tt -133.12 136.89 54.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.641 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.7 t -139.75 149.29 22.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.433 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -126.77 148.22 49.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.639 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -133.51 46.16 2.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.537 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -99.3 163.81 20.1 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.87 36.58 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.745 0.307 . . . . 0.0 110.535 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.431 ' H ' ' C ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -65.25 -167.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.646 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -122.78 -25.15 4.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.582 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.8 t -144.5 88.26 1.92 Allowed 'General case' 0 C--O 1.243 0.752 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.026 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 6.1 mt -100.6 149.2 6.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 120.833 0.349 . . . . 0.0 110.486 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.84 164.32 29.98 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 9.3 p -125.82 152.87 44.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.78 0.324 . . . . 0.0 110.698 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.06 141.11 24.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.491 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.9 mm -115.76 133.01 63.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.717 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.3 p -122.67 121.08 35.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.471 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.97 129.05 75.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.666 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.24 17.29 1.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.404 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 88.1 -8.57 77.87 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -101.45 147.5 26.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.322 . . . . 0.0 110.68 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.29 128.5 37.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.624 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.44 HH11 ' HB3' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -107.66 -65.53 1.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.401 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -149.34 127.28 11.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.042 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.31 130.27 12.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.036 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -111.97 115.6 29.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.918 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.58 124.93 72.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.054 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.4 m -127.6 126.28 41.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.04 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.09 129.22 40.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.008 0.432 . . . . 0.0 110.837 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -157.32 130.57 7.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.231 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.49 116.3 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.452 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.508 ' CG ' ' O ' ' A' ' 130' ' ' ASN . 4.7 t30 59.94 69.72 0.68 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.417 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.1 48.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.596 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.457 ' O ' ' C ' ' A' ' 133' ' ' THR . 54.4 t80 -140.25 10.0 2.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.529 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 134' ' ' TYR . 5.9 p 34.97 -125.87 0.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.787 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.598 ' N ' ' OG1' ' A' ' 133' ' ' THR . 23.4 m-85 -127.84 -168.62 1.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.625 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -158.48 173.81 16.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.417 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.405 ' CB ' ' O ' ' A' ' 135' ' ' CYS . 1.2 tt 74.89 -78.37 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.492 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.404 ' H ' ' HB3' ' A' ' 136' ' ' LEU . 3.3 t 64.52 118.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.448 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.426 ' HZ3' ' HG3' ' A' ' 138' ' ' LYS . 1.5 pttp -54.95 123.5 13.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.65 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.9 OUTLIER 60.44 138.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.647 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.551 179.942 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -116.0 128.79 56.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.341 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.493 ' CD1' ' O ' ' A' ' 53' ' ' LEU . 3.3 pp -96.27 120.51 36.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.928 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.58 133.95 50.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.68 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -120.86 149.59 42.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.378 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 1.072 ' HB2' ' HG ' ' A' ' 87' ' ' SER . 1.8 tm-20 -155.4 144.68 20.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.97 0.414 . . . . 0.0 110.923 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.461 HG22 HD13 ' A' ' 57' ' ' ILE . 34.6 mm -116.11 153.39 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.11 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -140.22 163.68 32.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.05 0.452 . . . . 0.0 111.04 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.34 171.23 43.49 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.505 ' O ' ' OG1' ' A' ' 63' ' ' THR . 53.9 Cg_exo -46.91 153.43 1.4 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.654 2.236 . . . . 0.0 111.985 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -64.68 119.59 6.66 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.721 2.281 . . . . 0.0 112.039 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.24 5.34 62.21 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 33.0 m -69.37 144.66 53.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 0.0 110.604 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 p -119.49 122.1 68.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.48 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.11 155.31 44.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.705 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.72 115.22 30.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.115 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 mp -90.36 127.7 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.829 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.4 t -128.13 116.06 19.36 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.021 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.512 ' CZ ' ' OD1' ' A' ' 71' ' ' ASP . 2.9 p90 -146.04 148.8 33.07 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.236 0.335 . . . . 0.0 110.413 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -88.13 121.37 30.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.379 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.512 ' OD1' ' CZ ' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -82.93 144.81 29.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.541 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.5 p -55.47 -11.02 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.95 0.405 . . . . 0.0 110.177 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 74' ' ' SER . 35.4 t30 -92.54 -8.97 42.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.417 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.563 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.5 p 85.24 3.74 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.423 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -114.29 95.82 40.51 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.52 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -79.38 139.54 14.68 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.552 2.168 . . . . 0.0 112.072 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -107.93 151.06 26.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -128.82 134.03 48.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.467 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.0 m -105.96 129.43 59.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.587 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 5.8 p-10 -111.98 132.88 54.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.697 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.16 28.65 63.82 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.51 147.63 52.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.799 0.333 . . . . 0.0 110.673 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.421 HG11 ' N ' ' A' ' 84' ' ' LEU . 10.0 p -100.3 -30.8 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.503 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.421 ' N ' HG11 ' A' ' 83' ' ' VAL . 2.6 tp -170.26 114.76 0.48 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.415 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -55.75 162.25 6.97 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.095 1.863 . . . . 0.0 111.895 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.465 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 7.1 m-90 -126.09 -150.7 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.558 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 1.072 ' HG ' ' HB2' ' A' ' 56' ' ' GLU . 59.1 m -121.87 165.5 15.81 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.004 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.78 150.18 35.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.783 0.325 . . . . 0.0 110.821 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -110.16 119.54 39.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.375 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.1 mt -126.57 135.53 63.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.627 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.41 123.41 48.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.598 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.55 ' O ' ' C ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -132.3 155.58 48.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.399 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.55 ' C ' ' O ' ' A' ' 92' ' ' THR . 3.4 p30 -26.73 124.06 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.668 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 93' ' ' ASN . 0.3 OUTLIER -32.08 98.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.449 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 93' ' ' ASN . . . 167.35 143.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.361 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.4 126.38 29.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.703 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.98 131.57 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.416 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.569 ' SD ' ' CB ' ' A' ' 122' ' ' ALA . 6.3 mtm -96.37 137.17 35.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.651 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.29 162.45 19.91 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -111.63 115.81 29.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.312 . . . . 0.0 110.64 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.1 tt -132.82 141.41 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.445 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.2 155.97 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 110.753 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -136.52 146.46 46.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.322 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -120.31 31.99 6.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.738 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.59 156.6 26.89 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -85.89 78.58 9.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.773 0.321 . . . . 0.0 110.405 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.6 m -107.5 179.18 4.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.637 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.56 -12.03 15.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.685 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.9 p -167.55 100.0 0.49 Allowed 'General case' 0 C--O 1.243 0.721 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.005 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' A' ' 110' ' ' ILE . 12.5 tt -132.36 132.27 60.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.846 0.355 . . . . 0.0 110.696 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -153.29 175.89 31.54 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 1.7 p -124.32 156.75 36.44 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.725 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -160.95 139.58 10.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.428 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.5 mp -126.94 118.0 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.906 0.384 . . . . 0.0 110.765 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.7 t -116.83 128.3 55.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.3 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.9 t -121.0 155.81 24.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.818 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 58.44 14.34 2.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.597 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.5 9.47 78.03 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -116.51 140.07 49.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.774 0.321 . . . . 0.0 110.56 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.89 132.41 33.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.43 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -129.33 -74.94 0.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.573 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.569 ' CB ' ' SD ' ' A' ' 98' ' ' MET . . . -125.47 129.0 48.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.679 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -149.49 133.06 16.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.637 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.9 mmt-85 -105.97 119.93 40.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.481 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 84.9 t -113.05 116.24 52.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.73 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.7 m -133.94 117.04 16.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.144 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.437 ' ND2' ' N ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -114.53 129.55 56.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.838 0.352 . . . . 0.0 110.877 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -154.97 130.62 9.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.42 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.7 t -85.56 139.26 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.756 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 60.76 42.52 13.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.697 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.25 151.95 34.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.491 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 53.98 103.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.558 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 134' ' ' TYR . 90.4 m -164.25 -71.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.565 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.453 ' O ' ' CB ' ' A' ' 135' ' ' CYS . 0.4 OUTLIER 47.97 -177.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.671 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . 0.471 ' O ' ' O ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER 77.81 16.11 1.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.773 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 135' ' ' CYS . 0.5 OUTLIER 39.51 95.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.509 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.656 ' O ' ' N ' ' A' ' 139' ' ' SER . 3.2 m -144.5 5.26 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.945 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.24 -70.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.419 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.656 ' N ' ' O ' ' A' ' 137' ' ' VAL . 8.3 p -133.39 -174.07 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.368 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 139' ' ' SER . . . . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.543 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.404 ' H2 ' ' CG2' ' A' ' 116' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -97.41 118.24 33.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.214 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.484 ' C ' ' CD1' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -96.0 115.2 27.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.767 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.444 ' N ' HD13 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -127.32 130.48 49.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.493 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.5 ' OH ' ' CZ ' ' A' ' 69' ' ' TYR . 33.0 p90 -119.97 148.71 43.2 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.274 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.847 ' HB2' ' HG ' ' A' ' 87' ' ' SER . 1.7 tm-20 -156.05 136.43 13.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.9 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.513 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 4.2 mp -99.15 167.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.745 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.404 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -132.79 163.65 28.59 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.145 -179.576 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.98 142.65 4.98 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -41.79 155.92 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.513 2.142 . . . . 0.0 112.202 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.07 134.77 28.1 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.76 2.306 . . . . 0.0 112.188 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.84 -4.16 71.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.56 ' O ' ' O ' ' A' ' 83' ' ' VAL . 15.7 m -86.64 130.84 34.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.0 110.723 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.36 126.11 60.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.428 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -136.72 152.85 50.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.661 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -106.45 116.56 32.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.361 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 mp -96.3 131.7 42.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.5 t -134.69 123.84 24.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.003 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.5 ' CZ ' ' OH ' ' A' ' 55' ' ' TYR . 37.3 p90 -151.48 170.76 18.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.909 0.385 . . . . 0.0 110.624 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.64 ' CE1' ' O ' ' A' ' 74' ' ' SER . 27.3 t80 -88.74 134.55 33.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.29 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 73' ' ' ASN . 0.9 OUTLIER -109.48 141.57 41.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.831 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.443 ' O ' ' CG1' ' A' ' 72' ' ' VAL . 17.2 t -52.73 -11.44 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.328 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.629 ' O ' ' CB ' ' A' ' 74' ' ' SER . 49.8 m-80 -83.86 1.26 44.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.461 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.64 ' O ' ' CE1' ' A' ' 70' ' ' PHE . 0.9 OUTLIER 92.27 -75.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.763 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.85 135.34 86.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.583 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.15 143.57 28.75 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.554 2.169 . . . . 0.0 112.133 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -104.12 135.97 44.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.392 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.8 125.93 24.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.861 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.2 m -109.07 127.14 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.425 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.664 ' OD1' ' N ' ' A' ' 81' ' ' GLY . 13.1 t0 -126.39 150.35 48.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.866 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.664 ' N ' ' OD1' ' A' ' 80' ' ' ASP . . . 85.21 12.19 74.08 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.37 140.63 30.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.746 0.308 . . . . 0.0 110.632 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.56 ' O ' ' O ' ' A' ' 63' ' ' THR . 1.5 p -81.66 -33.77 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.473 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.25 152.51 64.53 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.479 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.513 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 20.5 Cg_endo -62.41 160.48 31.35 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.888 2.392 . . . . 0.0 112.066 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.573 ' CD1' ' N ' ' A' ' 86' ' ' TRP . 10.5 m95 -123.6 172.65 8.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.395 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.847 ' HG ' ' HB2' ' A' ' 56' ' ' GLU . 70.5 m -114.83 144.8 42.94 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.032 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 89' ' ' HIS . 0.6 OUTLIER -131.35 141.02 49.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.853 0.358 . . . . 0.0 110.778 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.608 ' N ' ' CD2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -108.59 123.29 48.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.305 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.3 mt -129.35 124.17 59.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.932 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.506 ' H ' ' HG1' ' A' ' 91' ' ' THR . 0.1 OUTLIER -111.21 123.27 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.212 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.6 m -126.38 133.67 51.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 110.98 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.558 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 26.0 t-20 39.69 32.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.983 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.536 ' C ' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER 28.8 59.68 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.612 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.45 -146.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.385 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -119.47 123.29 43.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.5 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.2 p -159.71 139.7 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.645 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.51 177.66 5.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.649 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -138.14 162.73 25.68 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.527 ' N ' ' ND2' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -118.81 116.51 26.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.699 0.285 . . . . 0.0 110.561 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -133.33 142.54 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.805 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 98.5 t -121.97 146.66 26.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.206 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -140.08 138.86 35.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.959 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -131.39 102.28 5.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.208 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -131.04 163.83 23.42 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -78.97 19.69 0.52 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.853 0.359 . . . . 0.0 110.274 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.444 ' H ' ' C ' ' A' ' 105' ' ' GLY . 6.1 p -69.04 -171.72 0.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.64 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.83 8.23 12.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.675 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.0 p -172.79 104.84 0.15 Allowed 'General case' 0 C--O 1.242 0.686 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 126' ' ' SER . 2.9 mt -126.55 136.93 59.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 120.807 0.337 . . . . 0.0 110.341 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.54 175.98 41.8 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -126.18 167.54 15.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.762 0.315 . . . . 0.0 110.603 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -157.43 140.36 15.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.437 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.455 HD11 ' N ' ' A' ' 114' ' ' ILE . 3.6 mp -124.42 114.99 43.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.689 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.54 123.88 41.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.429 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.619 ' C ' ' H ' ' A' ' 118' ' ' GLY . 10.8 p -135.15 151.22 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.706 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 117' ' ' ASP . 13.2 t70 53.03 2.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.579 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.619 ' H ' ' C ' ' A' ' 116' ' ' VAL . . . 88.53 9.37 69.29 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -123.77 127.92 48.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.723 0.297 . . . . 0.0 110.629 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.5 p -80.03 136.47 23.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.425 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.38 -52.91 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.877 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -150.86 128.31 11.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.602 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.74 126.79 9.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.806 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -96.0 118.87 33.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.406 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.0 t -121.0 116.59 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.83 0.348 . . . . 0.0 110.885 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.57 ' C ' HD21 ' A' ' 127' ' ' ASN . 0.3 OUTLIER -134.03 116.09 15.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.456 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.768 ' N ' HD21 ' A' ' 127' ' ' ASN . 0.6 OUTLIER -100.16 132.51 45.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.569 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -136.25 138.66 42.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.502 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 26.4 m -68.22 -6.14 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.588 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -161.6 92.64 0.88 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.615 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -86.49 -37.55 18.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.489 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.688 ' CG ' ' N ' ' A' ' 133' ' ' THR . 51.0 t80 -73.99 -178.11 3.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.516 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.688 ' N ' ' CG ' ' A' ' 132' ' ' TYR . 65.0 p -133.4 -115.83 0.21 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.628 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -166.59 -24.69 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.523 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.58 118.15 3.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.802 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.0 mt -143.01 -173.34 3.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.553 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 138' ' ' LYS . 2.3 t -149.35 -15.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.602 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.542 ' O ' ' O ' ' A' ' 139' ' ' SER . 0.0 OUTLIER -37.24 105.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.436 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.542 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.6 OUTLIER 45.33 104.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.451 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.641 -179.923 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.6 mtt . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -92.76 129.03 38.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.461 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 tt -95.63 118.02 31.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.513 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.3 135.08 51.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.596 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.538 ' HH ' ' CD2' ' A' ' 88' ' ' LEU . 1.2 p90 -120.34 148.62 43.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.409 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.776 ' HB2' ' HG ' ' A' ' 87' ' ' SER . 0.3 OUTLIER -156.38 138.58 14.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.8 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.449 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 1.3 mm -105.95 174.73 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.905 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -133.36 171.94 13.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.991 0.424 . . . . 0.0 110.963 -179.591 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.86 147.13 5.07 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -39.16 152.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.758 2.306 . . . . 0.0 112.171 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -67.18 123.86 11.43 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.781 2.321 . . . . 0.0 112.151 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.87 -7.76 60.99 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -69.99 134.89 48.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.743 0.306 . . . . 0.0 110.493 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.9 t -111.7 125.71 69.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.632 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -141.13 155.37 46.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.371 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -98.9 123.15 42.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.717 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 52.2 mt -102.74 124.15 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.433 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 42.1 t -122.32 117.51 26.26 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.059 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.597 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 35.9 t80 -143.35 158.31 43.75 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.79 0.329 . . . . 0.0 110.489 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.597 ' O ' ' CE2' ' A' ' 69' ' ' TYR . 68.1 t80 -85.31 134.68 34.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.572 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' A' ' 73' ' ' ASN . 27.9 t0 -103.94 126.12 50.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.611 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.5 t -62.29 -5.49 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.687 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.647 ' O ' ' CB ' ' A' ' 74' ' ' SER . 63.3 m-20 -85.72 -22.32 27.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.615 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.647 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 2.3 p 146.24 -99.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.547 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.99 147.64 98.35 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.65 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.58 154.9 50.06 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.719 2.28 . . . . 0.0 112.152 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -90.25 149.37 22.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.396 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ttp85 -152.59 133.17 13.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.737 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.05 136.66 52.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.414 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.537 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 1.0 OUTLIER -127.36 121.62 31.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.709 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.36 26.78 32.26 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.33 128.31 34.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.752 0.311 . . . . 0.0 110.626 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.4 t -67.87 -31.56 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.496 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -161.54 156.5 20.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.491 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.449 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 11.6 Cg_endo -57.01 149.17 63.93 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.893 2.396 . . . . 0.0 112.282 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -120.6 -178.0 3.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.29 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.776 ' HG ' ' HB2' ' A' ' 56' ' ' GLU . 74.9 m -120.49 141.7 49.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.005 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.538 ' CD2' ' HH ' ' A' ' 55' ' ' TYR . 0.4 OUTLIER -128.37 139.61 52.29 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.596 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.659 ' H ' ' ND1' ' A' ' 89' ' ' HIS . 2.1 p-80 -114.83 127.79 55.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 0.0 110.963 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.405 HD12 HG21 ' A' ' 90' ' ' ILE . 96.4 mt -127.62 134.48 65.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.155 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -103.69 122.74 45.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.601 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.649 ' C ' ' H ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER -127.83 135.12 49.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.665 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 93' ' ' ASN . 0.5 OUTLIER -67.94 24.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.296 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.649 ' H ' ' C ' ' A' ' 92' ' ' THR . 2.2 t70 -114.07 0.87 14.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.536 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 60.7 -84.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.632 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.03 113.5 21.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.501 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.61 160.59 24.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.679 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.443 ' CG ' ' N ' ' A' ' 99' ' ' GLY . 4.3 ttt -130.15 158.21 40.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.381 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.443 ' N ' ' CG ' ' A' ' 98' ' ' MET . . . -156.38 152.3 23.7 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -110.47 117.46 33.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.864 0.364 . . . . 0.0 110.445 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.9 tt -132.08 137.48 54.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.535 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.2 t -138.05 149.93 24.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.554 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -120.79 150.24 41.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.58 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -135.59 79.46 1.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.646 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -131.64 161.24 23.69 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.582 ' N ' ' ND2' ' A' ' 106' ' ' ASN . 0.4 OUTLIER -79.07 28.57 0.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.84 0.352 . . . . 0.0 110.405 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.46 ' H ' ' HG ' ' A' ' 107' ' ' SER . 0.0 OUTLIER -62.96 -166.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.598 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 108' ' ' ASP . 1.4 m-20 -114.75 -28.25 7.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.668 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.4 t -141.74 126.68 18.26 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.898 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.509 ' O ' ' O ' ' A' ' 126' ' ' SER . 23.0 mt -135.67 154.1 34.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.412 ' N ' ' CG2' ' A' ' 110' ' ' ILE . . . 174.69 159.23 20.59 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 124' ' ' ARG . 5.7 p -117.93 161.46 19.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.766 0.317 . . . . 0.0 110.339 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -161.3 136.87 7.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.664 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.1 mt -127.5 122.77 60.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.416 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.45 139.6 51.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.53 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.6 m -133.06 135.27 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.682 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 53.23 30.65 10.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.67 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.98 -1.58 23.22 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -109.31 136.01 49.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.331 . . . . 0.0 110.556 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.9 t -77.54 128.7 38.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.779 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.95 -63.91 1.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.379 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.93 127.21 45.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -149.38 131.83 15.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.993 0.425 . . . . 0.0 111.066 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.475 ' O ' ' SG ' ' A' ' 112' ' ' CYS . 3.0 ttp180 -121.48 115.52 23.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.897 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.524 ' O ' ' CG2' ' A' ' 125' ' ' VAL . 1.1 m -111.16 125.59 68.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.907 0.384 . . . . 0.0 111.025 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.7 OUTLIER -131.46 115.93 16.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.016 179.473 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -101.81 131.01 48.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.885 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -156.63 136.64 12.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.613 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 20.4 t -88.99 140.95 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.568 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 46.02 53.75 8.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.272 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.42 113.02 4.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.631 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 65.75 115.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.522 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -133.94 169.4 17.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.287 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -171.52 73.58 0.05 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.998 0.428 . . . . 0.0 110.635 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . 0.701 ' SG ' ' N ' ' A' ' 136' ' ' LEU . 0.1 OUTLIER -129.72 163.99 24.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.448 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.701 ' N ' ' SG ' ' A' ' 135' ' ' CYS . 0.3 OUTLIER -110.59 105.62 14.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.684 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.7 m -107.8 -176.09 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.485 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.462 ' O ' ' C ' ' A' ' 139' ' ' SER . 32.7 mtmt -120.01 -66.31 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.551 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.462 ' C ' ' O ' ' A' ' 138' ' ' LYS . 31.3 t -35.49 -74.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.528 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.561 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.587 179.85 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.3 mtm . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -114.88 128.74 56.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.465 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.444 ' CD2' ' O ' ' A' ' 97' ' ' VAL . 14.5 tp -96.13 114.86 26.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.449 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.5 p -127.78 129.95 47.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.563 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.456 ' CD1' ' C ' ' A' ' 55' ' ' TYR . 26.0 p90 -123.47 148.33 46.31 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.474 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.748 ' HB2' ' HG ' ' A' ' 87' ' ' SER . 10.4 tt0 -156.65 133.53 10.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.777 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.563 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 1.9 mp -98.76 158.31 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.854 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.49 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -132.3 166.26 22.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.912 0.387 . . . . 0.0 110.781 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.66 163.16 19.88 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.06 109.61 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.655 2.237 . . . . 0.0 112.119 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -45.79 141.87 8.17 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.517 2.145 . . . . 0.0 112.008 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.53 -13.31 56.75 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.6 p -83.03 137.76 34.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.716 0.293 . . . . 0.0 110.56 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.9 m -103.31 132.37 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.739 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.49 153.83 43.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.306 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -97.27 114.88 26.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.623 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.456 ' N ' HD13 ' A' ' 67' ' ' ILE . 1.8 mp -87.71 122.67 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.583 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.4 t -130.26 116.28 18.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.98 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.61 ' CZ ' ' O ' ' A' ' 70' ' ' PHE . 16.3 t80 -149.86 149.43 30.47 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.822 0.344 . . . . 0.0 110.575 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.61 ' O ' ' CZ ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -84.71 130.53 34.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.389 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.67 ' OD1' ' N ' ' A' ' 72' ' ' VAL . 67.9 t0 -93.87 146.38 23.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.802 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.67 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 89.7 t -69.59 -34.3 60.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.46 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -81.01 11.76 3.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.761 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.9 m 61.49 71.4 0.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.61 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.461 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 3.2 tt0 -178.66 77.73 0.22 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.379 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.66 144.25 99.47 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.96 2.44 . . . . 0.0 112.177 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -107.66 134.85 50.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.382 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 mtm-85 -134.08 126.92 31.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.922 0.391 . . . . 0.0 110.656 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 t -115.94 119.77 62.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.513 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -108.51 121.6 45.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.566 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.21 15.38 38.68 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.72 130.59 43.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 0.0 110.648 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.3 t -73.47 -35.17 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.294 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.407 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -149.76 157.36 38.35 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.507 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.563 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 18.6 Cg_endo -61.33 157.08 42.3 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.989 2.459 . . . . 0.0 112.107 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -129.26 176.93 7.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.356 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.748 ' HG ' ' HB2' ' A' ' 56' ' ' GLU . 59.7 m -114.19 161.58 17.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.98 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.0 tp -147.98 134.97 20.24 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.244 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -109.15 126.36 53.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.841 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.415 HD11 ' N ' ' A' ' 90' ' ' ILE . 4.6 mp -130.46 136.79 57.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.388 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.6 p -122.63 130.03 52.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.524 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.676 ' O ' ' N ' ' A' ' 94' ' ' ASP . 2.0 m -113.3 156.11 23.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.696 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.551 ' O ' ' C ' ' A' ' 94' ' ' ASP . 11.2 t30 -28.59 84.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.786 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.676 ' N ' ' O ' ' A' ' 92' ' ' THR . 10.3 m-20 23.6 92.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.707 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 172.06 140.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.652 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.5 140.01 33.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.234 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.444 ' O ' ' CD2' ' A' ' 53' ' ' LEU . 9.2 p -150.86 142.97 16.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 110.888 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.547 ' N ' ' SD ' ' A' ' 98' ' ' MET . 3.1 mmt -93.31 161.13 14.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.129 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.43 154.7 20.99 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.383 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.433 HD21 ' N ' ' A' ' 100' ' ' ASN . 1.5 m-80 -109.92 115.38 29.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.681 0.277 . . . . 0.0 110.263 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.4 tt -131.96 142.38 43.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.957 0.408 . . . . 0.0 110.981 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.0 t -139.98 145.82 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.357 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -143.51 151.73 40.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.763 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.46 103.89 7.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.529 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.58 161.71 23.7 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.521 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.8 OUTLIER -82.87 54.92 2.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 0.0 110.574 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.27 -167.13 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.45 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -118.24 -10.94 10.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.618 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 t -154.84 102.41 2.35 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.56 ' O ' ' O ' ' A' ' 126' ' ' SER . 3.7 mt -127.23 127.06 68.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.854 0.359 . . . . 0.0 110.3 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.04 172.26 33.95 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.564 ' O ' ' O ' ' A' ' 124' ' ' ARG . 31.6 p -125.08 161.53 26.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.768 0.318 . . . . 0.0 110.694 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -156.41 147.04 21.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.496 179.799 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.8 mp -121.57 117.18 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 110.82 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.78 129.4 51.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.284 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.531 ' C ' ' H ' ' A' ' 118' ' ' GLY . 27.3 m -136.5 144.49 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.917 0.389 . . . . 0.0 110.969 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' A' ' 117' ' ' ASP . 21.7 t0 44.93 13.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.84 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 116' ' ' VAL . . . 83.64 -2.25 87.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 116' ' ' VAL . 4.6 ttmt -102.99 126.07 50.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.387 . . . . 0.0 110.396 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 20.9 t -80.86 140.33 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.631 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.415 ' NH1' ' HG3' ' A' ' 121' ' ' ARG . 1.7 mmm-85 -128.87 -48.94 1.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.497 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.91 135.99 9.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.535 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -149.54 155.9 41.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.502 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.564 ' O ' ' O ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -124.61 116.13 21.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.517 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.5 t -121.26 117.25 52.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.567 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.56 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.6 OUTLIER -130.54 121.75 26.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.588 -179.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.477 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -94.53 129.84 41.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.241 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -132.25 139.98 48.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.812 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.25 -8.98 12.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.413 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 132' ' ' TYR . 0.4 OUTLIER 178.93 82.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.41 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.82 71.25 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.675 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 130' ' ' ASN . 81.5 t80 -172.43 117.72 0.35 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.583 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.1 161.0 36.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.64 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.492 ' O ' ' O ' ' A' ' 135' ' ' CYS . 0.1 OUTLIER -65.06 91.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.394 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . 0.492 ' O ' ' O ' ' A' ' 134' ' ' TYR . 34.1 m -48.57 -174.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.7 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 45.34 88.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.759 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.35 84.5 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.491 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.43 94.88 5.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.55 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.1 t -171.18 56.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.435 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.53 -179.844 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.616 ' SD ' ' OD1' ' A' ' 117' ' ' ASP . 41.7 mtm . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.17 129.14 55.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.453 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.444 ' CD2' ' C ' ' A' ' 53' ' ' LEU . 7.0 tt -95.52 114.79 26.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.962 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.33 135.76 50.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 55' ' ' TYR . 26.8 p90 -130.13 149.3 51.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.096 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.981 ' OE1' ' OG ' ' A' ' 87' ' ' SER . 15.5 tt0 -155.64 150.72 26.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.963 0.411 . . . . 0.0 111.079 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.408 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 7.1 tt -112.1 163.21 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.887 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.642 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -139.96 165.08 28.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 110.993 -179.469 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.6 171.37 44.33 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -47.85 112.74 0.61 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.716 2.277 . . . . 0.0 111.976 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -44.62 146.79 2.01 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.431 2.087 . . . . 0.0 112.267 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.78 -10.7 59.2 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.411 HG21 ' N ' ' A' ' 64' ' ' VAL . 24.1 m -79.37 139.18 37.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 110.661 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.411 ' N ' HG21 ' A' ' 63' ' ' THR . 9.7 t -102.48 122.95 55.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.496 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.87 140.96 36.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.695 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -101.04 116.07 31.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.31 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.9 tt -102.06 138.4 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.81 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.2 t -124.48 118.67 27.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.949 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -128.19 167.12 17.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.756 0.312 . . . . 0.0 110.55 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -99.62 134.83 41.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.313 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -95.75 139.14 32.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.68 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -54.91 -29.77 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.549 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.577 ' N ' HD21 ' A' ' 73' ' ' ASN . 1.6 m120 -84.19 2.93 37.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.523 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.563 ' HG ' ' C ' ' A' ' 73' ' ' ASN . 0.7 OUTLIER 76.99 10.1 2.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.508 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -110.43 91.39 11.78 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.401 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.92 139.83 17.73 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.624 2.216 . . . . 0.0 112.309 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -107.83 158.35 17.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.592 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -145.58 126.35 14.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.624 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.0 m -108.21 135.57 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.499 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -128.96 132.96 47.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.74 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.31 17.65 42.02 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.87 149.44 36.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.837 0.351 . . . . 0.0 110.754 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.35 -42.43 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.302 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.49 154.07 56.1 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.187 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.28 147.37 47.39 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 122.96 2.44 . . . . 0.0 112.266 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.534 ' CD1' ' N ' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -114.23 -162.75 0.83 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.256 179.709 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.981 ' OG ' ' OE1' ' A' ' 56' ' ' GLU . 70.3 m -116.59 153.53 32.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.986 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 mt -128.23 141.74 51.37 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.737 0.303 . . . . 0.0 110.506 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.34 119.92 40.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.509 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.45 HG23 HD11 ' A' ' 90' ' ' ILE . 26.2 mm -126.7 121.55 58.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.75 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 p -105.38 122.48 46.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.344 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.2 m -122.08 149.25 43.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.716 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -86.83 31.31 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.454 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.575 ' C ' ' H ' ' A' ' 96' ' ' ALA . 32.8 m-20 -114.52 -4.07 12.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.548 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 70.77 -28.52 0.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.713 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.575 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -156.62 138.15 14.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.701 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.3 p -174.9 144.7 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.429 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -104.3 154.3 19.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.777 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -122.02 159.03 16.7 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.25 122.13 46.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.719 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.8 pt -132.53 139.52 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.531 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 103' ' ' ALA . 75.0 t -123.43 159.31 28.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.349 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.439 ' N ' ' CG1' ' A' ' 102' ' ' VAL . . . -131.05 152.08 50.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.982 0.42 . . . . 0.0 110.612 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.91 64.05 1.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.328 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.455 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -130.97 163.99 23.35 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.7 20.39 0.45 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 0.0 110.558 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.603 ' OG ' ' N ' ' A' ' 108' ' ' ASP . 6.0 t -53.47 -173.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.626 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.603 ' N ' ' OG ' ' A' ' 107' ' ' SER . 37.4 t0 -119.61 -73.44 0.64 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.615 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.691 ' OG ' ' ND2' ' A' ' 127' ' ' ASN . 30.1 t -89.21 122.12 32.18 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.975 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 126' ' ' SER . 12.7 mt -130.46 139.44 51.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.828 0.347 . . . . 0.0 110.5 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.17 144.36 7.98 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 10.7 p -117.96 156.91 27.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.73 0.3 . . . . 0.0 110.476 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -159.96 146.04 15.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.899 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.493 ' CD1' ' N ' ' A' ' 114' ' ' ILE . 3.8 mp -131.83 122.05 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.368 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.0 t -118.68 140.94 49.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.679 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.494 ' C ' ' H ' ' A' ' 118' ' ' GLY . 31.1 m -124.17 144.72 32.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.559 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.616 ' OD1' ' SD ' ' A' ' 51' ' ' MET . 0.5 OUTLIER 52.94 9.77 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.575 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 116' ' ' VAL . . . 88.02 5.6 76.75 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.6 mtmt -106.44 127.33 53.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.748 0.309 . . . . 0.0 110.512 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.5 m -70.9 118.84 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.74 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -103.44 -72.94 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.479 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -135.31 128.09 31.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.315 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -146.9 123.85 11.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.0 mtt-85 -100.61 115.46 30.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.286 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.9 t -123.98 117.25 50.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.61 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.2 OUTLIER -132.99 122.67 24.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.406 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.691 ' ND2' ' OG ' ' A' ' 109' ' ' SER . 11.3 m120 -94.2 129.74 40.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.342 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -152.85 130.74 11.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.718 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 129' ' ' VAL . 13.7 p -65.06 104.36 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.554 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.576 ' N ' HD21 ' A' ' 130' ' ' ASN . 1.0 OUTLIER 66.79 81.76 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.56 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.11 157.51 28.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.606 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.405 ' O ' ' C ' ' A' ' 133' ' ' THR . 4.4 m-85 59.84 -87.41 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.56 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 132' ' ' TYR . 0.8 OUTLIER -38.82 134.1 1.02 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.604 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.49 ' O ' ' O ' ' A' ' 135' ' ' CYS . 0.2 OUTLIER -125.32 -30.26 3.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.511 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 134' ' ' TYR . 0.0 OUTLIER -54.92 -157.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.44 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.86 -9.67 1.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.648 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 138' ' ' LYS . 79.4 t -147.3 132.72 11.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.754 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 137' ' ' VAL . 4.9 tttm 76.88 -177.26 0.12 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.727 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 139' ' ' SER . 1.3 t -128.89 6.07 5.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.515 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.56 -179.951 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -114.24 128.0 56.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.445 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.404 ' O ' ' CG ' ' A' ' 53' ' ' LEU . 2.2 pp -95.9 116.06 28.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.334 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.9 t -123.76 144.8 49.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.77 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.438 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -119.48 149.41 41.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.013 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.573 ' HB2' ' HG ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -155.76 136.88 13.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.946 0.403 . . . . 0.0 111.087 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.492 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 21.0 mt -116.31 161.81 14.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.002 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.474 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -141.32 151.02 43.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.018 0.437 . . . . 0.0 110.662 -179.878 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -165.93 168.83 39.93 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -46.11 144.72 6.06 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.651 2.234 . . . . 0.0 111.781 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -64.29 120.48 7.82 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.592 2.195 . . . . 0.0 112.17 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.09 2.94 59.13 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.579 ' O ' ' O ' ' A' ' 83' ' ' VAL . 6.7 t -78.71 141.48 37.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.861 0.363 . . . . 0.0 110.665 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.8 m -101.79 128.2 54.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.621 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.35 144.73 33.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.839 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.45 116.32 32.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.247 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.7 mt -101.03 124.71 54.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.023 0.439 . . . . 0.0 111.006 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.5 t -135.63 124.35 23.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.992 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' A' ' 69' ' ' TYR . 23.9 p90 -147.94 169.01 20.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.909 0.385 . . . . 0.0 110.965 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -87.35 125.7 34.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.455 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -90.95 155.07 19.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.632 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 73' ' ' ASN . 5.3 p -51.77 -37.07 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.495 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 74' ' ' SER . 0.9 OUTLIER -85.16 11.75 9.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.473 179.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.516 ' O ' ' C ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER 81.19 -68.03 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.313 -179.729 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.516 ' C ' ' O ' ' A' ' 74' ' ' SER . 5.6 tt0 -31.91 104.14 0.22 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.136 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -76.7 139.86 20.43 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.317 2.011 . . . . 0.0 112.318 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.79 147.66 24.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.498 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -144.73 130.01 18.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.465 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.9 m -109.8 124.5 66.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.411 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.01 117.99 31.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.73 16.73 27.93 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.86 135.66 48.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.774 0.321 . . . . 0.0 110.5 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.579 ' O ' ' O ' ' A' ' 63' ' ' THR . 0.5 OUTLIER -81.17 -38.68 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.659 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.16 157.06 43.24 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.119 0.485 . . . . 0.0 110.578 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.492 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 38.0 Cg_endo -68.82 160.31 50.19 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.867 2.378 . . . . 0.0 112.227 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.93 -169.65 2.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.498 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.573 ' HG ' ' HB2' ' A' ' 56' ' ' GLU . 70.5 m -133.83 144.98 49.3 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.952 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.3 tp -138.32 155.64 48.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.627 0.251 . . . . 0.0 110.398 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -115.82 135.37 54.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 110.984 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.7 mt -129.23 130.32 67.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.249 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.4 t -115.35 129.21 56.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.771 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.557 ' O ' ' C ' ' A' ' 93' ' ' ASN . 14.0 m -129.97 125.42 35.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.226 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.557 ' C ' ' O ' ' A' ' 92' ' ' THR . 1.9 m120 26.26 -104.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.544 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 94' ' ' ASP . 4.8 p-10 -160.05 81.23 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.484 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -167.43 147.41 5.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.664 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.36 127.21 33.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.361 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -140.56 150.07 21.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -102.39 172.59 6.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.208 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -138.44 161.8 25.72 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.534 ' C ' ' OD1' ' A' ' 100' ' ' ASN . 16.2 t-20 -114.96 115.22 26.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 0.0 110.498 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.7 tt -130.98 141.42 46.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.505 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.42 HG13 ' H ' ' A' ' 103' ' ' ALA . 77.8 t -129.36 155.43 41.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.879 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.42 ' H ' HG13 ' A' ' 102' ' ' VAL . . . -121.31 147.24 45.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.562 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.49 54.26 1.95 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.812 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.65 162.97 20.72 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.98 89.83 4.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.853 0.359 . . . . 0.0 110.448 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.2 p -117.82 177.7 4.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.774 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -116.91 -0.01 12.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.439 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.1 p -170.46 84.52 0.11 Allowed 'General case' 0 C--O 1.245 0.853 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.047 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.468 ' O ' ' CG2' ' A' ' 110' ' ' ILE . 0.4 OUTLIER -109.96 128.97 65.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 120.9 0.381 . . . . 0.0 110.774 -179.752 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -152.86 164.41 30.78 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 20.3 m -125.0 153.24 43.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.928 0.394 . . . . 0.0 110.727 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -159.87 144.89 15.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.309 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.438 HD13 ' CE2' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -126.56 133.67 68.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.833 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.8 m -122.79 124.02 42.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.432 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.454 ' C ' ' H ' ' A' ' 118' ' ' GLY . 0.5 OUTLIER -131.84 148.78 32.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.556 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.0 t0 49.87 13.46 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.691 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 116' ' ' VAL . . . 84.64 -0.14 89.22 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.62 138.34 50.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.717 0.294 . . . . 0.0 110.586 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.3 t -85.41 118.67 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.53 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -90.37 -62.09 1.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.5 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -114.7 131.75 56.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.449 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -129.52 121.75 27.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.773 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.457 ' O ' ' CG ' ' A' ' 124' ' ' ARG . 11.8 ptm180 -128.49 123.19 32.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.293 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.8 t -122.5 120.25 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.63 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.42 115.94 18.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.637 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -95.08 130.18 41.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.211 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -150.4 130.57 13.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.761 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.07 18.34 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.993 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.412 ' CG ' ' O ' ' A' ' 130' ' ' ASN . 2.4 t-20 -179.09 65.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.409 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.46 124.0 26.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.627 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.667 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 1.5 t80 -165.89 -25.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.425 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 30.7 p -101.57 -163.75 1.04 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.634 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.565 ' O ' ' N ' ' A' ' 136' ' ' LEU . 0.9 OUTLIER -111.58 44.25 1.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.669 -179.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.62 84.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.434 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' A' ' 134' ' ' TYR . 4.8 mt -66.65 82.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.532 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.6 t -132.35 155.32 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.433 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -87.49 -50.92 6.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.676 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.0 m -151.35 -136.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.538 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.574 -179.888 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.66 127.85 54.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.481 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.453 ' CD1' ' O ' ' A' ' 97' ' ' VAL . 1.5 tt -96.12 115.72 27.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.416 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.62 130.95 51.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.667 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -119.98 149.01 42.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.2 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.578 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 2.6 tm-20 -156.03 146.76 21.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.984 0.421 . . . . 0.0 111.002 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.462 HG22 HD12 ' A' ' 57' ' ' ILE . 74.7 mt -114.73 159.96 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.761 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 59' ' ' GLY . 11.8 t80 -140.28 156.86 46.3 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.245 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.589 ' N ' ' CD1' ' A' ' 58' ' ' PHE . . . -160.72 175.04 37.45 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.478 ' O ' ' OG1' ' A' ' 63' ' ' THR . 50.0 Cg_exo -50.93 157.98 3.44 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.623 2.216 . . . . 0.0 111.979 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -75.27 118.66 5.27 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.803 2.335 . . . . 0.0 112.187 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.03 9.9 55.5 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -83.77 150.67 25.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.785 0.326 . . . . 0.0 110.442 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.06 121.98 60.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.569 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.38 153.55 42.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.529 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.92 115.71 27.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.401 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.1 mm -93.24 132.73 36.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.853 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.5 t -135.8 127.54 29.15 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.909 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.454 ' CG ' ' N ' ' A' ' 70' ' ' PHE . 40.1 t80 -150.46 157.34 42.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.801 0.334 . . . . 0.0 110.678 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 12.9 t80 -87.44 124.35 33.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.439 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.83 156.81 22.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.483 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.454 HG11 ' N ' ' A' ' 73' ' ' ASN . 4.7 p -59.29 -30.84 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.473 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 74' ' ' SER . 34.9 m120 -95.72 11.6 32.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.31 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.63 ' OG ' ' N ' ' A' ' 75' ' ' GLU . 1.1 p 85.19 -69.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.379 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.63 ' N ' ' OG ' ' A' ' 74' ' ' SER . 11.4 pt-20 -29.63 94.86 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.495 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.498 ' N ' ' O ' ' A' ' 74' ' ' SER . 51.3 Cg_endo -77.01 141.6 21.2 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.506 2.137 . . . . 0.0 111.978 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.452 ' HG2' ' N ' ' A' ' 78' ' ' ARG . 1.4 tt0 -107.58 140.83 39.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.987 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.452 ' N ' ' HG2' ' A' ' 77' ' ' GLN . 4.4 mtt-85 -135.9 133.5 37.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.165 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 m -99.35 136.56 29.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.72 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -113.09 103.67 11.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.64 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.32 33.46 5.4 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.31 148.11 50.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.789 0.328 . . . . 0.0 110.559 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.5 m -107.56 -20.03 6.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.395 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.442 ' CD2' ' O ' ' A' ' 85' ' ' PRO . 5.3 tt -174.99 115.17 0.29 Allowed Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.222 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.442 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 27.4 Cg_exo -55.63 144.19 76.08 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.897 1.731 . . . . 0.0 111.803 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.526 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 4.4 m-90 -111.5 -144.54 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.528 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.578 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . 97.0 p -134.17 155.21 50.52 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.977 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -129.1 151.84 49.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.786 0.327 . . . . 0.0 110.492 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.594 ' N ' ' CD2' ' A' ' 89' ' ' HIS . 0.4 OUTLIER -105.86 119.05 38.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.629 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.433 HG23 HD13 ' A' ' 90' ' ' ILE . 50.3 mm -126.41 138.25 55.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.456 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 t -103.76 130.44 51.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.649 ' O ' ' N ' ' A' ' 94' ' ' ASP . 17.4 p -116.75 140.34 49.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.737 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.524 ' CG ' ' O ' ' A' ' 93' ' ' ASN . 1.8 t30 -49.5 79.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.59 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 92' ' ' THR . 21.9 m-20 34.08 79.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.55 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -169.41 145.79 3.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.508 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.5 113.6 26.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.439 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.453 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 7.7 p -133.91 156.78 41.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.674 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.43 ' HE3' ' NH2' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -108.07 117.26 33.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.533 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.38 161.87 54.39 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -112.9 115.39 28.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 0.0 110.595 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.4 tt -131.08 139.25 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.643 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 103' ' ' ALA . 8.2 t -130.39 155.16 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.397 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.451 ' N ' ' CG1' ' A' ' 102' ' ' VAL . . . -140.72 157.16 45.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.737 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -136.83 73.71 1.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.586 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -128.8 163.51 22.18 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -79.18 106.74 11.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.868 0.366 . . . . 0.0 110.516 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.0 p -140.9 -170.83 3.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.622 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 108' ' ' ASP . 2.3 t70 -134.15 4.93 3.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.5 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.8 p -174.73 62.46 0.02 OUTLIER 'General case' 0 C--O 1.245 0.847 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.959 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.504 ' O ' ' O ' ' A' ' 126' ' ' SER . 4.2 tt -98.99 129.52 49.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 O-C-N 123.16 0.288 . . . . 0.0 110.424 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -149.42 172.4 29.45 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.569 ' O ' ' O ' ' A' ' 124' ' ' ARG . 0.9 OUTLIER -118.99 157.32 27.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.765 0.317 . . . . 0.0 110.28 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.511 ' NH2' ' OE1' ' A' ' 56' ' ' GLU . 15.1 ptt-85 -161.41 141.78 10.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.642 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.1 mm -117.71 131.37 70.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.615 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.1 p -110.3 132.88 53.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.429 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.5 t -142.05 150.08 19.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.598 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 50.99 19.24 0.63 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.653 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.38 -4.73 24.9 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -120.94 132.03 54.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.797 0.332 . . . . 0.0 110.557 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.3 t -74.63 134.53 29.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.46 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.03 -46.82 2.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.789 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.64 129.73 14.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.69 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -150.19 155.73 40.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.576 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.569 ' O ' ' O ' ' A' ' 112' ' ' CYS . 25.8 mtt-85 -116.22 116.0 27.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.608 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.7 p -124.31 128.82 74.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.527 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 110' ' ' ILE . 4.7 m -128.71 130.46 47.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.534 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -99.41 137.92 37.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.517 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -145.64 166.47 25.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.459 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.424 ' C ' ' CG ' ' A' ' 130' ' ' ASN . 5.2 t -97.59 -3.37 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.443 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 132' ' ' TYR . 0.1 OUTLIER 172.33 79.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.354 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.72 76.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.513 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.441 ' N ' ' O ' ' A' ' 130' ' ' ASN . 2.3 t80 -117.99 -70.16 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.511 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 134' ' ' TYR . 1.3 t -56.57 -27.79 58.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.539 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.572 ' O ' ' N ' ' A' ' 136' ' ' LEU . 5.1 t80 58.62 130.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.702 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 17.7 t -53.69 80.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.613 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.572 ' N ' ' O ' ' A' ' 134' ' ' TYR . 8.3 tp -107.16 21.4 17.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.593 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 138' ' ' LYS . 2.4 t 64.72 156.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.674 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.446 ' H ' HG12 ' A' ' 137' ' ' VAL . 1.3 tttp 74.15 -168.71 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.63 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.5 m 70.7 12.85 7.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.554 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.613 -179.924 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.7 mpt? . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -113.13 128.59 56.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.604 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.649 HD11 ' CG2' ' A' ' 114' ' ' ILE . 39.1 tp -95.79 115.76 27.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.087 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.1 p -126.45 131.77 51.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 88' ' ' LEU . 26.1 p90 -119.77 148.88 42.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.832 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.46 ' O ' HD13 ' A' ' 57' ' ' ILE . 2.2 tm-20 -155.81 144.88 20.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.901 0.382 . . . . 0.0 110.919 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.554 HG22 ' N ' ' A' ' 58' ' ' PHE . 31.4 mm -116.11 165.59 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.901 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.686 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -133.01 165.42 24.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.023 0.44 . . . . 0.0 110.952 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.76 170.56 37.33 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.559 ' O ' ' OG1' ' A' ' 63' ' ' THR . 17.9 Cg_endo -64.82 161.2 37.25 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.518 2.146 . . . . 0.0 112.016 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -72.51 119.52 6.17 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.868 2.379 . . . . 0.0 112.163 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.69 7.31 45.24 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.559 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -82.92 136.02 34.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.809 0.338 . . . . 0.0 110.653 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -114.53 122.63 69.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.615 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.61 151.53 44.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.503 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.497 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 9.2 p30 -96.24 116.0 28.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.635 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 mt -96.83 130.45 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.572 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.4 t -134.19 126.06 29.14 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.02 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.657 ' CZ ' ' O ' ' A' ' 70' ' ' PHE . 11.0 t80 -151.38 152.64 33.39 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.876 0.369 . . . . 0.0 110.63 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.657 ' O ' ' CZ ' ' A' ' 69' ' ' TYR . 49.7 t80 -84.75 121.53 27.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.494 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.448 ' HB2' ' H ' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -81.52 151.18 27.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.627 -179.84 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.5 t -64.72 -35.27 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.604 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -89.7 10.24 24.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.657 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 70.52 79.56 0.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.582 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.448 ' H ' ' HB2' ' A' ' 71' ' ' ASP . 2.7 tt0 -170.77 85.17 0.52 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.469 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -59.31 139.95 92.31 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.859 2.373 . . . . 0.0 112.197 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -106.04 132.67 51.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.56 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.1 mtm-85 -140.43 126.22 19.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.468 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.3 m -121.31 136.97 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.735 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -129.95 126.2 37.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.516 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.68 23.96 17.03 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.98 153.36 22.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 110.467 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.472 HG23 ' CD1' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -92.93 -39.82 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.615 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.608 ' CD1' ' CH2' ' A' ' 86' ' ' TRP . 0.2 OUTLIER -147.83 157.8 43.33 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.976 0.417 . . . . 0.0 110.628 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.73 162.49 39.45 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.87 2.38 . . . . 0.0 112.268 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.608 ' CH2' ' CD1' ' A' ' 84' ' ' LEU . 2.1 m95 -132.86 -156.49 0.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.332 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.606 ' O ' HD22 ' A' ' 88' ' ' LEU . 96.7 p -130.49 161.22 31.92 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.946 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.606 HD22 ' O ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -132.47 155.42 48.59 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.405 178.796 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.533 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.2 OUTLIER -116.2 120.61 39.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.668 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 53' ' ' LEU . 3.8 mp -124.15 129.79 73.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.656 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.01 129.86 53.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.302 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.563 ' O ' ' O ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -125.79 157.97 36.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.659 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.563 ' O ' ' O ' ' A' ' 92' ' ' THR . 65.7 m-20 -34.76 -100.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.618 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.8 72.59 0.33 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.587 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -169.68 166.06 9.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.745 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.56 128.89 34.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.518 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 95' ' ' ALA . 0.7 OUTLIER -133.44 147.74 31.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.718 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.409 ' SD ' ' HB3' ' A' ' 122' ' ' ALA . 23.0 mtm -149.19 150.25 32.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.309 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.17 162.16 23.59 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -105.23 117.08 33.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.892 0.377 . . . . 0.0 110.589 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 tp -132.88 133.66 58.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.532 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.0 m -130.59 165.32 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.217 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -139.62 142.22 37.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.759 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -132.96 75.98 1.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.383 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -125.52 164.43 19.1 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.02 48.86 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.108 0.48 . . . . 0.0 110.458 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.8 173.23 7.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.613 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.603 ' N ' ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -101.61 -17.07 16.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.418 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.9 t -146.54 115.98 7.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.0 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 131' ' ' ALA . 3.4 mt -137.64 125.96 32.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.834 0.35 . . . . 0.0 110.51 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -154.83 175.27 32.95 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -120.23 169.62 10.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.687 0.279 . . . . 0.0 110.519 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.94 144.99 13.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.81 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.649 ' CG2' HD11 ' A' ' 53' ' ' LEU . 4.4 mt -140.74 122.97 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.579 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.0 p -122.72 122.29 38.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.371 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.594 ' O ' ' N ' ' A' ' 118' ' ' GLY . 55.9 t -122.12 157.74 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.857 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.494 ' N ' HG12 ' A' ' 116' ' ' VAL . 80.9 m-20 39.22 20.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.807 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 116' ' ' VAL . . . 70.44 0.95 33.46 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 116' ' ' VAL . 4.6 tttp -113.65 143.46 44.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 110.57 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 120' ' ' VAL . 14.4 p -71.56 124.23 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.784 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.443 ' HG2' ' NH1' ' A' ' 121' ' ' ARG . 26.9 mtt-85 -125.38 -41.4 2.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.175 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.409 ' HB3' ' SD ' ' A' ' 98' ' ' MET . . . -152.78 128.22 9.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.134 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -149.16 131.74 15.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.786 0.326 . . . . 0.0 111.026 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.0 119.06 28.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.351 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.649 ' O ' HG13 ' A' ' 125' ' ' VAL . 7.5 p -122.25 118.53 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.726 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.3 OUTLIER -115.35 127.16 55.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.538 179.806 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -95.6 133.15 39.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.714 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.573 ' O ' ' O ' ' A' ' 108' ' ' ASP . 9.6 mt-10 -148.97 130.51 14.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.355 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.01 -11.02 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.605 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -164.38 72.03 0.22 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.35 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.56 ' HB3' HD12 ' A' ' 110' ' ' ILE . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.669 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.9 ptp . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -116.22 119.27 35.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.512 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.524 ' O ' HD23 ' A' ' 53' ' ' LEU . 6.3 tt -98.5 115.2 28.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.026 0.441 . . . . 0.0 110.703 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -127.51 129.71 47.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.052 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -119.96 148.54 43.4 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.732 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.705 ' OE1' ' OG ' ' A' ' 87' ' ' SER . 6.0 tt0 -156.8 131.93 9.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.705 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.581 HG22 ' N ' ' A' ' 58' ' ' PHE . 4.6 mm -91.36 167.95 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.581 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -132.41 145.49 51.25 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.885 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.07 156.66 28.09 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -50.33 161.63 1.1 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.923 2.415 . . . . 0.0 111.987 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -76.95 133.74 14.02 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.953 2.435 . . . . 0.0 112.279 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.94 -9.92 67.37 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.6 m -81.68 130.23 34.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.841 0.353 . . . . 0.0 110.496 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.9 m -101.9 127.39 55.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.579 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.35 155.48 49.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.557 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.503 ' OD1' ' C ' ' A' ' 66' ' ' ASP . 44.2 t0 -103.18 129.15 50.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.555 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.497 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 2.9 mt -118.73 126.46 75.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.62 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 39.9 t -113.27 117.87 33.04 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.067 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.593 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 33.9 t80 -139.96 145.93 38.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.702 0.287 . . . . 0.0 110.538 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.593 ' O ' ' CE2' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -83.24 134.48 34.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.207 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -94.21 153.32 18.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.92 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 73' ' ' ASN . 12.2 p -48.84 -39.09 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.635 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.514 ' O ' ' CB ' ' A' ' 74' ' ' SER . 14.4 t-20 -87.71 11.75 14.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.409 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.68 ' OG ' ' N ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER 82.15 -71.65 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.507 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.68 ' N ' ' OG ' ' A' ' 74' ' ' SER . 1.1 tp10 -26.12 88.75 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.701 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.588 ' N ' ' O ' ' A' ' 74' ' ' SER . 14.8 Cg_exo -65.08 144.57 82.39 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.932 2.421 . . . . 0.0 112.083 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -107.72 150.07 27.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.285 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -138.24 129.92 28.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.787 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.2 m -102.46 123.54 55.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.476 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 0.5 OUTLIER -120.97 108.74 14.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.686 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.69 29.03 7.56 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.45 132.86 34.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 0.0 110.578 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.08 -76.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.607 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.756 ' H ' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -118.17 156.73 50.25 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.588 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.516 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 25.6 Cg_endo -64.1 151.33 85.78 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.904 2.403 . . . . 0.0 112.339 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -114.31 -171.2 1.87 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.396 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.705 ' OG ' ' OE1' ' A' ' 56' ' ' GLU . 70.9 m -125.03 151.54 45.46 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.044 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 88' ' ' LEU . 8.1 tp -130.73 154.6 47.8 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.863 0.363 . . . . 0.0 110.5 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -123.57 120.65 33.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.404 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.7 mt -130.9 132.09 64.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.571 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.77 126.03 51.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.569 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.507 ' O ' ' C ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -130.24 156.39 44.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.585 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.623 ' OD1' ' N ' ' A' ' 93' ' ' ASN . 0.4 OUTLIER -30.78 120.13 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.478 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -42.51 92.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.568 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 93' ' ' ASN . . . -175.03 -171.92 0.56 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.446 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.68 113.15 8.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.452 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 t -107.26 152.36 8.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.192 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.5 ttt -148.48 137.48 21.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 0.0 111.015 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.64 156.99 18.85 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -118.73 115.39 24.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.812 0.339 . . . . 0.0 110.794 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.9 140.5 49.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.609 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 89.1 t -127.19 147.64 32.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.465 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -139.41 140.37 37.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.746 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -139.05 78.89 1.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.587 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.56 163.8 23.63 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -78.77 52.13 1.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.8 0.333 . . . . 0.0 110.483 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 129' ' ' VAL . 70.9 m -100.49 175.05 5.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.554 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 109' ' ' SER . 6.9 t70 -104.59 128.52 52.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.505 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 108' ' ' ASP . 47.0 t 44.02 93.52 0.01 OUTLIER 'General case' 0 C--O 1.24 0.599 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.971 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.648 ' CG2' ' ND2' ' A' ' 127' ' ' ASN . 15.9 tt -124.56 127.1 72.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 120.793 0.33 . . . . 0.0 110.461 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 125' ' ' VAL . . . -147.22 172.09 27.73 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.675 ' SG ' ' N ' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -118.75 162.66 18.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.675 ' N ' ' SG ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -158.76 143.72 16.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.923 0.392 . . . . 0.0 110.887 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.539 HD12 ' C ' ' A' ' 113' ' ' ARG . 1.9 mp -118.72 124.95 73.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.306 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.88 127.69 54.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.765 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.67 136.59 31.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.462 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.515 ' OD1' ' O ' ' A' ' 117' ' ' ASP . 57.7 t0 65.55 9.45 5.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.449 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.13 -5.98 57.77 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -101.13 139.3 37.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.812 0.339 . . . . 0.0 110.579 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 m -78.24 142.51 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.602 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -168.14 24.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.573 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -123.67 152.85 41.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.772 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.1 147.55 23.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.263 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.0 ptt85 -127.78 135.41 50.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.767 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.415 ' O ' ' CA ' ' A' ' 111' ' ' GLY . 2.1 t -103.08 134.64 43.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.165 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.7 m -102.63 116.45 32.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.942 0.401 . . . . 0.0 110.901 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.648 ' ND2' ' CG2' ' A' ' 110' ' ' ILE . 0.0 OUTLIER -128.34 135.19 49.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.449 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.601 ' N ' ' OE1' ' A' ' 128' ' ' GLU . 1.1 pm0 -104.36 174.6 5.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.746 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.656 ' O ' HG22 ' A' ' 129' ' ' VAL . 1.8 p -55.35 1.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.752 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.596 ' H ' ' C ' ' A' ' 128' ' ' GLU . 25.3 m-80 -112.84 -5.5 13.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.59 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.454 179.945 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.545 ' N ' ' H ' ' A' ' 117' ' ' ASP . 9.2 mtt . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.437 ' O ' ' CG ' ' A' ' 52' ' ' HIS . 1.5 p-80 -109.36 125.81 52.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.308 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.733 ' C ' HD23 ' A' ' 53' ' ' LEU . 5.5 tt -96.1 115.87 28.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.785 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.635 ' N ' HD23 ' A' ' 53' ' ' LEU . 23.7 p -126.28 130.12 50.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.496 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.554 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 1.8 p90 -122.69 149.94 43.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.517 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.426 ' HG2' ' N ' ' A' ' 57' ' ' ILE . 17.0 tt0 -155.36 148.09 24.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.956 0.408 . . . . 0.0 111.042 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.522 HD11 HD13 ' A' ' 101' ' ' ILE . 1.6 mm -112.88 163.59 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.971 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.5 156.71 44.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.905 0.384 . . . . 0.0 110.698 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.65 170.21 42.93 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -47.56 152.87 2.38 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.854 2.369 . . . . 0.0 112.229 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -67.04 119.66 6.69 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.825 2.35 . . . . 0.0 111.933 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.99 -0.03 62.22 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.4 t -74.85 144.06 43.59 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.878 0.371 . . . . 0.0 110.559 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 64' ' ' VAL . 7.2 p -115.87 128.83 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.508 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.47 151.49 41.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.806 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.67 124.81 49.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.206 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.442 HG23 HD11 ' A' ' 101' ' ' ILE . 10.9 mt -111.17 133.64 56.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.017 0.437 . . . . 0.0 111.013 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.5 t -132.35 131.05 41.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.957 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.679 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 11.2 t80 -150.98 156.49 41.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.895 0.379 . . . . 0.0 110.986 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.679 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 10.0 t80 -83.76 119.63 25.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.282 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 75' ' ' GLU . 32.6 t70 -89.42 146.08 24.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.841 0.353 . . . . 0.0 110.775 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.482 HG13 ' OD1' ' A' ' 73' ' ' ASN . 4.5 p -53.99 -24.2 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.605 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.482 ' OD1' HG13 ' A' ' 72' ' ' VAL . 2.9 m-20 -86.55 -3.87 59.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.64 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.3 m 78.55 34.21 0.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.526 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.445 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 3.2 mm-40 -135.87 104.27 9.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.408 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -77.74 140.14 18.37 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.284 1.99 . . . . 0.0 112.086 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -107.42 148.11 29.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.563 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 75.4 mtm-85 -139.26 131.62 28.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.622 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.3 m -114.21 118.98 60.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.608 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -112.6 145.74 39.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.481 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.32 5.81 44.48 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.15 137.75 58.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.809 0.338 . . . . 0.0 110.413 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.45 -44.24 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.54 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.431 ' H ' HD12 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -147.55 155.27 45.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.109 0.48 . . . . 0.0 110.774 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.83 159.44 52.79 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 123.208 2.605 . . . . 0.0 112.533 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -129.13 -179.26 5.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.215 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 92.8 p -112.27 164.53 13.11 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.323 0.582 . . . . 0.0 111.004 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.88 145.8 33.46 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.937 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.508 ' CG ' ' O ' ' A' ' 89' ' ' HIS . 19.8 p80 -121.52 123.53 42.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 110.851 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.3 mt -128.51 121.3 54.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.513 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.4 m -104.14 122.47 45.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.548 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.553 ' O ' ' C ' ' A' ' 93' ' ' ASN . 1.9 m -129.19 158.33 39.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.536 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.553 ' C ' ' O ' ' A' ' 92' ' ' THR . 41.9 m-20 -25.54 91.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.713 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.658 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -31.47 124.98 0.24 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.566 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 163.75 -71.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.595 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -156.25 120.42 4.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.447 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 t -127.81 147.26 32.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.711 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.6 ttm -151.51 159.42 44.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.517 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -153.46 156.26 26.65 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -119.19 115.83 25.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.327 . . . . 0.0 110.611 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.522 HD13 HD11 ' A' ' 57' ' ' ILE . 11.9 tt -130.95 137.26 56.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.71 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.34 145.52 33.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.536 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -123.84 158.84 30.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.702 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -143.79 76.16 1.5 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.386 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -116.79 163.61 12.47 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -79.28 28.44 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.572 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.418 ' H ' ' C ' ' A' ' 105' ' ' GLY . 2.0 p -73.05 -174.41 1.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.538 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' A' ' 128' ' ' GLU . 3.0 m-20 -113.25 -24.9 9.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.716 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 t -151.21 101.52 2.86 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.959 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.539 ' O ' ' O ' ' A' ' 126' ' ' SER . 15.6 tt -138.39 135.6 44.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.896 0.379 . . . . 0.0 110.577 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.73 173.1 35.67 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 1.4 p -124.93 162.31 24.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.821 0.343 . . . . 0.0 110.771 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -149.07 158.25 44.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.457 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.9 mm -126.56 127.68 70.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.634 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.57 132.4 53.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.567 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.455 ' C ' ' N ' ' A' ' 118' ' ' GLY . 7.6 p -143.14 149.65 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.571 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.545 ' H ' ' N ' ' A' ' 51' ' ' MET . 5.9 m-20 48.89 15.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.391 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.455 ' N ' ' C ' ' A' ' 116' ' ' VAL . . . 77.69 1.42 77.46 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -116.79 126.88 53.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.731 0.3 . . . . 0.0 110.607 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.0 t -74.88 136.51 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.475 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -129.13 -33.59 1.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.841 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.06 129.53 14.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.486 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -151.58 126.73 9.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.807 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.461 ' HD3' ' N ' ' A' ' 124' ' ' ARG . 0.2 OUTLIER -113.6 115.73 28.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.238 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.7 m -114.97 133.21 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.696 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.5 OUTLIER -132.61 115.88 15.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.454 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -97.81 130.03 44.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.393 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.517 ' O ' ' O ' ' A' ' 108' ' ' ASP . 3.9 mm-40 -138.68 130.77 28.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.908 0.385 . . . . 0.0 110.806 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.9 m -73.4 -4.04 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.266 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.2 73.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.059 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.659 -179.711 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -112.57 126.16 55.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.558 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.45 HD13 HG23 ' A' ' 114' ' ' ILE . 11.6 tp -97.32 115.28 27.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.56 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.438 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -127.14 142.85 51.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.509 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -126.0 148.43 49.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.42 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.716 ' OE1' ' OG ' ' A' ' 87' ' ' SER . 11.7 tt0 -156.7 134.4 10.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.979 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.569 HG22 ' H ' ' A' ' 58' ' ' PHE . 20.7 mm -101.98 170.57 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.569 ' H ' HG22 ' A' ' 57' ' ' ILE . 29.5 m-85 -132.19 173.04 11.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 111.085 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.21 151.51 6.15 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -40.16 139.16 1.07 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.586 2.191 . . . . 0.0 111.938 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.75 135.56 36.02 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.588 2.192 . . . . 0.0 112.22 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.6 -0.89 58.22 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.7 m -86.21 139.37 31.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.792 0.33 . . . . 0.0 110.645 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 p -111.55 123.4 67.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.384 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -137.45 156.71 47.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.537 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.15 115.17 27.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.331 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.454 HG23 HD11 ' A' ' 101' ' ' ILE . 72.7 mt -105.34 131.18 55.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.708 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.5 t -134.74 125.94 27.99 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.952 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.661 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 42.7 t80 -145.87 158.98 43.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.834 0.35 . . . . 0.0 110.647 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.661 ' O ' ' CE2' ' A' ' 69' ' ' TYR . 4.6 t80 -88.83 136.72 32.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.679 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.32 116.71 32.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.36 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 72' ' ' VAL . 18.0 t -75.5 -5.81 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.758 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.92 -17.98 25.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.593 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.6 t -176.72 -127.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.714 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -94.52 150.95 38.89 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.515 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.37 139.69 90.91 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.53 2.153 . . . . 0.0 111.871 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.58 156.84 17.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.697 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.7 ttm-85 -141.52 125.12 16.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.515 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.31 118.44 58.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.513 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 0.9 OUTLIER -115.74 133.62 55.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.658 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.55 31.37 8.89 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.57 148.98 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.863 0.363 . . . . 0.0 110.455 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.5 t -81.62 -53.35 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.301 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.528 ' O ' ' NE1' ' A' ' 86' ' ' TRP . 0.2 OUTLIER -140.67 151.89 64.51 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.209 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.516 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 11.5 Cg_endo -57.15 158.17 18.84 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.8 2.333 . . . . 0.0 112.071 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.528 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 37.4 m95 -130.15 -160.6 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.485 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.716 ' OG ' ' OE1' ' A' ' 56' ' ' GLU . 71.2 m -132.86 144.98 50.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.016 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.564 HD23 ' H ' ' A' ' 89' ' ' HIS . 0.4 OUTLIER -128.48 144.1 51.09 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 178.698 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.564 ' H ' HD23 ' A' ' 88' ' ' LEU . 0.8 OUTLIER -108.29 124.87 50.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.919 0.39 . . . . 0.0 110.943 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.6 mt -130.58 128.58 63.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.087 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.26 122.54 47.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.858 0.361 . . . . 0.0 110.934 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.537 ' O ' ' C ' ' A' ' 93' ' ' ASN . 5.3 m -126.14 125.57 42.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.236 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.537 ' C ' ' O ' ' A' ' 92' ' ' THR . 1.2 m-20 28.77 -134.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.494 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -139.41 98.74 3.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.563 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 168.35 -171.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.573 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -91.24 135.96 33.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.62 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.92 159.42 36.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.452 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.03 146.55 51.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.746 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.77 151.54 18.35 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -112.12 114.99 28.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.723 0.297 . . . . 0.0 110.596 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.454 HD11 HG23 ' A' ' 67' ' ' ILE . 0.8 OUTLIER -133.29 139.13 49.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.515 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 103' ' ' ALA . 2.3 t -131.96 165.14 32.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.519 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.404 ' H ' HG12 ' A' ' 102' ' ' VAL . . . -143.61 148.13 35.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.447 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -130.46 63.97 1.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.175 0.512 . . . . 0.0 110.359 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -118.16 163.53 12.93 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.43 52.42 2.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.733 0.301 . . . . 0.0 110.636 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.1 m -88.98 -167.82 2.0 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.388 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -112.26 -42.42 3.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.805 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.3 t -128.01 128.06 44.31 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.99 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.537 ' O ' ' O ' ' A' ' 126' ' ' SER . 7.5 mt -141.75 148.08 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.706 0.289 . . . . 0.0 110.307 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 177.8 163.86 30.21 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -117.83 160.14 21.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 0.0 110.611 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -151.3 155.48 38.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.635 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.45 HG23 HD13 ' A' ' 53' ' ' LEU . 4.4 mt -138.32 114.93 10.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.424 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.9 p -117.24 126.81 53.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.619 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 t -125.46 134.62 66.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.27 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 52.0 23.25 2.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.476 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.6 8.37 87.16 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -119.06 126.18 51.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.631 0.253 . . . . 0.0 110.399 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.2 p -74.26 138.72 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.769 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -115.35 -68.22 0.94 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.278 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -142.79 126.98 17.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.276 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -148.28 129.23 14.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.89 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -95.36 127.44 41.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.374 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 125' ' ' VAL . 10.8 p -117.45 117.31 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.806 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.6 OUTLIER -126.82 115.97 20.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.377 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 128' ' ' GLU . 54.9 t-20 -96.98 130.21 44.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.642 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.416 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 14.5 mt-10 -141.72 130.45 22.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.36 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 130' ' ' ASN . 0.3 OUTLIER -82.74 92.56 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.655 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 129' ' ' VAL . 1.0 OUTLIER 83.3 62.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.529 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 121.08 0.467 . . . . 0.0 110.572 179.943 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.443 ' SD ' ' OD1' ' A' ' 117' ' ' ASP . 17.2 mmt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.95 117.65 33.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.439 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.57 114.85 26.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.39 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.5 t -127.47 140.82 51.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.786 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.454 ' HE2' HD11 ' A' ' 90' ' ' ILE . 37.4 p90 -127.57 149.34 50.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.282 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -155.66 154.75 32.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 0.0 110.931 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.595 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 4.9 mm -116.51 161.38 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.294 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.535 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 7.9 m-85 -134.96 158.6 43.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.709 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.37 167.95 36.41 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -46.65 148.77 3.4 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.737 2.291 . . . . 0.0 112.08 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -70.29 134.7 27.47 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.703 2.268 . . . . 0.0 112.091 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.61 1.39 71.26 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 95.9 m -81.25 135.53 35.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.908 0.385 . . . . 0.0 110.44 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.0 t -113.33 123.44 68.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.491 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.07 153.13 43.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.778 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.22 121.36 40.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.366 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.485 HD12 ' N ' ' A' ' 67' ' ' ILE . 1.9 mp -98.81 131.2 46.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.766 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.3 t -129.62 119.2 23.18 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.019 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.6 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 2.6 p90 -142.23 171.34 14.19 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.631 0.253 . . . . 0.0 110.443 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.636 ' CD1' ' O ' ' A' ' 70' ' ' PHE . 0.6 OUTLIER -87.57 130.68 34.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.492 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 72' ' ' VAL . 33.3 t0 -88.83 139.1 30.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.519 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.557 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 6.2 p -54.56 -25.93 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.805 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.31 8.94 25.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.74 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.5 m 69.6 62.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.523 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.425 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 21.0 tt0 -170.43 92.26 0.48 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.263 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -58.84 139.82 92.47 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.712 2.275 . . . . 0.0 112.342 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -108.23 155.61 20.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.732 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -137.37 125.58 23.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.265 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.5 m -106.69 120.91 58.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.844 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.69 129.05 53.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.385 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.07 13.8 58.47 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.79 128.03 34.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.742 0.306 . . . . 0.0 110.618 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.42 HG12 ' HG ' ' A' ' 84' ' ' LEU . 58.4 t -61.35 -96.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.307 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.507 ' CD1' ' H ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -90.0 158.42 44.44 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.924 0.392 . . . . 0.0 110.453 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.595 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 17.4 Cg_endo -60.41 154.87 50.28 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.992 2.462 . . . . 0.0 112.194 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.9 175.42 6.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.429 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.0 m -113.21 152.35 29.86 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.946 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tp -129.67 151.72 49.96 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.041 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.594 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -112.32 126.0 54.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 0.0 110.898 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.454 HD11 ' HE2' ' A' ' 55' ' ' TYR . 21.5 mt -131.09 132.46 63.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.48 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.85 129.3 56.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.541 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 p -122.61 140.62 52.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.627 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.546 ' O ' ' C ' ' A' ' 94' ' ' ASP . 3.3 p30 -74.89 108.61 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.801 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.546 ' C ' ' O ' ' A' ' 93' ' ' ASN . 1.4 t70 26.39 83.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.642 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 177.59 139.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.549 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.02 125.01 42.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.718 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.1 t -141.38 123.73 14.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.503 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.85 136.0 33.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.499 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.41 148.7 20.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -102.87 115.59 30.89 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.5 tt -130.18 142.07 44.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.892 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 103' ' ' ALA . 69.4 t -136.7 162.64 34.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.224 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.561 ' N ' HG12 ' A' ' 102' ' ' VAL . . . -142.98 144.83 32.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.698 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -120.52 42.75 2.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.401 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -96.32 157.82 21.53 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.408 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 4.9 p30 -79.3 26.79 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.743 0.306 . . . . 0.0 110.536 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.564 ' OG ' ' N ' ' A' ' 108' ' ' ASP . 12.3 t -63.97 -173.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.483 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.564 ' N ' ' OG ' ' A' ' 107' ' ' SER . 12.8 t0 -119.45 -58.85 1.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.778 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.2 t -99.96 98.25 9.03 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.987 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 6.9 mt -117.02 149.37 19.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.74 0.305 . . . . 0.0 110.341 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.9 161.59 26.83 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.592 ' SG ' ' N ' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -118.74 157.55 27.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 110.95 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.719 ' C ' HD12 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -151.3 138.24 19.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.342 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.719 HD12 ' C ' ' A' ' 113' ' ' ARG . 1.7 mp -125.7 125.71 68.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.719 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 p -123.54 129.23 50.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.38 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.2 p -126.53 126.04 68.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.594 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.443 ' OD1' ' SD ' ' A' ' 51' ' ' MET . 4.0 t70 65.13 12.23 7.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.559 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.73 -4.53 84.62 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -96.61 132.43 42.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.861 0.362 . . . . 0.0 110.46 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 120' ' ' VAL . 7.3 p -84.69 125.09 40.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.566 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.9 mmt85 -127.28 -53.99 1.37 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.612 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -119.46 129.17 54.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.502 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -151.59 122.86 7.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.37 118.93 33.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.261 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.3 t -127.46 118.99 51.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.069 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -133.17 116.98 16.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.323 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.23 128.78 40.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.909 0.385 . . . . 0.0 110.859 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.587 ' C ' ' H ' ' A' ' 130' ' ' ASN . 0.8 OUTLIER -157.9 130.35 7.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.381 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 129' ' ' VAL . 74.0 t -63.17 6.27 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.034 0.445 . . . . 0.0 110.163 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.587 ' H ' ' C ' ' A' ' 128' ' ' GLU . 0.7 OUTLIER -167.31 66.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.161 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.751 -179.716 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.44 ' O ' ' CG ' ' A' ' 52' ' ' HIS . 9.7 p-80 -105.96 128.44 53.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.401 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.578 ' CD1' ' O ' ' A' ' 97' ' ' VAL . 1.6 tt -97.01 115.52 27.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.618 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.03 139.53 52.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.642 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.468 ' CE1' HG21 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -121.37 148.52 44.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.243 179.632 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -156.25 144.01 19.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.932 0.396 . . . . 0.0 111.087 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.597 HG22 ' N ' ' A' ' 58' ' ' PHE . 6.1 mm -115.23 167.47 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.483 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.597 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -140.97 163.87 31.8 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.524 -0.471 . . . . 0.0 111.172 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.62 165.39 37.84 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.584 ' O ' ' OG1' ' A' ' 63' ' ' THR . 71.3 Cg_exo -41.71 166.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.882 2.388 . . . . 0.0 111.985 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -80.14 116.64 3.4 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.723 2.282 . . . . 0.0 112.283 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.08 12.9 62.89 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.584 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -86.22 148.84 25.46 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.46 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 64' ' ' VAL . 11.4 m -112.32 122.69 67.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.549 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.21 143.56 32.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.463 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.75 126.97 40.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.535 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.459 ' H ' HG13 ' A' ' 79' ' ' VAL . 3.7 mp -107.81 126.57 64.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.503 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.4 t -130.71 125.49 34.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.921 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.774 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 31.2 p90 -146.42 169.97 17.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.727 0.299 . . . . 0.0 110.561 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -85.98 119.19 26.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.579 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 73' ' ' ASN . 4.2 t0 -90.97 105.9 18.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.507 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 72' ' ' VAL . 61.6 t -59.1 -5.07 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.659 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.516 ' O ' ' CB ' ' A' ' 74' ' ' SER . 15.7 t-20 -77.58 -21.5 52.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.726 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.7 t 159.56 -93.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.715 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.497 ' N ' ' OG ' ' A' ' 74' ' ' SER . 8.1 pt-20 -100.91 148.92 35.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.616 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.29 145.69 49.1 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.759 2.306 . . . . 0.0 112.339 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.774 ' NE2' ' CE1' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -107.69 154.76 21.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.599 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 -132.08 135.08 46.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.579 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.459 HG13 ' H ' ' A' ' 67' ' ' ILE . 1.7 p -116.96 125.51 73.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.59 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -136.87 134.2 36.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.489 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.03 7.66 59.54 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.81 153.26 35.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.733 0.301 . . . . 0.0 110.604 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.805 HG13 ' HG ' ' A' ' 84' ' ' LEU . 3.0 p -90.86 -30.47 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.449 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.805 ' HG ' HG13 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -156.92 154.3 26.14 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 110.733 179.456 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.569 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 18.7 Cg_endo -61.64 158.47 36.97 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.873 2.382 . . . . 0.0 112.111 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -121.42 -160.13 0.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.54 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.1 t -136.3 138.24 41.52 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.969 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.487 HD23 ' H ' ' A' ' 89' ' ' HIS . 0.5 OUTLIER -128.21 143.45 51.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.728 0.299 . . . . 0.0 110.29 179.053 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.646 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -105.94 121.07 43.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.771 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.1 mp -121.47 130.63 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.567 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.9 p -112.69 131.61 55.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.495 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.57 157.57 21.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.553 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -52.94 -16.37 1.02 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.418 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -103.37 -115.94 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.538 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -166.33 -56.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.698 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.31 121.77 37.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.576 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.578 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 39.9 t -150.69 160.92 3.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.537 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.527 ' N ' ' CG1' ' A' ' 97' ' ' VAL . 4.8 mtt -121.62 157.45 30.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.408 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -142.96 148.31 20.01 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -102.96 118.28 36.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.796 0.331 . . . . 0.0 110.479 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.468 HG21 ' CE1' ' A' ' 55' ' ' TYR . 14.9 tt -133.19 142.13 42.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.546 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 103' ' ' ALA . 38.5 t -140.68 163.73 22.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.662 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.574 ' N ' HG12 ' A' ' 102' ' ' VAL . . . -138.42 158.68 43.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.408 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -135.64 75.74 1.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.73 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.23 155.23 19.25 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.0 55.2 1.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 110.359 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.649 ' OG ' ' N ' ' A' ' 108' ' ' ASP . 6.3 t -85.48 -167.56 1.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.712 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.649 ' N ' ' OG ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -119.84 -14.21 9.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.594 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.9 t -159.24 125.39 4.44 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.971 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.577 ' O ' ' O ' ' A' ' 126' ' ' SER . 26.1 mt -138.03 158.16 32.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.728 0.299 . . . . 0.0 110.514 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.489 ' N ' ' CG2' ' A' ' 110' ' ' ILE . . . -177.2 156.74 20.93 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.532 ' O ' ' O ' ' A' ' 124' ' ' ARG . 3.8 p -122.57 151.73 41.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.659 0.266 . . . . 0.0 110.449 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -160.01 148.22 16.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.663 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.68 123.22 56.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.802 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 72.5 p -119.16 136.53 54.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.333 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.417 ' C ' ' H ' ' A' ' 118' ' ' GLY . 84.9 t -132.44 149.09 31.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.792 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 55.39 8.88 0.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.58 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 116' ' ' VAL . . . 79.81 11.02 85.07 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -116.8 135.24 53.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.769 0.319 . . . . 0.0 110.546 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 71.9 t -70.08 120.57 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.616 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.424 ' NH1' ' HB3' ' A' ' 121' ' ' ARG . 4.0 mtp-105 -116.53 -72.26 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.655 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.22 134.92 46.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.676 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -149.65 157.19 43.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.489 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.532 ' O ' ' O ' ' A' ' 112' ' ' CYS . 7.5 ttt85 -123.52 130.14 52.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.646 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 54.6 t -114.03 118.52 58.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.527 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.577 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.7 OUTLIER -132.77 121.93 23.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.509 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -106.34 129.63 54.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.7 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 131' ' ' ALA . 3.9 mt-10 -157.35 133.88 9.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.496 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' A' ' 130' ' ' ASN . 4.2 m -82.64 135.88 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.433 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 107' ' ' SER . 4.3 m120 36.26 53.36 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.443 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . . . . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.722 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 30.8 mtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -110.95 123.68 50.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.326 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.661 ' C ' HD23 ' A' ' 53' ' ' LEU . 6.9 tt -95.84 114.58 26.33 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.286 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.423 ' N ' HD23 ' A' ' 53' ' ' LEU . 10.7 p -127.34 132.85 50.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.771 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 13.0 p90 -123.69 148.17 46.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.373 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.53 149.48 23.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.658 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.555 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -109.19 175.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.104 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -139.96 147.67 40.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.724 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.32 157.97 29.64 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -42.19 161.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.88 2.386 . . . . 0.0 112.164 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.41 122.77 7.21 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.933 2.422 . . . . 0.0 112.293 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.43 11.18 59.85 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.5 m -83.28 130.81 35.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 0.0 110.549 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -113.94 121.73 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.577 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.42 155.73 44.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.661 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -95.44 115.8 27.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.105 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.453 HD12 ' H ' ' A' ' 67' ' ' ILE . 3.3 mp -99.95 134.72 38.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.739 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.5 t -135.58 132.39 37.11 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.974 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 77' ' ' GLN . 24.1 p90 -145.31 164.7 30.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.766 0.317 . . . . 0.0 110.531 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.14 135.44 33.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.484 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -98.65 152.38 19.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.588 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 p -63.84 -31.23 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.549 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.629 ' O ' ' CB ' ' A' ' 74' ' ' SER . 18.3 m-20 -75.78 2.84 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.494 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.629 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.0 OUTLIER 91.34 -52.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.281 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -60.0 113.98 8.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.13 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -74.5 141.28 28.03 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.245 1.964 . . . . 0.0 112.25 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 69' ' ' TYR . 24.5 tt0 -107.14 145.61 32.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.621 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -139.4 130.45 26.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.536 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.8 t -105.05 123.22 59.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.549 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 81' ' ' GLY . 19.5 t0 -121.96 134.71 54.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.675 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.488 ' N ' ' OD1' ' A' ' 80' ' ' ASP . . . 94.17 18.35 36.93 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.31 128.53 35.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.761 0.315 . . . . 0.0 110.563 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.818 HG13 ' HG ' ' A' ' 84' ' ' LEU . 2.2 p -76.78 -14.63 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.519 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.818 ' HG ' HG13 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -159.72 155.96 23.69 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.562 179.664 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.555 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 11.7 Cg_endo -57.08 152.95 41.39 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.989 2.46 . . . . 0.0 112.273 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.64 162.17 18.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.413 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 72.6 m -110.29 139.13 45.77 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.988 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 tp -130.41 140.46 50.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.767 0.318 . . . . 0.0 110.438 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.529 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 1.0 OUTLIER -110.73 119.27 38.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.621 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 64.0 mt -129.07 130.02 68.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.324 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.61 123.66 47.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.864 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.62 ' C ' ' H ' ' A' ' 94' ' ' ASP . 0.2 OUTLIER -99.35 153.34 19.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.247 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -60.31 7.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.621 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.62 ' H ' ' C ' ' A' ' 92' ' ' THR . 11.1 t0 -123.26 -103.28 0.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.489 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 168.81 -56.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.686 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -88.55 114.65 25.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.548 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.408 ' O ' HD11 ' A' ' 53' ' ' LEU . 13.8 p -168.47 144.74 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.936 0.398 . . . . 0.0 110.835 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -121.13 143.21 49.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.354 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.09 162.6 12.43 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 100' ' ' ASN . 2.8 m-20 -104.89 117.94 35.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.754 0.311 . . . . 0.0 110.519 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 101' ' ' ILE . 13.2 tt -131.18 131.75 63.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.698 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.15 147.61 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.483 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -128.8 138.38 52.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.662 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -122.56 73.17 1.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.452 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.73 163.37 20.67 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.536 ' O ' ' OD1' ' A' ' 106' ' ' ASN . 24.9 t30 -84.0 37.89 0.62 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.749 0.309 . . . . 0.0 110.767 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.74 ' OG ' HD11 ' A' ' 110' ' ' ILE . 4.5 p -70.23 -177.68 1.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.531 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.49 -40.13 5.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.632 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.5 t -137.0 115.91 12.28 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.981 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.74 HD11 ' OG ' ' A' ' 107' ' ' SER . 10.3 mt -117.55 159.82 17.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.844 0.354 . . . . 0.0 110.529 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.547 ' N ' HG22 ' A' ' 110' ' ' ILE . . . 174.8 149.24 7.08 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.524 ' O ' ' O ' ' A' ' 124' ' ' ARG . 11.7 p -117.92 151.88 36.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.735 0.302 . . . . 0.0 110.587 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -154.31 154.85 34.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.507 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.639 ' O ' HG23 ' A' ' 120' ' ' VAL . 4.0 mp -137.54 124.4 28.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.581 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.3 p -122.35 141.17 51.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.686 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 119' ' ' LYS . 15.6 m -146.0 149.27 16.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.521 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 t0 49.41 17.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.639 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.411 ' N ' ' C ' ' A' ' 116' ' ' VAL . . . 84.87 -9.59 65.32 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 116' ' ' VAL . 15.9 mttm -112.07 124.72 53.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 0.0 110.539 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 114' ' ' ILE . 6.1 p -82.24 124.65 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.575 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -94.27 -34.91 12.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.531 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -141.05 141.28 34.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.505 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -148.99 122.47 9.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.783 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.524 ' O ' ' O ' ' A' ' 112' ' ' CYS . 27.2 mtt85 -127.29 115.87 19.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.205 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.25 118.23 54.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.001 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.9 OUTLIER -120.1 118.57 30.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.153 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.491 ' O ' ' OE1' ' A' ' 128' ' ' GLU . 46.7 m-20 -94.23 129.9 40.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.842 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 131' ' ' ALA . 0.3 OUTLIER -151.21 136.55 17.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.383 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.617 HG12 HD21 ' A' ' 130' ' ' ASN . 52.2 t -95.98 128.61 47.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.779 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.617 HD21 HG12 ' A' ' 129' ' ' VAL . 26.2 m-80 60.89 35.75 19.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.911 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.597 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . . . . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.338 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -102.48 120.0 39.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.453 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.835 ' C ' HD23 ' A' ' 53' ' ' LEU . 5.9 tt -96.19 115.87 28.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.743 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.627 ' N ' HD23 ' A' ' 53' ' ' LEU . 1.1 t -126.71 132.55 51.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.348 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -120.08 149.75 41.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.849 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.424 ' OE1' ' CD2' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -155.66 141.76 18.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.671 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.563 HD11 HG21 ' A' ' 101' ' ' ILE . 4.5 mp -112.12 157.76 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.188 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.656 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -133.07 170.83 14.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.98 0.419 . . . . 0.0 111.047 -179.606 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.24 179.97 39.99 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -47.44 158.66 0.58 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.648 2.232 . . . . 0.0 112.062 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.0 110.95 3.05 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.77 2.313 . . . . 0.0 112.159 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.51 8.91 57.1 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -85.2 141.19 30.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.742 0.306 . . . . 0.0 110.527 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.45 130.67 59.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.307 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -135.67 155.7 50.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.637 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 11.6 p-10 -97.96 127.6 44.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.445 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.69 HG23 HD11 ' A' ' 101' ' ' ILE . 3.4 mp -99.31 120.73 49.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.638 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.1 t -135.65 117.04 14.67 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.987 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -143.83 171.11 14.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.768 0.318 . . . . 0.0 110.431 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -83.96 128.25 34.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.551 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' A' ' 72' ' ' VAL . 15.3 t0 -91.3 142.9 27.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.607 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.567 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 1.0 OUTLIER -63.68 -25.03 37.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.554 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.427 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 0.9 OUTLIER -96.36 11.43 34.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.454 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 70.26 15.75 7.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.345 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 71' ' ' ASP . 1.9 tt0 -118.52 93.03 44.99 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.295 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -77.43 139.64 18.59 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.463 2.109 . . . . 0.0 112.333 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.435 ' HG2' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -107.67 143.34 36.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.572 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.435 ' N ' ' HG2' ' A' ' 77' ' ' GLN . 14.4 mtp-105 -139.65 125.35 19.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.536 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.7 m -107.66 134.5 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.621 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.632 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -104.91 142.46 34.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.451 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.54 31.81 81.03 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.52 131.26 34.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.842 0.353 . . . . 0.0 110.524 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.418 ' H ' HG12 ' A' ' 83' ' ' VAL . 1.8 p -87.05 113.5 24.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.514 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tp 60.51 118.34 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.462 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -55.24 160.96 7.62 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.953 1.769 . . . . 0.0 111.844 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.584 ' CD1' ' C ' ' A' ' 86' ' ' TRP . 0.1 OUTLIER -112.14 -172.69 2.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.655 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 92.1 p -111.19 155.46 22.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 89' ' ' HIS . 6.3 tp -140.25 143.77 36.13 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.495 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.456 ' N ' ' HG ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -107.6 128.1 54.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.765 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.5 mt -125.55 130.83 72.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.487 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -122.95 122.76 39.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.747 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.553 ' O ' ' C ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -117.58 156.82 27.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.465 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.553 ' C ' ' O ' ' A' ' 92' ' ' THR . 4.4 m-20 -24.15 -60.13 0.05 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.841 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.447 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 0.3 OUTLIER 165.51 92.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.546 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -175.33 133.94 0.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.53 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.55 116.17 15.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.614 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.5 p -139.26 138.26 40.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.426 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.42 165.26 12.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.684 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -127.45 144.24 14.96 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -103.46 119.77 39.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.75 0.31 . . . . 0.0 110.736 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.69 HD11 HG23 ' A' ' 67' ' ' ILE . 7.5 tt -133.02 136.63 55.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.698 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.0 t -127.85 149.34 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.308 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -120.8 148.63 43.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 0.0 110.76 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.449 ' OE1' ' OD2' ' A' ' 66' ' ' ASP . 2.7 mp0 -119.32 51.38 1.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.576 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -112.16 159.47 13.7 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -81.95 62.23 5.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.771 0.319 . . . . 0.0 110.62 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.444 ' OG ' ' CD1' ' A' ' 110' ' ' ILE . 77.4 p -93.95 -172.84 2.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.504 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 109' ' ' SER . 26.6 m-20 -131.65 20.78 4.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.619 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 87.8 p 177.4 91.42 0.01 OUTLIER 'General case' 0 C--O 1.244 0.787 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.983 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.567 ' O ' ' O ' ' A' ' 126' ' ' SER . 12.0 mt -115.96 128.43 73.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 120.772 0.32 . . . . 0.0 110.325 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -152.48 173.34 31.56 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -119.9 165.14 15.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.713 0.292 . . . . 0.0 110.475 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.656 ' NH1' ' OE1' ' A' ' 123' ' ' GLU . 5.6 ttm-85 -154.46 139.49 17.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.588 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.423 ' H ' ' HB3' ' A' ' 123' ' ' GLU . 4.4 mm -134.07 114.02 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.517 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.7 m -117.93 138.0 52.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.656 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 119' ' ' LYS . 30.4 m -140.62 148.78 21.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.732 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.425 ' C ' ' H ' ' A' ' 119' ' ' LYS . 34.1 m-20 44.97 26.57 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.73 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.99 -9.66 5.04 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 116' ' ' VAL . 14.1 mttp -106.28 127.37 53.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.751 0.31 . . . . 0.0 110.363 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.76 130.95 32.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.929 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -105.85 -67.78 0.91 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.419 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -150.47 132.33 15.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.364 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.656 ' OE1' ' NH1' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -150.67 146.88 26.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.585 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -109.74 121.77 45.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.576 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.63 ' O ' HG23 ' A' ' 125' ' ' VAL . 16.3 m -114.54 118.24 58.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.546 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.567 ' O ' ' O ' ' A' ' 110' ' ' ILE . 24.3 p -124.37 117.62 24.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.513 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' A' ' 127' ' ' ASN . 0.8 OUTLIER -99.57 129.85 45.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.414 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.05 145.09 21.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.681 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.402 ' H ' HG13 ' A' ' 129' ' ' VAL . 2.2 m -70.3 -17.8 21.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.625 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -167.55 98.57 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.407 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.422 -179.922 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 27.3 mmm . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -110.18 123.12 49.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.45 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.757 ' C ' HD23 ' A' ' 53' ' ' LEU . 5.8 tt -95.79 115.79 27.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.214 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.657 ' N ' HD23 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -126.33 139.52 53.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.704 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -119.82 149.83 41.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.018 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.79 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 0.3 OUTLIER -154.44 134.75 13.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.983 0.421 . . . . 0.0 110.954 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.572 HG22 ' H ' ' A' ' 58' ' ' PHE . 4.5 mm -97.76 170.32 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.587 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.572 ' H ' HG22 ' A' ' 57' ' ' ILE . 4.9 t80 -142.6 154.38 44.36 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.782 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.498 ' N ' ' CD1' ' A' ' 58' ' ' PHE . . . -168.48 173.97 43.19 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.559 ' C ' ' HG1' ' A' ' 63' ' ' THR . 1.3 Cg_endo -47.02 167.79 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 122.793 2.328 . . . . 0.0 111.936 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.33 117.63 5.18 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.857 2.371 . . . . 0.0 112.265 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.2 18.21 67.52 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.559 ' HG1' ' C ' ' A' ' 60' ' ' PRO . 4.0 m -72.31 132.0 43.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.807 0.337 . . . . 0.0 110.607 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 64' ' ' VAL . 5.2 m -108.03 122.93 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.578 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -141.34 155.92 45.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.295 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.45 126.98 42.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.621 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.607 HG23 HD11 ' A' ' 101' ' ' ILE . 2.6 mp -108.3 136.68 43.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.582 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.4 t -134.33 116.84 15.71 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.973 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.533 ' CG ' ' N ' ' A' ' 70' ' ' PHE . 50.5 t80 -143.96 165.08 28.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.753 0.311 . . . . 0.0 110.508 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.533 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 29.4 t80 -84.89 120.37 26.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.608 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -84.69 135.5 34.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.559 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.7 p -70.04 -15.25 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.69 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.643 ' O ' ' CB ' ' A' ' 74' ' ' SER . 3.9 t30 -78.81 -21.99 46.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.698 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.643 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 2.0 t 149.79 -104.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.567 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.617 ' N ' ' OG ' ' A' ' 74' ' ' SER . 0.4 OUTLIER -62.78 152.92 81.09 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.756 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -72.09 145.41 44.39 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.877 2.385 . . . . 0.0 112.289 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -102.74 144.48 31.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.32 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -144.87 138.37 26.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.952 0.406 . . . . 0.0 110.963 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.8 m -115.39 131.86 66.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.209 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.67 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -121.45 149.31 43.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.922 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 61.69 -6.59 0.21 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.551 ' H ' ' C ' ' A' ' 80' ' ' ASP . . . -63.94 134.42 55.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 0.0 110.573 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.536 ' O ' ' C ' ' A' ' 84' ' ' LEU . 3.6 m -47.5 -176.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.55 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.639 ' N ' HD23 ' A' ' 84' ' ' LEU . 1.8 pt? -28.46 148.04 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.62 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -56.15 146.51 70.47 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.757 2.305 . . . . 0.0 112.233 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -112.29 -166.52 1.09 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.556 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.79 ' OG ' ' HB2' ' A' ' 56' ' ' GLU . 59.2 m -117.85 165.1 14.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.959 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.59 HD23 ' H ' ' A' ' 89' ' ' HIS . 0.4 OUTLIER -135.79 155.19 50.74 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.627 178.715 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.59 ' H ' HD23 ' A' ' 88' ' ' LEU . 7.4 m80 -114.12 124.34 51.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.598 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.513 HD13 ' O ' ' A' ' 89' ' ' HIS . 3.0 mm -129.57 124.72 60.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.445 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 p -119.38 128.46 54.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.562 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.66 133.59 48.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.585 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -61.06 -7.3 2.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.618 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 45.0 t0 -73.51 -95.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.656 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 177.07 -92.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.234 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.68 121.31 29.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.319 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.86 155.75 37.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.785 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.78 146.32 52.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.263 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -130.89 162.12 23.47 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -119.12 114.64 22.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.707 0.289 . . . . 0.0 110.356 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.607 HD11 HG23 ' A' ' 67' ' ' ILE . 1.1 tt -133.33 140.38 47.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.706 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.6 p -142.21 146.8 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.584 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -129.85 144.32 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.664 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -125.7 76.84 1.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.498 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.96 160.9 13.26 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.555 ' O ' ' O ' ' A' ' 107' ' ' SER . 1.4 m-20 -79.47 13.58 1.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.743 0.306 . . . . 0.0 110.494 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.555 ' O ' ' O ' ' A' ' 106' ' ' ASN . 25.3 p -48.54 -170.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.578 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -104.35 -15.03 15.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.553 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.0 t -168.78 122.36 0.84 Allowed 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.982 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 126' ' ' SER . 11.2 mt -125.93 138.62 53.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.724 0.297 . . . . 0.0 110.49 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.7 160.38 31.01 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 31.8 p -118.52 155.08 31.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 0.0 110.678 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.31 144.51 22.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.662 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.641 ' CG2' HD11 ' A' ' 53' ' ' LEU . 2.3 mt -138.31 114.95 10.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.389 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.71 140.78 49.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.723 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.7 p -145.76 150.09 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.476 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.6 10.99 2.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.483 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 83.64 -3.48 85.07 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.453 ' HB3' ' NH2' ' A' ' 121' ' ' ARG . 13.8 tptm -121.21 137.33 54.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.775 0.321 . . . . 0.0 110.569 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.452 ' H ' HG13 ' A' ' 120' ' ' VAL . 1.2 m -73.96 143.77 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.539 ' HE ' ' CA ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -111.7 -60.09 1.9 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.383 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.5 126.94 5.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.249 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -151.69 129.33 11.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.83 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.484 ' HA ' ' HE ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -98.02 115.71 28.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.326 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 74.2 t -114.99 117.55 56.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.687 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 110' ' ' ILE . 16.6 m -131.88 132.61 43.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.621 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.28 138.17 32.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.24 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -150.21 130.76 13.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.934 0.397 . . . . 0.0 110.831 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.629 HG12 ' OD1' ' A' ' 130' ' ' ASN . 2.0 t -93.71 122.03 44.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.432 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.629 ' OD1' HG12 ' A' ' 129' ' ' VAL . 0.4 OUTLIER 70.9 39.86 0.99 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.685 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.362 179.874 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.5 mtp . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -91.1 128.15 36.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.22 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 97' ' ' VAL . 35.7 tp -97.5 114.9 26.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.814 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.4 t -127.78 133.41 49.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.533 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.572 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -121.8 149.47 43.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 0.0 110.461 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.736 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -155.52 143.66 20.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.808 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.6 HG22 ' N ' ' A' ' 58' ' ' PHE . 42.9 mm -111.22 167.81 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.917 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.6 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -129.42 173.57 10.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.013 0.435 . . . . 0.0 110.989 -179.68 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.47 157.57 10.4 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -43.64 155.58 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.495 2.13 . . . . 0.0 112.034 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -66.94 117.9 5.14 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.844 2.363 . . . . 0.0 112.27 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.85 3.78 58.04 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.627 HG23 ' OD1' ' A' ' 106' ' ' ASN . 98.9 m -86.77 139.94 30.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 0.0 110.739 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.464 HG11 ' HA2' ' A' ' 81' ' ' GLY . 2.4 m -106.78 131.41 56.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.389 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.94 149.34 50.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.649 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 104' ' ' GLN . 0.0 OUTLIER -99.14 121.8 41.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.44 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.524 HD12 ' N ' ' A' ' 67' ' ' ILE . 2.1 mp -108.14 125.78 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.566 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.5 t -127.62 116.26 20.05 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.032 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -151.38 170.85 18.54 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.806 0.336 . . . . 0.0 110.636 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.486 ' CE1' ' O ' ' A' ' 71' ' ' ASP . 52.1 t80 -84.19 133.11 34.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.737 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.486 ' O ' ' CE1' ' A' ' 70' ' ' PHE . 21.1 t0 -104.44 149.6 25.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.555 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.82 -33.76 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.684 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -80.47 11.35 3.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.632 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.58 47.55 10.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.503 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.421 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 66.8 mt-10 -149.38 96.8 3.62 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.45 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.25 139.61 90.89 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.453 2.102 . . . . 0.0 111.893 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 67' ' ' ILE . 11.9 mt-30 -107.84 132.09 53.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.755 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 -131.84 129.39 40.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.345 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.7 m -120.3 136.64 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.857 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.9 143.62 51.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.343 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.464 ' HA2' HG11 ' A' ' 64' ' ' VAL . . . 58.95 13.61 20.07 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.21 147.53 31.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.758 0.314 . . . . 0.0 110.642 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.565 ' O ' ' O ' ' A' ' 84' ' ' LEU . 4.1 p -52.25 165.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.424 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.565 ' O ' ' O ' ' A' ' 83' ' ' VAL . 0.3 OUTLIER -27.49 149.46 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.941 0.4 . . . . 0.0 110.813 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.59 141.01 94.11 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.902 2.401 . . . . 0.0 112.251 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -113.17 -168.88 1.39 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.547 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.736 ' OG ' ' HB2' ' A' ' 56' ' ' GLU . 59.6 m -115.34 155.44 27.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.008 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.405 ' C ' ' ND1' ' A' ' 89' ' ' HIS . 0.7 OUTLIER -135.21 151.24 50.44 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.22 178.517 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.759 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -125.61 127.35 46.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.006 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mt -130.81 134.58 61.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.343 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 m -120.96 131.5 54.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.498 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.542 ' O ' ' C ' ' A' ' 93' ' ' ASN . 91.8 m -117.14 135.06 54.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.529 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.542 ' C ' ' O ' ' A' ' 92' ' ' THR . 73.0 m-80 28.05 -93.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.641 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 92' ' ' THR . 11.1 t70 -172.33 76.25 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.688 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -171.62 167.09 6.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.6 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.648 ' HB1' HG21 ' A' ' 116' ' ' VAL . . . -69.67 151.1 46.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.293 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.411 ' O ' HD13 ' A' ' 53' ' ' LEU . 93.0 t -153.12 151.21 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.0 0.428 . . . . 0.0 110.937 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -120.05 173.25 7.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.891 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.4 142.76 8.55 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.587 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -104.11 116.38 32.11 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.28 140.29 48.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.98 0.419 . . . . 0.0 111.039 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.1 148.99 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.263 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.412 ' O ' HG21 ' A' ' 110' ' ' ILE . . . -135.83 135.02 39.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 110.696 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.418 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 7.6 mt-30 -127.77 83.95 2.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.608 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.62 163.91 14.92 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.627 ' OD1' HG23 ' A' ' 63' ' ' THR . 39.3 p-10 -78.71 49.6 0.91 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.854 0.359 . . . . 0.0 110.418 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.48 ' OG ' ' N ' ' A' ' 108' ' ' ASP . 28.9 t -92.94 -172.37 2.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.515 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.48 ' N ' ' OG ' ' A' ' 107' ' ' SER . 4.8 m-20 -97.62 -38.35 9.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.535 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.2 t -141.01 112.04 7.2 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.987 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 126' ' ' SER . 5.4 mt -112.63 123.02 67.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.856 0.36 . . . . 0.0 110.677 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -150.51 173.5 30.1 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 11.8 p -127.9 165.98 19.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.743 0.306 . . . . 0.0 110.494 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 113' ' ' ARG . 18.4 mtm-85 -151.32 144.04 24.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.489 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.4 mm -127.79 115.97 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.568 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 81.8 p -122.0 122.01 38.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.465 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.648 HG21 ' HB1' ' A' ' 96' ' ' ALA . 3.5 p -145.65 150.86 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.764 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.9 t70 58.54 16.86 4.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.647 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.91 -1.6 10.03 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -117.52 137.86 52.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.596 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.413 ' O ' ' CG1' ' A' ' 120' ' ' VAL . 2.0 p -78.75 132.28 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.615 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.4 mtm-85 -123.46 -47.03 2.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.711 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -145.09 128.82 17.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.783 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -149.73 128.39 12.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.414 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.443 ' HG2' HH11 ' A' ' 124' ' ' ARG . 5.3 tpp85 -116.24 116.29 27.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.71 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.2 122.53 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.358 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 110' ' ' ILE . 65.6 m -126.53 124.63 40.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.733 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -95.65 131.61 41.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.465 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 108' ' ' ASP . 78.2 tt0 -153.73 134.2 13.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.572 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.4 t -93.13 123.39 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.549 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 60.72 44.77 10.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.46 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.463 -179.903 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.2 mmt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -114.91 125.33 53.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.546 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.66 117.24 34.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.397 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 t -126.2 142.13 51.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.009 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.63 148.49 43.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.023 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.474 ' C ' ' CD ' ' A' ' 56' ' ' GLU . 8.0 tm-20 -156.48 134.42 11.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.868 0.366 . . . . 0.0 111.047 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.63 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 9.7 tt -116.53 139.07 44.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.943 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.88 172.3 10.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.748 0.308 . . . . 0.0 110.766 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.41 -81.97 0.2 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.46 109.34 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.896 2.397 . . . . 0.0 111.97 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.8 96.39 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.531 2.154 . . . . 0.0 111.896 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.28 -16.7 16.02 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.05 152.0 46.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.766 0.317 . . . . 0.0 110.401 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 64' ' ' VAL . 17.0 m -101.21 123.58 54.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.818 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.21 155.54 46.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.335 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -95.29 121.9 37.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.75 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.52 138.0 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.333 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.2 t -134.15 125.96 29.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.965 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.601 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 12.6 t80 -137.45 152.74 49.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.848 0.356 . . . . 0.0 110.603 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.601 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 83.9 t80 -83.58 126.5 32.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.649 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.09 154.06 22.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.536 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.0 p -72.34 -32.03 40.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.799 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.58 ' O ' ' CB ' ' A' ' 74' ' ' SER . 1.8 p-10 -81.63 -7.4 59.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.945 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.58 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.5 t 86.58 86.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.822 0.344 . . . . 0.0 110.373 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 171.24 92.55 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.323 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -59.4 139.97 92.1 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.716 2.277 . . . . 0.0 112.147 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -106.06 140.56 38.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.417 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.8 ttp-105 -141.48 132.49 26.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.679 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.1 m -123.26 129.17 75.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.469 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -119.62 127.74 53.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.736 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.55 13.05 79.22 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.7 137.02 33.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 0.0 110.608 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.584 ' O ' ' O ' ' A' ' 84' ' ' LEU . 4.2 m -59.48 -167.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.442 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.584 ' O ' ' O ' ' A' ' 83' ' ' VAL . 0.3 OUTLIER -32.22 156.94 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.533 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.63 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 10.7 Cg_endo -56.84 159.43 14.38 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 123.006 2.471 . . . . 0.0 112.301 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -125.09 -164.23 1.27 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.531 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 99.1 p -135.43 153.78 51.67 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.962 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.2 mp -129.7 155.43 45.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.715 0.293 . . . . 0.0 110.583 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -109.84 120.23 41.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.636 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.6 mt -128.75 133.64 65.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.526 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.8 p -118.21 124.34 47.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.463 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.45 ' C ' ' H ' ' A' ' 94' ' ' ASP . 3.1 m -116.25 135.19 54.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.628 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -72.64 39.83 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.58 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 92' ' ' THR . 33.2 t0 -122.16 -97.15 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.616 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 176.28 -78.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.582 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -102.14 125.57 48.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.404 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 98' ' ' MET . 93.5 t -148.63 155.58 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.419 . . . . 0.0 110.827 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.464 ' N ' HG12 ' A' ' 97' ' ' VAL . 7.8 mtt -127.59 179.25 5.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.315 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -158.87 153.79 24.9 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -113.07 121.84 45.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.748 0.309 . . . . 0.0 110.355 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.49 ' O ' HG23 ' A' ' 101' ' ' ILE . 9.7 tt -133.13 128.93 56.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.711 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.9 t -127.15 145.22 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.41 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.484 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -127.74 156.74 41.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.704 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -119.43 66.45 0.8 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.579 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 131' ' ' ALA . . . -119.1 157.93 15.12 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -93.45 83.01 4.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.808 0.337 . . . . 0.0 110.595 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.7 p -115.56 -166.93 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.406 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -124.55 10.2 8.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.593 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.5 p -170.72 105.0 0.26 Allowed 'General case' 0 C--O 1.242 0.71 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.867 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.55 ' O ' ' O ' ' A' ' 126' ' ' SER . 5.4 tt -132.09 136.63 56.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 120.683 0.278 . . . . 0.0 110.378 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.55 176.77 41.03 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 32.0 m -120.46 149.55 42.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.793 0.33 . . . . 0.0 110.391 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.413 ' HB3' ' NH1' ' A' ' 113' ' ' ARG . 19.2 mtp-105 -144.37 146.19 32.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.754 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.41 122.97 58.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.236 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 115' ' ' THR . 9.1 t -118.36 126.12 51.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.954 0.407 . . . . 0.0 110.787 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.9 p -136.48 138.99 46.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.333 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.2 t0 48.1 22.99 0.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.525 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.9 -7.42 9.53 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.6 mttp -99.84 133.08 44.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.871 0.367 . . . . 0.0 110.651 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 p -67.36 141.34 17.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.418 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -118.02 -75.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.588 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -150.67 128.55 11.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.481 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -150.95 160.17 44.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.611 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -121.05 124.67 45.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.561 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.33 117.28 52.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.57 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.55 ' O ' ' O ' ' A' ' 110' ' ' ILE . 48.1 p -132.22 120.94 22.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.583 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -100.18 129.88 46.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.505 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.45 162.12 31.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.463 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.6 p -102.31 -8.49 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.561 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.609 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 0.4 OUTLIER -164.83 63.24 0.13 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.499 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 105' ' ' GLY . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.528 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.449 ' N ' ' HA ' ' A' ' 117' ' ' ASP . 4.6 ttt . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.92 128.82 56.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.293 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.836 HD13 ' C ' ' A' ' 53' ' ' LEU . 3.1 tm? -95.72 115.27 27.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 0.0 110.203 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.604 ' N ' HD13 ' A' ' 53' ' ' LEU . 18.6 p -127.33 131.99 50.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.583 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -125.84 149.48 48.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.218 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -155.5 142.42 19.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.918 0.39 . . . . 0.0 110.845 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.588 HG22 ' N ' ' A' ' 58' ' ' PHE . 48.1 mm -109.6 165.78 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.187 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.69 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -143.77 149.34 36.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.9 0.381 . . . . 0.0 110.349 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.45 163.34 33.94 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -41.68 145.82 0.62 Allowed 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.685 2.257 . . . . 0.0 111.724 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.53 115.96 3.99 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.636 2.224 . . . . 0.0 112.294 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.35 2.66 50.84 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.56 ' O ' ' O ' ' A' ' 83' ' ' VAL . 7.9 m -86.54 141.21 29.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.788 0.327 . . . . 0.0 110.949 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 64' ' ' VAL . 35.2 m -104.25 127.16 58.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.202 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.67 154.7 48.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.913 0.387 . . . . 0.0 110.889 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -107.81 121.54 44.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.578 HG23 HD11 ' A' ' 101' ' ' ILE . 42.7 mt -108.52 131.59 58.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.744 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.3 t -134.75 119.72 18.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.026 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.464 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 69.6 t80 -132.19 162.17 31.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.831 0.348 . . . . 0.0 110.724 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.464 ' O ' ' CE2' ' A' ' 69' ' ' TYR . 51.2 t80 -88.89 126.4 35.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.662 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -84.46 141.29 30.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.44 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.19 -23.94 29.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.712 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.629 ' O ' ' CB ' ' A' ' 74' ' ' SER . 0.2 OUTLIER -85.0 -13.35 50.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.762 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.629 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 6.0 p 92.18 15.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.64 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -125.08 78.89 66.18 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.411 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.3 139.06 20.67 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.507 2.138 . . . . 0.0 112.454 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -108.46 158.61 17.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.146 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -130.36 136.97 49.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.869 0.366 . . . . 0.0 110.83 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.602 ' O ' HG13 ' A' ' 79' ' ' VAL . 14.7 p -119.28 118.13 56.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.18 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.16 136.16 54.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.585 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.44 7.95 61.5 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.87 139.0 55.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.748 0.308 . . . . 0.0 110.562 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.56 ' O ' ' O ' ' A' ' 63' ' ' THR . 2.1 t -70.94 -53.1 22.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.293 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.87 154.13 80.25 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.609 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -66.24 155.08 71.59 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 122.91 2.407 . . . . 0.0 112.101 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.553 ' CG ' ' N ' ' A' ' 87' ' ' SER . 43.1 t-105 -123.54 -161.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.265 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.553 ' N ' ' CG ' ' A' ' 86' ' ' TRP . 99.7 p -139.69 150.82 45.33 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 120.604 0.24 . . . . 0.0 110.993 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.5 tp -128.16 147.06 50.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.219 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.484 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -108.62 120.26 41.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.804 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.0 mt -130.53 128.93 64.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.6 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.5 m -111.06 122.87 48.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.283 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.538 ' O ' ' C ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -124.7 130.62 52.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.816 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.538 ' C ' ' O ' ' A' ' 92' ' ' THR . 1.3 p30 24.31 -120.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.89 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -163.36 88.41 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.469 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -174.44 -159.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.549 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.418 ' HA ' HG11 ' A' ' 116' ' ' VAL . . . -83.57 119.56 24.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.374 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.2 t -114.39 142.19 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.796 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.4 ptp -128.29 166.02 19.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.005 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.94 145.77 12.62 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -116.08 115.11 25.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.349 . . . . 0.0 110.261 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.578 HD11 HG23 ' A' ' 67' ' ' ILE . 1.9 tt -132.41 135.28 58.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.61 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 93.7 t -128.03 150.24 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.463 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -122.81 140.93 52.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.39 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -118.93 77.74 1.21 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.667 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.01 159.66 23.1 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -82.16 46.6 1.04 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.85 0.357 . . . . 0.0 110.497 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.402 ' OG ' HD11 ' A' ' 110' ' ' ILE . 72.4 p -80.01 -174.66 4.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.577 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -124.77 9.97 8.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.59 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.1 t -171.09 122.48 0.57 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.936 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.583 ' O ' ' O ' ' A' ' 126' ' ' SER . 15.6 mt -142.23 152.47 18.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 120.824 0.345 . . . . 0.0 110.404 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.402 ' N ' ' CG2' ' A' ' 110' ' ' ILE . . . -176.59 158.68 25.01 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.648 ' SG ' ' O ' ' A' ' 124' ' ' ARG . 0.5 OUTLIER -118.03 167.76 11.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 0.0 110.674 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.403 ' O ' HD13 ' A' ' 114' ' ' ILE . 21.6 ttm180 -159.39 123.95 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.312 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 113' ' ' ARG . 3.3 mm -125.37 112.61 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.926 0.393 . . . . 0.0 110.782 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.78 135.62 55.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.458 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' A' ' 96' ' ' ALA . 31.0 t -118.79 150.8 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.559 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.449 ' HA ' ' N ' ' A' ' 51' ' ' MET . 37.4 t70 51.88 24.21 2.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.585 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.27 4.99 39.76 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -110.4 138.84 46.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.875 0.369 . . . . 0.0 110.69 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 120' ' ' VAL . 7.4 p -86.17 119.34 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.502 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.5 -35.85 2.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.304 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.81 127.04 5.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.499 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -151.56 145.66 25.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.439 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.648 ' O ' ' SG ' ' A' ' 112' ' ' CYS . 1.8 ttt180 -116.36 123.44 47.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.699 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 125' ' ' VAL . 3.0 p -138.95 116.25 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.619 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.583 ' O ' ' O ' ' A' ' 110' ' ' ILE . 51.4 m -133.81 121.74 22.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.443 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.95 137.32 36.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 110.773 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -155.01 134.02 12.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.333 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.2 t -68.1 129.52 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.559 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 40.32 69.78 0.29 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.402 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.488 -179.919 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 12.4 mtm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -96.86 127.62 43.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.407 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.616 HD13 ' O ' ' A' ' 97' ' ' VAL . 2.1 tt -96.84 115.79 28.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.594 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.93 137.23 53.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.674 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.442 ' OH ' ' CD2' ' A' ' 69' ' ' TYR . 23.8 p90 -120.07 149.56 42.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.979 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.658 ' C ' HD13 ' A' ' 57' ' ' ILE . 26.0 tt0 -155.59 156.03 34.35 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.34 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.857 HD11 HD13 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -115.85 175.74 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.956 179.296 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.63 145.61 36.85 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.028 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -168.66 160.45 33.95 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -43.48 155.59 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.707 2.272 . . . . 0.0 112.147 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.0 114.51 3.41 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.729 2.286 . . . . 0.0 112.053 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.02 15.49 30.72 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.3 m -79.31 139.06 37.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.829 0.347 . . . . 0.0 110.638 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.525 ' O ' HG23 ' A' ' 64' ' ' VAL . 31.2 m -109.76 123.06 65.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.447 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.46 154.22 44.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.786 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.28 115.59 27.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.374 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.467 HG23 HD11 ' A' ' 101' ' ' ILE . 5.3 mm -102.05 121.59 53.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.587 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.3 t -135.59 120.3 18.36 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.916 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.442 ' CD2' ' OH ' ' A' ' 55' ' ' TYR . 22.7 p90 -141.26 158.05 44.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.869 0.366 . . . . 0.0 110.7 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -83.5 136.57 34.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.27 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.18 137.71 41.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.579 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.8 t -62.34 -18.69 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.4 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.515 ' O ' ' OG ' ' A' ' 74' ' ' SER . 3.0 m-20 -89.31 -0.19 57.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.696 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' A' ' 73' ' ' ASN . 7.9 p 73.44 40.82 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.573 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -154.05 91.35 3.17 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.48 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.94 141.55 15.06 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.749 2.299 . . . . 0.0 112.315 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -107.24 147.97 29.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.478 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.421 ' NH1' ' HG3' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -135.91 133.09 37.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.676 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.7 t -112.88 118.87 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.66 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.1 116.61 32.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.376 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.27 20.87 16.56 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.43 153.86 25.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.368 . . . . 0.0 110.617 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.18 -39.49 8.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.374 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.63 152.48 28.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.5 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.485 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 19.8 Cg_endo -61.42 150.45 85.0 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.943 2.429 . . . . 0.0 112.363 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -128.75 -172.45 2.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.458 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.637 ' C ' HD12 ' A' ' 88' ' ' LEU . 97.3 p -127.81 155.04 44.72 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.041 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.637 HD12 ' C ' ' A' ' 87' ' ' SER . 6.8 mp -130.99 148.19 52.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.859 0.361 . . . . 0.0 110.942 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' A' ' 89' ' ' HIS . 6.5 p80 -110.16 124.23 51.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.017 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.9 mt -129.01 134.79 63.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.926 0.394 . . . . 0.0 110.932 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.17 122.95 46.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.322 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.591 ' O ' ' N ' ' A' ' 94' ' ' ASP . 2.2 m -126.96 128.16 45.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.768 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.526 ' C ' ' O ' ' A' ' 92' ' ' THR . 4.4 t-20 -29.2 -37.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.555 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 92' ' ' THR . 1.6 m-20 -66.03 -135.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.684 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.45 -35.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.385 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.72 137.45 52.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.558 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.616 ' O ' HD13 ' A' ' 53' ' ' LEU . 21.0 t -150.09 124.28 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.581 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 5.5 mtt -96.55 131.31 43.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.605 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.23 146.79 18.88 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.505 ' O ' ' CG ' ' A' ' 100' ' ' ASN . 2.4 p-10 -102.79 116.51 32.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.791 0.329 . . . . 0.0 110.453 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.857 HD13 HD11 ' A' ' 57' ' ' ILE . 17.0 tt -133.12 136.89 54.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.641 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.7 t -139.75 149.29 22.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.433 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -126.77 148.22 49.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.639 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -133.51 46.16 2.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.537 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -99.3 163.81 20.1 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.87 36.58 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.745 0.307 . . . . 0.0 110.535 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.417 ' OG ' HD11 ' A' ' 110' ' ' ILE . 0.8 OUTLIER -65.25 -167.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.646 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -122.78 -25.15 4.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.582 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.8 t -144.5 88.26 1.92 Allowed 'General case' 0 C--O 1.243 0.752 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.026 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.417 HD11 ' OG ' ' A' ' 107' ' ' SER . 6.1 mt -100.6 149.2 6.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 120.833 0.349 . . . . 0.0 110.486 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.84 164.32 29.98 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 9.3 p -125.82 152.87 44.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.78 0.324 . . . . 0.0 110.698 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.06 141.11 24.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.491 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.468 ' CG2' HD11 ' A' ' 53' ' ' LEU . 6.9 mm -115.76 133.01 63.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.717 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.3 p -122.67 121.08 35.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.471 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.97 129.05 75.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.666 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.24 17.29 1.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.404 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 88.1 -8.57 77.87 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -101.45 147.5 26.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.322 . . . . 0.0 110.68 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.29 128.5 37.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.624 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.46 HH11 ' HB3' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -107.66 -65.53 1.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.401 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -149.34 127.28 11.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.042 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.31 130.27 12.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.036 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -111.97 115.6 29.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.918 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.58 124.93 72.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.054 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.4 m -127.6 126.28 41.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.04 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.09 129.22 40.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.008 0.432 . . . . 0.0 110.837 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -157.32 130.57 7.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.231 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.49 116.3 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.452 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.508 ' CG ' ' O ' ' A' ' 130' ' ' ASN . 4.7 t30 59.94 69.72 0.68 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.417 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.596 -179.817 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.405 ' HG3' ' CD2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.405 ' CD2' ' HG3' ' A' ' 51' ' ' MET . 25.4 m-70 -116.0 128.79 56.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.341 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.734 HD12 ' O ' ' A' ' 53' ' ' LEU . 3.3 pp -96.27 120.51 36.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.928 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.58 133.95 50.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.68 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -120.86 149.59 42.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.378 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.756 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 1.8 tm-20 -155.4 144.68 20.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.97 0.414 . . . . 0.0 110.923 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 57' ' ' ILE . 34.6 mm -116.11 153.39 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.11 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -140.22 163.68 32.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.05 0.452 . . . . 0.0 111.04 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.34 171.23 43.49 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.505 ' O ' ' OG1' ' A' ' 63' ' ' THR . 53.9 Cg_exo -46.91 153.43 1.4 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.654 2.236 . . . . 0.0 111.985 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -64.68 119.59 6.66 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.721 2.281 . . . . 0.0 112.039 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.24 5.34 62.21 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 33.0 m -69.37 144.66 53.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 0.0 110.604 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 p -119.49 122.1 68.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.48 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.408 ' HB1' ' HB1' ' A' ' 103' ' ' ALA . . . -143.11 155.31 44.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.705 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.72 115.22 30.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.115 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 mp -90.36 127.7 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.829 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.4 t -128.13 116.06 19.36 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.021 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.512 ' CZ ' ' OD1' ' A' ' 71' ' ' ASP . 2.9 p90 -146.04 148.8 33.07 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.236 0.335 . . . . 0.0 110.413 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -88.13 121.37 30.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.379 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.512 ' OD1' ' CZ ' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -82.93 144.81 29.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.541 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.5 p -55.47 -11.02 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.95 0.405 . . . . 0.0 110.177 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 74' ' ' SER . 35.4 t30 -92.54 -8.97 42.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.417 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.563 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.5 p 85.24 3.74 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.423 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -114.29 95.82 40.51 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.52 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -79.38 139.54 14.68 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.552 2.168 . . . . 0.0 112.072 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -107.93 151.06 26.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -128.82 134.03 48.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.467 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.0 m -105.96 129.43 59.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.587 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 5.8 p-10 -111.98 132.88 54.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.697 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.16 28.65 63.82 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.51 147.63 52.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.799 0.333 . . . . 0.0 110.673 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.0 p -100.3 -30.8 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.503 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tp -170.26 114.76 0.48 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.415 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -55.75 162.25 6.97 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.095 1.863 . . . . 0.0 111.895 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.465 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 7.1 m-90 -126.09 -150.7 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.558 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.756 ' OG ' ' HB2' ' A' ' 56' ' ' GLU . 59.1 m -121.87 165.5 15.81 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.004 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.78 150.18 35.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.783 0.325 . . . . 0.0 110.821 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -110.16 119.54 39.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.375 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.1 mt -126.57 135.53 63.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.627 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.41 123.41 48.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.598 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.55 ' O ' ' C ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -132.3 155.58 48.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.399 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.55 ' C ' ' O ' ' A' ' 92' ' ' THR . 7.2 p-10 -26.73 124.06 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.668 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.605 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.3 OUTLIER -32.08 98.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.449 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.605 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 167.35 143.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.361 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.4 126.38 29.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.703 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.98 131.57 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.416 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.569 ' SD ' ' CB ' ' A' ' 122' ' ' ALA . 6.3 mtm -96.37 137.17 35.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.651 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.29 162.45 19.91 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -111.63 115.81 29.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.312 . . . . 0.0 110.64 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.1 tt -132.82 141.41 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.445 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.2 155.97 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 110.753 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.408 ' HB1' ' HB1' ' A' ' 65' ' ' ALA . . . -136.52 146.46 46.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.322 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -120.31 31.99 6.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.738 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.59 156.6 26.89 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -85.89 78.58 9.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.773 0.321 . . . . 0.0 110.405 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.6 m -107.5 179.18 4.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.637 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.56 -12.03 15.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.685 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.9 p -167.55 100.0 0.49 Allowed 'General case' 0 C--O 1.243 0.721 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.005 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' A' ' 110' ' ' ILE . 12.5 tt -132.36 132.27 60.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.846 0.355 . . . . 0.0 110.696 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -153.29 175.89 31.54 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 1.7 p -124.32 156.75 36.44 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.725 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -160.95 139.58 10.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.428 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.5 mp -126.94 118.0 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.906 0.384 . . . . 0.0 110.765 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.7 t -116.83 128.3 55.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.3 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.9 t -121.0 155.81 24.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.818 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 58.44 14.34 2.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.597 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.5 9.47 78.03 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -116.51 140.07 49.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.774 0.321 . . . . 0.0 110.56 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.89 132.41 33.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.43 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -129.33 -74.94 0.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.573 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.569 ' CB ' ' SD ' ' A' ' 98' ' ' MET . . . -125.47 129.0 48.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.679 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -149.49 133.06 16.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.637 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.9 mmt-85 -105.97 119.93 40.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.481 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 84.9 t -113.05 116.24 52.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.73 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.7 m -133.94 117.04 16.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.144 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.53 129.55 56.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.838 0.352 . . . . 0.0 110.877 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -154.97 130.62 9.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.42 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.7 t -85.56 139.26 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.756 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 60.76 42.52 13.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.697 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.491 179.8 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -97.41 118.24 33.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.214 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.903 HD21 HG23 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -96.0 115.2 27.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.767 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.705 ' N ' HD13 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -127.32 130.48 49.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.493 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.5 ' OH ' ' CZ ' ' A' ' 69' ' ' TYR . 33.0 p90 -119.97 148.71 43.2 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.274 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.58 ' HG3' ' OG ' ' A' ' 87' ' ' SER . 1.7 tm-20 -156.05 136.43 13.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.9 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.589 HG22 ' N ' ' A' ' 58' ' ' PHE . 4.2 mp -99.15 167.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.745 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.589 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -132.79 163.65 28.59 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.145 -179.576 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.98 142.65 4.98 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -41.79 155.92 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.513 2.142 . . . . 0.0 112.202 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.07 134.77 28.1 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.76 2.306 . . . . 0.0 112.188 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.84 -4.16 71.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.56 ' O ' ' O ' ' A' ' 83' ' ' VAL . 15.7 m -86.64 130.84 34.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.0 110.723 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 64' ' ' VAL . 7.7 p -105.36 126.11 60.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.428 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -136.72 152.85 50.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.661 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -106.45 116.56 32.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.361 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 mp -96.3 131.7 42.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.5 t -134.69 123.84 24.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.003 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.5 ' CZ ' ' OH ' ' A' ' 55' ' ' TYR . 37.3 p90 -151.48 170.76 18.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.909 0.385 . . . . 0.0 110.624 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.64 ' CE1' ' O ' ' A' ' 74' ' ' SER . 27.3 t80 -88.74 134.55 33.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.29 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.436 ' C ' ' N ' ' A' ' 73' ' ' ASN . 0.9 OUTLIER -109.48 141.57 41.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.831 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.451 ' O ' HG12 ' A' ' 72' ' ' VAL . 17.2 t -52.73 -11.44 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.328 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.629 ' O ' ' CB ' ' A' ' 74' ' ' SER . 49.8 m-80 -83.86 1.26 44.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.461 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.64 ' O ' ' CE1' ' A' ' 70' ' ' PHE . 0.9 OUTLIER 92.27 -75.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.763 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.85 135.34 86.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.583 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.15 143.57 28.75 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.554 2.169 . . . . 0.0 112.133 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -104.12 135.97 44.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.392 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.8 125.93 24.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.861 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 79' ' ' VAL . 28.2 m -109.07 127.14 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.425 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.664 ' OD1' ' N ' ' A' ' 81' ' ' GLY . 13.1 t0 -126.39 150.35 48.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.866 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.664 ' N ' ' OD1' ' A' ' 80' ' ' ASP . . . 85.21 12.19 74.08 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.37 140.63 30.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.746 0.308 . . . . 0.0 110.632 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.786 HG13 ' HG ' ' A' ' 84' ' ' LEU . 1.5 p -81.66 -33.77 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.473 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.786 ' HG ' HG13 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -141.25 152.51 64.53 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.479 179.615 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.513 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 20.5 Cg_endo -62.41 160.48 31.35 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.888 2.392 . . . . 0.0 112.066 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.573 ' CD1' ' N ' ' A' ' 86' ' ' TRP . 10.5 m95 -123.6 172.65 8.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.395 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.58 ' OG ' ' HG3' ' A' ' 56' ' ' GLU . 70.5 m -114.83 144.8 42.94 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.032 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.604 HD23 ' N ' ' A' ' 89' ' ' HIS . 0.6 OUTLIER -131.35 141.02 49.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.853 0.358 . . . . 0.0 110.778 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.604 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -108.59 123.29 48.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.305 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.3 mt -129.35 124.17 59.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.932 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.21 123.27 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.212 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.6 m -126.38 133.67 51.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 110.98 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.558 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 26.0 t-20 39.69 32.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.983 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.536 ' C ' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER 28.8 59.68 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.612 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.45 -146.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.385 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -119.47 123.29 43.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.5 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.2 p -159.71 139.7 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.645 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.617 ' HB3' HG21 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -96.51 177.66 5.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.649 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -138.14 162.73 25.68 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -118.81 116.51 26.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.699 0.285 . . . . 0.0 110.561 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -133.33 142.54 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.805 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 98.5 t -121.97 146.66 26.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.206 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -140.08 138.86 35.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.959 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -131.39 102.28 5.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.208 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -131.04 163.83 23.42 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -78.97 19.69 0.52 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.853 0.359 . . . . 0.0 110.274 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 105' ' ' GLY . 6.1 p -69.04 -171.72 0.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.64 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.83 8.23 12.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.675 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.0 p -172.79 104.84 0.15 Allowed 'General case' 0 C--O 1.242 0.686 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 126' ' ' SER . 2.9 mt -126.55 136.93 59.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 120.807 0.337 . . . . 0.0 110.341 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.54 175.98 41.8 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -126.18 167.54 15.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.762 0.315 . . . . 0.0 110.603 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -157.43 140.36 15.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.437 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.903 HG23 HD21 ' A' ' 53' ' ' LEU . 3.6 mp -124.42 114.99 43.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.689 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.54 123.88 41.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.429 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.573 ' C ' ' H ' ' A' ' 118' ' ' GLY . 10.8 p -135.15 151.22 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.706 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 117' ' ' ASP . 13.2 t70 53.03 2.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.579 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.573 ' H ' ' C ' ' A' ' 116' ' ' VAL . . . 88.53 9.37 69.29 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -123.77 127.92 48.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.723 0.297 . . . . 0.0 110.629 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.5 p -80.03 136.47 23.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.425 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.38 -52.91 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.877 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -150.86 128.31 11.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.602 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.74 126.79 9.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.806 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -96.0 118.87 33.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.406 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.0 t -121.0 116.59 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.83 0.348 . . . . 0.0 110.885 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.555 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.3 OUTLIER -134.03 116.09 15.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.456 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.41 ' OD1' ' N ' ' A' ' 127' ' ' ASN . 2.6 m-20 -100.16 132.51 45.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.569 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -136.25 138.66 42.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.502 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 26.4 m -68.22 -6.14 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.588 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -161.6 92.64 0.88 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.615 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.489 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.6 mtt . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -92.76 129.03 38.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.461 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.422 ' O ' HD23 ' A' ' 53' ' ' LEU . 2.7 tt -95.63 118.02 31.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.513 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.3 135.08 51.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.596 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.537 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 1.2 p90 -120.34 148.62 43.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.409 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.562 ' C ' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -156.38 138.58 14.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.8 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.767 HD11 HD13 ' A' ' 101' ' ' ILE . 1.3 mm -105.95 174.73 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.905 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -133.36 171.94 13.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.991 0.424 . . . . 0.0 110.963 -179.591 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.86 147.13 5.07 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -39.16 152.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.758 2.306 . . . . 0.0 112.171 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -67.18 123.86 11.43 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.781 2.321 . . . . 0.0 112.151 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.87 -7.76 60.99 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -69.99 134.89 48.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.743 0.306 . . . . 0.0 110.493 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.9 t -111.7 125.71 69.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.632 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -141.13 155.37 46.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.371 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -98.9 123.15 42.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.717 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 52.2 mt -102.74 124.15 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.433 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 42.1 t -122.32 117.51 26.26 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.059 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.597 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 35.9 t80 -143.35 158.31 43.75 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.79 0.329 . . . . 0.0 110.489 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.597 ' O ' ' CE2' ' A' ' 69' ' ' TYR . 68.1 t80 -85.31 134.68 34.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.572 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -103.94 126.12 50.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.611 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 72' ' ' VAL . 60.5 t -62.29 -5.49 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.687 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.647 ' O ' ' CB ' ' A' ' 74' ' ' SER . 63.3 m-20 -85.72 -22.32 27.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.615 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.647 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 2.3 p 146.24 -99.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.547 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 75' ' ' GLU . 0.7 OUTLIER -64.99 147.64 98.35 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.65 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.58 154.9 50.06 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.719 2.28 . . . . 0.0 112.152 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -90.25 149.37 22.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.396 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ttp85 -152.59 133.17 13.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.737 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.05 136.66 52.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.414 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.537 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 1.0 OUTLIER -127.36 121.62 31.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.709 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.36 26.78 32.26 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.33 128.31 34.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.752 0.311 . . . . 0.0 110.626 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.4 t -67.87 -31.56 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.496 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.507 ' O ' HD12 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -161.54 156.5 20.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.491 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.449 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 11.6 Cg_endo -57.01 149.17 63.93 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.893 2.396 . . . . 0.0 112.282 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -120.6 -178.0 3.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.29 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.9 m -120.49 141.7 49.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.005 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.37 139.61 52.29 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.607 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 2.1 p-80 -114.83 127.79 55.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 0.0 110.963 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.4 mt -127.62 134.48 65.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.155 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -103.69 122.74 45.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.601 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.621 ' C ' ' H ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER -127.83 135.12 49.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.665 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 93' ' ' ASN . 0.5 OUTLIER -67.94 24.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.296 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.621 ' H ' ' C ' ' A' ' 92' ' ' THR . 2.2 t70 -114.07 0.87 14.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.536 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 60.7 -84.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.632 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.03 113.5 21.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.501 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.61 160.59 24.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.679 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.443 ' CG ' ' N ' ' A' ' 99' ' ' GLY . 4.3 ttt -130.15 158.21 40.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.381 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.443 ' N ' ' CG ' ' A' ' 98' ' ' MET . . . -156.38 152.3 23.7 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -110.47 117.46 33.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.864 0.364 . . . . 0.0 110.445 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.767 HD13 HD11 ' A' ' 57' ' ' ILE . 9.9 tt -132.08 137.48 54.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.535 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.2 t -138.05 149.93 24.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.554 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -120.79 150.24 41.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.58 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -135.59 79.46 1.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.646 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -131.64 161.24 23.69 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.435 ' N ' ' OD1' ' A' ' 106' ' ' ASN . 0.5 OUTLIER -79.07 28.57 0.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.84 0.352 . . . . 0.0 110.405 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -62.96 -166.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.598 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 108' ' ' ASP . 1.4 m-20 -114.75 -28.25 7.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.668 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.4 t -141.74 126.68 18.26 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.898 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.509 ' O ' ' O ' ' A' ' 126' ' ' SER . 23.0 mt -135.67 154.1 34.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.412 ' N ' ' CG2' ' A' ' 110' ' ' ILE . . . 174.69 159.23 20.59 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 5.7 p -117.93 161.46 19.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.766 0.317 . . . . 0.0 110.339 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 113' ' ' ARG . 2.8 ptp180 -161.3 136.87 7.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.664 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.1 mt -127.5 122.77 60.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.416 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.45 139.6 51.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.53 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.541 HG21 ' NH1' ' A' ' 121' ' ' ARG . 19.6 m -133.06 135.27 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.682 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 53.23 30.65 10.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.67 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.98 -1.58 23.22 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -109.31 136.01 49.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.331 . . . . 0.0 110.556 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.9 t -77.54 128.7 38.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.779 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.541 ' NH1' HG21 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -116.95 -63.91 1.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.379 179.773 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.93 127.21 45.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -149.38 131.83 15.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.993 0.425 . . . . 0.0 111.066 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -121.48 115.52 23.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.897 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.524 ' O ' ' CG2' ' A' ' 125' ' ' VAL . 1.1 m -111.16 125.59 68.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.907 0.384 . . . . 0.0 111.025 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.7 OUTLIER -131.46 115.93 16.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.016 179.473 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -101.81 131.01 48.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.885 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -156.63 136.64 12.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.613 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 20.4 t -88.99 140.95 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.568 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 46.02 53.75 8.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.272 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.631 -179.935 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.3 mtm . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -114.88 128.74 56.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.465 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.931 HD22 ' O ' ' A' ' 97' ' ' VAL . 14.5 tp -96.13 114.86 26.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.449 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.5 p -127.78 129.95 47.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.563 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.456 ' CD1' ' C ' ' A' ' 55' ' ' TYR . 26.0 p90 -123.47 148.33 46.31 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.474 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.457 ' HG3' ' OG ' ' A' ' 87' ' ' SER . 10.4 tt0 -156.65 133.53 10.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.777 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.9 mp -98.76 158.31 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.854 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.49 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -132.3 166.26 22.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.912 0.387 . . . . 0.0 110.781 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.66 163.16 19.88 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.06 109.61 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.655 2.237 . . . . 0.0 112.119 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -45.79 141.87 8.17 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.517 2.145 . . . . 0.0 112.008 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.53 -13.31 56.75 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.6 p -83.03 137.76 34.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.716 0.293 . . . . 0.0 110.56 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 64' ' ' VAL . 20.9 m -103.31 132.37 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.739 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.49 153.83 43.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.306 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -97.27 114.88 26.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.623 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 67' ' ' ILE . 1.8 mp -87.71 122.67 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.583 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.4 t -130.26 116.28 18.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.98 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.61 ' CZ ' ' O ' ' A' ' 70' ' ' PHE . 16.3 t80 -149.86 149.43 30.47 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.822 0.344 . . . . 0.0 110.575 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.61 ' O ' ' CZ ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -84.71 130.53 34.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.389 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.67 ' OD1' ' N ' ' A' ' 72' ' ' VAL . 67.9 t0 -93.87 146.38 23.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.802 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.67 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 89.7 t -69.59 -34.3 60.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.46 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -81.01 11.76 3.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.761 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.9 m 61.49 71.4 0.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.61 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.524 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 3.2 tt0 -178.66 77.73 0.22 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.379 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.66 144.25 99.47 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.96 2.44 . . . . 0.0 112.177 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -107.66 134.85 50.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.382 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 mtm-85 -134.08 126.92 31.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.922 0.391 . . . . 0.0 110.656 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 t -115.94 119.77 62.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.513 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -108.51 121.6 45.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.566 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.21 15.38 38.68 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.72 130.59 43.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 0.0 110.648 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.3 t -73.47 -35.17 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.294 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.61 ' H ' HD12 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -149.76 157.36 38.35 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.507 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.563 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 18.6 Cg_endo -61.33 157.08 42.3 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.989 2.459 . . . . 0.0 112.107 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -129.26 176.93 7.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.356 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.457 ' OG ' ' HG3' ' A' ' 56' ' ' GLU . 59.7 m -114.19 161.58 17.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.98 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.0 tp -147.98 134.97 20.24 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.244 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -109.15 126.36 53.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.841 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 90' ' ' ILE . 4.6 mp -130.46 136.79 57.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.388 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.6 p -122.63 130.03 52.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.524 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.676 ' O ' ' N ' ' A' ' 94' ' ' ASP . 2.0 m -113.3 156.11 23.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.696 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.551 ' O ' ' C ' ' A' ' 94' ' ' ASP . 11.2 t30 -28.59 84.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.786 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.676 ' N ' ' O ' ' A' ' 92' ' ' THR . 10.3 m-20 23.6 92.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.707 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 172.06 140.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.652 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.5 140.01 33.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.234 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.931 ' O ' HD22 ' A' ' 53' ' ' LEU . 9.2 p -150.86 142.97 16.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 110.888 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.547 ' N ' ' SD ' ' A' ' 98' ' ' MET . 3.1 mmt -93.31 161.13 14.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.129 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.43 154.7 20.99 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.383 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -109.92 115.38 29.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.681 0.277 . . . . 0.0 110.263 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.4 tt -131.96 142.38 43.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.957 0.408 . . . . 0.0 110.981 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.0 t -139.98 145.82 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.357 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -143.51 151.73 40.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.763 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.46 103.89 7.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.529 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.58 161.71 23.7 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -82.87 54.92 2.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 0.0 110.574 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.27 -167.13 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.45 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -118.24 -10.94 10.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.618 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 t -154.84 102.41 2.35 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.56 ' O ' ' O ' ' A' ' 126' ' ' SER . 3.7 mt -127.23 127.06 68.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.854 0.359 . . . . 0.0 110.3 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.04 172.26 33.95 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.564 ' O ' ' O ' ' A' ' 124' ' ' ARG . 31.6 p -125.08 161.53 26.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.768 0.318 . . . . 0.0 110.694 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.793 ' C ' HD12 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -156.41 147.04 21.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.496 179.799 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.793 HD12 ' C ' ' A' ' 113' ' ' ARG . 1.8 mp -121.57 117.18 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 110.82 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.78 129.4 51.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.284 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 118' ' ' GLY . 27.3 m -136.5 144.49 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.917 0.389 . . . . 0.0 110.969 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' A' ' 117' ' ' ASP . 21.7 t0 44.93 13.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.84 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 116' ' ' VAL . . . 83.64 -2.25 87.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 116' ' ' VAL . 4.6 ttmt -102.99 126.07 50.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.387 . . . . 0.0 110.396 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 20.9 t -80.86 140.33 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.631 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.423 ' NH1' ' HG3' ' A' ' 121' ' ' ARG . 1.7 mmm-85 -128.87 -48.94 1.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.497 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.91 135.99 9.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.535 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -149.54 155.9 41.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.502 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.564 ' O ' ' O ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -124.61 116.13 21.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.517 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.5 t -121.26 117.25 52.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.567 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.56 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.6 OUTLIER -130.54 121.75 26.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.588 -179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.53 129.84 41.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.241 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -132.25 139.98 48.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.812 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.25 -8.98 12.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.413 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 178.93 82.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.41 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.675 -179.799 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.616 ' SD ' ' OD1' ' A' ' 117' ' ' ASP . 41.7 mtm . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.17 129.14 55.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.453 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.699 ' C ' HD23 ' A' ' 53' ' ' LEU . 7.0 tt -95.52 114.79 26.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.962 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.433 ' N ' HD23 ' A' ' 53' ' ' LEU . 0.7 OUTLIER -127.33 135.76 50.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 55' ' ' TYR . 26.8 p90 -130.13 149.3 51.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.096 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.981 ' OE1' ' OG ' ' A' ' 87' ' ' SER . 15.5 tt0 -155.64 150.72 26.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.963 0.411 . . . . 0.0 111.079 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.488 HD11 HG23 ' A' ' 110' ' ' ILE . 7.1 tt -112.1 163.21 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.887 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.642 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -139.96 165.08 28.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 110.993 -179.469 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.6 171.37 44.33 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -47.85 112.74 0.61 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.716 2.277 . . . . 0.0 111.976 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -44.62 146.79 2.01 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.431 2.087 . . . . 0.0 112.267 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.78 -10.7 59.2 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.1 m -79.37 139.18 37.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 110.661 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.7 t -102.48 122.95 55.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.496 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.87 140.96 36.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.695 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -101.04 116.07 31.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.31 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.9 tt -102.06 138.4 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.81 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.2 t -124.48 118.67 27.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.949 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -128.19 167.12 17.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.756 0.312 . . . . 0.0 110.55 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.4 ' CE1' ' HA ' ' A' ' 74' ' ' SER . 55.7 t80 -99.62 134.83 41.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.313 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -95.75 139.14 32.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.68 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -54.91 -29.77 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.549 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.441 ' O ' ' CB ' ' A' ' 74' ' ' SER . 10.0 m-20 -84.19 2.93 37.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.523 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 0.7 OUTLIER 76.99 10.1 2.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.508 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -110.43 91.39 11.78 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.401 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.92 139.83 17.73 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.624 2.216 . . . . 0.0 112.309 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -107.83 158.35 17.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.592 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -145.58 126.35 14.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.624 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.0 m -108.21 135.57 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.499 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -128.96 132.96 47.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.74 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.31 17.65 42.02 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.87 149.44 36.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.837 0.351 . . . . 0.0 110.754 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.556 HG23 ' CD1' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -88.35 -42.43 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.302 179.775 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.556 ' CD1' HG23 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -144.49 154.07 56.1 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.187 179.662 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.28 147.37 47.39 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 122.96 2.44 . . . . 0.0 112.266 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.534 ' CD1' ' N ' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -114.23 -162.75 0.83 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.256 179.709 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.981 ' OG ' ' OE1' ' A' ' 56' ' ' GLU . 70.3 m -116.59 153.53 32.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.986 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 mt -128.23 141.74 51.37 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.737 0.303 . . . . 0.0 110.506 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.34 119.92 40.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.509 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.444 ' HA ' HD13 ' A' ' 90' ' ' ILE . 26.2 mm -126.7 121.55 58.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.75 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 p -105.38 122.48 46.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.344 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.2 m -122.08 149.25 43.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.716 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -86.83 31.31 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.454 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.538 ' C ' ' H ' ' A' ' 96' ' ' ALA . 32.8 m-20 -114.52 -4.07 12.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.548 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 94' ' ' ASP . . . 70.77 -28.52 0.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.713 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.538 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -156.62 138.15 14.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.701 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.3 p -174.9 144.7 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.429 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -104.3 154.3 19.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.777 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -122.02 159.03 16.7 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.25 122.13 46.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.719 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.8 pt -132.53 139.52 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.531 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 103' ' ' ALA . 75.0 t -123.43 159.31 28.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.349 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.517 ' N ' HG12 ' A' ' 102' ' ' VAL . . . -131.05 152.08 50.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.982 0.42 . . . . 0.0 110.612 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.91 64.05 1.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.328 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -130.97 163.99 23.35 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.7 20.39 0.45 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 0.0 110.558 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.603 ' OG ' ' N ' ' A' ' 108' ' ' ASP . 6.0 t -53.47 -173.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.626 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.603 ' N ' ' OG ' ' A' ' 107' ' ' SER . 37.4 t0 -119.61 -73.44 0.64 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.615 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.1 t -89.21 122.12 32.18 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.975 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.488 HG23 HD11 ' A' ' 57' ' ' ILE . 12.7 mt -130.46 139.44 51.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.828 0.347 . . . . 0.0 110.5 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.17 144.36 7.98 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 10.7 p -117.96 156.91 27.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.73 0.3 . . . . 0.0 110.476 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.766 ' C ' HD12 ' A' ' 114' ' ' ILE . 13.8 ptm180 -159.96 146.04 15.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.766 HD12 ' C ' ' A' ' 113' ' ' ARG . 3.8 mp -131.83 122.05 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.368 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.0 t -118.68 140.94 49.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.679 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.454 ' C ' ' H ' ' A' ' 118' ' ' GLY . 31.1 m -124.17 144.72 32.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.559 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.616 ' OD1' ' SD ' ' A' ' 51' ' ' MET . 0.5 OUTLIER 52.94 9.77 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.575 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 116' ' ' VAL . . . 88.02 5.6 76.75 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.6 mtmt -106.44 127.33 53.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.748 0.309 . . . . 0.0 110.512 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.486 ' O ' HG23 ' A' ' 120' ' ' VAL . 26.5 m -70.9 118.84 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.74 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -103.44 -72.94 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.479 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -135.31 128.09 31.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.315 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -146.9 123.85 11.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.0 mtt-85 -100.61 115.46 30.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.286 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.9 t -123.98 117.25 50.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.61 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.2 OUTLIER -132.99 122.67 24.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.406 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -94.2 129.74 40.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.342 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -152.85 130.74 11.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.718 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.72 ' O ' HG13 ' A' ' 129' ' ' VAL . 13.7 p -65.06 104.36 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.554 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 66.79 81.76 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.56 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.606 -179.882 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -114.24 128.0 56.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.445 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 53' ' ' LEU . 2.2 pp -95.9 116.06 28.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.334 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.9 t -123.76 144.8 49.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.77 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.4 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -119.48 149.41 41.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.013 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.492 ' OE1' ' C ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -155.76 136.88 13.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.946 0.403 . . . . 0.0 111.087 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.519 HG22 ' N ' ' A' ' 58' ' ' PHE . 21.0 mt -116.31 161.81 14.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.002 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.519 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -141.32 151.02 43.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.018 0.437 . . . . 0.0 110.662 -179.878 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -165.93 168.83 39.93 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -46.11 144.72 6.06 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.651 2.234 . . . . 0.0 111.781 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -64.29 120.48 7.82 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.592 2.195 . . . . 0.0 112.17 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.09 2.94 59.13 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.579 ' O ' ' O ' ' A' ' 83' ' ' VAL . 6.7 t -78.71 141.48 37.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.861 0.363 . . . . 0.0 110.665 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 64' ' ' VAL . 33.8 m -101.79 128.2 54.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.621 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.35 144.73 33.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.839 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.45 116.32 32.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.247 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.699 HG23 HD11 ' A' ' 101' ' ' ILE . 23.7 mt -101.03 124.71 54.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.023 0.439 . . . . 0.0 111.006 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.5 t -135.63 124.35 23.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.992 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' A' ' 69' ' ' TYR . 23.9 p90 -147.94 169.01 20.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.909 0.385 . . . . 0.0 110.965 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -87.35 125.7 34.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.455 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -90.95 155.07 19.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.632 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 73' ' ' ASN . 5.3 p -51.77 -37.07 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.495 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 74' ' ' SER . 0.9 OUTLIER -85.16 11.75 9.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.473 179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.516 ' O ' ' C ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER 81.19 -68.03 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.313 -179.729 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.516 ' C ' ' O ' ' A' ' 74' ' ' SER . 5.6 tt0 -31.91 104.14 0.22 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.136 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -76.7 139.86 20.43 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.317 2.011 . . . . 0.0 112.318 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -97.79 147.66 24.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.498 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 78' ' ' ARG . 14.8 mtp180 -144.73 130.01 18.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.465 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.9 m -109.8 124.5 66.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.411 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.01 117.99 31.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.73 16.73 27.93 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.86 135.66 48.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.774 0.321 . . . . 0.0 110.5 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.579 ' O ' ' O ' ' A' ' 63' ' ' THR . 0.5 OUTLIER -81.17 -38.68 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.659 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.407 ' CD1' HG23 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -148.16 157.06 43.24 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.119 0.485 . . . . 0.0 110.578 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.492 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 38.0 Cg_endo -68.82 160.31 50.19 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.867 2.378 . . . . 0.0 112.227 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.93 -169.65 2.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.498 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.5 m -133.83 144.98 49.3 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.952 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.3 tp -138.32 155.64 48.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.627 0.251 . . . . 0.0 110.398 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -115.82 135.37 54.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 110.984 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.7 mt -129.23 130.32 67.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.249 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 91' ' ' THR . 5.4 t -115.35 129.21 56.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.771 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.557 ' O ' ' C ' ' A' ' 93' ' ' ASN . 14.0 m -129.97 125.42 35.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.226 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.557 ' C ' ' O ' ' A' ' 92' ' ' THR . 26.3 m-20 26.26 -104.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.544 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 94' ' ' ASP . 4.8 p-10 -160.05 81.23 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.484 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -167.43 147.41 5.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.664 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.36 127.21 33.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.361 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -140.56 150.07 21.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -102.39 172.59 6.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.208 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -138.44 161.8 25.72 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.534 ' C ' ' OD1' ' A' ' 100' ' ' ASN . 16.2 t-20 -114.96 115.22 26.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 0.0 110.498 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.699 HD11 HG23 ' A' ' 67' ' ' ILE . 18.7 tt -130.98 141.42 46.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.505 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 103' ' ' ALA . 77.8 t -129.36 155.43 41.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.879 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.465 ' HB3' HG12 ' A' ' 110' ' ' ILE . . . -121.31 147.24 45.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.562 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -134.49 54.26 1.95 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.812 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.65 162.97 20.72 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.98 89.83 4.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.853 0.359 . . . . 0.0 110.448 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.2 p -117.82 177.7 4.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.774 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -116.91 -0.01 12.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.439 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.1 p -170.46 84.52 0.11 Allowed 'General case' 0 C--O 1.245 0.853 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.047 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.468 ' O ' ' CG2' ' A' ' 110' ' ' ILE . 0.4 OUTLIER -109.96 128.97 65.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 120.9 0.381 . . . . 0.0 110.774 -179.752 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -152.86 164.41 30.78 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 20.3 m -125.0 153.24 43.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.928 0.394 . . . . 0.0 110.727 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -159.87 144.89 15.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.309 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -126.56 133.67 68.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.833 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.8 m -122.79 124.02 42.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.432 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.444 ' C ' ' N ' ' A' ' 118' ' ' GLY . 0.5 OUTLIER -131.84 148.78 32.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.556 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.0 t0 49.87 13.46 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.691 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.444 ' N ' ' C ' ' A' ' 116' ' ' VAL . . . 84.64 -0.14 89.22 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.62 138.34 50.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.717 0.294 . . . . 0.0 110.586 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.3 t -85.41 118.67 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.53 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -90.37 -62.09 1.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.5 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -114.7 131.75 56.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.449 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -129.52 121.75 27.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.773 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.457 ' O ' ' CG ' ' A' ' 124' ' ' ARG . 11.8 ptm180 -128.49 123.19 32.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.293 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.8 t -122.5 120.25 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.63 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.42 115.94 18.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.637 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -95.08 130.18 41.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.211 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -150.4 130.57 13.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.761 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.07 18.34 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.993 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.412 ' CG ' ' O ' ' A' ' 130' ' ' ASN . 17.4 t30 -179.09 65.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.409 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.627 -179.889 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.66 127.85 54.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.481 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.453 ' CD1' ' O ' ' A' ' 97' ' ' VAL . 1.5 tt -96.12 115.72 27.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.416 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.62 130.95 51.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.667 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -119.98 149.01 42.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.2 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 2.6 tm-20 -156.03 146.76 21.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.984 0.421 . . . . 0.0 111.002 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 58' ' ' PHE . 74.7 mt -114.73 159.96 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.761 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.672 ' CE2' HD11 ' A' ' 84' ' ' LEU . 11.8 t80 -140.28 156.86 46.3 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.245 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.589 ' N ' ' CD1' ' A' ' 58' ' ' PHE . . . -160.72 175.04 37.45 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -50.93 157.98 3.44 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.623 2.216 . . . . 0.0 111.979 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -75.27 118.66 5.27 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.803 2.335 . . . . 0.0 112.187 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.03 9.9 55.5 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.77 150.67 25.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.785 0.326 . . . . 0.0 110.442 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 64' ' ' VAL . 7.6 p -126.06 121.98 60.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.569 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.38 153.55 42.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.529 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.92 115.71 27.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.401 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.499 ' CD1' HD12 ' A' ' 57' ' ' ILE . 4.1 mm -93.24 132.73 36.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.853 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.5 t -135.8 127.54 29.15 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.909 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.454 ' CG ' ' N ' ' A' ' 70' ' ' PHE . 40.1 t80 -150.46 157.34 42.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.801 0.334 . . . . 0.0 110.678 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 12.9 t80 -87.44 124.35 33.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.439 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.83 156.81 22.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.483 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.29 -30.84 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.473 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 74' ' ' SER . 34.9 m120 -95.72 11.6 32.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.31 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.63 ' OG ' ' N ' ' A' ' 75' ' ' GLU . 1.1 p 85.19 -69.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.379 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.63 ' N ' ' OG ' ' A' ' 74' ' ' SER . 11.4 pt-20 -29.63 94.86 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.495 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.498 ' N ' ' O ' ' A' ' 74' ' ' SER . 51.3 Cg_endo -77.01 141.6 21.2 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.506 2.137 . . . . 0.0 111.978 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.452 ' HG2' ' N ' ' A' ' 78' ' ' ARG . 1.4 tt0 -107.58 140.83 39.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.987 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.452 ' N ' ' HG2' ' A' ' 77' ' ' GLN . 4.4 mtt-85 -135.9 133.5 37.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.165 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 m -99.35 136.56 29.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.72 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -113.09 103.67 11.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.64 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.32 33.46 5.4 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.31 148.11 50.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.789 0.328 . . . . 0.0 110.559 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.5 m -107.56 -20.03 6.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.395 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.672 HD11 ' CE2' ' A' ' 58' ' ' PHE . 5.3 tt -174.99 115.17 0.29 Allowed Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.222 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.567 ' N ' HD23 ' A' ' 84' ' ' LEU . 27.4 Cg_exo -55.63 144.19 76.08 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.897 1.731 . . . . 0.0 111.803 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.526 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 4.4 m-90 -111.5 -144.54 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.528 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.707 ' O ' HD22 ' A' ' 88' ' ' LEU . 97.0 p -134.17 155.21 50.52 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.977 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.707 HD22 ' O ' ' A' ' 87' ' ' SER . 1.5 mm? -129.1 151.84 49.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.786 0.327 . . . . 0.0 110.492 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.433 ' O ' HD13 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -105.86 119.05 38.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.629 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.433 HD13 ' O ' ' A' ' 89' ' ' HIS . 50.3 mm -126.41 138.25 55.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.456 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 91' ' ' THR . 12.0 t -103.76 130.44 51.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.649 ' O ' ' N ' ' A' ' 94' ' ' ASP . 17.4 p -116.75 140.34 49.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.737 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.524 ' CG ' ' O ' ' A' ' 93' ' ' ASN . 1.8 t30 -49.5 79.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.59 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 92' ' ' THR . 21.9 m-20 34.08 79.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.55 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -169.41 145.79 3.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.508 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.432 ' CB ' HG11 ' A' ' 116' ' ' VAL . . . -108.5 113.6 26.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.439 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.453 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 7.7 p -133.91 156.78 41.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.674 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.444 ' HA ' HG21 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -108.07 117.26 33.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.533 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.38 161.87 54.39 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -112.9 115.39 28.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 0.0 110.595 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.4 tt -131.08 139.25 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.643 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 103' ' ' ALA . 8.2 t -130.39 155.16 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.397 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.451 ' N ' ' CG1' ' A' ' 102' ' ' VAL . . . -140.72 157.16 45.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.737 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -136.83 73.71 1.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.586 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -128.8 163.51 22.18 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -79.18 106.74 11.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.868 0.366 . . . . 0.0 110.516 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.0 p -140.9 -170.83 3.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.622 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 108' ' ' ASP . 2.3 t70 -134.15 4.93 3.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.5 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.8 p -174.73 62.46 0.02 OUTLIER 'General case' 0 C--O 1.245 0.847 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.959 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.504 ' O ' ' O ' ' A' ' 126' ' ' SER . 4.2 tt -98.99 129.52 49.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 O-C-N 123.16 0.288 . . . . 0.0 110.424 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -149.42 172.4 29.45 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.569 ' O ' ' O ' ' A' ' 124' ' ' ARG . 0.9 OUTLIER -118.99 157.32 27.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.765 0.317 . . . . 0.0 110.28 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.511 ' NH2' ' OE1' ' A' ' 56' ' ' GLU . 15.1 ptt-85 -161.41 141.78 10.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.642 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 113' ' ' ARG . 20.1 mm -117.71 131.37 70.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.615 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.1 p -110.3 132.88 53.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.429 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.432 HG11 ' CB ' ' A' ' 96' ' ' ALA . 24.5 t -142.05 150.08 19.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.598 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 50.99 19.24 0.63 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.653 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.38 -4.73 24.9 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -120.94 132.03 54.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.797 0.332 . . . . 0.0 110.557 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.3 t -74.63 134.53 29.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.46 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.03 -46.82 2.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.789 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.64 129.73 14.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.69 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -150.19 155.73 40.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.576 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.569 ' O ' ' O ' ' A' ' 112' ' ' CYS . 25.8 mtt-85 -116.22 116.0 27.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.608 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.7 p -124.31 128.82 74.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.527 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 110' ' ' ILE . 4.7 m -128.71 130.46 47.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.534 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -99.41 137.92 37.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.517 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -145.64 166.47 25.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.459 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.424 ' C ' ' CG ' ' A' ' 130' ' ' ASN . 5.2 t -97.59 -3.37 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.443 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.424 ' CG ' ' C ' ' A' ' 129' ' ' VAL . 0.1 OUTLIER 172.33 79.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.354 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.513 -179.83 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.7 mpt? . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -113.13 128.59 56.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.604 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.649 HD11 ' CG2' ' A' ' 114' ' ' ILE . 39.1 tp -95.79 115.76 27.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.087 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.1 p -126.45 131.77 51.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 88' ' ' LEU . 26.1 p90 -119.77 148.88 42.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.832 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.46 ' O ' HD13 ' A' ' 57' ' ' ILE . 2.2 tm-20 -155.81 144.88 20.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.901 0.382 . . . . 0.0 110.919 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.554 HG22 ' N ' ' A' ' 58' ' ' PHE . 31.4 mm -116.11 165.59 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.901 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.686 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -133.01 165.42 24.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.023 0.44 . . . . 0.0 110.952 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.76 170.56 37.33 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.559 ' O ' ' OG1' ' A' ' 63' ' ' THR . 17.9 Cg_endo -64.82 161.2 37.25 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.518 2.146 . . . . 0.0 112.016 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -72.51 119.52 6.17 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.868 2.379 . . . . 0.0 112.163 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.69 7.31 45.24 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.559 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -82.92 136.02 34.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.809 0.338 . . . . 0.0 110.653 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -114.53 122.63 69.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.615 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.61 151.53 44.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.503 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.497 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 9.2 p30 -96.24 116.0 28.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.635 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 mt -96.83 130.45 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.572 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.4 t -134.19 126.06 29.14 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.02 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.657 ' CZ ' ' O ' ' A' ' 70' ' ' PHE . 11.0 t80 -151.38 152.64 33.39 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.876 0.369 . . . . 0.0 110.63 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.657 ' O ' ' CZ ' ' A' ' 69' ' ' TYR . 49.7 t80 -84.75 121.53 27.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.494 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.448 ' HB2' ' H ' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -81.52 151.18 27.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.627 -179.84 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.5 t -64.72 -35.27 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.604 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -89.7 10.24 24.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.657 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 70.52 79.56 0.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.582 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.448 ' H ' ' HB2' ' A' ' 71' ' ' ASP . 2.7 tt0 -170.77 85.17 0.52 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.469 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -59.31 139.95 92.31 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.859 2.373 . . . . 0.0 112.197 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -106.04 132.67 51.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.56 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.1 mtm-85 -140.43 126.22 19.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.468 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.3 m -121.31 136.97 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.735 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -129.95 126.2 37.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.516 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.68 23.96 17.03 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.98 153.36 22.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 110.467 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.472 HG23 ' CD1' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -92.93 -39.82 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.615 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.608 ' CD1' ' CH2' ' A' ' 86' ' ' TRP . 0.2 OUTLIER -147.83 157.8 43.33 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.976 0.417 . . . . 0.0 110.628 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.73 162.49 39.45 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.87 2.38 . . . . 0.0 112.268 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.608 ' CH2' ' CD1' ' A' ' 84' ' ' LEU . 2.1 m95 -132.86 -156.49 0.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.332 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.606 ' O ' HD22 ' A' ' 88' ' ' LEU . 96.7 p -130.49 161.22 31.92 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.946 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.606 HD22 ' O ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -132.47 155.42 48.59 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.405 178.796 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.533 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.2 OUTLIER -116.2 120.61 39.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.668 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 53' ' ' LEU . 3.8 mp -124.15 129.79 73.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.656 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.01 129.86 53.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.302 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.563 ' O ' ' O ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -125.79 157.97 36.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.659 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.563 ' O ' ' O ' ' A' ' 92' ' ' THR . 65.7 m-20 -34.76 -100.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.618 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.8 72.59 0.33 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.587 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -169.68 166.06 9.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.745 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.56 128.89 34.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.518 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 95' ' ' ALA . 0.7 OUTLIER -133.44 147.74 31.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.718 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.409 ' SD ' ' HB3' ' A' ' 122' ' ' ALA . 23.0 mtm -149.19 150.25 32.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.309 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.17 162.16 23.59 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -105.23 117.08 33.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.892 0.377 . . . . 0.0 110.589 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 tp -132.88 133.66 58.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.532 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.0 m -130.59 165.32 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.217 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -139.62 142.22 37.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.759 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -132.96 75.98 1.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.383 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -125.52 164.43 19.1 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.02 48.86 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.108 0.48 . . . . 0.0 110.458 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.8 173.23 7.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.613 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.603 ' N ' ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -101.61 -17.07 16.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.418 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.9 t -146.54 115.98 7.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.0 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 131' ' ' ALA . 3.4 mt -137.64 125.96 32.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.834 0.35 . . . . 0.0 110.51 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -154.83 175.27 32.95 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -120.23 169.62 10.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.687 0.279 . . . . 0.0 110.519 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.94 144.99 13.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.81 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.649 ' CG2' HD11 ' A' ' 53' ' ' LEU . 4.4 mt -140.74 122.97 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.579 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.0 p -122.72 122.29 38.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.371 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.594 ' O ' ' N ' ' A' ' 118' ' ' GLY . 55.9 t -122.12 157.74 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.857 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.494 ' N ' HG12 ' A' ' 116' ' ' VAL . 80.9 m-20 39.22 20.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.807 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 116' ' ' VAL . . . 70.44 0.95 33.46 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 116' ' ' VAL . 4.6 tttp -113.65 143.46 44.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 110.57 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 120' ' ' VAL . 14.4 p -71.56 124.23 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.784 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.443 ' HG2' ' NH1' ' A' ' 121' ' ' ARG . 26.9 mtt-85 -125.38 -41.4 2.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.175 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.409 ' HB3' ' SD ' ' A' ' 98' ' ' MET . . . -152.78 128.22 9.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.134 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -149.16 131.74 15.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.786 0.326 . . . . 0.0 111.026 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.0 119.06 28.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.351 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.649 ' O ' HG13 ' A' ' 125' ' ' VAL . 7.5 p -122.25 118.53 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.726 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.3 OUTLIER -115.35 127.16 55.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.538 179.806 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -95.6 133.15 39.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.714 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.573 ' O ' ' O ' ' A' ' 108' ' ' ASP . 9.6 mt-10 -148.97 130.51 14.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.355 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.01 -11.02 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.605 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 132' ' ' TYR . 9.7 m120 -164.38 72.03 0.22 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.35 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.56 ' HB3' HD12 ' A' ' 110' ' ' ILE . . . -66.49 71.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.669 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.56 ' O ' ' CE1' ' A' ' 134' ' ' TYR . 38.3 t80 -157.99 6.18 0.13 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.447 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.592 ' C ' ' H ' ' A' ' 135' ' ' CYS . 68.1 p -90.39 -16.66 28.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.621 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 134' ' ' TYR . 0.4 OUTLIER 67.8 -33.79 0.23 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.466 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' CYS . . . . . 0.592 ' H ' ' C ' ' A' ' 133' ' ' THR . 0.5 OUTLIER 178.23 98.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.474 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.3 tp -156.64 90.3 1.15 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.716 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.545 ' O ' ' C ' ' A' ' 138' ' ' LYS . 16.9 t -84.4 124.45 39.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.416 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.545 ' C ' ' O ' ' A' ' 137' ' ' VAL . 3.5 tppt? -27.32 128.29 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.815 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.84 -16.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.575 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.617 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.9 ptp . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -116.22 119.27 35.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.512 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.524 ' O ' HD23 ' A' ' 53' ' ' LEU . 6.3 tt -98.5 115.2 28.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.026 0.441 . . . . 0.0 110.703 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -127.51 129.71 47.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.052 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -119.96 148.54 43.4 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.732 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.705 ' OE1' ' OG ' ' A' ' 87' ' ' SER . 6.0 tt0 -156.8 131.93 9.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.705 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.581 HG22 ' N ' ' A' ' 58' ' ' PHE . 4.6 mm -91.36 167.95 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.581 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -132.41 145.49 51.25 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.885 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.07 156.66 28.09 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -50.33 161.63 1.1 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.923 2.415 . . . . 0.0 111.987 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -76.95 133.74 14.02 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.953 2.435 . . . . 0.0 112.279 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.94 -9.92 67.37 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.6 m -81.68 130.23 34.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.841 0.353 . . . . 0.0 110.496 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.9 m -101.9 127.39 55.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.579 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.35 155.48 49.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.557 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.503 ' OD1' ' C ' ' A' ' 66' ' ' ASP . 44.2 t0 -103.18 129.15 50.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.555 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.497 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 2.9 mt -118.73 126.46 75.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.62 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 39.9 t -113.27 117.87 33.04 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.067 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.593 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 33.9 t80 -139.96 145.93 38.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.702 0.287 . . . . 0.0 110.538 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.593 ' O ' ' CE2' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -83.24 134.48 34.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.207 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -94.21 153.32 18.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.92 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 73' ' ' ASN . 12.2 p -48.84 -39.09 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.635 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.514 ' O ' ' CB ' ' A' ' 74' ' ' SER . 14.4 t-20 -87.71 11.75 14.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.409 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.68 ' OG ' ' N ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER 82.15 -71.65 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.507 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.68 ' N ' ' OG ' ' A' ' 74' ' ' SER . 1.1 tp10 -26.12 88.75 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.701 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.588 ' N ' ' O ' ' A' ' 74' ' ' SER . 14.8 Cg_exo -65.08 144.57 82.39 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.932 2.421 . . . . 0.0 112.083 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -107.72 150.07 27.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.285 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -138.24 129.92 28.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.787 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.2 m -102.46 123.54 55.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.476 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 0.5 OUTLIER -120.97 108.74 14.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.686 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.69 29.03 7.56 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.45 132.86 34.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 0.0 110.578 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.08 -76.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.607 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.756 ' H ' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -118.17 156.73 50.25 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.588 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.516 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 25.6 Cg_endo -64.1 151.33 85.78 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.904 2.403 . . . . 0.0 112.339 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -114.31 -171.2 1.87 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.396 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.705 ' OG ' ' OE1' ' A' ' 56' ' ' GLU . 70.9 m -125.03 151.54 45.46 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.044 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 88' ' ' LEU . 8.1 tp -130.73 154.6 47.8 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.863 0.363 . . . . 0.0 110.5 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -123.57 120.65 33.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.404 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.7 mt -130.9 132.09 64.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.571 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.77 126.03 51.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.569 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.507 ' O ' ' C ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -130.24 156.39 44.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.585 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.623 ' OD1' ' N ' ' A' ' 93' ' ' ASN . 0.4 OUTLIER -30.78 120.13 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.478 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -42.51 92.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.568 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 93' ' ' ASN . . . -175.03 -171.92 0.56 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.446 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.68 113.15 8.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.452 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 t -107.26 152.36 8.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.192 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.5 ttt -148.48 137.48 21.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 0.0 111.015 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.64 156.99 18.85 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -118.73 115.39 24.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.812 0.339 . . . . 0.0 110.794 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.9 140.5 49.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.609 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 89.1 t -127.19 147.64 32.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.465 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -139.41 140.37 37.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.746 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -139.05 78.89 1.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.587 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.56 163.8 23.63 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -78.77 52.13 1.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.8 0.333 . . . . 0.0 110.483 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 129' ' ' VAL . 70.9 m -100.49 175.05 5.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.554 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 109' ' ' SER . 6.9 t70 -104.59 128.52 52.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.505 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 108' ' ' ASP . 47.0 t 44.02 93.52 0.01 OUTLIER 'General case' 0 C--O 1.24 0.599 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.971 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.648 ' CG2' ' ND2' ' A' ' 127' ' ' ASN . 15.9 tt -124.56 127.1 72.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 120.793 0.33 . . . . 0.0 110.461 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 125' ' ' VAL . . . -147.22 172.09 27.73 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.675 ' SG ' ' N ' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -118.75 162.66 18.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.675 ' N ' ' SG ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -158.76 143.72 16.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.923 0.392 . . . . 0.0 110.887 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.539 HD12 ' C ' ' A' ' 113' ' ' ARG . 1.9 mp -118.72 124.95 73.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.306 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.88 127.69 54.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.765 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.67 136.59 31.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.462 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.515 ' OD1' ' O ' ' A' ' 117' ' ' ASP . 57.7 t0 65.55 9.45 5.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.449 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.13 -5.98 57.77 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -101.13 139.3 37.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.812 0.339 . . . . 0.0 110.579 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 m -78.24 142.51 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.602 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -168.14 24.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.573 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -123.67 152.85 41.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.772 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.1 147.55 23.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.263 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.0 ptt85 -127.78 135.41 50.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.767 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.415 ' O ' ' CA ' ' A' ' 111' ' ' GLY . 2.1 t -103.08 134.64 43.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.165 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.7 m -102.63 116.45 32.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.942 0.401 . . . . 0.0 110.901 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.648 ' ND2' ' CG2' ' A' ' 110' ' ' ILE . 0.0 OUTLIER -128.34 135.19 49.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.449 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.601 ' N ' ' OE1' ' A' ' 128' ' ' GLU . 1.1 pm0 -104.36 174.6 5.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.746 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.656 ' O ' HG22 ' A' ' 129' ' ' VAL . 1.8 p -55.35 1.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.752 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.596 ' H ' ' C ' ' A' ' 128' ' ' GLU . 25.3 m-80 -112.84 -5.5 13.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.59 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.41 73.98 6.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.454 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -128.55 -171.3 2.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.509 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.4 m -59.14 97.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.57 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -174.41 102.88 0.1 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.682 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 1.3 m -109.37 121.23 44.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.451 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.481 ' O ' ' C ' ' A' ' 137' ' ' VAL . 3.5 mt -80.05 -91.14 0.05 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.79 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.481 ' C ' ' O ' ' A' ' 136' ' ' LEU . 41.2 t -33.42 95.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.695 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -75.07 -27.99 60.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.559 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.434 ' N ' ' HG2' ' A' ' 138' ' ' LYS . 1.2 m -63.19 147.99 49.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.585 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.564 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.545 ' N ' ' H ' ' A' ' 117' ' ' ASP . 9.2 mtt . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.437 ' O ' ' CG ' ' A' ' 52' ' ' HIS . 1.5 p-80 -109.36 125.81 52.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.308 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.733 ' C ' HD23 ' A' ' 53' ' ' LEU . 5.5 tt -96.1 115.87 28.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.785 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.635 ' N ' HD23 ' A' ' 53' ' ' LEU . 23.7 p -126.28 130.12 50.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.496 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.554 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 1.8 p90 -122.69 149.94 43.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.517 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.426 ' HG2' ' N ' ' A' ' 57' ' ' ILE . 17.0 tt0 -155.36 148.09 24.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.956 0.408 . . . . 0.0 111.042 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.522 HD11 HD13 ' A' ' 101' ' ' ILE . 1.6 mm -112.88 163.59 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.971 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.5 156.71 44.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.905 0.384 . . . . 0.0 110.698 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.65 170.21 42.93 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -47.56 152.87 2.38 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.854 2.369 . . . . 0.0 112.229 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -67.04 119.66 6.69 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.825 2.35 . . . . 0.0 111.933 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.99 -0.03 62.22 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.4 t -74.85 144.06 43.59 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.878 0.371 . . . . 0.0 110.559 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 64' ' ' VAL . 7.2 p -115.87 128.83 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.508 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.47 151.49 41.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.806 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.67 124.81 49.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.206 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.442 HG23 HD11 ' A' ' 101' ' ' ILE . 10.9 mt -111.17 133.64 56.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.017 0.437 . . . . 0.0 111.013 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.5 t -132.35 131.05 41.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.957 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.679 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 11.2 t80 -150.98 156.49 41.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.895 0.379 . . . . 0.0 110.986 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.679 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 10.0 t80 -83.76 119.63 25.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.282 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 75' ' ' GLU . 32.6 t70 -89.42 146.08 24.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.841 0.353 . . . . 0.0 110.775 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.482 HG13 ' OD1' ' A' ' 73' ' ' ASN . 4.5 p -53.99 -24.2 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.605 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.482 ' OD1' HG13 ' A' ' 72' ' ' VAL . 2.9 m-20 -86.55 -3.87 59.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.64 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.3 m 78.55 34.21 0.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.526 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.445 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 3.2 mm-40 -135.87 104.27 9.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.408 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -77.74 140.14 18.37 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.284 1.99 . . . . 0.0 112.086 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -107.42 148.11 29.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.563 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 75.4 mtm-85 -139.26 131.62 28.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.622 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.3 m -114.21 118.98 60.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.608 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -112.6 145.74 39.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.481 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.32 5.81 44.48 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.15 137.75 58.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.809 0.338 . . . . 0.0 110.413 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.45 -44.24 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.54 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.431 ' H ' HD12 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -147.55 155.27 45.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.109 0.48 . . . . 0.0 110.774 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.83 159.44 52.79 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 123.208 2.605 . . . . 0.0 112.533 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -129.13 -179.26 5.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.215 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 92.8 p -112.27 164.53 13.11 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.323 0.582 . . . . 0.0 111.004 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.88 145.8 33.46 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.937 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.508 ' CG ' ' O ' ' A' ' 89' ' ' HIS . 19.8 p80 -121.52 123.53 42.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 110.851 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.3 mt -128.51 121.3 54.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.513 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.4 m -104.14 122.47 45.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.548 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.553 ' O ' ' C ' ' A' ' 93' ' ' ASN . 1.9 m -129.19 158.33 39.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.536 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.553 ' C ' ' O ' ' A' ' 92' ' ' THR . 41.9 m-20 -25.54 91.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.713 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.658 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -31.47 124.98 0.24 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.566 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 163.75 -71.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.595 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -156.25 120.42 4.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.447 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 t -127.81 147.26 32.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.711 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.6 ttm -151.51 159.42 44.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.517 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -153.46 156.26 26.65 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -119.19 115.83 25.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.327 . . . . 0.0 110.611 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.522 HD13 HD11 ' A' ' 57' ' ' ILE . 11.9 tt -130.95 137.26 56.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.71 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.34 145.52 33.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.536 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -123.84 158.84 30.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.702 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -143.79 76.16 1.5 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.386 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -116.79 163.61 12.47 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -79.28 28.44 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.572 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.418 ' H ' ' C ' ' A' ' 105' ' ' GLY . 2.0 p -73.05 -174.41 1.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.538 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' A' ' 128' ' ' GLU . 3.0 m-20 -113.25 -24.9 9.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.716 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 t -151.21 101.52 2.86 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.959 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.539 ' O ' ' O ' ' A' ' 126' ' ' SER . 15.6 tt -138.39 135.6 44.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.896 0.379 . . . . 0.0 110.577 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.73 173.1 35.67 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 1.4 p -124.93 162.31 24.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.821 0.343 . . . . 0.0 110.771 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -149.07 158.25 44.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.457 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.9 mm -126.56 127.68 70.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.634 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.57 132.4 53.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.567 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.455 ' C ' ' N ' ' A' ' 118' ' ' GLY . 7.6 p -143.14 149.65 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.571 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.545 ' H ' ' N ' ' A' ' 51' ' ' MET . 5.9 m-20 48.89 15.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.391 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.455 ' N ' ' C ' ' A' ' 116' ' ' VAL . . . 77.69 1.42 77.46 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -116.79 126.88 53.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.731 0.3 . . . . 0.0 110.607 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.0 t -74.88 136.51 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.475 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -129.13 -33.59 1.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.841 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.06 129.53 14.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.486 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -151.58 126.73 9.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.807 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.461 ' HD3' ' N ' ' A' ' 124' ' ' ARG . 0.2 OUTLIER -113.6 115.73 28.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.238 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.7 m -114.97 133.21 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.696 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.5 OUTLIER -132.61 115.88 15.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.454 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -97.81 130.03 44.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.393 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.517 ' O ' ' O ' ' A' ' 108' ' ' ASP . 3.9 mm-40 -138.68 130.77 28.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.908 0.385 . . . . 0.0 110.806 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.9 m -73.4 -4.04 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.266 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.2 73.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.059 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -73.31 100.86 3.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.659 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -138.34 22.64 2.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.445 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.4 p -58.22 174.43 0.29 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.644 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.57 ' O ' ' O ' ' A' ' 135' ' ' CYS . 1.2 m-85 -118.83 40.44 3.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.676 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' CYS . . . . . 0.57 ' O ' ' O ' ' A' ' 134' ' ' TYR . 0.1 OUTLIER 34.34 101.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.815 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' A' ' 136' ' ' LEU . 27.9 mt -49.5 131.38 20.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.506 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.7 p -177.21 -26.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.816 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -82.77 141.73 32.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.529 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.76 -38.66 91.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.514 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.584 179.983 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -112.57 126.16 55.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.558 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.45 HD13 HG23 ' A' ' 114' ' ' ILE . 11.6 tp -97.32 115.28 27.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.56 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.438 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -127.14 142.85 51.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.509 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -126.0 148.43 49.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.42 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.716 ' OE1' ' OG ' ' A' ' 87' ' ' SER . 11.7 tt0 -156.7 134.4 10.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.979 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.569 HG22 ' H ' ' A' ' 58' ' ' PHE . 20.7 mm -101.98 170.57 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.569 ' H ' HG22 ' A' ' 57' ' ' ILE . 29.5 m-85 -132.19 173.04 11.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 111.085 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.21 151.51 6.15 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -40.16 139.16 1.07 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.586 2.191 . . . . 0.0 111.938 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.75 135.56 36.02 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.588 2.192 . . . . 0.0 112.22 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.6 -0.89 58.22 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.7 m -86.21 139.37 31.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.792 0.33 . . . . 0.0 110.645 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 p -111.55 123.4 67.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.384 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -137.45 156.71 47.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.537 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.15 115.17 27.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.331 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.454 HG23 HD11 ' A' ' 101' ' ' ILE . 72.7 mt -105.34 131.18 55.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.708 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.5 t -134.74 125.94 27.99 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.952 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.661 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 42.7 t80 -145.87 158.98 43.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.834 0.35 . . . . 0.0 110.647 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.661 ' O ' ' CE2' ' A' ' 69' ' ' TYR . 4.6 t80 -88.83 136.72 32.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.679 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.32 116.71 32.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.36 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 72' ' ' VAL . 18.0 t -75.5 -5.81 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.758 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.92 -17.98 25.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.593 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.6 t -176.72 -127.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.714 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -94.52 150.95 38.89 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.515 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.37 139.69 90.91 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.53 2.153 . . . . 0.0 111.871 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.58 156.84 17.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.697 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.7 ttm-85 -141.52 125.12 16.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.515 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.31 118.44 58.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.513 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 0.9 OUTLIER -115.74 133.62 55.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.658 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.55 31.37 8.89 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.57 148.98 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.863 0.363 . . . . 0.0 110.455 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.5 t -81.62 -53.35 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.301 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.528 ' O ' ' NE1' ' A' ' 86' ' ' TRP . 0.2 OUTLIER -140.67 151.89 64.51 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.209 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.516 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 11.5 Cg_endo -57.15 158.17 18.84 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.8 2.333 . . . . 0.0 112.071 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.528 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 37.4 m95 -130.15 -160.6 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.485 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.716 ' OG ' ' OE1' ' A' ' 56' ' ' GLU . 71.2 m -132.86 144.98 50.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.016 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.564 HD23 ' H ' ' A' ' 89' ' ' HIS . 0.4 OUTLIER -128.48 144.1 51.09 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 178.698 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.564 ' H ' HD23 ' A' ' 88' ' ' LEU . 0.8 OUTLIER -108.29 124.87 50.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.919 0.39 . . . . 0.0 110.943 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.6 mt -130.58 128.58 63.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.087 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.26 122.54 47.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.858 0.361 . . . . 0.0 110.934 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.537 ' O ' ' C ' ' A' ' 93' ' ' ASN . 5.3 m -126.14 125.57 42.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.236 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.537 ' C ' ' O ' ' A' ' 92' ' ' THR . 1.2 m-20 28.77 -134.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.494 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -139.41 98.74 3.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.563 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 168.35 -171.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.573 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -91.24 135.96 33.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.62 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.92 159.42 36.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.452 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.03 146.55 51.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.746 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.77 151.54 18.35 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -112.12 114.99 28.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.723 0.297 . . . . 0.0 110.596 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.454 HD11 HG23 ' A' ' 67' ' ' ILE . 0.8 OUTLIER -133.29 139.13 49.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.515 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 103' ' ' ALA . 2.3 t -131.96 165.14 32.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.519 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.404 ' H ' HG12 ' A' ' 102' ' ' VAL . . . -143.61 148.13 35.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.447 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -130.46 63.97 1.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.175 0.512 . . . . 0.0 110.359 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -118.16 163.53 12.93 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.43 52.42 2.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.733 0.301 . . . . 0.0 110.636 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.1 m -88.98 -167.82 2.0 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.388 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -112.26 -42.42 3.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.805 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.3 t -128.01 128.06 44.31 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.99 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.537 ' O ' ' O ' ' A' ' 126' ' ' SER . 7.5 mt -141.75 148.08 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.706 0.289 . . . . 0.0 110.307 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 177.8 163.86 30.21 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -117.83 160.14 21.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 0.0 110.611 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -151.3 155.48 38.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.635 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.45 HG23 HD13 ' A' ' 53' ' ' LEU . 4.4 mt -138.32 114.93 10.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.424 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.9 p -117.24 126.81 53.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.619 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 t -125.46 134.62 66.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.27 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 52.0 23.25 2.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.476 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.6 8.37 87.16 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -119.06 126.18 51.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.631 0.253 . . . . 0.0 110.399 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.2 p -74.26 138.72 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.769 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -115.35 -68.22 0.94 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.278 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -142.79 126.98 17.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.276 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -148.28 129.23 14.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.89 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -95.36 127.44 41.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.374 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 125' ' ' VAL . 10.8 p -117.45 117.31 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.806 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.6 OUTLIER -126.82 115.97 20.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.377 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 128' ' ' GLU . 54.9 t-20 -96.98 130.21 44.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.642 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.416 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 14.5 mt-10 -141.72 130.45 22.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.36 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 130' ' ' ASN . 0.3 OUTLIER -82.74 92.56 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.655 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.569 ' O ' ' N ' ' A' ' 132' ' ' TYR . 1.0 OUTLIER 83.3 62.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.529 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.3 71.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.08 0.467 . . . . 0.0 110.572 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.569 ' N ' ' O ' ' A' ' 130' ' ' ASN . 3.8 t80 -126.03 42.64 3.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.41 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.558 ' O ' ' O ' ' A' ' 132' ' ' TYR . 0.7 OUTLIER -39.58 171.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.91 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.454 ' O ' ' SG ' ' A' ' 135' ' ' CYS . 41.7 t80 62.08 146.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.676 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 134' ' ' TYR . 1.4 m -168.86 144.53 3.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.463 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 81.6 mt -100.53 102.53 13.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.507 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 137' ' ' VAL . 14.6 p -147.14 -0.22 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.74 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.544 ' O ' ' O ' ' A' ' 137' ' ' VAL . 17.7 tttt 46.97 106.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.598 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 140' ' ' ALA . 5.4 m -77.81 -66.81 0.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.732 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 139' ' ' SER . . . . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.514 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.443 ' SD ' ' OD1' ' A' ' 117' ' ' ASP . 17.2 mmt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.95 117.65 33.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.439 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.57 114.85 26.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.39 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.5 t -127.47 140.82 51.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.786 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.454 ' HE2' HD11 ' A' ' 90' ' ' ILE . 37.4 p90 -127.57 149.34 50.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.282 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -155.66 154.75 32.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 0.0 110.931 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.595 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 4.9 mm -116.51 161.38 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.294 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.535 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 7.9 m-85 -134.96 158.6 43.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.709 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.37 167.95 36.41 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -46.65 148.77 3.4 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.737 2.291 . . . . 0.0 112.08 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -70.29 134.7 27.47 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.703 2.268 . . . . 0.0 112.091 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.61 1.39 71.26 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 95.9 m -81.25 135.53 35.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.908 0.385 . . . . 0.0 110.44 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.0 t -113.33 123.44 68.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.491 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.07 153.13 43.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.778 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.22 121.36 40.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.366 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.485 HD12 ' N ' ' A' ' 67' ' ' ILE . 1.9 mp -98.81 131.2 46.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.766 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.3 t -129.62 119.2 23.18 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.019 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.6 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 2.6 p90 -142.23 171.34 14.19 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.631 0.253 . . . . 0.0 110.443 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.636 ' CD1' ' O ' ' A' ' 70' ' ' PHE . 0.6 OUTLIER -87.57 130.68 34.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.492 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 72' ' ' VAL . 33.3 t0 -88.83 139.1 30.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.519 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.557 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 6.2 p -54.56 -25.93 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.805 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.31 8.94 25.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.74 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.5 m 69.6 62.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.523 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.425 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 21.0 tt0 -170.43 92.26 0.48 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.263 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -58.84 139.82 92.47 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.712 2.275 . . . . 0.0 112.342 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -108.23 155.61 20.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.732 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -137.37 125.58 23.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.265 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.5 m -106.69 120.91 58.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.844 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.69 129.05 53.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.385 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.07 13.8 58.47 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.79 128.03 34.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.742 0.306 . . . . 0.0 110.618 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.42 HG12 ' HG ' ' A' ' 84' ' ' LEU . 58.4 t -61.35 -96.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.307 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.507 ' CD1' ' H ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -90.0 158.42 44.44 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.924 0.392 . . . . 0.0 110.453 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.595 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 17.4 Cg_endo -60.41 154.87 50.28 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.992 2.462 . . . . 0.0 112.194 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.9 175.42 6.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.429 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.0 m -113.21 152.35 29.86 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.946 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tp -129.67 151.72 49.96 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.041 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.594 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -112.32 126.0 54.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 0.0 110.898 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.454 HD11 ' HE2' ' A' ' 55' ' ' TYR . 21.5 mt -131.09 132.46 63.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.48 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.85 129.3 56.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.541 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 p -122.61 140.62 52.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.627 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.546 ' O ' ' C ' ' A' ' 94' ' ' ASP . 3.3 p30 -74.89 108.61 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.801 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.546 ' C ' ' O ' ' A' ' 93' ' ' ASN . 1.4 t70 26.39 83.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.642 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 177.59 139.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.549 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.02 125.01 42.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.718 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.1 t -141.38 123.73 14.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.503 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.85 136.0 33.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.499 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.41 148.7 20.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -102.87 115.59 30.89 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.5 tt -130.18 142.07 44.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.892 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 103' ' ' ALA . 69.4 t -136.7 162.64 34.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.224 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.561 ' N ' HG12 ' A' ' 102' ' ' VAL . . . -142.98 144.83 32.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.698 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.602 ' OE1' ' CZ ' ' A' ' 132' ' ' TYR . 3.2 mt-30 -120.52 42.75 2.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.401 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -96.32 157.82 21.53 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.408 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 4.9 p30 -79.3 26.79 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.743 0.306 . . . . 0.0 110.536 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.564 ' OG ' ' N ' ' A' ' 108' ' ' ASP . 12.3 t -63.97 -173.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.483 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.564 ' N ' ' OG ' ' A' ' 107' ' ' SER . 12.8 t0 -119.45 -58.85 1.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.778 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.2 t -99.96 98.25 9.03 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.987 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 6.9 mt -117.02 149.37 19.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.74 0.305 . . . . 0.0 110.341 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.9 161.59 26.83 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.592 ' SG ' ' N ' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -118.74 157.55 27.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 110.95 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.719 ' C ' HD12 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -151.3 138.24 19.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.342 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.719 HD12 ' C ' ' A' ' 113' ' ' ARG . 1.7 mp -125.7 125.71 68.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.719 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 p -123.54 129.23 50.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.38 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.2 p -126.53 126.04 68.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.594 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.443 ' OD1' ' SD ' ' A' ' 51' ' ' MET . 4.0 t70 65.13 12.23 7.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.559 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.73 -4.53 84.62 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -96.61 132.43 42.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.861 0.362 . . . . 0.0 110.46 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 120' ' ' VAL . 7.3 p -84.69 125.09 40.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.566 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.9 mmt85 -127.28 -53.99 1.37 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.612 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -119.46 129.17 54.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.502 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -151.59 122.86 7.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.37 118.93 33.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.261 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.3 t -127.46 118.99 51.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.069 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -133.17 116.98 16.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.323 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.23 128.78 40.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.909 0.385 . . . . 0.0 110.859 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.587 ' C ' ' H ' ' A' ' 130' ' ' ASN . 0.8 OUTLIER -157.9 130.35 7.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.381 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 129' ' ' VAL . 74.0 t -63.17 6.27 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.034 0.445 . . . . 0.0 110.163 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.587 ' H ' ' C ' ' A' ' 128' ' ' GLU . 0.7 OUTLIER -167.31 66.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.161 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.68 38.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.751 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.602 ' CZ ' ' OE1' ' A' ' 104' ' ' GLN . 28.0 t80 -177.15 111.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.529 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.558 ' O ' ' C ' ' A' ' 134' ' ' TYR . 0.2 OUTLIER -116.94 95.99 5.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.806 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.558 ' C ' ' O ' ' A' ' 133' ' ' THR . 2.0 m-85 23.38 -138.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.093 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -168.03 111.62 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.523 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -55.92 -178.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.636 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.52 105.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.514 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -125.03 -61.56 1.29 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.49 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.06 83.58 0.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.477 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.534 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.682 -179.895 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.44 ' O ' ' CG ' ' A' ' 52' ' ' HIS . 9.7 p-80 -105.96 128.44 53.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.401 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.578 ' CD1' ' O ' ' A' ' 97' ' ' VAL . 1.6 tt -97.01 115.52 27.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.618 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.03 139.53 52.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.642 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.468 ' CE1' HG21 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -121.37 148.52 44.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.243 179.632 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -156.25 144.01 19.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.932 0.396 . . . . 0.0 111.087 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.597 HG22 ' N ' ' A' ' 58' ' ' PHE . 6.1 mm -115.23 167.47 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.483 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.597 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -140.97 163.87 31.8 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.524 -0.471 . . . . 0.0 111.172 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.62 165.39 37.84 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.584 ' O ' ' OG1' ' A' ' 63' ' ' THR . 71.3 Cg_exo -41.71 166.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.882 2.388 . . . . 0.0 111.985 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -80.14 116.64 3.4 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.723 2.282 . . . . 0.0 112.283 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.08 12.9 62.89 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.584 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -86.22 148.84 25.46 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.46 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 64' ' ' VAL . 11.4 m -112.32 122.69 67.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.549 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.21 143.56 32.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.463 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.75 126.97 40.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.535 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.459 ' H ' HG13 ' A' ' 79' ' ' VAL . 3.7 mp -107.81 126.57 64.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.503 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.4 t -130.71 125.49 34.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.921 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.774 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 31.2 p90 -146.42 169.97 17.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.727 0.299 . . . . 0.0 110.561 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -85.98 119.19 26.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.579 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 73' ' ' ASN . 4.2 t0 -90.97 105.9 18.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.507 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 72' ' ' VAL . 61.6 t -59.1 -5.07 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.659 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.516 ' O ' ' CB ' ' A' ' 74' ' ' SER . 15.7 t-20 -77.58 -21.5 52.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.726 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.7 t 159.56 -93.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.715 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.497 ' N ' ' OG ' ' A' ' 74' ' ' SER . 8.1 pt-20 -100.91 148.92 35.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.616 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.29 145.69 49.1 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.759 2.306 . . . . 0.0 112.339 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.774 ' NE2' ' CE1' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -107.69 154.76 21.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.599 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 -132.08 135.08 46.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.579 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.459 HG13 ' H ' ' A' ' 67' ' ' ILE . 1.7 p -116.96 125.51 73.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.59 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -136.87 134.2 36.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.489 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.03 7.66 59.54 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.81 153.26 35.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.733 0.301 . . . . 0.0 110.604 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.805 HG13 ' HG ' ' A' ' 84' ' ' LEU . 3.0 p -90.86 -30.47 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.449 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.805 ' HG ' HG13 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -156.92 154.3 26.14 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 110.733 179.456 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.569 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 18.7 Cg_endo -61.64 158.47 36.97 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.873 2.382 . . . . 0.0 112.111 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -121.42 -160.13 0.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.54 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.1 t -136.3 138.24 41.52 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.969 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.487 HD23 ' H ' ' A' ' 89' ' ' HIS . 0.5 OUTLIER -128.21 143.45 51.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.728 0.299 . . . . 0.0 110.29 179.053 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.646 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -105.94 121.07 43.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.771 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.1 mp -121.47 130.63 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.567 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.9 p -112.69 131.61 55.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.495 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.57 157.57 21.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.553 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -52.94 -16.37 1.02 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.418 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -103.37 -115.94 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.538 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -166.33 -56.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.698 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.31 121.77 37.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.576 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.578 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 39.9 t -150.69 160.92 3.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.537 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.527 ' N ' ' CG1' ' A' ' 97' ' ' VAL . 4.8 mtt -121.62 157.45 30.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.408 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -142.96 148.31 20.01 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -102.96 118.28 36.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.796 0.331 . . . . 0.0 110.479 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.468 HG21 ' CE1' ' A' ' 55' ' ' TYR . 14.9 tt -133.19 142.13 42.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.546 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 103' ' ' ALA . 38.5 t -140.68 163.73 22.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.662 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.574 ' N ' HG12 ' A' ' 102' ' ' VAL . . . -138.42 158.68 43.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.408 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -135.64 75.74 1.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.73 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.23 155.23 19.25 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.0 55.2 1.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 110.359 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.649 ' OG ' ' N ' ' A' ' 108' ' ' ASP . 6.3 t -85.48 -167.56 1.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.712 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.649 ' N ' ' OG ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -119.84 -14.21 9.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.594 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.9 t -159.24 125.39 4.44 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.971 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.577 ' O ' ' O ' ' A' ' 126' ' ' SER . 26.1 mt -138.03 158.16 32.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.728 0.299 . . . . 0.0 110.514 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.489 ' N ' ' CG2' ' A' ' 110' ' ' ILE . . . -177.2 156.74 20.93 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.532 ' O ' ' O ' ' A' ' 124' ' ' ARG . 3.8 p -122.57 151.73 41.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.659 0.266 . . . . 0.0 110.449 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -160.01 148.22 16.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.663 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.68 123.22 56.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.802 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 72.5 p -119.16 136.53 54.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.333 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.417 ' C ' ' H ' ' A' ' 118' ' ' GLY . 84.9 t -132.44 149.09 31.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.792 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 55.39 8.88 0.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.58 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 116' ' ' VAL . . . 79.81 11.02 85.07 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -116.8 135.24 53.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.769 0.319 . . . . 0.0 110.546 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 71.9 t -70.08 120.57 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.616 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.424 ' NH1' ' HB3' ' A' ' 121' ' ' ARG . 4.0 mtp-105 -116.53 -72.26 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.655 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.22 134.92 46.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.676 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -149.65 157.19 43.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.489 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.532 ' O ' ' O ' ' A' ' 112' ' ' CYS . 7.5 ttt85 -123.52 130.14 52.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.646 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 54.6 t -114.03 118.52 58.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.527 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.577 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.7 OUTLIER -132.77 121.93 23.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.509 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -106.34 129.63 54.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.7 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 131' ' ' ALA . 3.9 mt-10 -157.35 133.88 9.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.496 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' A' ' 130' ' ' ASN . 4.2 m -82.64 135.88 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.433 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 107' ' ' SER . 4.3 m120 36.26 53.36 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.443 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . . . -63.34 95.08 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.722 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.513 ' O ' ' CG ' ' A' ' 132' ' ' TYR . 1.9 p90 -131.79 22.26 4.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.319 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 69.9 p -67.01 117.79 9.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.682 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.45 ' O ' ' CB ' ' A' ' 135' ' ' CYS . 2.7 t80 -100.39 66.31 1.26 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.642 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' CYS . . . . . 0.45 ' CB ' ' O ' ' A' ' 134' ' ' TYR . 0.1 OUTLIER 77.71 25.73 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.595 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.443 ' N ' ' CD2' ' A' ' 136' ' ' LEU . 3.8 mm? -73.12 128.87 36.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.613 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.903 HG23 ' H ' ' A' ' 138' ' ' LYS . 16.1 m -130.82 -65.06 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.78 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.903 ' H ' HG23 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -53.56 -60.41 3.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.614 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.0 t 70.11 -76.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.606 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.373 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.55 179.975 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 30.8 mtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -110.95 123.68 50.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.326 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.661 ' C ' HD23 ' A' ' 53' ' ' LEU . 6.9 tt -95.84 114.58 26.33 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.286 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.423 ' N ' HD23 ' A' ' 53' ' ' LEU . 10.7 p -127.34 132.85 50.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.771 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 13.0 p90 -123.69 148.17 46.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.373 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.53 149.48 23.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.658 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.555 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -109.19 175.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.104 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -139.96 147.67 40.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.724 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.32 157.97 29.64 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -42.19 161.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.88 2.386 . . . . 0.0 112.164 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.41 122.77 7.21 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.933 2.422 . . . . 0.0 112.293 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.43 11.18 59.85 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.5 m -83.28 130.81 35.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 0.0 110.549 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -113.94 121.73 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.577 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.42 155.73 44.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.661 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -95.44 115.8 27.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.105 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.453 HD12 ' H ' ' A' ' 67' ' ' ILE . 3.3 mp -99.95 134.72 38.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.739 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.5 t -135.58 132.39 37.11 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.974 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 77' ' ' GLN . 24.1 p90 -145.31 164.7 30.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.766 0.317 . . . . 0.0 110.531 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.14 135.44 33.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.484 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -98.65 152.38 19.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.588 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 p -63.84 -31.23 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.549 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.629 ' O ' ' CB ' ' A' ' 74' ' ' SER . 18.3 m-20 -75.78 2.84 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.494 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.629 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.0 OUTLIER 91.34 -52.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.281 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -60.0 113.98 8.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.13 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -74.5 141.28 28.03 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.245 1.964 . . . . 0.0 112.25 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 69' ' ' TYR . 24.5 tt0 -107.14 145.61 32.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.621 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -139.4 130.45 26.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.536 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.8 t -105.05 123.22 59.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.549 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 81' ' ' GLY . 19.5 t0 -121.96 134.71 54.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.675 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.488 ' N ' ' OD1' ' A' ' 80' ' ' ASP . . . 94.17 18.35 36.93 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.31 128.53 35.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.761 0.315 . . . . 0.0 110.563 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.818 HG13 ' HG ' ' A' ' 84' ' ' LEU . 2.2 p -76.78 -14.63 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.519 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.818 ' HG ' HG13 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -159.72 155.96 23.69 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.562 179.664 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.555 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 11.7 Cg_endo -57.08 152.95 41.39 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.989 2.46 . . . . 0.0 112.273 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.64 162.17 18.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.413 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 72.6 m -110.29 139.13 45.77 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.988 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 tp -130.41 140.46 50.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.767 0.318 . . . . 0.0 110.438 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.529 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 1.0 OUTLIER -110.73 119.27 38.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.621 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 64.0 mt -129.07 130.02 68.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.324 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.61 123.66 47.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.864 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.62 ' C ' ' H ' ' A' ' 94' ' ' ASP . 0.2 OUTLIER -99.35 153.34 19.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.247 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -60.31 7.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.621 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.62 ' H ' ' C ' ' A' ' 92' ' ' THR . 11.1 t0 -123.26 -103.28 0.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.489 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 168.81 -56.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.686 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -88.55 114.65 25.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.548 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.408 ' O ' HD11 ' A' ' 53' ' ' LEU . 13.8 p -168.47 144.74 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.936 0.398 . . . . 0.0 110.835 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -121.13 143.21 49.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.354 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.09 162.6 12.43 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 100' ' ' ASN . 2.8 m-20 -104.89 117.94 35.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.754 0.311 . . . . 0.0 110.519 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 101' ' ' ILE . 13.2 tt -131.18 131.75 63.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.698 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.15 147.61 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.483 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -128.8 138.38 52.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.662 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.421 ' OE1' ' OG1' ' A' ' 133' ' ' THR . 33.7 mm-40 -122.56 73.17 1.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.452 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.73 163.37 20.67 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.536 ' O ' ' OD1' ' A' ' 106' ' ' ASN . 24.9 t30 -84.0 37.89 0.62 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.749 0.309 . . . . 0.0 110.767 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.74 ' OG ' HD11 ' A' ' 110' ' ' ILE . 4.5 p -70.23 -177.68 1.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.531 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.49 -40.13 5.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.632 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.5 t -137.0 115.91 12.28 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.981 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.74 HD11 ' OG ' ' A' ' 107' ' ' SER . 10.3 mt -117.55 159.82 17.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.844 0.354 . . . . 0.0 110.529 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.547 ' N ' HG22 ' A' ' 110' ' ' ILE . . . 174.8 149.24 7.08 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.524 ' O ' ' O ' ' A' ' 124' ' ' ARG . 11.7 p -117.92 151.88 36.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.735 0.302 . . . . 0.0 110.587 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -154.31 154.85 34.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.507 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.639 ' O ' HG23 ' A' ' 120' ' ' VAL . 4.0 mp -137.54 124.4 28.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.581 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.3 p -122.35 141.17 51.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.686 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 119' ' ' LYS . 15.6 m -146.0 149.27 16.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.521 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 t0 49.41 17.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.639 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.411 ' N ' ' C ' ' A' ' 116' ' ' VAL . . . 84.87 -9.59 65.32 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 116' ' ' VAL . 15.9 mttm -112.07 124.72 53.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 0.0 110.539 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 114' ' ' ILE . 6.1 p -82.24 124.65 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.575 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -94.27 -34.91 12.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.531 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -141.05 141.28 34.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.505 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -148.99 122.47 9.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.783 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.524 ' O ' ' O ' ' A' ' 112' ' ' CYS . 27.2 mtt85 -127.29 115.87 19.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.205 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.25 118.23 54.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.001 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.9 OUTLIER -120.1 118.57 30.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.153 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.491 ' O ' ' OE1' ' A' ' 128' ' ' GLU . 46.7 m-20 -94.23 129.9 40.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.842 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 131' ' ' ALA . 0.3 OUTLIER -151.21 136.55 17.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.383 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.617 HG12 HD21 ' A' ' 130' ' ' ASN . 52.2 t -95.98 128.61 47.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.779 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.617 HD21 HG12 ' A' ' 129' ' ' VAL . 26.2 m-80 60.89 35.75 19.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.911 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.597 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . . . -62.11 124.16 20.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.338 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.647 ' O ' ' CD2' ' A' ' 132' ' ' TYR . 88.9 t80 -154.85 22.89 0.45 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.695 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.513 ' CB ' ' O ' ' A' ' 132' ' ' TYR . 0.2 OUTLIER 81.39 115.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.571 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -72.46 -134.21 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.623 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' CYS . . . . . 0.511 ' O ' ' N ' ' A' ' 137' ' ' VAL . 7.6 t -148.01 -80.91 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.425 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.792 HD22 ' H ' ' A' ' 136' ' ' LEU . 3.5 mm? 33.7 -94.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.435 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.538 ' O ' ' C ' ' A' ' 138' ' ' LYS . 14.8 m -62.98 145.94 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.586 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.573 ' O ' ' O ' ' A' ' 139' ' ' SER . 15.4 pttt 27.81 -124.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.526 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.573 ' O ' ' O ' ' A' ' 138' ' ' LYS . 46.1 t 47.0 173.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.43 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.52 ' O ' ' O ' ' A' ' 139' ' ' SER . . . . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.597 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -102.48 120.0 39.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.453 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.835 ' C ' HD23 ' A' ' 53' ' ' LEU . 5.9 tt -96.19 115.87 28.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.743 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.627 ' N ' HD23 ' A' ' 53' ' ' LEU . 1.1 t -126.71 132.55 51.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.348 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -120.08 149.75 41.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.849 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.424 ' OE1' ' CD2' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -155.66 141.76 18.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.671 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.563 HD11 HG21 ' A' ' 101' ' ' ILE . 4.5 mp -112.12 157.76 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.188 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.656 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -133.07 170.83 14.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.98 0.419 . . . . 0.0 111.047 -179.606 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.24 179.97 39.99 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -47.44 158.66 0.58 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.648 2.232 . . . . 0.0 112.062 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.0 110.95 3.05 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.77 2.313 . . . . 0.0 112.159 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.51 8.91 57.1 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -85.2 141.19 30.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.742 0.306 . . . . 0.0 110.527 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.45 130.67 59.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.307 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -135.67 155.7 50.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.637 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 11.6 p-10 -97.96 127.6 44.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.445 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.69 HG23 HD11 ' A' ' 101' ' ' ILE . 3.4 mp -99.31 120.73 49.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.638 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.1 t -135.65 117.04 14.67 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.987 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -143.83 171.11 14.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.768 0.318 . . . . 0.0 110.431 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -83.96 128.25 34.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.551 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' A' ' 72' ' ' VAL . 15.3 t0 -91.3 142.9 27.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.607 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.567 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 1.0 OUTLIER -63.68 -25.03 37.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.554 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.427 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 0.9 OUTLIER -96.36 11.43 34.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.454 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 70.26 15.75 7.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.345 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 71' ' ' ASP . 1.9 tt0 -118.52 93.03 44.99 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.295 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -77.43 139.64 18.59 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.463 2.109 . . . . 0.0 112.333 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.435 ' HG2' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -107.67 143.34 36.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.572 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.435 ' N ' ' HG2' ' A' ' 77' ' ' GLN . 14.4 mtp-105 -139.65 125.35 19.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.536 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.7 m -107.66 134.5 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.621 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.632 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -104.91 142.46 34.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.451 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.54 31.81 81.03 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.52 131.26 34.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.842 0.353 . . . . 0.0 110.524 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.418 ' H ' HG12 ' A' ' 83' ' ' VAL . 1.8 p -87.05 113.5 24.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.514 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tp 60.51 118.34 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.462 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -55.24 160.96 7.62 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.953 1.769 . . . . 0.0 111.844 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.584 ' CD1' ' C ' ' A' ' 86' ' ' TRP . 0.1 OUTLIER -112.14 -172.69 2.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.655 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 92.1 p -111.19 155.46 22.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 89' ' ' HIS . 6.3 tp -140.25 143.77 36.13 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.495 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.456 ' N ' ' HG ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -107.6 128.1 54.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.765 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.5 mt -125.55 130.83 72.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.487 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -122.95 122.76 39.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.747 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.553 ' O ' ' C ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -117.58 156.82 27.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.465 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.553 ' C ' ' O ' ' A' ' 92' ' ' THR . 4.4 m-20 -24.15 -60.13 0.05 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.841 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.447 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 0.3 OUTLIER 165.51 92.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.546 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -175.33 133.94 0.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.53 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.55 116.17 15.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.614 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.5 p -139.26 138.26 40.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.426 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.42 165.26 12.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.684 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -127.45 144.24 14.96 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -103.46 119.77 39.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.75 0.31 . . . . 0.0 110.736 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.69 HD11 HG23 ' A' ' 67' ' ' ILE . 7.5 tt -133.02 136.63 55.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.698 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.0 t -127.85 149.34 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.308 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -120.8 148.63 43.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 0.0 110.76 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.449 ' OE1' ' OD2' ' A' ' 66' ' ' ASP . 2.7 mp0 -119.32 51.38 1.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.576 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -112.16 159.47 13.7 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -81.95 62.23 5.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.771 0.319 . . . . 0.0 110.62 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.444 ' OG ' ' CD1' ' A' ' 110' ' ' ILE . 77.4 p -93.95 -172.84 2.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.504 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 109' ' ' SER . 26.6 m-20 -131.65 20.78 4.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.619 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 87.8 p 177.4 91.42 0.01 OUTLIER 'General case' 0 C--O 1.244 0.787 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.983 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.567 ' O ' ' O ' ' A' ' 126' ' ' SER . 12.0 mt -115.96 128.43 73.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 120.772 0.32 . . . . 0.0 110.325 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -152.48 173.34 31.56 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -119.9 165.14 15.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.713 0.292 . . . . 0.0 110.475 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.656 ' NH1' ' OE1' ' A' ' 123' ' ' GLU . 5.6 ttm-85 -154.46 139.49 17.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.588 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.423 ' H ' ' HB3' ' A' ' 123' ' ' GLU . 4.4 mm -134.07 114.02 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.517 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.7 m -117.93 138.0 52.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.656 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 119' ' ' LYS . 30.4 m -140.62 148.78 21.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.732 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.425 ' C ' ' H ' ' A' ' 119' ' ' LYS . 34.1 m-20 44.97 26.57 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.73 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.99 -9.66 5.04 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 116' ' ' VAL . 14.1 mttp -106.28 127.37 53.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.751 0.31 . . . . 0.0 110.363 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.76 130.95 32.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.929 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -105.85 -67.78 0.91 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.419 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -150.47 132.33 15.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.364 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.656 ' OE1' ' NH1' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -150.67 146.88 26.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.585 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -109.74 121.77 45.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.576 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.63 ' O ' HG23 ' A' ' 125' ' ' VAL . 16.3 m -114.54 118.24 58.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.546 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.567 ' O ' ' O ' ' A' ' 110' ' ' ILE . 24.3 p -124.37 117.62 24.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.513 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' A' ' 127' ' ' ASN . 0.8 OUTLIER -99.57 129.85 45.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.414 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.05 145.09 21.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.681 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.402 ' H ' HG13 ' A' ' 129' ' ' VAL . 2.2 m -70.3 -17.8 21.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.625 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -167.55 98.57 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.407 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.78 166.79 23.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.422 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 30.1 t80 66.26 69.47 0.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.463 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.7 m -160.91 -19.84 0.05 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.559 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -51.09 111.01 0.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.543 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' CYS . . . . . 0.568 ' SG ' ' N ' ' A' ' 136' ' ' LEU . 2.8 t -136.93 158.04 45.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.459 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.568 ' N ' ' SG ' ' A' ' 135' ' ' CYS . 1.8 mp -99.45 -122.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.592 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.13 34.29 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.526 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -144.71 175.02 10.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.681 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 m -101.86 -9.72 20.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.544 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.064 -0.969 . . . . 0.0 110.547 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 27.3 mmm . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -110.18 123.12 49.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.45 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.757 ' C ' HD23 ' A' ' 53' ' ' LEU . 5.8 tt -95.79 115.79 27.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.214 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.657 ' N ' HD23 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -126.33 139.52 53.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.704 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -119.82 149.83 41.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.018 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.79 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 0.3 OUTLIER -154.44 134.75 13.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.983 0.421 . . . . 0.0 110.954 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.572 HG22 ' H ' ' A' ' 58' ' ' PHE . 4.5 mm -97.76 170.32 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.587 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.572 ' H ' HG22 ' A' ' 57' ' ' ILE . 4.9 t80 -142.6 154.38 44.36 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.782 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.498 ' N ' ' CD1' ' A' ' 58' ' ' PHE . . . -168.48 173.97 43.19 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.559 ' C ' ' HG1' ' A' ' 63' ' ' THR . 1.3 Cg_endo -47.02 167.79 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 122.793 2.328 . . . . 0.0 111.936 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.33 117.63 5.18 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.857 2.371 . . . . 0.0 112.265 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.2 18.21 67.52 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.559 ' HG1' ' C ' ' A' ' 60' ' ' PRO . 4.0 m -72.31 132.0 43.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.807 0.337 . . . . 0.0 110.607 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 64' ' ' VAL . 5.2 m -108.03 122.93 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.578 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -141.34 155.92 45.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.295 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.45 126.98 42.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.621 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.607 HG23 HD11 ' A' ' 101' ' ' ILE . 2.6 mp -108.3 136.68 43.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.582 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.4 t -134.33 116.84 15.71 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.973 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.533 ' CG ' ' N ' ' A' ' 70' ' ' PHE . 50.5 t80 -143.96 165.08 28.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.753 0.311 . . . . 0.0 110.508 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.533 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 29.4 t80 -84.89 120.37 26.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.608 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -84.69 135.5 34.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.559 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.7 p -70.04 -15.25 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.69 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.643 ' O ' ' CB ' ' A' ' 74' ' ' SER . 3.9 t30 -78.81 -21.99 46.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.698 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.643 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 2.0 t 149.79 -104.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.567 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.617 ' N ' ' OG ' ' A' ' 74' ' ' SER . 0.4 OUTLIER -62.78 152.92 81.09 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.756 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -72.09 145.41 44.39 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.877 2.385 . . . . 0.0 112.289 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -102.74 144.48 31.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.32 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -144.87 138.37 26.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.952 0.406 . . . . 0.0 110.963 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.8 m -115.39 131.86 66.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.209 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.67 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -121.45 149.31 43.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.922 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 61.69 -6.59 0.21 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.551 ' H ' ' C ' ' A' ' 80' ' ' ASP . . . -63.94 134.42 55.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 0.0 110.573 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.536 ' O ' ' C ' ' A' ' 84' ' ' LEU . 3.6 m -47.5 -176.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.55 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.639 ' N ' HD23 ' A' ' 84' ' ' LEU . 1.8 pt? -28.46 148.04 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.62 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -56.15 146.51 70.47 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.757 2.305 . . . . 0.0 112.233 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -112.29 -166.52 1.09 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.556 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.79 ' OG ' ' HB2' ' A' ' 56' ' ' GLU . 59.2 m -117.85 165.1 14.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.959 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.59 HD23 ' H ' ' A' ' 89' ' ' HIS . 0.4 OUTLIER -135.79 155.19 50.74 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.627 178.715 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.59 ' H ' HD23 ' A' ' 88' ' ' LEU . 7.4 m80 -114.12 124.34 51.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.598 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.513 HD13 ' O ' ' A' ' 89' ' ' HIS . 3.0 mm -129.57 124.72 60.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.445 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 p -119.38 128.46 54.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.562 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.66 133.59 48.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.585 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -61.06 -7.3 2.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.618 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 45.0 t0 -73.51 -95.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.656 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 177.07 -92.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.234 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.68 121.31 29.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.319 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.86 155.75 37.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.785 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.78 146.32 52.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.263 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -130.89 162.12 23.47 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -119.12 114.64 22.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.707 0.289 . . . . 0.0 110.356 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.607 HD11 HG23 ' A' ' 67' ' ' ILE . 1.1 tt -133.33 140.38 47.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.706 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.6 p -142.21 146.8 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.584 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -129.85 144.32 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.664 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -125.7 76.84 1.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.498 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.96 160.9 13.26 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.555 ' O ' ' O ' ' A' ' 107' ' ' SER . 1.4 m-20 -79.47 13.58 1.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.743 0.306 . . . . 0.0 110.494 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.555 ' O ' ' O ' ' A' ' 106' ' ' ASN . 25.3 p -48.54 -170.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.578 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -104.35 -15.03 15.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.553 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.0 t -168.78 122.36 0.84 Allowed 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.982 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 126' ' ' SER . 11.2 mt -125.93 138.62 53.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.724 0.297 . . . . 0.0 110.49 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.7 160.38 31.01 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 31.8 p -118.52 155.08 31.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 0.0 110.678 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.31 144.51 22.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.662 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.641 ' CG2' HD11 ' A' ' 53' ' ' LEU . 2.3 mt -138.31 114.95 10.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.389 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.71 140.78 49.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.723 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.7 p -145.76 150.09 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.476 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.6 10.99 2.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.483 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 83.64 -3.48 85.07 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.453 ' HB3' ' NH2' ' A' ' 121' ' ' ARG . 13.8 tptm -121.21 137.33 54.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.775 0.321 . . . . 0.0 110.569 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.452 ' H ' HG13 ' A' ' 120' ' ' VAL . 1.2 m -73.96 143.77 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.539 ' HE ' ' CA ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -111.7 -60.09 1.9 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.383 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.5 126.94 5.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.249 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -151.69 129.33 11.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.83 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.484 ' HA ' ' HE ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -98.02 115.71 28.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.326 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 74.2 t -114.99 117.55 56.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.687 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 110' ' ' ILE . 16.6 m -131.88 132.61 43.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.621 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.28 138.17 32.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.24 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -150.21 130.76 13.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.934 0.397 . . . . 0.0 110.831 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.629 HG12 ' OD1' ' A' ' 130' ' ' ASN . 2.0 t -93.71 122.03 44.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.432 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.629 ' OD1' HG12 ' A' ' 129' ' ' VAL . 0.4 OUTLIER 70.9 39.86 0.99 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.685 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.14 67.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.362 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.678 ' CG ' ' O ' ' A' ' 132' ' ' TYR . 37.1 t80 -139.91 21.53 2.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.539 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 73.4 p -152.73 -124.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.654 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -110.91 80.4 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.588 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 1.5 t -51.74 104.36 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.537 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 60.2 mt -76.21 100.83 5.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.595 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -113.16 23.09 5.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.471 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 29.1 mttm -77.88 76.58 4.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.615 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.573 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -63.83 112.95 3.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.498 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.573 ' O ' ' O ' ' A' ' 139' ' ' SER . . . . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.604 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.5 mtp . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -91.1 128.15 36.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.22 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 97' ' ' VAL . 35.7 tp -97.5 114.9 26.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.814 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.4 t -127.78 133.41 49.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.533 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.572 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -121.8 149.47 43.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 0.0 110.461 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.736 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -155.52 143.66 20.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.808 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.6 HG22 ' N ' ' A' ' 58' ' ' PHE . 42.9 mm -111.22 167.81 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.917 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.6 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -129.42 173.57 10.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.013 0.435 . . . . 0.0 110.989 -179.68 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.47 157.57 10.4 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -43.64 155.58 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.495 2.13 . . . . 0.0 112.034 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -66.94 117.9 5.14 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.844 2.363 . . . . 0.0 112.27 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.85 3.78 58.04 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.627 HG23 ' OD1' ' A' ' 106' ' ' ASN . 98.9 m -86.77 139.94 30.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 0.0 110.739 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.464 HG11 ' HA2' ' A' ' 81' ' ' GLY . 2.4 m -106.78 131.41 56.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.389 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.94 149.34 50.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.649 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 104' ' ' GLN . 0.0 OUTLIER -99.14 121.8 41.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.44 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.524 HD12 ' N ' ' A' ' 67' ' ' ILE . 2.1 mp -108.14 125.78 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.566 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.5 t -127.62 116.26 20.05 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.032 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -151.38 170.85 18.54 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.806 0.336 . . . . 0.0 110.636 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.486 ' CE1' ' O ' ' A' ' 71' ' ' ASP . 52.1 t80 -84.19 133.11 34.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.737 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.486 ' O ' ' CE1' ' A' ' 70' ' ' PHE . 21.1 t0 -104.44 149.6 25.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.555 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.82 -33.76 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.684 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -80.47 11.35 3.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.632 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.58 47.55 10.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.503 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.421 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 66.8 mt-10 -149.38 96.8 3.62 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.45 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.25 139.61 90.89 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.453 2.102 . . . . 0.0 111.893 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 67' ' ' ILE . 11.9 mt-30 -107.84 132.09 53.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.755 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 -131.84 129.39 40.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.345 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.7 m -120.3 136.64 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.857 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.9 143.62 51.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.343 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.464 ' HA2' HG11 ' A' ' 64' ' ' VAL . . . 58.95 13.61 20.07 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.21 147.53 31.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.758 0.314 . . . . 0.0 110.642 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.565 ' O ' ' O ' ' A' ' 84' ' ' LEU . 4.1 p -52.25 165.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.424 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.565 ' O ' ' O ' ' A' ' 83' ' ' VAL . 0.3 OUTLIER -27.49 149.46 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.941 0.4 . . . . 0.0 110.813 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.59 141.01 94.11 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.902 2.401 . . . . 0.0 112.251 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -113.17 -168.88 1.39 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.547 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.736 ' OG ' ' HB2' ' A' ' 56' ' ' GLU . 59.6 m -115.34 155.44 27.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.008 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.405 ' C ' ' ND1' ' A' ' 89' ' ' HIS . 0.7 OUTLIER -135.21 151.24 50.44 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.22 178.517 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.759 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -125.61 127.35 46.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.006 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mt -130.81 134.58 61.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.343 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 m -120.96 131.5 54.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.498 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.542 ' O ' ' C ' ' A' ' 93' ' ' ASN . 91.8 m -117.14 135.06 54.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.529 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.542 ' C ' ' O ' ' A' ' 92' ' ' THR . 73.0 m-80 28.05 -93.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.641 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 92' ' ' THR . 11.1 t70 -172.33 76.25 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.688 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -171.62 167.09 6.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.6 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.648 ' HB1' HG21 ' A' ' 116' ' ' VAL . . . -69.67 151.1 46.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.293 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.411 ' O ' HD13 ' A' ' 53' ' ' LEU . 93.0 t -153.12 151.21 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.0 0.428 . . . . 0.0 110.937 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -120.05 173.25 7.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.891 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.4 142.76 8.55 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.587 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -104.11 116.38 32.11 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.28 140.29 48.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.98 0.419 . . . . 0.0 111.039 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.1 148.99 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.263 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.412 ' O ' HG21 ' A' ' 110' ' ' ILE . . . -135.83 135.02 39.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 110.696 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.418 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 7.6 mt-30 -127.77 83.95 2.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.608 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.62 163.91 14.92 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.627 ' OD1' HG23 ' A' ' 63' ' ' THR . 39.3 p-10 -78.71 49.6 0.91 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.854 0.359 . . . . 0.0 110.418 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.48 ' OG ' ' N ' ' A' ' 108' ' ' ASP . 28.9 t -92.94 -172.37 2.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.515 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.48 ' N ' ' OG ' ' A' ' 107' ' ' SER . 4.8 m-20 -97.62 -38.35 9.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.535 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.2 t -141.01 112.04 7.2 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.987 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 126' ' ' SER . 5.4 mt -112.63 123.02 67.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.856 0.36 . . . . 0.0 110.677 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -150.51 173.5 30.1 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 11.8 p -127.9 165.98 19.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.743 0.306 . . . . 0.0 110.494 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 113' ' ' ARG . 18.4 mtm-85 -151.32 144.04 24.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.489 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.4 mm -127.79 115.97 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.568 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 81.8 p -122.0 122.01 38.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.465 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.648 HG21 ' HB1' ' A' ' 96' ' ' ALA . 3.5 p -145.65 150.86 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.764 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.9 t70 58.54 16.86 4.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.647 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.91 -1.6 10.03 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -117.52 137.86 52.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.596 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.413 ' O ' ' CG1' ' A' ' 120' ' ' VAL . 2.0 p -78.75 132.28 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.615 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.4 mtm-85 -123.46 -47.03 2.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.711 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -145.09 128.82 17.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.783 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -149.73 128.39 12.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.414 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.443 ' HG2' HH11 ' A' ' 124' ' ' ARG . 5.3 tpp85 -116.24 116.29 27.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.71 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.2 122.53 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.358 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 110' ' ' ILE . 65.6 m -126.53 124.63 40.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.733 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -95.65 131.61 41.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.465 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 108' ' ' ASP . 78.2 tt0 -153.73 134.2 13.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.572 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.4 t -93.13 123.39 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.549 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 132' ' ' TYR . 50.8 t-20 60.72 44.77 10.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.46 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.35 71.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.463 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.573 ' N ' ' O ' ' A' ' 130' ' ' ASN . 57.6 t80 -88.77 127.29 35.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.403 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.546 ' C ' ' O ' ' A' ' 132' ' ' TYR . 29.6 p -26.28 111.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.832 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -86.48 172.39 10.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.576 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -57.94 167.81 1.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.467 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 137' ' ' VAL . 87.3 mt -120.65 -2.04 9.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.664 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.502 ' O ' ' O ' ' A' ' 136' ' ' LEU . 62.5 t 57.26 145.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.479 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.456 ' CG ' ' H ' ' A' ' 139' ' ' SER . 9.5 pttm -91.73 -108.15 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.673 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.456 ' H ' ' CG ' ' A' ' 138' ' ' LYS . 2.5 t 179.7 -78.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.601 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.442 179.986 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.2 mmt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -114.91 125.33 53.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.546 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.66 117.24 34.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.397 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 t -126.2 142.13 51.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.009 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.63 148.49 43.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.023 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.474 ' C ' ' CD ' ' A' ' 56' ' ' GLU . 8.0 tm-20 -156.48 134.42 11.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.868 0.366 . . . . 0.0 111.047 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.63 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 9.7 tt -116.53 139.07 44.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.943 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.88 172.3 10.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.748 0.308 . . . . 0.0 110.766 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.41 -81.97 0.2 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.46 109.34 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.896 2.397 . . . . 0.0 111.97 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.8 96.39 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.531 2.154 . . . . 0.0 111.896 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.28 -16.7 16.02 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.05 152.0 46.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.766 0.317 . . . . 0.0 110.401 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 64' ' ' VAL . 17.0 m -101.21 123.58 54.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.818 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.21 155.54 46.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.335 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -95.29 121.9 37.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.75 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.52 138.0 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.333 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.2 t -134.15 125.96 29.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.965 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.601 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 12.6 t80 -137.45 152.74 49.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.848 0.356 . . . . 0.0 110.603 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.601 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 83.9 t80 -83.58 126.5 32.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.649 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.09 154.06 22.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.536 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.0 p -72.34 -32.03 40.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.799 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.58 ' O ' ' CB ' ' A' ' 74' ' ' SER . 1.8 p-10 -81.63 -7.4 59.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.945 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.58 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.5 t 86.58 86.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.822 0.344 . . . . 0.0 110.373 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 171.24 92.55 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.323 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -59.4 139.97 92.1 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.716 2.277 . . . . 0.0 112.147 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -106.06 140.56 38.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.417 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.8 ttp-105 -141.48 132.49 26.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.679 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.1 m -123.26 129.17 75.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.469 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -119.62 127.74 53.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.736 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.55 13.05 79.22 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.7 137.02 33.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 0.0 110.608 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.584 ' O ' ' O ' ' A' ' 84' ' ' LEU . 4.2 m -59.48 -167.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.442 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.584 ' O ' ' O ' ' A' ' 83' ' ' VAL . 0.3 OUTLIER -32.22 156.94 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.533 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.63 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 10.7 Cg_endo -56.84 159.43 14.38 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 123.006 2.471 . . . . 0.0 112.301 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -125.09 -164.23 1.27 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.531 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 99.1 p -135.43 153.78 51.67 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.962 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.2 mp -129.7 155.43 45.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.715 0.293 . . . . 0.0 110.583 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -109.84 120.23 41.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.636 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.6 mt -128.75 133.64 65.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.526 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.8 p -118.21 124.34 47.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.463 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.45 ' C ' ' H ' ' A' ' 94' ' ' ASP . 3.1 m -116.25 135.19 54.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.628 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -72.64 39.83 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.58 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 92' ' ' THR . 33.2 t0 -122.16 -97.15 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.616 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 176.28 -78.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.582 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -102.14 125.57 48.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.404 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 98' ' ' MET . 93.5 t -148.63 155.58 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.419 . . . . 0.0 110.827 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.464 ' N ' HG12 ' A' ' 97' ' ' VAL . 7.8 mtt -127.59 179.25 5.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.315 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -158.87 153.79 24.9 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -113.07 121.84 45.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.748 0.309 . . . . 0.0 110.355 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.49 ' O ' HG23 ' A' ' 101' ' ' ILE . 9.7 tt -133.13 128.93 56.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.711 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.9 t -127.15 145.22 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.41 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.484 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -127.74 156.74 41.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.704 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -119.43 66.45 0.8 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.579 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 131' ' ' ALA . . . -119.1 157.93 15.12 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -93.45 83.01 4.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.808 0.337 . . . . 0.0 110.595 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.7 p -115.56 -166.93 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.406 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -124.55 10.2 8.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.593 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.5 p -170.72 105.0 0.26 Allowed 'General case' 0 C--O 1.242 0.71 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.867 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.55 ' O ' ' O ' ' A' ' 126' ' ' SER . 5.4 tt -132.09 136.63 56.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 120.683 0.278 . . . . 0.0 110.378 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.55 176.77 41.03 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 32.0 m -120.46 149.55 42.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.793 0.33 . . . . 0.0 110.391 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.413 ' HB3' ' NH1' ' A' ' 113' ' ' ARG . 19.2 mtp-105 -144.37 146.19 32.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.754 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.41 122.97 58.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.236 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 115' ' ' THR . 9.1 t -118.36 126.12 51.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.954 0.407 . . . . 0.0 110.787 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.9 p -136.48 138.99 46.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.333 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.2 t0 48.1 22.99 0.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.525 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.9 -7.42 9.53 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.6 mttp -99.84 133.08 44.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.871 0.367 . . . . 0.0 110.651 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 p -67.36 141.34 17.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.418 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -118.02 -75.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.588 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -150.67 128.55 11.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.481 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -150.95 160.17 44.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.611 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -121.05 124.67 45.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.561 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.33 117.28 52.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.57 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.55 ' O ' ' O ' ' A' ' 110' ' ' ILE . 48.1 p -132.22 120.94 22.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.583 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -100.18 129.88 46.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.505 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.45 162.12 31.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.463 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.6 p -102.31 -8.49 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.561 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.609 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 0.4 OUTLIER -164.83 63.24 0.13 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.499 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 105' ' ' GLY . . . -61.3 98.24 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.528 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -161.24 -20.66 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.43 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.5 m -73.31 78.71 1.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.42 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -44.21 -69.91 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.632 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 72.3 m -93.65 130.4 39.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.69 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.1 96.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.537 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.8 p -171.76 149.51 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.646 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.482 ' O ' ' C ' ' A' ' 139' ' ' SER . 3.7 ptpt -151.17 -174.44 4.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.479 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.514 ' O ' ' C ' ' A' ' 140' ' ' ALA . 10.8 p 32.76 63.49 0.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.557 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.514 ' C ' ' O ' ' A' ' 139' ' ' SER . . . . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.659 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.449 ' N ' ' HA ' ' A' ' 117' ' ' ASP . 4.6 ttt . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.92 128.82 56.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.293 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.836 HD13 ' C ' ' A' ' 53' ' ' LEU . 3.1 tm? -95.72 115.27 27.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 0.0 110.203 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.604 ' N ' HD13 ' A' ' 53' ' ' LEU . 18.6 p -127.33 131.99 50.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.583 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -125.84 149.48 48.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.218 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -155.5 142.42 19.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.918 0.39 . . . . 0.0 110.845 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.588 HG22 ' N ' ' A' ' 58' ' ' PHE . 48.1 mm -109.6 165.78 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.187 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.69 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -143.77 149.34 36.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.9 0.381 . . . . 0.0 110.349 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.45 163.34 33.94 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -41.68 145.82 0.62 Allowed 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.685 2.257 . . . . 0.0 111.724 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.53 115.96 3.99 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.636 2.224 . . . . 0.0 112.294 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.35 2.66 50.84 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.56 ' O ' ' O ' ' A' ' 83' ' ' VAL . 7.9 m -86.54 141.21 29.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.788 0.327 . . . . 0.0 110.949 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 64' ' ' VAL . 35.2 m -104.25 127.16 58.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.202 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.67 154.7 48.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.913 0.387 . . . . 0.0 110.889 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -107.81 121.54 44.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.578 HG23 HD11 ' A' ' 101' ' ' ILE . 42.7 mt -108.52 131.59 58.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.744 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.3 t -134.75 119.72 18.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.026 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.464 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 69.6 t80 -132.19 162.17 31.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.831 0.348 . . . . 0.0 110.724 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.464 ' O ' ' CE2' ' A' ' 69' ' ' TYR . 51.2 t80 -88.89 126.4 35.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.662 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -84.46 141.29 30.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.44 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.19 -23.94 29.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.712 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.629 ' O ' ' CB ' ' A' ' 74' ' ' SER . 0.2 OUTLIER -85.0 -13.35 50.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.762 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.629 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 6.0 p 92.18 15.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.64 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -125.08 78.89 66.18 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.411 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.3 139.06 20.67 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.507 2.138 . . . . 0.0 112.454 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -108.46 158.61 17.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.146 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -130.36 136.97 49.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.869 0.366 . . . . 0.0 110.83 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.602 ' O ' HG13 ' A' ' 79' ' ' VAL . 14.7 p -119.28 118.13 56.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.18 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.16 136.16 54.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.585 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.44 7.95 61.5 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.87 139.0 55.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.748 0.308 . . . . 0.0 110.562 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.56 ' O ' ' O ' ' A' ' 63' ' ' THR . 2.1 t -70.94 -53.1 22.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.293 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.87 154.13 80.25 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.609 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -66.24 155.08 71.59 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 122.91 2.407 . . . . 0.0 112.101 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.553 ' CG ' ' N ' ' A' ' 87' ' ' SER . 43.1 t-105 -123.54 -161.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.265 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.553 ' N ' ' CG ' ' A' ' 86' ' ' TRP . 99.7 p -139.69 150.82 45.33 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 120.604 0.24 . . . . 0.0 110.993 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.5 tp -128.16 147.06 50.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.219 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.484 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -108.62 120.26 41.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.804 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.0 mt -130.53 128.93 64.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.6 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.5 m -111.06 122.87 48.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.283 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.538 ' O ' ' C ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -124.7 130.62 52.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.816 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.538 ' C ' ' O ' ' A' ' 92' ' ' THR . 1.3 p30 24.31 -120.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.89 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -163.36 88.41 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.469 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -174.44 -159.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.549 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.418 ' HA ' HG11 ' A' ' 116' ' ' VAL . . . -83.57 119.56 24.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.374 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.2 t -114.39 142.19 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.796 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.4 ptp -128.29 166.02 19.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.005 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.94 145.77 12.62 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -116.08 115.11 25.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.349 . . . . 0.0 110.261 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.578 HD11 HG23 ' A' ' 67' ' ' ILE . 1.9 tt -132.41 135.28 58.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.61 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 93.7 t -128.03 150.24 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.463 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -122.81 140.93 52.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.39 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -118.93 77.74 1.21 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.667 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.01 159.66 23.1 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -82.16 46.6 1.04 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.85 0.357 . . . . 0.0 110.497 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.402 ' OG ' HD11 ' A' ' 110' ' ' ILE . 72.4 p -80.01 -174.66 4.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.577 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -124.77 9.97 8.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.59 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.1 t -171.09 122.48 0.57 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.936 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.583 ' O ' ' O ' ' A' ' 126' ' ' SER . 15.6 mt -142.23 152.47 18.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 120.824 0.345 . . . . 0.0 110.404 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.402 ' N ' ' CG2' ' A' ' 110' ' ' ILE . . . -176.59 158.68 25.01 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.648 ' SG ' ' O ' ' A' ' 124' ' ' ARG . 0.5 OUTLIER -118.03 167.76 11.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 0.0 110.674 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.403 ' O ' HD13 ' A' ' 114' ' ' ILE . 21.6 ttm180 -159.39 123.95 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.312 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 113' ' ' ARG . 3.3 mm -125.37 112.61 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.926 0.393 . . . . 0.0 110.782 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.78 135.62 55.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.458 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' A' ' 96' ' ' ALA . 31.0 t -118.79 150.8 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.559 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.449 ' HA ' ' N ' ' A' ' 51' ' ' MET . 37.4 t70 51.88 24.21 2.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.585 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.27 4.99 39.76 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -110.4 138.84 46.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.875 0.369 . . . . 0.0 110.69 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 120' ' ' VAL . 7.4 p -86.17 119.34 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.502 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.5 -35.85 2.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.304 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.81 127.04 5.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.499 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -151.56 145.66 25.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.439 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.648 ' O ' ' SG ' ' A' ' 112' ' ' CYS . 1.8 ttt180 -116.36 123.44 47.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.699 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 125' ' ' VAL . 3.0 p -138.95 116.25 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.619 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.583 ' O ' ' O ' ' A' ' 110' ' ' ILE . 51.4 m -133.81 121.74 22.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.443 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.95 137.32 36.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 110.773 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -155.01 134.02 12.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.333 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.2 t -68.1 129.52 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.559 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 40.32 69.78 0.29 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.402 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.21 89.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.488 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.65 93.8 1.51 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.737 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.757 HG22 ' O ' ' A' ' 133' ' ' THR . 89.6 m 58.61 52.3 7.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.958 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.422 ' CB ' ' O ' ' A' ' 133' ' ' THR . 1.4 t80 74.47 -167.86 0.1 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.889 0.376 . . . . 0.0 110.741 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' CYS . . . . . 0.647 ' O ' ' N ' ' A' ' 137' ' ' VAL . 0.8 OUTLIER -148.63 -58.1 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.501 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.544 HD23 ' H ' ' A' ' 138' ' ' LYS . 0.7 OUTLIER 54.53 -73.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.412 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.647 ' N ' ' O ' ' A' ' 135' ' ' CYS . 14.8 t 41.3 60.39 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.683 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.544 ' H ' HD23 ' A' ' 136' ' ' LEU . 29.5 tttt -123.42 -10.42 7.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.474 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.7 p -46.7 97.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.561 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.544 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.445 179.936 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 12.4 mtm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -96.86 127.62 43.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.407 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.616 HD13 ' O ' ' A' ' 97' ' ' VAL . 2.1 tt -96.84 115.79 28.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.594 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.93 137.23 53.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.674 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.442 ' OH ' ' CD2' ' A' ' 69' ' ' TYR . 23.8 p90 -120.07 149.56 42.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.979 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.658 ' C ' HD13 ' A' ' 57' ' ' ILE . 26.0 tt0 -155.59 156.03 34.35 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.34 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.857 HD11 HD13 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -115.85 175.74 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.956 179.296 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.63 145.61 36.85 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.028 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -168.66 160.45 33.95 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -43.48 155.59 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.707 2.272 . . . . 0.0 112.147 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.0 114.51 3.41 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.729 2.286 . . . . 0.0 112.053 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.02 15.49 30.72 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.3 m -79.31 139.06 37.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.829 0.347 . . . . 0.0 110.638 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.525 ' O ' HG23 ' A' ' 64' ' ' VAL . 31.2 m -109.76 123.06 65.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.447 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.46 154.22 44.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.786 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.28 115.59 27.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.374 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.467 HG23 HD11 ' A' ' 101' ' ' ILE . 5.3 mm -102.05 121.59 53.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.587 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.3 t -135.59 120.3 18.36 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.916 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.442 ' CD2' ' OH ' ' A' ' 55' ' ' TYR . 22.7 p90 -141.26 158.05 44.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.869 0.366 . . . . 0.0 110.7 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -83.5 136.57 34.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.27 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.18 137.71 41.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.579 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.8 t -62.34 -18.69 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.4 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.515 ' O ' ' OG ' ' A' ' 74' ' ' SER . 3.0 m-20 -89.31 -0.19 57.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.696 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' A' ' 73' ' ' ASN . 7.9 p 73.44 40.82 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.573 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -154.05 91.35 3.17 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.48 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.94 141.55 15.06 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.749 2.299 . . . . 0.0 112.315 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -107.24 147.97 29.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.478 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.421 ' NH1' ' HG3' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -135.91 133.09 37.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.676 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.7 t -112.88 118.87 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.66 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.1 116.61 32.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.376 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.27 20.87 16.56 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.43 153.86 25.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.368 . . . . 0.0 110.617 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.18 -39.49 8.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.374 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.63 152.48 28.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.5 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.485 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 19.8 Cg_endo -61.42 150.45 85.0 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.943 2.429 . . . . 0.0 112.363 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -128.75 -172.45 2.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.458 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.637 ' C ' HD12 ' A' ' 88' ' ' LEU . 97.3 p -127.81 155.04 44.72 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.041 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.637 HD12 ' C ' ' A' ' 87' ' ' SER . 6.8 mp -130.99 148.19 52.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.859 0.361 . . . . 0.0 110.942 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' A' ' 89' ' ' HIS . 6.5 p80 -110.16 124.23 51.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.017 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.9 mt -129.01 134.79 63.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.926 0.394 . . . . 0.0 110.932 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.17 122.95 46.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.322 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.591 ' O ' ' N ' ' A' ' 94' ' ' ASP . 2.2 m -126.96 128.16 45.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.768 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.526 ' C ' ' O ' ' A' ' 92' ' ' THR . 4.4 t-20 -29.2 -37.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.555 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 92' ' ' THR . 1.6 m-20 -66.03 -135.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.684 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.45 -35.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.385 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.72 137.45 52.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.558 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.616 ' O ' HD13 ' A' ' 53' ' ' LEU . 21.0 t -150.09 124.28 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.581 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 5.5 mtt -96.55 131.31 43.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.605 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.23 146.79 18.88 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.505 ' O ' ' CG ' ' A' ' 100' ' ' ASN . 2.4 p-10 -102.79 116.51 32.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.791 0.329 . . . . 0.0 110.453 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.857 HD13 HD11 ' A' ' 57' ' ' ILE . 17.0 tt -133.12 136.89 54.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.641 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.7 t -139.75 149.29 22.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.433 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -126.77 148.22 49.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.639 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -133.51 46.16 2.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.537 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -99.3 163.81 20.1 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.87 36.58 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.745 0.307 . . . . 0.0 110.535 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.417 ' OG ' HD11 ' A' ' 110' ' ' ILE . 0.8 OUTLIER -65.25 -167.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.646 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -122.78 -25.15 4.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.582 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.8 t -144.5 88.26 1.92 Allowed 'General case' 0 C--O 1.243 0.752 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.026 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.417 HD11 ' OG ' ' A' ' 107' ' ' SER . 6.1 mt -100.6 149.2 6.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 120.833 0.349 . . . . 0.0 110.486 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.84 164.32 29.98 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 9.3 p -125.82 152.87 44.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.78 0.324 . . . . 0.0 110.698 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.06 141.11 24.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.491 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.468 ' CG2' HD11 ' A' ' 53' ' ' LEU . 6.9 mm -115.76 133.01 63.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.717 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.3 p -122.67 121.08 35.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.471 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.97 129.05 75.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.666 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.24 17.29 1.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.404 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 88.1 -8.57 77.87 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -101.45 147.5 26.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.322 . . . . 0.0 110.68 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.29 128.5 37.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.624 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.46 HH11 ' HB3' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -107.66 -65.53 1.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.401 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -149.34 127.28 11.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.042 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.31 130.27 12.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.036 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -111.97 115.6 29.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.918 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.58 124.93 72.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.054 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.4 m -127.6 126.28 41.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.04 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.09 129.22 40.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.008 0.432 . . . . 0.0 110.837 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -157.32 130.57 7.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.231 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.49 116.3 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.452 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.508 ' CG ' ' O ' ' A' ' 130' ' ' ASN . 4.7 t30 59.94 69.72 0.68 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.417 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.1 48.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.596 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.457 ' O ' ' C ' ' A' ' 133' ' ' THR . 54.4 t80 -140.25 10.0 2.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.529 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 134' ' ' TYR . 5.9 p 34.97 -125.87 0.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.787 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.598 ' N ' ' OG1' ' A' ' 133' ' ' THR . 23.4 m-85 -127.84 -168.62 1.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.625 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' CYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -158.48 173.81 16.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.417 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.405 ' CB ' ' O ' ' A' ' 135' ' ' CYS . 1.2 tt 74.89 -78.37 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.492 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.3 t 64.52 118.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.448 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 139' ' ' SER . 1.5 pttp -54.95 123.5 13.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.65 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.9 OUTLIER 60.44 138.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.647 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.551 179.942 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.405 ' HG3' ' CD2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.405 ' CD2' ' HG3' ' A' ' 51' ' ' MET . 25.4 m-70 -116.0 128.79 56.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.341 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.734 HD12 ' O ' ' A' ' 53' ' ' LEU . 3.3 pp -96.27 120.51 36.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.928 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.58 133.95 50.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.68 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -120.86 149.59 42.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.378 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.756 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 1.8 tm-20 -155.4 144.68 20.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.97 0.414 . . . . 0.0 110.923 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 57' ' ' ILE . 34.6 mm -116.11 153.39 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.11 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -140.22 163.68 32.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.05 0.452 . . . . 0.0 111.04 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.34 171.23 43.49 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.505 ' O ' ' OG1' ' A' ' 63' ' ' THR . 53.9 Cg_exo -46.91 153.43 1.4 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.654 2.236 . . . . 0.0 111.985 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -64.68 119.59 6.66 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.721 2.281 . . . . 0.0 112.039 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.24 5.34 62.21 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 33.0 m -69.37 144.66 53.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 0.0 110.604 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 p -119.49 122.1 68.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.48 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.408 ' HB1' ' HB1' ' A' ' 103' ' ' ALA . . . -143.11 155.31 44.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.705 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.72 115.22 30.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.115 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 mp -90.36 127.7 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.829 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.4 t -128.13 116.06 19.36 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.021 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.512 ' CZ ' ' OD1' ' A' ' 71' ' ' ASP . 2.9 p90 -146.04 148.8 33.07 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.236 0.335 . . . . 0.0 110.413 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -88.13 121.37 30.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.379 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.512 ' OD1' ' CZ ' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -82.93 144.81 29.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.541 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.5 p -55.47 -11.02 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.95 0.405 . . . . 0.0 110.177 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 74' ' ' SER . 35.4 t30 -92.54 -8.97 42.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.417 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.563 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.5 p 85.24 3.74 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.423 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -114.29 95.82 40.51 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.52 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -79.38 139.54 14.68 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.552 2.168 . . . . 0.0 112.072 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -107.93 151.06 26.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -128.82 134.03 48.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.467 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.0 m -105.96 129.43 59.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.587 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 5.8 p-10 -111.98 132.88 54.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.697 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.16 28.65 63.82 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.51 147.63 52.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.799 0.333 . . . . 0.0 110.673 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.0 p -100.3 -30.8 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.503 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tp -170.26 114.76 0.48 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.415 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -55.75 162.25 6.97 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.095 1.863 . . . . 0.0 111.895 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.465 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 7.1 m-90 -126.09 -150.7 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.558 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.756 ' OG ' ' HB2' ' A' ' 56' ' ' GLU . 59.1 m -121.87 165.5 15.81 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.004 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.78 150.18 35.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.783 0.325 . . . . 0.0 110.821 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -110.16 119.54 39.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.375 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.1 mt -126.57 135.53 63.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.627 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.41 123.41 48.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.598 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.55 ' O ' ' C ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -132.3 155.58 48.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.399 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.55 ' C ' ' O ' ' A' ' 92' ' ' THR . 7.2 p-10 -26.73 124.06 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.668 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.605 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.3 OUTLIER -32.08 98.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.449 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.605 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 167.35 143.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.361 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.4 126.38 29.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.703 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.98 131.57 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.416 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.569 ' SD ' ' CB ' ' A' ' 122' ' ' ALA . 6.3 mtm -96.37 137.17 35.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.651 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.29 162.45 19.91 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -111.63 115.81 29.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.312 . . . . 0.0 110.64 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.1 tt -132.82 141.41 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.445 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.2 155.97 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 110.753 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.408 ' HB1' ' HB1' ' A' ' 65' ' ' ALA . . . -136.52 146.46 46.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.322 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -120.31 31.99 6.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.738 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.59 156.6 26.89 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -85.89 78.58 9.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.773 0.321 . . . . 0.0 110.405 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.6 m -107.5 179.18 4.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.637 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.56 -12.03 15.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.685 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.9 p -167.55 100.0 0.49 Allowed 'General case' 0 C--O 1.243 0.721 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.005 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' A' ' 110' ' ' ILE . 12.5 tt -132.36 132.27 60.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.846 0.355 . . . . 0.0 110.696 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -153.29 175.89 31.54 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 1.7 p -124.32 156.75 36.44 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.725 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -160.95 139.58 10.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.428 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.5 mp -126.94 118.0 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.906 0.384 . . . . 0.0 110.765 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.7 t -116.83 128.3 55.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.3 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.9 t -121.0 155.81 24.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.818 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 58.44 14.34 2.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.597 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.5 9.47 78.03 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -116.51 140.07 49.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.774 0.321 . . . . 0.0 110.56 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.89 132.41 33.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.43 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -129.33 -74.94 0.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.573 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.569 ' CB ' ' SD ' ' A' ' 98' ' ' MET . . . -125.47 129.0 48.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.679 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -149.49 133.06 16.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.637 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.9 mmt-85 -105.97 119.93 40.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.481 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 84.9 t -113.05 116.24 52.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.73 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.7 m -133.94 117.04 16.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.144 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.53 129.55 56.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.838 0.352 . . . . 0.0 110.877 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -154.97 130.62 9.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.42 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.7 t -85.56 139.26 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.756 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 60.76 42.52 13.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.697 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.25 151.95 34.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.491 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 53.98 103.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.558 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 134' ' ' TYR . 90.4 m -164.25 -71.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.565 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.453 ' O ' ' CB ' ' A' ' 135' ' ' CYS . 0.4 OUTLIER 47.97 -177.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.671 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' CYS . . . . . 0.471 ' O ' ' O ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER 77.81 16.11 1.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.773 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 135' ' ' CYS . 0.5 OUTLIER 39.51 95.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.509 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.656 ' O ' ' N ' ' A' ' 139' ' ' SER . 3.2 m -144.5 5.26 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.945 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.24 -70.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.419 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.656 ' N ' ' O ' ' A' ' 137' ' ' VAL . 8.3 p -133.39 -174.07 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.368 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 139' ' ' SER . . . . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.543 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -97.41 118.24 33.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.214 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.903 HD21 HG23 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -96.0 115.2 27.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.767 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.705 ' N ' HD13 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -127.32 130.48 49.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.493 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.5 ' OH ' ' CZ ' ' A' ' 69' ' ' TYR . 33.0 p90 -119.97 148.71 43.2 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.274 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.58 ' HG3' ' OG ' ' A' ' 87' ' ' SER . 1.7 tm-20 -156.05 136.43 13.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.9 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.589 HG22 ' N ' ' A' ' 58' ' ' PHE . 4.2 mp -99.15 167.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.745 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.589 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -132.79 163.65 28.59 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.145 -179.576 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.98 142.65 4.98 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -41.79 155.92 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.513 2.142 . . . . 0.0 112.202 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.07 134.77 28.1 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.76 2.306 . . . . 0.0 112.188 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.84 -4.16 71.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.56 ' O ' ' O ' ' A' ' 83' ' ' VAL . 15.7 m -86.64 130.84 34.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.0 110.723 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 64' ' ' VAL . 7.7 p -105.36 126.11 60.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.428 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -136.72 152.85 50.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.661 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -106.45 116.56 32.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.361 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 mp -96.3 131.7 42.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.5 t -134.69 123.84 24.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.003 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.5 ' CZ ' ' OH ' ' A' ' 55' ' ' TYR . 37.3 p90 -151.48 170.76 18.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.909 0.385 . . . . 0.0 110.624 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.64 ' CE1' ' O ' ' A' ' 74' ' ' SER . 27.3 t80 -88.74 134.55 33.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.29 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.436 ' C ' ' N ' ' A' ' 73' ' ' ASN . 0.9 OUTLIER -109.48 141.57 41.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.831 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.451 ' O ' HG12 ' A' ' 72' ' ' VAL . 17.2 t -52.73 -11.44 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.328 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.629 ' O ' ' CB ' ' A' ' 74' ' ' SER . 49.8 m-80 -83.86 1.26 44.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.461 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.64 ' O ' ' CE1' ' A' ' 70' ' ' PHE . 0.9 OUTLIER 92.27 -75.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.763 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.85 135.34 86.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.583 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.15 143.57 28.75 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.554 2.169 . . . . 0.0 112.133 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -104.12 135.97 44.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.392 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.8 125.93 24.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.861 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 79' ' ' VAL . 28.2 m -109.07 127.14 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.425 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.664 ' OD1' ' N ' ' A' ' 81' ' ' GLY . 13.1 t0 -126.39 150.35 48.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.866 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.664 ' N ' ' OD1' ' A' ' 80' ' ' ASP . . . 85.21 12.19 74.08 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.37 140.63 30.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.746 0.308 . . . . 0.0 110.632 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.786 HG13 ' HG ' ' A' ' 84' ' ' LEU . 1.5 p -81.66 -33.77 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.473 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.786 ' HG ' HG13 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -141.25 152.51 64.53 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.479 179.615 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.513 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 20.5 Cg_endo -62.41 160.48 31.35 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.888 2.392 . . . . 0.0 112.066 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.573 ' CD1' ' N ' ' A' ' 86' ' ' TRP . 10.5 m95 -123.6 172.65 8.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.395 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.58 ' OG ' ' HG3' ' A' ' 56' ' ' GLU . 70.5 m -114.83 144.8 42.94 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.032 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.604 HD23 ' N ' ' A' ' 89' ' ' HIS . 0.6 OUTLIER -131.35 141.02 49.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.853 0.358 . . . . 0.0 110.778 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.604 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -108.59 123.29 48.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.305 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.3 mt -129.35 124.17 59.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.932 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.21 123.27 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.212 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.6 m -126.38 133.67 51.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 110.98 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.558 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 26.0 t-20 39.69 32.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.983 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.536 ' C ' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER 28.8 59.68 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.612 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.45 -146.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.385 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -119.47 123.29 43.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.5 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.2 p -159.71 139.7 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.645 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.617 ' HB3' HG21 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -96.51 177.66 5.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.649 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -138.14 162.73 25.68 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -118.81 116.51 26.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.699 0.285 . . . . 0.0 110.561 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -133.33 142.54 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.805 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 98.5 t -121.97 146.66 26.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.206 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -140.08 138.86 35.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.959 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -131.39 102.28 5.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.208 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -131.04 163.83 23.42 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -78.97 19.69 0.52 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.853 0.359 . . . . 0.0 110.274 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 105' ' ' GLY . 6.1 p -69.04 -171.72 0.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.64 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.83 8.23 12.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.675 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.0 p -172.79 104.84 0.15 Allowed 'General case' 0 C--O 1.242 0.686 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 126' ' ' SER . 2.9 mt -126.55 136.93 59.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 120.807 0.337 . . . . 0.0 110.341 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.54 175.98 41.8 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -126.18 167.54 15.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.762 0.315 . . . . 0.0 110.603 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -157.43 140.36 15.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.437 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.903 HG23 HD21 ' A' ' 53' ' ' LEU . 3.6 mp -124.42 114.99 43.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.689 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.54 123.88 41.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.429 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.573 ' C ' ' H ' ' A' ' 118' ' ' GLY . 10.8 p -135.15 151.22 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.706 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 117' ' ' ASP . 13.2 t70 53.03 2.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.579 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.573 ' H ' ' C ' ' A' ' 116' ' ' VAL . . . 88.53 9.37 69.29 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -123.77 127.92 48.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.723 0.297 . . . . 0.0 110.629 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.5 p -80.03 136.47 23.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.425 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.38 -52.91 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.877 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -150.86 128.31 11.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.602 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.74 126.79 9.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.806 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -96.0 118.87 33.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.406 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.0 t -121.0 116.59 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.83 0.348 . . . . 0.0 110.885 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.555 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.3 OUTLIER -134.03 116.09 15.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.456 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.41 ' OD1' ' N ' ' A' ' 127' ' ' ASN . 2.6 m-20 -100.16 132.51 45.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.569 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -136.25 138.66 42.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.502 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 26.4 m -68.22 -6.14 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.588 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -161.6 92.64 0.88 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.615 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -86.49 -37.55 18.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.489 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.688 ' CG ' ' N ' ' A' ' 133' ' ' THR . 51.0 t80 -73.99 -178.11 3.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.516 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.688 ' N ' ' CG ' ' A' ' 132' ' ' TYR . 65.0 p -133.4 -115.83 0.21 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.628 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -166.59 -24.69 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.523 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.58 118.15 3.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.802 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.0 mt -143.01 -173.34 3.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.553 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 138' ' ' LYS . 2.3 t -149.35 -15.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.602 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.542 ' O ' ' O ' ' A' ' 139' ' ' SER . 0.0 OUTLIER -37.24 105.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.436 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.542 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.6 OUTLIER 45.33 104.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.451 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.641 -179.923 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.6 mtt . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -92.76 129.03 38.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.461 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.422 ' O ' HD23 ' A' ' 53' ' ' LEU . 2.7 tt -95.63 118.02 31.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.513 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.3 135.08 51.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.596 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.537 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 1.2 p90 -120.34 148.62 43.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.409 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.562 ' C ' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -156.38 138.58 14.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.8 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.767 HD11 HD13 ' A' ' 101' ' ' ILE . 1.3 mm -105.95 174.73 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.905 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -133.36 171.94 13.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.991 0.424 . . . . 0.0 110.963 -179.591 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.86 147.13 5.07 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -39.16 152.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.758 2.306 . . . . 0.0 112.171 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -67.18 123.86 11.43 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.781 2.321 . . . . 0.0 112.151 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.87 -7.76 60.99 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -69.99 134.89 48.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.743 0.306 . . . . 0.0 110.493 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.9 t -111.7 125.71 69.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.632 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -141.13 155.37 46.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.371 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -98.9 123.15 42.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.717 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 52.2 mt -102.74 124.15 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.433 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 42.1 t -122.32 117.51 26.26 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.059 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.597 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 35.9 t80 -143.35 158.31 43.75 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.79 0.329 . . . . 0.0 110.489 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.597 ' O ' ' CE2' ' A' ' 69' ' ' TYR . 68.1 t80 -85.31 134.68 34.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.572 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -103.94 126.12 50.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.611 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 72' ' ' VAL . 60.5 t -62.29 -5.49 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.687 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.647 ' O ' ' CB ' ' A' ' 74' ' ' SER . 63.3 m-20 -85.72 -22.32 27.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.615 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.647 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 2.3 p 146.24 -99.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.547 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 75' ' ' GLU . 0.7 OUTLIER -64.99 147.64 98.35 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.65 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.58 154.9 50.06 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.719 2.28 . . . . 0.0 112.152 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -90.25 149.37 22.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.396 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ttp85 -152.59 133.17 13.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.737 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.05 136.66 52.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.414 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.537 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 1.0 OUTLIER -127.36 121.62 31.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.709 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.36 26.78 32.26 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.33 128.31 34.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.752 0.311 . . . . 0.0 110.626 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.4 t -67.87 -31.56 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.496 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.507 ' O ' HD12 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -161.54 156.5 20.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.491 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.449 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 11.6 Cg_endo -57.01 149.17 63.93 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.893 2.396 . . . . 0.0 112.282 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -120.6 -178.0 3.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.29 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.9 m -120.49 141.7 49.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.005 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.37 139.61 52.29 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.607 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 2.1 p-80 -114.83 127.79 55.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 0.0 110.963 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.4 mt -127.62 134.48 65.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.155 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -103.69 122.74 45.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.601 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.621 ' C ' ' H ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER -127.83 135.12 49.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.665 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 93' ' ' ASN . 0.5 OUTLIER -67.94 24.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.296 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.621 ' H ' ' C ' ' A' ' 92' ' ' THR . 2.2 t70 -114.07 0.87 14.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.536 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 60.7 -84.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.632 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.03 113.5 21.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.501 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.61 160.59 24.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.679 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.443 ' CG ' ' N ' ' A' ' 99' ' ' GLY . 4.3 ttt -130.15 158.21 40.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.381 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.443 ' N ' ' CG ' ' A' ' 98' ' ' MET . . . -156.38 152.3 23.7 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -110.47 117.46 33.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.864 0.364 . . . . 0.0 110.445 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.767 HD13 HD11 ' A' ' 57' ' ' ILE . 9.9 tt -132.08 137.48 54.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.535 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.2 t -138.05 149.93 24.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.554 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -120.79 150.24 41.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.58 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -135.59 79.46 1.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.646 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -131.64 161.24 23.69 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.435 ' N ' ' OD1' ' A' ' 106' ' ' ASN . 0.5 OUTLIER -79.07 28.57 0.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.84 0.352 . . . . 0.0 110.405 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -62.96 -166.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.598 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 108' ' ' ASP . 1.4 m-20 -114.75 -28.25 7.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.668 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.4 t -141.74 126.68 18.26 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.898 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.509 ' O ' ' O ' ' A' ' 126' ' ' SER . 23.0 mt -135.67 154.1 34.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.412 ' N ' ' CG2' ' A' ' 110' ' ' ILE . . . 174.69 159.23 20.59 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 5.7 p -117.93 161.46 19.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.766 0.317 . . . . 0.0 110.339 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 113' ' ' ARG . 2.8 ptp180 -161.3 136.87 7.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.664 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.1 mt -127.5 122.77 60.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.416 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.45 139.6 51.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.53 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.541 HG21 ' NH1' ' A' ' 121' ' ' ARG . 19.6 m -133.06 135.27 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.682 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 53.23 30.65 10.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.67 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.98 -1.58 23.22 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -109.31 136.01 49.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.331 . . . . 0.0 110.556 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.9 t -77.54 128.7 38.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.779 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.541 ' NH1' HG21 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -116.95 -63.91 1.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.379 179.773 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.93 127.21 45.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -149.38 131.83 15.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.993 0.425 . . . . 0.0 111.066 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -121.48 115.52 23.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.897 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.524 ' O ' ' CG2' ' A' ' 125' ' ' VAL . 1.1 m -111.16 125.59 68.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.907 0.384 . . . . 0.0 111.025 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.7 OUTLIER -131.46 115.93 16.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.016 179.473 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -101.81 131.01 48.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.885 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -156.63 136.64 12.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.613 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 20.4 t -88.99 140.95 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.568 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 46.02 53.75 8.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.272 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.42 113.02 4.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.631 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 65.75 115.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.522 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -133.94 169.4 17.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.287 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -171.52 73.58 0.05 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.998 0.428 . . . . 0.0 110.635 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' CYS . . . . . 0.701 ' SG ' ' N ' ' A' ' 136' ' ' LEU . 0.1 OUTLIER -129.72 163.99 24.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.448 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.701 ' N ' ' SG ' ' A' ' 135' ' ' CYS . 0.3 OUTLIER -110.59 105.62 14.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.684 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 140' ' ' ALA . 18.7 m -107.8 -176.09 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.485 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.462 ' O ' ' C ' ' A' ' 139' ' ' SER . 32.7 mtmt -120.01 -66.31 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.551 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.462 ' C ' ' O ' ' A' ' 138' ' ' LYS . 31.3 t -35.49 -74.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.528 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 139' ' ' SER . . . . . . . . 0 C--O 1.218 -0.561 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.587 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.3 mtm . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -114.88 128.74 56.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.465 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.931 HD22 ' O ' ' A' ' 97' ' ' VAL . 14.5 tp -96.13 114.86 26.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.449 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.5 p -127.78 129.95 47.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.563 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.456 ' CD1' ' C ' ' A' ' 55' ' ' TYR . 26.0 p90 -123.47 148.33 46.31 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.474 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.457 ' HG3' ' OG ' ' A' ' 87' ' ' SER . 10.4 tt0 -156.65 133.53 10.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.777 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.9 mp -98.76 158.31 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.854 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.49 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -132.3 166.26 22.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.912 0.387 . . . . 0.0 110.781 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.66 163.16 19.88 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.06 109.61 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.655 2.237 . . . . 0.0 112.119 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -45.79 141.87 8.17 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.517 2.145 . . . . 0.0 112.008 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.53 -13.31 56.75 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.6 p -83.03 137.76 34.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.716 0.293 . . . . 0.0 110.56 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 64' ' ' VAL . 20.9 m -103.31 132.37 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.739 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.49 153.83 43.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.306 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -97.27 114.88 26.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.623 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 67' ' ' ILE . 1.8 mp -87.71 122.67 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.583 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.4 t -130.26 116.28 18.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.98 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.61 ' CZ ' ' O ' ' A' ' 70' ' ' PHE . 16.3 t80 -149.86 149.43 30.47 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.822 0.344 . . . . 0.0 110.575 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.61 ' O ' ' CZ ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -84.71 130.53 34.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.389 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.67 ' OD1' ' N ' ' A' ' 72' ' ' VAL . 67.9 t0 -93.87 146.38 23.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.802 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.67 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 89.7 t -69.59 -34.3 60.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.46 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -81.01 11.76 3.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.761 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.9 m 61.49 71.4 0.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.61 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.524 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 3.2 tt0 -178.66 77.73 0.22 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.379 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.66 144.25 99.47 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.96 2.44 . . . . 0.0 112.177 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -107.66 134.85 50.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.382 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 mtm-85 -134.08 126.92 31.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.922 0.391 . . . . 0.0 110.656 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 t -115.94 119.77 62.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.513 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -108.51 121.6 45.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.566 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.21 15.38 38.68 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.72 130.59 43.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 0.0 110.648 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.3 t -73.47 -35.17 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.294 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.61 ' H ' HD12 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -149.76 157.36 38.35 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.507 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.563 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 18.6 Cg_endo -61.33 157.08 42.3 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.989 2.459 . . . . 0.0 112.107 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -129.26 176.93 7.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.356 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.457 ' OG ' ' HG3' ' A' ' 56' ' ' GLU . 59.7 m -114.19 161.58 17.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.98 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.0 tp -147.98 134.97 20.24 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.244 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -109.15 126.36 53.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.841 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 90' ' ' ILE . 4.6 mp -130.46 136.79 57.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.388 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.6 p -122.63 130.03 52.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.524 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.676 ' O ' ' N ' ' A' ' 94' ' ' ASP . 2.0 m -113.3 156.11 23.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.696 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.551 ' O ' ' C ' ' A' ' 94' ' ' ASP . 11.2 t30 -28.59 84.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.786 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.676 ' N ' ' O ' ' A' ' 92' ' ' THR . 10.3 m-20 23.6 92.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.707 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 172.06 140.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.652 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.5 140.01 33.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.234 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.931 ' O ' HD22 ' A' ' 53' ' ' LEU . 9.2 p -150.86 142.97 16.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 110.888 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.547 ' N ' ' SD ' ' A' ' 98' ' ' MET . 3.1 mmt -93.31 161.13 14.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.129 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.43 154.7 20.99 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.383 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -109.92 115.38 29.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.681 0.277 . . . . 0.0 110.263 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.4 tt -131.96 142.38 43.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.957 0.408 . . . . 0.0 110.981 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.0 t -139.98 145.82 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.357 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -143.51 151.73 40.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.763 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.46 103.89 7.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.529 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.58 161.71 23.7 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -82.87 54.92 2.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 0.0 110.574 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.27 -167.13 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.45 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -118.24 -10.94 10.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.618 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 t -154.84 102.41 2.35 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.56 ' O ' ' O ' ' A' ' 126' ' ' SER . 3.7 mt -127.23 127.06 68.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.854 0.359 . . . . 0.0 110.3 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.04 172.26 33.95 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.564 ' O ' ' O ' ' A' ' 124' ' ' ARG . 31.6 p -125.08 161.53 26.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.768 0.318 . . . . 0.0 110.694 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.793 ' C ' HD12 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -156.41 147.04 21.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.496 179.799 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.793 HD12 ' C ' ' A' ' 113' ' ' ARG . 1.8 mp -121.57 117.18 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 110.82 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.78 129.4 51.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.284 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 118' ' ' GLY . 27.3 m -136.5 144.49 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.917 0.389 . . . . 0.0 110.969 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' A' ' 117' ' ' ASP . 21.7 t0 44.93 13.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.84 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 116' ' ' VAL . . . 83.64 -2.25 87.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 116' ' ' VAL . 4.6 ttmt -102.99 126.07 50.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.387 . . . . 0.0 110.396 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 20.9 t -80.86 140.33 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.631 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.423 ' NH1' ' HG3' ' A' ' 121' ' ' ARG . 1.7 mmm-85 -128.87 -48.94 1.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.497 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.91 135.99 9.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.535 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -149.54 155.9 41.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.502 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.564 ' O ' ' O ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -124.61 116.13 21.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.517 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.5 t -121.26 117.25 52.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.567 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.56 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.6 OUTLIER -130.54 121.75 26.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.588 -179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.53 129.84 41.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.241 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -132.25 139.98 48.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.812 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.25 -8.98 12.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.413 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 132' ' ' TYR . 0.4 OUTLIER 178.93 82.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.41 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.82 71.25 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.675 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 130' ' ' ASN . 81.5 t80 -172.43 117.72 0.35 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.583 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.1 161.0 36.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.64 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.492 ' O ' ' O ' ' A' ' 135' ' ' CYS . 0.1 OUTLIER -65.06 91.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.394 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 135' ' ' CYS . . . . . 0.492 ' O ' ' O ' ' A' ' 134' ' ' TYR . 34.1 m -48.57 -174.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.7 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 45.34 88.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.759 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.35 84.5 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.491 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.43 94.88 5.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.55 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.1 t -171.18 56.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.435 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.53 -179.844 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.616 ' SD ' ' OD1' ' A' ' 117' ' ' ASP . 41.7 mtm . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.17 129.14 55.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.453 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.699 ' C ' HD23 ' A' ' 53' ' ' LEU . 7.0 tt -95.52 114.79 26.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.962 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.433 ' N ' HD23 ' A' ' 53' ' ' LEU . 0.7 OUTLIER -127.33 135.76 50.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 55' ' ' TYR . 26.8 p90 -130.13 149.3 51.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.096 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.981 ' OE1' ' OG ' ' A' ' 87' ' ' SER . 15.5 tt0 -155.64 150.72 26.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.963 0.411 . . . . 0.0 111.079 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.488 HD11 HG23 ' A' ' 110' ' ' ILE . 7.1 tt -112.1 163.21 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.887 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.642 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -139.96 165.08 28.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 110.993 -179.469 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.6 171.37 44.33 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -47.85 112.74 0.61 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.716 2.277 . . . . 0.0 111.976 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -44.62 146.79 2.01 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.431 2.087 . . . . 0.0 112.267 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.78 -10.7 59.2 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.1 m -79.37 139.18 37.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 110.661 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.7 t -102.48 122.95 55.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.496 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.87 140.96 36.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.695 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -101.04 116.07 31.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.31 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.9 tt -102.06 138.4 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.81 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.2 t -124.48 118.67 27.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.949 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -128.19 167.12 17.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.756 0.312 . . . . 0.0 110.55 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.4 ' CE1' ' HA ' ' A' ' 74' ' ' SER . 55.7 t80 -99.62 134.83 41.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.313 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -95.75 139.14 32.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.68 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -54.91 -29.77 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.549 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.441 ' O ' ' CB ' ' A' ' 74' ' ' SER . 10.0 m-20 -84.19 2.93 37.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.523 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 0.7 OUTLIER 76.99 10.1 2.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.508 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -110.43 91.39 11.78 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.401 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.92 139.83 17.73 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.624 2.216 . . . . 0.0 112.309 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -107.83 158.35 17.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.592 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -145.58 126.35 14.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.624 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.0 m -108.21 135.57 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.499 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -128.96 132.96 47.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.74 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.31 17.65 42.02 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.87 149.44 36.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.837 0.351 . . . . 0.0 110.754 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.556 HG23 ' CD1' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -88.35 -42.43 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.302 179.775 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.556 ' CD1' HG23 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -144.49 154.07 56.1 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.187 179.662 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.28 147.37 47.39 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 122.96 2.44 . . . . 0.0 112.266 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.534 ' CD1' ' N ' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -114.23 -162.75 0.83 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.256 179.709 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.981 ' OG ' ' OE1' ' A' ' 56' ' ' GLU . 70.3 m -116.59 153.53 32.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.986 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 mt -128.23 141.74 51.37 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.737 0.303 . . . . 0.0 110.506 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.34 119.92 40.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.509 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.444 ' HA ' HD13 ' A' ' 90' ' ' ILE . 26.2 mm -126.7 121.55 58.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.75 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 p -105.38 122.48 46.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.344 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.2 m -122.08 149.25 43.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.716 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -86.83 31.31 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.454 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.538 ' C ' ' H ' ' A' ' 96' ' ' ALA . 32.8 m-20 -114.52 -4.07 12.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.548 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 94' ' ' ASP . . . 70.77 -28.52 0.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.713 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.538 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -156.62 138.15 14.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.701 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.3 p -174.9 144.7 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.429 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -104.3 154.3 19.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.777 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -122.02 159.03 16.7 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.25 122.13 46.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.719 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.8 pt -132.53 139.52 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.531 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 103' ' ' ALA . 75.0 t -123.43 159.31 28.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.349 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.517 ' N ' HG12 ' A' ' 102' ' ' VAL . . . -131.05 152.08 50.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.982 0.42 . . . . 0.0 110.612 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.91 64.05 1.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.328 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -130.97 163.99 23.35 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.7 20.39 0.45 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 0.0 110.558 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.603 ' OG ' ' N ' ' A' ' 108' ' ' ASP . 6.0 t -53.47 -173.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.626 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.603 ' N ' ' OG ' ' A' ' 107' ' ' SER . 37.4 t0 -119.61 -73.44 0.64 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.615 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.1 t -89.21 122.12 32.18 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.975 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.488 HG23 HD11 ' A' ' 57' ' ' ILE . 12.7 mt -130.46 139.44 51.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.828 0.347 . . . . 0.0 110.5 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.17 144.36 7.98 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 10.7 p -117.96 156.91 27.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.73 0.3 . . . . 0.0 110.476 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.766 ' C ' HD12 ' A' ' 114' ' ' ILE . 13.8 ptm180 -159.96 146.04 15.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.766 HD12 ' C ' ' A' ' 113' ' ' ARG . 3.8 mp -131.83 122.05 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.368 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.0 t -118.68 140.94 49.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.679 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.454 ' C ' ' H ' ' A' ' 118' ' ' GLY . 31.1 m -124.17 144.72 32.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.559 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.616 ' OD1' ' SD ' ' A' ' 51' ' ' MET . 0.5 OUTLIER 52.94 9.77 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.575 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 116' ' ' VAL . . . 88.02 5.6 76.75 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.6 mtmt -106.44 127.33 53.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.748 0.309 . . . . 0.0 110.512 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.486 ' O ' HG23 ' A' ' 120' ' ' VAL . 26.5 m -70.9 118.84 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.74 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -103.44 -72.94 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.479 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -135.31 128.09 31.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.315 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -146.9 123.85 11.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.0 mtt-85 -100.61 115.46 30.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.286 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.9 t -123.98 117.25 50.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.61 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.2 OUTLIER -132.99 122.67 24.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.406 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -94.2 129.74 40.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.342 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -152.85 130.74 11.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.718 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.72 ' O ' HG13 ' A' ' 129' ' ' VAL . 13.7 p -65.06 104.36 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.554 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 66.79 81.76 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.56 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.11 157.51 28.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.606 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.405 ' O ' ' C ' ' A' ' 133' ' ' THR . 4.4 m-85 59.84 -87.41 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.56 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 132' ' ' TYR . 0.8 OUTLIER -38.82 134.1 1.02 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.604 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.49 ' O ' ' O ' ' A' ' 135' ' ' CYS . 0.2 OUTLIER -125.32 -30.26 3.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.511 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 134' ' ' TYR . 0.0 OUTLIER -54.92 -157.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.44 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.86 -9.67 1.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.648 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 138' ' ' LYS . 79.4 t -147.3 132.72 11.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.754 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 137' ' ' VAL . 4.9 tttm 76.88 -177.26 0.12 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.727 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.3 t -128.89 6.07 5.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.515 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.56 -179.951 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -114.24 128.0 56.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.445 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 53' ' ' LEU . 2.2 pp -95.9 116.06 28.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.334 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.9 t -123.76 144.8 49.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.77 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.4 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -119.48 149.41 41.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.013 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.492 ' OE1' ' C ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -155.76 136.88 13.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.946 0.403 . . . . 0.0 111.087 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.519 HG22 ' N ' ' A' ' 58' ' ' PHE . 21.0 mt -116.31 161.81 14.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.002 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.519 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -141.32 151.02 43.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.018 0.437 . . . . 0.0 110.662 -179.878 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -165.93 168.83 39.93 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -46.11 144.72 6.06 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.651 2.234 . . . . 0.0 111.781 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -64.29 120.48 7.82 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.592 2.195 . . . . 0.0 112.17 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.09 2.94 59.13 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.579 ' O ' ' O ' ' A' ' 83' ' ' VAL . 6.7 t -78.71 141.48 37.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.861 0.363 . . . . 0.0 110.665 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 64' ' ' VAL . 33.8 m -101.79 128.2 54.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.621 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.35 144.73 33.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.839 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.45 116.32 32.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.247 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.699 HG23 HD11 ' A' ' 101' ' ' ILE . 23.7 mt -101.03 124.71 54.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.023 0.439 . . . . 0.0 111.006 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.5 t -135.63 124.35 23.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.992 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' A' ' 69' ' ' TYR . 23.9 p90 -147.94 169.01 20.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.909 0.385 . . . . 0.0 110.965 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -87.35 125.7 34.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.455 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -90.95 155.07 19.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.632 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 73' ' ' ASN . 5.3 p -51.77 -37.07 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.495 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 74' ' ' SER . 0.9 OUTLIER -85.16 11.75 9.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.473 179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.516 ' O ' ' C ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER 81.19 -68.03 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.313 -179.729 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.516 ' C ' ' O ' ' A' ' 74' ' ' SER . 5.6 tt0 -31.91 104.14 0.22 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.136 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -76.7 139.86 20.43 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.317 2.011 . . . . 0.0 112.318 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -97.79 147.66 24.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.498 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 78' ' ' ARG . 14.8 mtp180 -144.73 130.01 18.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.465 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.9 m -109.8 124.5 66.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.411 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.01 117.99 31.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.73 16.73 27.93 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.86 135.66 48.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.774 0.321 . . . . 0.0 110.5 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.579 ' O ' ' O ' ' A' ' 63' ' ' THR . 0.5 OUTLIER -81.17 -38.68 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.659 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.407 ' CD1' HG23 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -148.16 157.06 43.24 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.119 0.485 . . . . 0.0 110.578 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.492 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 38.0 Cg_endo -68.82 160.31 50.19 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.867 2.378 . . . . 0.0 112.227 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.93 -169.65 2.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.498 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.5 m -133.83 144.98 49.3 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.952 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.3 tp -138.32 155.64 48.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.627 0.251 . . . . 0.0 110.398 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -115.82 135.37 54.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 110.984 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.7 mt -129.23 130.32 67.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.249 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 91' ' ' THR . 5.4 t -115.35 129.21 56.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.771 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.557 ' O ' ' C ' ' A' ' 93' ' ' ASN . 14.0 m -129.97 125.42 35.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.226 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.557 ' C ' ' O ' ' A' ' 92' ' ' THR . 26.3 m-20 26.26 -104.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.544 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 94' ' ' ASP . 4.8 p-10 -160.05 81.23 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.484 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -167.43 147.41 5.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.664 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.36 127.21 33.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.361 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -140.56 150.07 21.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -102.39 172.59 6.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.208 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -138.44 161.8 25.72 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.534 ' C ' ' OD1' ' A' ' 100' ' ' ASN . 16.2 t-20 -114.96 115.22 26.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 0.0 110.498 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.699 HD11 HG23 ' A' ' 67' ' ' ILE . 18.7 tt -130.98 141.42 46.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.505 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 103' ' ' ALA . 77.8 t -129.36 155.43 41.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.879 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.465 ' HB3' HG12 ' A' ' 110' ' ' ILE . . . -121.31 147.24 45.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.562 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -134.49 54.26 1.95 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.812 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.65 162.97 20.72 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.98 89.83 4.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.853 0.359 . . . . 0.0 110.448 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.2 p -117.82 177.7 4.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.774 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -116.91 -0.01 12.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.439 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.1 p -170.46 84.52 0.11 Allowed 'General case' 0 C--O 1.245 0.853 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.047 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.468 ' O ' ' CG2' ' A' ' 110' ' ' ILE . 0.4 OUTLIER -109.96 128.97 65.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 120.9 0.381 . . . . 0.0 110.774 -179.752 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -152.86 164.41 30.78 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 20.3 m -125.0 153.24 43.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.928 0.394 . . . . 0.0 110.727 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -159.87 144.89 15.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.309 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -126.56 133.67 68.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.833 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.8 m -122.79 124.02 42.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.432 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.444 ' C ' ' N ' ' A' ' 118' ' ' GLY . 0.5 OUTLIER -131.84 148.78 32.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.556 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.0 t0 49.87 13.46 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.691 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.444 ' N ' ' C ' ' A' ' 116' ' ' VAL . . . 84.64 -0.14 89.22 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.62 138.34 50.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.717 0.294 . . . . 0.0 110.586 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.3 t -85.41 118.67 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.53 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -90.37 -62.09 1.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.5 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -114.7 131.75 56.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.449 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -129.52 121.75 27.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.773 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.457 ' O ' ' CG ' ' A' ' 124' ' ' ARG . 11.8 ptm180 -128.49 123.19 32.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.293 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.8 t -122.5 120.25 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.63 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.42 115.94 18.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.637 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -95.08 130.18 41.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.211 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -150.4 130.57 13.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.761 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.07 18.34 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.993 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.412 ' CG ' ' O ' ' A' ' 130' ' ' ASN . 17.4 t30 -179.09 65.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.409 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.46 124.0 26.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.627 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.667 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 1.5 t80 -165.89 -25.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.425 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 30.7 p -101.57 -163.75 1.04 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.634 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.565 ' O ' ' N ' ' A' ' 136' ' ' LEU . 0.9 OUTLIER -111.58 44.25 1.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.669 -179.854 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' CYS . . . . . 0.433 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -51.62 84.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.434 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' A' ' 134' ' ' TYR . 4.8 mt -66.65 82.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.532 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 135' ' ' CYS . 1.6 t -132.35 155.32 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.433 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -87.49 -50.92 6.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.676 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.0 m -151.35 -136.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.538 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.574 -179.888 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.66 127.85 54.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.481 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.453 ' CD1' ' O ' ' A' ' 97' ' ' VAL . 1.5 tt -96.12 115.72 27.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.416 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.62 130.95 51.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.667 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -119.98 149.01 42.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.2 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 2.6 tm-20 -156.03 146.76 21.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.984 0.421 . . . . 0.0 111.002 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 58' ' ' PHE . 74.7 mt -114.73 159.96 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.761 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.672 ' CE2' HD11 ' A' ' 84' ' ' LEU . 11.8 t80 -140.28 156.86 46.3 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.245 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.589 ' N ' ' CD1' ' A' ' 58' ' ' PHE . . . -160.72 175.04 37.45 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -50.93 157.98 3.44 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.623 2.216 . . . . 0.0 111.979 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -75.27 118.66 5.27 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.803 2.335 . . . . 0.0 112.187 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.03 9.9 55.5 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.77 150.67 25.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.785 0.326 . . . . 0.0 110.442 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 64' ' ' VAL . 7.6 p -126.06 121.98 60.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.569 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.38 153.55 42.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.529 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.92 115.71 27.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.401 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.499 ' CD1' HD12 ' A' ' 57' ' ' ILE . 4.1 mm -93.24 132.73 36.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.853 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.5 t -135.8 127.54 29.15 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.909 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.454 ' CG ' ' N ' ' A' ' 70' ' ' PHE . 40.1 t80 -150.46 157.34 42.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.801 0.334 . . . . 0.0 110.678 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 12.9 t80 -87.44 124.35 33.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.439 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.83 156.81 22.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.483 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.29 -30.84 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.473 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 74' ' ' SER . 34.9 m120 -95.72 11.6 32.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.31 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.63 ' OG ' ' N ' ' A' ' 75' ' ' GLU . 1.1 p 85.19 -69.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.379 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.63 ' N ' ' OG ' ' A' ' 74' ' ' SER . 11.4 pt-20 -29.63 94.86 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.495 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.498 ' N ' ' O ' ' A' ' 74' ' ' SER . 51.3 Cg_endo -77.01 141.6 21.2 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.506 2.137 . . . . 0.0 111.978 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.452 ' HG2' ' N ' ' A' ' 78' ' ' ARG . 1.4 tt0 -107.58 140.83 39.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.987 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.452 ' N ' ' HG2' ' A' ' 77' ' ' GLN . 4.4 mtt-85 -135.9 133.5 37.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.165 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 m -99.35 136.56 29.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.72 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -113.09 103.67 11.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.64 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.32 33.46 5.4 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.31 148.11 50.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.789 0.328 . . . . 0.0 110.559 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.5 m -107.56 -20.03 6.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.395 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.672 HD11 ' CE2' ' A' ' 58' ' ' PHE . 5.3 tt -174.99 115.17 0.29 Allowed Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.222 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.567 ' N ' HD23 ' A' ' 84' ' ' LEU . 27.4 Cg_exo -55.63 144.19 76.08 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.897 1.731 . . . . 0.0 111.803 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.526 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 4.4 m-90 -111.5 -144.54 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.528 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.707 ' O ' HD22 ' A' ' 88' ' ' LEU . 97.0 p -134.17 155.21 50.52 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.977 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.707 HD22 ' O ' ' A' ' 87' ' ' SER . 1.5 mm? -129.1 151.84 49.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.786 0.327 . . . . 0.0 110.492 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.433 ' O ' HD13 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -105.86 119.05 38.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.629 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.433 HD13 ' O ' ' A' ' 89' ' ' HIS . 50.3 mm -126.41 138.25 55.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.456 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 91' ' ' THR . 12.0 t -103.76 130.44 51.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.649 ' O ' ' N ' ' A' ' 94' ' ' ASP . 17.4 p -116.75 140.34 49.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.737 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.524 ' CG ' ' O ' ' A' ' 93' ' ' ASN . 1.8 t30 -49.5 79.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.59 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 92' ' ' THR . 21.9 m-20 34.08 79.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.55 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -169.41 145.79 3.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.508 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.432 ' CB ' HG11 ' A' ' 116' ' ' VAL . . . -108.5 113.6 26.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.439 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.453 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 7.7 p -133.91 156.78 41.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.674 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.444 ' HA ' HG21 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -108.07 117.26 33.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.533 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.38 161.87 54.39 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -112.9 115.39 28.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 0.0 110.595 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.4 tt -131.08 139.25 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.643 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 103' ' ' ALA . 8.2 t -130.39 155.16 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.397 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.451 ' N ' ' CG1' ' A' ' 102' ' ' VAL . . . -140.72 157.16 45.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.737 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -136.83 73.71 1.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.586 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -128.8 163.51 22.18 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -79.18 106.74 11.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.868 0.366 . . . . 0.0 110.516 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.0 p -140.9 -170.83 3.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.622 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 108' ' ' ASP . 2.3 t70 -134.15 4.93 3.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.5 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.8 p -174.73 62.46 0.02 OUTLIER 'General case' 0 C--O 1.245 0.847 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.959 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.504 ' O ' ' O ' ' A' ' 126' ' ' SER . 4.2 tt -98.99 129.52 49.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 O-C-N 123.16 0.288 . . . . 0.0 110.424 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -149.42 172.4 29.45 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.569 ' O ' ' O ' ' A' ' 124' ' ' ARG . 0.9 OUTLIER -118.99 157.32 27.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.765 0.317 . . . . 0.0 110.28 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.511 ' NH2' ' OE1' ' A' ' 56' ' ' GLU . 15.1 ptt-85 -161.41 141.78 10.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.642 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 113' ' ' ARG . 20.1 mm -117.71 131.37 70.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.615 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.1 p -110.3 132.88 53.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.429 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.432 HG11 ' CB ' ' A' ' 96' ' ' ALA . 24.5 t -142.05 150.08 19.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.598 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 50.99 19.24 0.63 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.653 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.38 -4.73 24.9 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -120.94 132.03 54.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.797 0.332 . . . . 0.0 110.557 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.3 t -74.63 134.53 29.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.46 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.03 -46.82 2.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.789 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.64 129.73 14.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.69 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -150.19 155.73 40.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.576 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.569 ' O ' ' O ' ' A' ' 112' ' ' CYS . 25.8 mtt-85 -116.22 116.0 27.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.608 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.7 p -124.31 128.82 74.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.527 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 110' ' ' ILE . 4.7 m -128.71 130.46 47.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.534 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -99.41 137.92 37.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.517 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -145.64 166.47 25.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.459 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.424 ' C ' ' CG ' ' A' ' 130' ' ' ASN . 5.2 t -97.59 -3.37 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.443 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 132' ' ' TYR . 0.1 OUTLIER 172.33 79.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.354 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.72 76.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.513 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.448 ' N ' ' O ' ' A' ' 130' ' ' ASN . 2.3 t80 -117.99 -70.16 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.511 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 134' ' ' TYR . 1.3 t -56.57 -27.79 58.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.539 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.572 ' O ' ' N ' ' A' ' 136' ' ' LEU . 5.1 t80 58.62 130.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.702 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 17.7 t -53.69 80.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.613 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.572 ' N ' ' O ' ' A' ' 134' ' ' TYR . 8.3 tp -107.16 21.4 17.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.593 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.416 HG23 ' C ' ' A' ' 136' ' ' LEU . 2.4 t 64.72 156.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.674 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.3 tttp 74.15 -168.71 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.63 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.5 m 70.7 12.85 7.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.554 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.613 -179.924 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.7 mpt? . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -113.13 128.59 56.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.604 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.649 HD11 ' CG2' ' A' ' 114' ' ' ILE . 39.1 tp -95.79 115.76 27.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.087 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.1 p -126.45 131.77 51.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 88' ' ' LEU . 26.1 p90 -119.77 148.88 42.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.832 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.46 ' O ' HD13 ' A' ' 57' ' ' ILE . 2.2 tm-20 -155.81 144.88 20.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.901 0.382 . . . . 0.0 110.919 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.554 HG22 ' N ' ' A' ' 58' ' ' PHE . 31.4 mm -116.11 165.59 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.901 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.686 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -133.01 165.42 24.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.023 0.44 . . . . 0.0 110.952 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.76 170.56 37.33 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.559 ' O ' ' OG1' ' A' ' 63' ' ' THR . 17.9 Cg_endo -64.82 161.2 37.25 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.518 2.146 . . . . 0.0 112.016 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -72.51 119.52 6.17 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.868 2.379 . . . . 0.0 112.163 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.69 7.31 45.24 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.559 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -82.92 136.02 34.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.809 0.338 . . . . 0.0 110.653 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -114.53 122.63 69.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.615 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.61 151.53 44.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.503 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.497 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 9.2 p30 -96.24 116.0 28.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.635 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 mt -96.83 130.45 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.572 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.4 t -134.19 126.06 29.14 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.02 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.657 ' CZ ' ' O ' ' A' ' 70' ' ' PHE . 11.0 t80 -151.38 152.64 33.39 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.876 0.369 . . . . 0.0 110.63 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.657 ' O ' ' CZ ' ' A' ' 69' ' ' TYR . 49.7 t80 -84.75 121.53 27.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.494 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.448 ' HB2' ' H ' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -81.52 151.18 27.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.627 -179.84 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.5 t -64.72 -35.27 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.604 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -89.7 10.24 24.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.657 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 70.52 79.56 0.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.582 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.448 ' H ' ' HB2' ' A' ' 71' ' ' ASP . 2.7 tt0 -170.77 85.17 0.52 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.469 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -59.31 139.95 92.31 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.859 2.373 . . . . 0.0 112.197 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -106.04 132.67 51.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.56 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.1 mtm-85 -140.43 126.22 19.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.468 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.3 m -121.31 136.97 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.735 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -129.95 126.2 37.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.516 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.68 23.96 17.03 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.98 153.36 22.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 110.467 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.472 HG23 ' CD1' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -92.93 -39.82 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.615 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.608 ' CD1' ' CH2' ' A' ' 86' ' ' TRP . 0.2 OUTLIER -147.83 157.8 43.33 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.976 0.417 . . . . 0.0 110.628 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.73 162.49 39.45 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.87 2.38 . . . . 0.0 112.268 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.608 ' CH2' ' CD1' ' A' ' 84' ' ' LEU . 2.1 m95 -132.86 -156.49 0.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.332 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.606 ' O ' HD22 ' A' ' 88' ' ' LEU . 96.7 p -130.49 161.22 31.92 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.946 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.606 HD22 ' O ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -132.47 155.42 48.59 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.405 178.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.533 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.2 OUTLIER -116.2 120.61 39.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.668 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 53' ' ' LEU . 3.8 mp -124.15 129.79 73.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.656 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.01 129.86 53.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.302 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.563 ' O ' ' O ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -125.79 157.97 36.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.659 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.563 ' O ' ' O ' ' A' ' 92' ' ' THR . 5.1 m120 -34.76 -100.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.618 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.8 72.59 0.33 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.587 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -169.68 166.06 9.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.745 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.56 128.89 34.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.518 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 95' ' ' ALA . 0.7 OUTLIER -133.44 147.74 31.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.718 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.409 ' SD ' ' HB3' ' A' ' 122' ' ' ALA . 23.0 mtm -149.19 150.25 32.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.309 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.17 162.16 23.59 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -105.23 117.08 33.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.892 0.377 . . . . 0.0 110.589 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 tp -132.88 133.66 58.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.532 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.0 m -130.59 165.32 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.217 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -139.62 142.22 37.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.759 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -132.96 75.98 1.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.383 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -125.52 164.43 19.1 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.631 ' ND2' ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -78.02 48.86 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.108 0.48 . . . . 0.0 110.458 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.8 173.23 7.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.613 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.603 ' N ' ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -101.61 -17.07 16.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.418 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.9 t -146.54 115.98 7.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.0 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 131' ' ' ALA . 3.4 mt -137.64 125.96 32.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.834 0.35 . . . . 0.0 110.51 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -154.83 175.27 32.95 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -120.23 169.62 10.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.687 0.279 . . . . 0.0 110.519 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.94 144.99 13.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.81 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.649 ' CG2' HD11 ' A' ' 53' ' ' LEU . 4.4 mt -140.74 122.97 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.579 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.0 p -122.72 122.29 38.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.371 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.594 ' O ' ' N ' ' A' ' 118' ' ' GLY . 55.9 t -122.12 157.74 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.857 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.494 ' N ' HG12 ' A' ' 116' ' ' VAL . 80.9 m-20 39.22 20.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.807 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 116' ' ' VAL . . . 70.44 0.95 33.46 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 116' ' ' VAL . 4.6 tttp -113.65 143.46 44.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 110.57 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 120' ' ' VAL . 14.4 p -71.56 124.23 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.784 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.443 ' HG2' ' NH1' ' A' ' 121' ' ' ARG . 26.9 mtt-85 -125.38 -41.4 2.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.175 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.409 ' HB3' ' SD ' ' A' ' 98' ' ' MET . . . -152.78 128.22 9.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.134 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -149.16 131.74 15.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.786 0.326 . . . . 0.0 111.026 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.0 119.06 28.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.351 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.649 ' O ' HG13 ' A' ' 125' ' ' VAL . 7.5 p -122.25 118.53 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.726 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.3 OUTLIER -115.35 127.16 55.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.538 179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -95.6 133.15 39.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.714 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.573 ' O ' ' O ' ' A' ' 108' ' ' ASP . 9.6 mt-10 -148.97 130.51 14.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.355 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.01 -11.02 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.605 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -164.38 72.03 0.22 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.35 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.56 ' HB3' HD12 ' A' ' 110' ' ' ILE . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.669 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.9 ptp . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -116.22 119.27 35.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.512 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.524 ' O ' HD23 ' A' ' 53' ' ' LEU . 6.3 tt -98.5 115.2 28.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.026 0.441 . . . . 0.0 110.703 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -127.51 129.71 47.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.052 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -119.96 148.54 43.4 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.732 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.705 ' OE1' ' OG ' ' A' ' 87' ' ' SER . 6.0 tt0 -156.8 131.93 9.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.705 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.581 HG22 ' N ' ' A' ' 58' ' ' PHE . 4.6 mm -91.36 167.95 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.581 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -132.41 145.49 51.25 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.885 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.07 156.66 28.09 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -50.33 161.63 1.1 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.923 2.415 . . . . 0.0 111.987 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -76.95 133.74 14.02 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.953 2.435 . . . . 0.0 112.279 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.94 -9.92 67.37 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.6 m -81.68 130.23 34.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.841 0.353 . . . . 0.0 110.496 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.9 m -101.9 127.39 55.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.579 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.35 155.48 49.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.557 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.503 ' OD1' ' C ' ' A' ' 66' ' ' ASP . 44.2 t0 -103.18 129.15 50.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.555 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.497 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 2.9 mt -118.73 126.46 75.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.62 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 39.9 t -113.27 117.87 33.04 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.067 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.593 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 33.9 t80 -139.96 145.93 38.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.702 0.287 . . . . 0.0 110.538 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.593 ' O ' ' CE2' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -83.24 134.48 34.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.207 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -94.21 153.32 18.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.92 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 73' ' ' ASN . 12.2 p -48.84 -39.09 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.635 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.514 ' O ' ' CB ' ' A' ' 74' ' ' SER . 0.3 OUTLIER -87.71 11.75 14.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.409 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.68 ' OG ' ' N ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER 82.15 -71.65 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.507 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.68 ' N ' ' OG ' ' A' ' 74' ' ' SER . 1.1 tp10 -26.12 88.75 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.701 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.588 ' N ' ' O ' ' A' ' 74' ' ' SER . 14.8 Cg_exo -65.08 144.57 82.39 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.932 2.421 . . . . 0.0 112.083 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -107.72 150.07 27.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.285 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -138.24 129.92 28.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.787 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.2 m -102.46 123.54 55.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.476 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 0.5 OUTLIER -120.97 108.74 14.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.686 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.69 29.03 7.56 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.45 132.86 34.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 0.0 110.578 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.08 -76.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.607 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.756 ' H ' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -118.17 156.73 50.25 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.588 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.516 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 25.6 Cg_endo -64.1 151.33 85.78 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.904 2.403 . . . . 0.0 112.339 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -114.31 -171.2 1.87 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.396 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.705 ' OG ' ' OE1' ' A' ' 56' ' ' GLU . 70.9 m -125.03 151.54 45.46 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.044 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 88' ' ' LEU . 8.1 tp -130.73 154.6 47.8 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.863 0.363 . . . . 0.0 110.5 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -123.57 120.65 33.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.404 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.7 mt -130.9 132.09 64.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.571 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.77 126.03 51.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.569 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.507 ' O ' ' C ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -130.24 156.39 44.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.585 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.623 ' OD1' ' N ' ' A' ' 93' ' ' ASN . 0.4 OUTLIER -30.78 120.13 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.478 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -42.51 92.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.568 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 93' ' ' ASN . . . -175.03 -171.92 0.56 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.446 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.68 113.15 8.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.452 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 t -107.26 152.36 8.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.192 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.5 ttt -148.48 137.48 21.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 0.0 111.015 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.64 156.99 18.85 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -118.73 115.39 24.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.812 0.339 . . . . 0.0 110.794 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.9 140.5 49.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.609 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 89.1 t -127.19 147.64 32.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.465 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -139.41 140.37 37.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.746 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -139.05 78.89 1.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.587 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.56 163.8 23.63 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -78.77 52.13 1.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.8 0.333 . . . . 0.0 110.483 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 129' ' ' VAL . 70.9 m -100.49 175.05 5.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.554 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 109' ' ' SER . 6.9 t70 -104.59 128.52 52.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.505 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 108' ' ' ASP . 47.0 t 44.02 93.52 0.01 OUTLIER 'General case' 0 C--O 1.24 0.599 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.971 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.498 ' CG2' ' OD1' ' A' ' 127' ' ' ASN . 15.9 tt -124.56 127.1 72.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 120.793 0.33 . . . . 0.0 110.461 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 125' ' ' VAL . . . -147.22 172.09 27.73 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.675 ' SG ' ' N ' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -118.75 162.66 18.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.675 ' N ' ' SG ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -158.76 143.72 16.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.923 0.392 . . . . 0.0 110.887 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.539 HD12 ' C ' ' A' ' 113' ' ' ARG . 1.9 mp -118.72 124.95 73.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.306 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.88 127.69 54.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.765 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.67 136.59 31.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.462 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.515 ' OD1' ' O ' ' A' ' 117' ' ' ASP . 57.7 t0 65.55 9.45 5.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.449 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.13 -5.98 57.77 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -101.13 139.3 37.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.812 0.339 . . . . 0.0 110.579 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 m -78.24 142.51 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.602 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -168.14 24.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.573 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -123.67 152.85 41.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.772 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.1 147.55 23.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.263 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.0 ptt85 -127.78 135.41 50.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.767 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.415 ' O ' ' CA ' ' A' ' 111' ' ' GLY . 2.1 t -103.08 134.64 43.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.165 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.667 ' C ' HD22 ' A' ' 127' ' ' ASN . 46.7 m -102.63 116.45 32.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.942 0.401 . . . . 0.0 110.901 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.69 ' N ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -128.34 135.19 49.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.449 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.601 ' N ' ' OE1' ' A' ' 128' ' ' GLU . 1.1 pm0 -104.36 174.6 5.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.746 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.656 ' O ' HG22 ' A' ' 129' ' ' VAL . 1.8 p -55.35 1.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.752 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.596 ' H ' ' C ' ' A' ' 128' ' ' GLU . 25.3 m-80 -112.84 -5.5 13.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.59 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.454 179.945 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.545 ' N ' ' H ' ' A' ' 117' ' ' ASP . 9.2 mtt . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.437 ' O ' ' CG ' ' A' ' 52' ' ' HIS . 1.5 p-80 -109.36 125.81 52.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.308 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.733 ' C ' HD23 ' A' ' 53' ' ' LEU . 5.5 tt -96.1 115.87 28.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.785 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.635 ' N ' HD23 ' A' ' 53' ' ' LEU . 23.7 p -126.28 130.12 50.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.496 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.554 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 1.8 p90 -122.69 149.94 43.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.517 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.426 ' HG2' ' N ' ' A' ' 57' ' ' ILE . 17.0 tt0 -155.36 148.09 24.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.956 0.408 . . . . 0.0 111.042 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.522 HD11 HD13 ' A' ' 101' ' ' ILE . 1.6 mm -112.88 163.59 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.971 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.5 156.71 44.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.905 0.384 . . . . 0.0 110.698 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.65 170.21 42.93 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -47.56 152.87 2.38 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.854 2.369 . . . . 0.0 112.229 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -67.04 119.66 6.69 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.825 2.35 . . . . 0.0 111.933 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.99 -0.03 62.22 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.4 t -74.85 144.06 43.59 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.878 0.371 . . . . 0.0 110.559 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 64' ' ' VAL . 7.2 p -115.87 128.83 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.508 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.47 151.49 41.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.806 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.67 124.81 49.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.206 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.442 HG23 HD11 ' A' ' 101' ' ' ILE . 10.9 mt -111.17 133.64 56.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.017 0.437 . . . . 0.0 111.013 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.5 t -132.35 131.05 41.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.957 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.679 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 11.2 t80 -150.98 156.49 41.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.895 0.379 . . . . 0.0 110.986 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.679 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 10.0 t80 -83.76 119.63 25.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.282 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 75' ' ' GLU . 32.6 t70 -89.42 146.08 24.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.841 0.353 . . . . 0.0 110.775 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.482 HG13 ' OD1' ' A' ' 73' ' ' ASN . 4.5 p -53.99 -24.2 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.605 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.482 ' OD1' HG13 ' A' ' 72' ' ' VAL . 2.9 m-20 -86.55 -3.87 59.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.64 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.3 m 78.55 34.21 0.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.526 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.445 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 3.2 mm-40 -135.87 104.27 9.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.408 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -77.74 140.14 18.37 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.284 1.99 . . . . 0.0 112.086 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -107.42 148.11 29.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.563 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 75.4 mtm-85 -139.26 131.62 28.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.622 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.3 m -114.21 118.98 60.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.608 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -112.6 145.74 39.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.481 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.32 5.81 44.48 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.15 137.75 58.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.809 0.338 . . . . 0.0 110.413 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.45 -44.24 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.54 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.431 ' H ' HD12 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -147.55 155.27 45.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.109 0.48 . . . . 0.0 110.774 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.83 159.44 52.79 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 123.208 2.605 . . . . 0.0 112.533 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -129.13 -179.26 5.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.215 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 92.8 p -112.27 164.53 13.11 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.323 0.582 . . . . 0.0 111.004 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.88 145.8 33.46 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.937 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.508 ' CG ' ' O ' ' A' ' 89' ' ' HIS . 19.8 p80 -121.52 123.53 42.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 110.851 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.3 mt -128.51 121.3 54.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.513 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.4 m -104.14 122.47 45.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.548 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.553 ' O ' ' C ' ' A' ' 93' ' ' ASN . 1.9 m -129.19 158.33 39.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.536 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.553 ' C ' ' O ' ' A' ' 92' ' ' THR . 41.9 m-20 -25.54 91.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.713 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.658 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -31.47 124.98 0.24 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.566 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 163.75 -71.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.595 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -156.25 120.42 4.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.447 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 t -127.81 147.26 32.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.711 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.6 ttm -151.51 159.42 44.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.517 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -153.46 156.26 26.65 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.564 HD21 ' NH2' ' A' ' 124' ' ' ARG . 0.8 OUTLIER -119.19 115.83 25.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.327 . . . . 0.0 110.611 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.522 HD13 HD11 ' A' ' 57' ' ' ILE . 11.9 tt -130.95 137.26 56.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.71 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.34 145.52 33.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.536 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -123.84 158.84 30.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.702 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -143.79 76.16 1.5 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.386 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -116.79 163.61 12.47 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.763 HD22 ' N ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -79.28 28.44 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.572 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.418 ' H ' ' C ' ' A' ' 105' ' ' GLY . 2.0 p -73.05 -174.41 1.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.538 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' A' ' 128' ' ' GLU . 3.0 m-20 -113.25 -24.9 9.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.716 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 t -151.21 101.52 2.86 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.959 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.539 ' O ' ' O ' ' A' ' 126' ' ' SER . 15.6 tt -138.39 135.6 44.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.896 0.379 . . . . 0.0 110.577 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.73 173.1 35.67 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 1.4 p -124.93 162.31 24.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.821 0.343 . . . . 0.0 110.771 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -149.07 158.25 44.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.457 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.9 mm -126.56 127.68 70.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.634 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.57 132.4 53.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.567 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.455 ' C ' ' N ' ' A' ' 118' ' ' GLY . 7.6 p -143.14 149.65 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.571 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.545 ' H ' ' N ' ' A' ' 51' ' ' MET . 5.9 m-20 48.89 15.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.391 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.455 ' N ' ' C ' ' A' ' 116' ' ' VAL . . . 77.69 1.42 77.46 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -116.79 126.88 53.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.731 0.3 . . . . 0.0 110.607 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.0 t -74.88 136.51 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.475 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -129.13 -33.59 1.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.841 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.06 129.53 14.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.486 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -151.58 126.73 9.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.807 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.564 ' NH2' HD21 ' A' ' 100' ' ' ASN . 0.2 OUTLIER -113.6 115.73 28.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.238 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.7 m -114.97 133.21 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.696 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.5 OUTLIER -132.61 115.88 15.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.454 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -97.81 130.03 44.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.393 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.517 ' O ' ' O ' ' A' ' 108' ' ' ASP . 3.9 mm-40 -138.68 130.77 28.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.908 0.385 . . . . 0.0 110.806 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.9 m -73.4 -4.04 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.266 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.2 73.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.059 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.659 -179.711 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -112.57 126.16 55.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.558 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.45 HD13 HG23 ' A' ' 114' ' ' ILE . 11.6 tp -97.32 115.28 27.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.56 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.438 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -127.14 142.85 51.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.509 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -126.0 148.43 49.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.42 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.716 ' OE1' ' OG ' ' A' ' 87' ' ' SER . 11.7 tt0 -156.7 134.4 10.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.979 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.569 HG22 ' H ' ' A' ' 58' ' ' PHE . 20.7 mm -101.98 170.57 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.569 ' H ' HG22 ' A' ' 57' ' ' ILE . 29.5 m-85 -132.19 173.04 11.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 111.085 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.21 151.51 6.15 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -40.16 139.16 1.07 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.586 2.191 . . . . 0.0 111.938 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.75 135.56 36.02 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.588 2.192 . . . . 0.0 112.22 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.6 -0.89 58.22 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.7 m -86.21 139.37 31.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.792 0.33 . . . . 0.0 110.645 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 p -111.55 123.4 67.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.384 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -137.45 156.71 47.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.537 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.15 115.17 27.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.331 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.454 HG23 HD11 ' A' ' 101' ' ' ILE . 72.7 mt -105.34 131.18 55.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.708 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.5 t -134.74 125.94 27.99 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.952 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.661 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 42.7 t80 -145.87 158.98 43.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.834 0.35 . . . . 0.0 110.647 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.661 ' O ' ' CE2' ' A' ' 69' ' ' TYR . 4.6 t80 -88.83 136.72 32.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.679 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.32 116.71 32.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.36 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 72' ' ' VAL . 18.0 t -75.5 -5.81 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.758 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.92 -17.98 25.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.593 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.6 t -176.72 -127.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.714 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -94.52 150.95 38.89 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.515 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.37 139.69 90.91 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.53 2.153 . . . . 0.0 111.871 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.58 156.84 17.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.697 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.7 ttm-85 -141.52 125.12 16.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.515 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.31 118.44 58.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.513 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 0.9 OUTLIER -115.74 133.62 55.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.658 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.55 31.37 8.89 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.57 148.98 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.863 0.363 . . . . 0.0 110.455 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.5 t -81.62 -53.35 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.301 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.528 ' O ' ' NE1' ' A' ' 86' ' ' TRP . 0.2 OUTLIER -140.67 151.89 64.51 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.209 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.516 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 11.5 Cg_endo -57.15 158.17 18.84 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.8 2.333 . . . . 0.0 112.071 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.528 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 37.4 m95 -130.15 -160.6 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.485 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.716 ' OG ' ' OE1' ' A' ' 56' ' ' GLU . 71.2 m -132.86 144.98 50.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.016 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.564 HD23 ' H ' ' A' ' 89' ' ' HIS . 0.4 OUTLIER -128.48 144.1 51.09 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 178.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.762 ' H ' ' CD2' ' A' ' 89' ' ' HIS . 0.7 OUTLIER -108.29 124.87 50.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.919 0.39 . . . . 0.0 110.943 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.6 mt -130.58 128.58 63.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.087 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.26 122.54 47.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.858 0.361 . . . . 0.0 110.934 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.537 ' O ' ' C ' ' A' ' 93' ' ' ASN . 5.3 m -126.14 125.57 42.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.236 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.537 ' C ' ' O ' ' A' ' 92' ' ' THR . 1.2 m-20 28.77 -134.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.494 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -139.41 98.74 3.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.563 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 168.35 -171.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.573 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -91.24 135.96 33.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.62 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.92 159.42 36.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.452 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.03 146.55 51.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.746 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.77 151.54 18.35 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -112.12 114.99 28.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.723 0.297 . . . . 0.0 110.596 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.454 HD11 HG23 ' A' ' 67' ' ' ILE . 0.8 OUTLIER -133.29 139.13 49.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.515 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 103' ' ' ALA . 2.3 t -131.96 165.14 32.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.519 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.404 ' H ' HG12 ' A' ' 102' ' ' VAL . . . -143.61 148.13 35.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.447 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.46 63.97 1.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.175 0.512 . . . . 0.0 110.359 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -118.16 163.53 12.93 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.43 52.42 2.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.733 0.301 . . . . 0.0 110.636 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.1 m -88.98 -167.82 2.0 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.388 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -112.26 -42.42 3.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.805 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.3 t -128.01 128.06 44.31 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.99 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.537 ' O ' ' O ' ' A' ' 126' ' ' SER . 7.5 mt -141.75 148.08 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.706 0.289 . . . . 0.0 110.307 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 177.8 163.86 30.21 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -117.83 160.14 21.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 0.0 110.611 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -151.3 155.48 38.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.635 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.45 HG23 HD13 ' A' ' 53' ' ' LEU . 4.4 mt -138.32 114.93 10.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.424 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.9 p -117.24 126.81 53.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.619 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 t -125.46 134.62 66.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.27 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 52.0 23.25 2.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.476 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.6 8.37 87.16 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -119.06 126.18 51.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.631 0.253 . . . . 0.0 110.399 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.2 p -74.26 138.72 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.769 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -115.35 -68.22 0.94 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.278 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -142.79 126.98 17.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.276 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -148.28 129.23 14.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.89 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -95.36 127.44 41.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.374 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 125' ' ' VAL . 10.8 p -117.45 117.31 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.806 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.6 OUTLIER -126.82 115.97 20.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.377 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 128' ' ' GLU . 54.9 t-20 -96.98 130.21 44.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.642 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.416 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 14.5 mt-10 -141.72 130.45 22.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.36 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 130' ' ' ASN . 0.3 OUTLIER -82.74 92.56 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.655 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 129' ' ' VAL . 1.0 OUTLIER 83.3 62.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.529 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 121.08 0.467 . . . . 0.0 110.572 179.943 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.443 ' SD ' ' OD1' ' A' ' 117' ' ' ASP . 17.2 mmt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.95 117.65 33.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.439 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.57 114.85 26.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.39 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.5 t -127.47 140.82 51.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.786 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.454 ' HE2' HD11 ' A' ' 90' ' ' ILE . 37.4 p90 -127.57 149.34 50.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.282 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -155.66 154.75 32.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 0.0 110.931 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.595 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 4.9 mm -116.51 161.38 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.294 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.535 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 7.9 m-85 -134.96 158.6 43.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.709 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.37 167.95 36.41 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -46.65 148.77 3.4 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.737 2.291 . . . . 0.0 112.08 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -70.29 134.7 27.47 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.703 2.268 . . . . 0.0 112.091 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.61 1.39 71.26 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 95.9 m -81.25 135.53 35.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.908 0.385 . . . . 0.0 110.44 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.0 t -113.33 123.44 68.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.491 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.07 153.13 43.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.778 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.22 121.36 40.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.366 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.485 HD12 ' N ' ' A' ' 67' ' ' ILE . 1.9 mp -98.81 131.2 46.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.766 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.3 t -129.62 119.2 23.18 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.019 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.6 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 2.6 p90 -142.23 171.34 14.19 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.631 0.253 . . . . 0.0 110.443 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.636 ' CD1' ' O ' ' A' ' 70' ' ' PHE . 0.6 OUTLIER -87.57 130.68 34.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.492 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 72' ' ' VAL . 33.3 t0 -88.83 139.1 30.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.519 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.557 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 6.2 p -54.56 -25.93 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.805 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.31 8.94 25.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.74 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.5 m 69.6 62.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.523 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.425 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 21.0 tt0 -170.43 92.26 0.48 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.263 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -58.84 139.82 92.47 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.712 2.275 . . . . 0.0 112.342 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -108.23 155.61 20.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.732 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -137.37 125.58 23.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.265 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.5 m -106.69 120.91 58.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.844 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.69 129.05 53.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.385 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.07 13.8 58.47 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.79 128.03 34.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.742 0.306 . . . . 0.0 110.618 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.42 HG12 ' HG ' ' A' ' 84' ' ' LEU . 58.4 t -61.35 -96.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.307 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.507 ' CD1' ' H ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -90.0 158.42 44.44 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.924 0.392 . . . . 0.0 110.453 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.595 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 17.4 Cg_endo -60.41 154.87 50.28 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.992 2.462 . . . . 0.0 112.194 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.9 175.42 6.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.429 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.0 m -113.21 152.35 29.86 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.946 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tp -129.67 151.72 49.96 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.041 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.594 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -112.32 126.0 54.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 0.0 110.898 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.454 HD11 ' HE2' ' A' ' 55' ' ' TYR . 21.5 mt -131.09 132.46 63.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.48 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.85 129.3 56.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.541 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 p -122.61 140.62 52.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.627 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.546 ' O ' ' C ' ' A' ' 94' ' ' ASP . 3.3 p30 -74.89 108.61 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.801 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.546 ' C ' ' O ' ' A' ' 93' ' ' ASN . 1.4 t70 26.39 83.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.642 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 177.59 139.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.549 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.02 125.01 42.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.718 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.1 t -141.38 123.73 14.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.503 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.85 136.0 33.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.499 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.41 148.7 20.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -102.87 115.59 30.89 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.5 tt -130.18 142.07 44.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.892 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 103' ' ' ALA . 69.4 t -136.7 162.64 34.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.224 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.561 ' N ' HG12 ' A' ' 102' ' ' VAL . . . -142.98 144.83 32.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.698 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -120.52 42.75 2.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.401 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -96.32 157.82 21.53 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.408 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 4.9 p30 -79.3 26.79 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.743 0.306 . . . . 0.0 110.536 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.564 ' OG ' ' N ' ' A' ' 108' ' ' ASP . 12.3 t -63.97 -173.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.483 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.564 ' N ' ' OG ' ' A' ' 107' ' ' SER . 12.8 t0 -119.45 -58.85 1.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.778 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.2 t -99.96 98.25 9.03 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.987 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 6.9 mt -117.02 149.37 19.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.74 0.305 . . . . 0.0 110.341 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.9 161.59 26.83 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.592 ' SG ' ' N ' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -118.74 157.55 27.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 110.95 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.719 ' C ' HD12 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -151.3 138.24 19.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.342 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.719 HD12 ' C ' ' A' ' 113' ' ' ARG . 1.7 mp -125.7 125.71 68.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.719 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 p -123.54 129.23 50.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.38 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.2 p -126.53 126.04 68.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.594 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.443 ' OD1' ' SD ' ' A' ' 51' ' ' MET . 4.0 t70 65.13 12.23 7.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.559 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.73 -4.53 84.62 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -96.61 132.43 42.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.861 0.362 . . . . 0.0 110.46 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 120' ' ' VAL . 7.3 p -84.69 125.09 40.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.566 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.9 mmt85 -127.28 -53.99 1.37 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.612 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -119.46 129.17 54.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.502 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -151.59 122.86 7.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.37 118.93 33.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.261 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.3 t -127.46 118.99 51.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.069 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -133.17 116.98 16.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.323 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.23 128.78 40.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.909 0.385 . . . . 0.0 110.859 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.587 ' C ' ' H ' ' A' ' 130' ' ' ASN . 0.8 OUTLIER -157.9 130.35 7.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.381 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 129' ' ' VAL . 74.0 t -63.17 6.27 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.034 0.445 . . . . 0.0 110.163 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.587 ' H ' ' C ' ' A' ' 128' ' ' GLU . 0.7 OUTLIER -167.31 66.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.161 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.751 -179.716 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.44 ' O ' ' CG ' ' A' ' 52' ' ' HIS . 9.7 p-80 -105.96 128.44 53.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.401 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.578 ' CD1' ' O ' ' A' ' 97' ' ' VAL . 1.6 tt -97.01 115.52 27.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.618 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.03 139.53 52.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.642 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.468 ' CE1' HG21 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -121.37 148.52 44.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.243 179.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -156.25 144.01 19.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.932 0.396 . . . . 0.0 111.087 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.597 HG22 ' N ' ' A' ' 58' ' ' PHE . 6.1 mm -115.23 167.47 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.483 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.597 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -140.97 163.87 31.8 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.524 -0.471 . . . . 0.0 111.172 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.62 165.39 37.84 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.584 ' O ' ' OG1' ' A' ' 63' ' ' THR . 71.3 Cg_exo -41.71 166.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.882 2.388 . . . . 0.0 111.985 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -80.14 116.64 3.4 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.723 2.282 . . . . 0.0 112.283 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.08 12.9 62.89 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.584 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -86.22 148.84 25.46 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.46 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 64' ' ' VAL . 11.4 m -112.32 122.69 67.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.549 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.21 143.56 32.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.463 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.75 126.97 40.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.535 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.459 ' H ' HG13 ' A' ' 79' ' ' VAL . 3.7 mp -107.81 126.57 64.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.503 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.4 t -130.71 125.49 34.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.921 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.774 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 31.2 p90 -146.42 169.97 17.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.727 0.299 . . . . 0.0 110.561 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -85.98 119.19 26.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.579 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 73' ' ' ASN . 4.2 t0 -90.97 105.9 18.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.507 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 72' ' ' VAL . 61.6 t -59.1 -5.07 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.659 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.516 ' O ' ' CB ' ' A' ' 74' ' ' SER . 0.3 OUTLIER -77.58 -21.5 52.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.726 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.7 t 159.56 -93.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.715 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.497 ' N ' ' OG ' ' A' ' 74' ' ' SER . 8.1 pt-20 -100.91 148.92 35.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.616 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.29 145.69 49.1 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.759 2.306 . . . . 0.0 112.339 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.774 ' NE2' ' CE1' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -107.69 154.76 21.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.599 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 -132.08 135.08 46.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.579 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.459 HG13 ' H ' ' A' ' 67' ' ' ILE . 1.7 p -116.96 125.51 73.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.59 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -136.87 134.2 36.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.489 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.03 7.66 59.54 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.81 153.26 35.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.733 0.301 . . . . 0.0 110.604 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.805 HG13 ' HG ' ' A' ' 84' ' ' LEU . 3.0 p -90.86 -30.47 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.449 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.805 ' HG ' HG13 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -156.92 154.3 26.14 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 110.733 179.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.569 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 18.7 Cg_endo -61.64 158.47 36.97 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.873 2.382 . . . . 0.0 112.111 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -121.42 -160.13 0.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.54 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.1 t -136.3 138.24 41.52 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.969 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.487 HD23 ' H ' ' A' ' 89' ' ' HIS . 0.5 OUTLIER -128.21 143.45 51.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.728 0.299 . . . . 0.0 110.29 179.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.646 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -105.94 121.07 43.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.771 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.1 mp -121.47 130.63 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.567 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.9 p -112.69 131.61 55.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.495 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.57 157.57 21.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.553 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -52.94 -16.37 1.02 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.418 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -103.37 -115.94 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.538 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -166.33 -56.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.698 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.31 121.77 37.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.576 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.578 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 39.9 t -150.69 160.92 3.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.537 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.527 ' N ' ' CG1' ' A' ' 97' ' ' VAL . 4.8 mtt -121.62 157.45 30.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.408 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -142.96 148.31 20.01 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -102.96 118.28 36.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.796 0.331 . . . . 0.0 110.479 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.468 HG21 ' CE1' ' A' ' 55' ' ' TYR . 14.9 tt -133.19 142.13 42.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.546 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 103' ' ' ALA . 38.5 t -140.68 163.73 22.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.662 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.574 ' N ' HG12 ' A' ' 102' ' ' VAL . . . -138.42 158.68 43.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.408 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -135.64 75.74 1.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.73 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.23 155.23 19.25 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.0 55.2 1.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 110.359 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.649 ' OG ' ' N ' ' A' ' 108' ' ' ASP . 6.3 t -85.48 -167.56 1.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.712 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.649 ' N ' ' OG ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -119.84 -14.21 9.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.594 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.9 t -159.24 125.39 4.44 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.971 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.577 ' O ' ' O ' ' A' ' 126' ' ' SER . 26.1 mt -138.03 158.16 32.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.728 0.299 . . . . 0.0 110.514 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.489 ' N ' ' CG2' ' A' ' 110' ' ' ILE . . . -177.2 156.74 20.93 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.532 ' O ' ' O ' ' A' ' 124' ' ' ARG . 3.8 p -122.57 151.73 41.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.659 0.266 . . . . 0.0 110.449 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -160.01 148.22 16.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.663 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.68 123.22 56.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.802 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 72.5 p -119.16 136.53 54.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.333 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.417 ' C ' ' H ' ' A' ' 118' ' ' GLY . 84.9 t -132.44 149.09 31.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.792 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 55.39 8.88 0.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.58 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 116' ' ' VAL . . . 79.81 11.02 85.07 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -116.8 135.24 53.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.769 0.319 . . . . 0.0 110.546 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 71.9 t -70.08 120.57 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.616 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.424 ' NH1' ' HB3' ' A' ' 121' ' ' ARG . 4.0 mtp-105 -116.53 -72.26 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.655 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.22 134.92 46.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.676 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -149.65 157.19 43.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.489 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.532 ' O ' ' O ' ' A' ' 112' ' ' CYS . 7.5 ttt85 -123.52 130.14 52.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.646 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 54.6 t -114.03 118.52 58.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.527 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.577 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.7 OUTLIER -132.77 121.93 23.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.509 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -106.34 129.63 54.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.7 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 131' ' ' ALA . 3.9 mt-10 -157.35 133.88 9.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.496 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' A' ' 130' ' ' ASN . 4.2 m -82.64 135.88 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.433 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 107' ' ' SER . 1.7 m-80 36.26 53.36 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.443 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . . . . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.722 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 30.8 mtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -110.95 123.68 50.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.326 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.661 ' C ' HD23 ' A' ' 53' ' ' LEU . 6.9 tt -95.84 114.58 26.33 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.286 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.423 ' N ' HD23 ' A' ' 53' ' ' LEU . 10.7 p -127.34 132.85 50.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.771 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 13.0 p90 -123.69 148.17 46.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.373 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.53 149.48 23.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.658 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.555 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -109.19 175.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.104 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -139.96 147.67 40.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.724 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.32 157.97 29.64 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -42.19 161.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.88 2.386 . . . . 0.0 112.164 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.41 122.77 7.21 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.933 2.422 . . . . 0.0 112.293 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.43 11.18 59.85 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.5 m -83.28 130.81 35.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 0.0 110.549 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -113.94 121.73 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.577 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.42 155.73 44.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.661 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -95.44 115.8 27.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.105 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.453 HD12 ' H ' ' A' ' 67' ' ' ILE . 3.3 mp -99.95 134.72 38.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.739 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.5 t -135.58 132.39 37.11 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.974 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 77' ' ' GLN . 24.1 p90 -145.31 164.7 30.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.766 0.317 . . . . 0.0 110.531 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.14 135.44 33.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.484 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -98.65 152.38 19.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.588 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 p -63.84 -31.23 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.549 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.629 ' O ' ' CB ' ' A' ' 74' ' ' SER . 18.3 m-20 -75.78 2.84 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.494 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.629 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.0 OUTLIER 91.34 -52.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.281 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -60.0 113.98 8.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.13 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -74.5 141.28 28.03 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.245 1.964 . . . . 0.0 112.25 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 69' ' ' TYR . 24.5 tt0 -107.14 145.61 32.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.621 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -139.4 130.45 26.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.536 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.8 t -105.05 123.22 59.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.549 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 81' ' ' GLY . 19.5 t0 -121.96 134.71 54.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.675 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.488 ' N ' ' OD1' ' A' ' 80' ' ' ASP . . . 94.17 18.35 36.93 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.31 128.53 35.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.761 0.315 . . . . 0.0 110.563 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.818 HG13 ' HG ' ' A' ' 84' ' ' LEU . 2.2 p -76.78 -14.63 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.519 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.818 ' HG ' HG13 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -159.72 155.96 23.69 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.562 179.664 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.555 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 11.7 Cg_endo -57.08 152.95 41.39 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.989 2.46 . . . . 0.0 112.273 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.64 162.17 18.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.413 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 72.6 m -110.29 139.13 45.77 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.988 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 tp -130.41 140.46 50.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.767 0.318 . . . . 0.0 110.438 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.529 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 1.0 OUTLIER -110.73 119.27 38.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.621 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 64.0 mt -129.07 130.02 68.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.324 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.61 123.66 47.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.864 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.62 ' C ' ' H ' ' A' ' 94' ' ' ASP . 0.2 OUTLIER -99.35 153.34 19.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.247 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -60.31 7.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.621 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.62 ' H ' ' C ' ' A' ' 92' ' ' THR . 11.1 t0 -123.26 -103.28 0.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.489 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 168.81 -56.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.686 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -88.55 114.65 25.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.548 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.408 ' O ' HD11 ' A' ' 53' ' ' LEU . 13.8 p -168.47 144.74 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.936 0.398 . . . . 0.0 110.835 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -121.13 143.21 49.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.354 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.595 ' C ' HD22 ' A' ' 100' ' ' ASN . . . -111.09 162.6 12.43 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.595 HD22 ' C ' ' A' ' 99' ' ' GLY . 1.0 OUTLIER -104.89 117.94 35.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.754 0.311 . . . . 0.0 110.519 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 101' ' ' ILE . 13.2 tt -131.18 131.75 63.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.698 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.15 147.61 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.483 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -128.8 138.38 52.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.662 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -122.56 73.17 1.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.452 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.73 163.37 20.67 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.62 ' OD1' ' ND2' ' A' ' 130' ' ' ASN . 24.9 t30 -84.0 37.89 0.62 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.749 0.309 . . . . 0.0 110.767 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.74 ' OG ' HD11 ' A' ' 110' ' ' ILE . 4.5 p -70.23 -177.68 1.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.531 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.49 -40.13 5.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.632 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.5 t -137.0 115.91 12.28 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.981 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.74 HD11 ' OG ' ' A' ' 107' ' ' SER . 10.3 mt -117.55 159.82 17.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.844 0.354 . . . . 0.0 110.529 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.547 ' N ' HG22 ' A' ' 110' ' ' ILE . . . 174.8 149.24 7.08 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.524 ' O ' ' O ' ' A' ' 124' ' ' ARG . 11.7 p -117.92 151.88 36.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.735 0.302 . . . . 0.0 110.587 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -154.31 154.85 34.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.507 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.639 ' O ' HG23 ' A' ' 120' ' ' VAL . 4.0 mp -137.54 124.4 28.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.581 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.3 p -122.35 141.17 51.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.686 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 119' ' ' LYS . 15.6 m -146.0 149.27 16.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.521 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 t0 49.41 17.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.639 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.411 ' N ' ' C ' ' A' ' 116' ' ' VAL . . . 84.87 -9.59 65.32 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 116' ' ' VAL . 15.9 mttm -112.07 124.72 53.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 0.0 110.539 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 114' ' ' ILE . 6.1 p -82.24 124.65 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.575 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -94.27 -34.91 12.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.531 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -141.05 141.28 34.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.505 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -148.99 122.47 9.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.783 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.524 ' O ' ' O ' ' A' ' 112' ' ' CYS . 27.2 mtt85 -127.29 115.87 19.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.205 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.25 118.23 54.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.001 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.9 OUTLIER -120.1 118.57 30.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.153 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.491 ' O ' ' OE1' ' A' ' 128' ' ' GLU . 2.7 m120 -94.23 129.9 40.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.842 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 131' ' ' ALA . 0.3 OUTLIER -151.21 136.55 17.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.383 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 52.2 t -95.98 128.61 47.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.779 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.62 ' ND2' ' OD1' ' A' ' 106' ' ' ASN . 7.8 m120 60.89 35.75 19.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.911 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.597 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . . . . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.338 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -102.48 120.0 39.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.453 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.835 ' C ' HD23 ' A' ' 53' ' ' LEU . 5.9 tt -96.19 115.87 28.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.743 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.627 ' N ' HD23 ' A' ' 53' ' ' LEU . 1.1 t -126.71 132.55 51.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.348 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -120.08 149.75 41.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.849 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.424 ' OE1' ' CD2' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -155.66 141.76 18.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.671 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.563 HD11 HG21 ' A' ' 101' ' ' ILE . 4.5 mp -112.12 157.76 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.188 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.656 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -133.07 170.83 14.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.98 0.419 . . . . 0.0 111.047 -179.606 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.24 179.97 39.99 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -47.44 158.66 0.58 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.648 2.232 . . . . 0.0 112.062 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.0 110.95 3.05 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.77 2.313 . . . . 0.0 112.159 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.51 8.91 57.1 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -85.2 141.19 30.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.742 0.306 . . . . 0.0 110.527 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.45 130.67 59.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.307 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -135.67 155.7 50.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.637 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.599 ' OD2' ' NE2' ' A' ' 104' ' ' GLN . 11.6 p-10 -97.96 127.6 44.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.445 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.69 HG23 HD11 ' A' ' 101' ' ' ILE . 3.4 mp -99.31 120.73 49.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.638 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.1 t -135.65 117.04 14.67 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.987 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -143.83 171.11 14.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.768 0.318 . . . . 0.0 110.431 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -83.96 128.25 34.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.551 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' A' ' 72' ' ' VAL . 15.3 t0 -91.3 142.9 27.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.607 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.567 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 1.0 OUTLIER -63.68 -25.03 37.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.554 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.427 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 0.9 OUTLIER -96.36 11.43 34.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.454 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 70.26 15.75 7.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.345 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 71' ' ' ASP . 1.9 tt0 -118.52 93.03 44.99 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.295 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -77.43 139.64 18.59 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.463 2.109 . . . . 0.0 112.333 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.435 ' HG2' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -107.67 143.34 36.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.572 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.435 ' N ' ' HG2' ' A' ' 77' ' ' GLN . 14.4 mtp-105 -139.65 125.35 19.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.536 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.7 m -107.66 134.5 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.621 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.632 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -104.91 142.46 34.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.451 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.54 31.81 81.03 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.52 131.26 34.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.842 0.353 . . . . 0.0 110.524 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.418 ' H ' HG12 ' A' ' 83' ' ' VAL . 1.8 p -87.05 113.5 24.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.514 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tp 60.51 118.34 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.462 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -55.24 160.96 7.62 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.953 1.769 . . . . 0.0 111.844 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.584 ' CD1' ' C ' ' A' ' 86' ' ' TRP . 0.1 OUTLIER -112.14 -172.69 2.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.655 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 92.1 p -111.19 155.46 22.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 89' ' ' HIS . 6.3 tp -140.25 143.77 36.13 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.495 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.573 ' N ' ' CD2' ' A' ' 89' ' ' HIS . 0.2 OUTLIER -107.6 128.1 54.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.765 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.5 mt -125.55 130.83 72.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.487 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -122.95 122.76 39.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.747 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.553 ' O ' ' C ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -117.58 156.82 27.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.465 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.553 ' C ' ' O ' ' A' ' 92' ' ' THR . 4.4 m-20 -24.15 -60.13 0.05 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.841 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.447 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 0.3 OUTLIER 165.51 92.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.546 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -175.33 133.94 0.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.53 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.55 116.17 15.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.614 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.5 p -139.26 138.26 40.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.426 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.42 165.26 12.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.684 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -127.45 144.24 14.96 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -103.46 119.77 39.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.75 0.31 . . . . 0.0 110.736 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.69 HD11 HG23 ' A' ' 67' ' ' ILE . 7.5 tt -133.02 136.63 55.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.698 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.0 t -127.85 149.34 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.308 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -120.8 148.63 43.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 0.0 110.76 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.599 ' NE2' ' OD2' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -119.32 51.38 1.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.576 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -112.16 159.47 13.7 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -81.95 62.23 5.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.771 0.319 . . . . 0.0 110.62 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.444 ' OG ' ' CD1' ' A' ' 110' ' ' ILE . 77.4 p -93.95 -172.84 2.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.504 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 109' ' ' SER . 26.6 m-20 -131.65 20.78 4.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.619 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 87.8 p 177.4 91.42 0.01 OUTLIER 'General case' 0 C--O 1.244 0.787 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.983 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.567 ' O ' ' O ' ' A' ' 126' ' ' SER . 12.0 mt -115.96 128.43 73.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 120.772 0.32 . . . . 0.0 110.325 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -152.48 173.34 31.56 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -119.9 165.14 15.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.713 0.292 . . . . 0.0 110.475 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.656 ' NH1' ' OE1' ' A' ' 123' ' ' GLU . 5.6 ttm-85 -154.46 139.49 17.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.588 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.423 ' H ' ' HB3' ' A' ' 123' ' ' GLU . 4.4 mm -134.07 114.02 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.517 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.7 m -117.93 138.0 52.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.656 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 119' ' ' LYS . 30.4 m -140.62 148.78 21.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.732 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.425 ' C ' ' H ' ' A' ' 119' ' ' LYS . 34.1 m-20 44.97 26.57 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.73 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.99 -9.66 5.04 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 116' ' ' VAL . 14.1 mttp -106.28 127.37 53.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.751 0.31 . . . . 0.0 110.363 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.76 130.95 32.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.929 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -105.85 -67.78 0.91 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.419 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -150.47 132.33 15.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.364 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.656 ' OE1' ' NH1' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -150.67 146.88 26.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.585 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -109.74 121.77 45.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.576 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.63 ' O ' HG23 ' A' ' 125' ' ' VAL . 16.3 m -114.54 118.24 58.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.546 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.567 ' O ' ' O ' ' A' ' 110' ' ' ILE . 24.3 p -124.37 117.62 24.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.513 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' A' ' 127' ' ' ASN . 0.8 OUTLIER -99.57 129.85 45.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.414 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.05 145.09 21.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.681 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.402 ' H ' HG13 ' A' ' 129' ' ' VAL . 2.2 m -70.3 -17.8 21.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.625 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -167.55 98.57 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.407 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.422 -179.922 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 27.3 mmm . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -110.18 123.12 49.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.45 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.757 ' C ' HD23 ' A' ' 53' ' ' LEU . 5.8 tt -95.79 115.79 27.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.214 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.657 ' N ' HD23 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -126.33 139.52 53.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.704 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -119.82 149.83 41.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.018 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.79 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 0.3 OUTLIER -154.44 134.75 13.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.983 0.421 . . . . 0.0 110.954 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.572 HG22 ' H ' ' A' ' 58' ' ' PHE . 4.5 mm -97.76 170.32 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.587 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.572 ' H ' HG22 ' A' ' 57' ' ' ILE . 4.9 t80 -142.6 154.38 44.36 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.782 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.498 ' N ' ' CD1' ' A' ' 58' ' ' PHE . . . -168.48 173.97 43.19 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.559 ' C ' ' HG1' ' A' ' 63' ' ' THR . 1.3 Cg_endo -47.02 167.79 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 122.793 2.328 . . . . 0.0 111.936 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.33 117.63 5.18 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.857 2.371 . . . . 0.0 112.265 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.2 18.21 67.52 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.559 ' HG1' ' C ' ' A' ' 60' ' ' PRO . 4.0 m -72.31 132.0 43.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.807 0.337 . . . . 0.0 110.607 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 64' ' ' VAL . 5.2 m -108.03 122.93 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.578 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -141.34 155.92 45.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.295 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.45 126.98 42.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.621 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.607 HG23 HD11 ' A' ' 101' ' ' ILE . 2.6 mp -108.3 136.68 43.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.582 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.4 t -134.33 116.84 15.71 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.973 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.533 ' CG ' ' N ' ' A' ' 70' ' ' PHE . 50.5 t80 -143.96 165.08 28.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.753 0.311 . . . . 0.0 110.508 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.533 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 29.4 t80 -84.89 120.37 26.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.608 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -84.69 135.5 34.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.559 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.7 p -70.04 -15.25 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.69 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.643 ' O ' ' CB ' ' A' ' 74' ' ' SER . 3.9 t30 -78.81 -21.99 46.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.698 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.643 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 2.0 t 149.79 -104.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.567 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.617 ' N ' ' OG ' ' A' ' 74' ' ' SER . 0.4 OUTLIER -62.78 152.92 81.09 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.756 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -72.09 145.41 44.39 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.877 2.385 . . . . 0.0 112.289 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -102.74 144.48 31.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.32 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -144.87 138.37 26.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.952 0.406 . . . . 0.0 110.963 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.8 m -115.39 131.86 66.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.209 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.67 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -121.45 149.31 43.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.922 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 61.69 -6.59 0.21 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.551 ' H ' ' C ' ' A' ' 80' ' ' ASP . . . -63.94 134.42 55.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 0.0 110.573 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.536 ' O ' ' C ' ' A' ' 84' ' ' LEU . 3.6 m -47.5 -176.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.55 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.639 ' N ' HD23 ' A' ' 84' ' ' LEU . 1.8 pt? -28.46 148.04 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.62 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -56.15 146.51 70.47 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.757 2.305 . . . . 0.0 112.233 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -112.29 -166.52 1.09 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.556 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.79 ' OG ' ' HB2' ' A' ' 56' ' ' GLU . 59.2 m -117.85 165.1 14.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.959 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.59 HD23 ' H ' ' A' ' 89' ' ' HIS . 0.4 OUTLIER -135.79 155.19 50.74 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.627 178.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.59 ' H ' HD23 ' A' ' 88' ' ' LEU . 7.4 m80 -114.12 124.34 51.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.598 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.513 HD13 ' O ' ' A' ' 89' ' ' HIS . 3.0 mm -129.57 124.72 60.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.445 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 p -119.38 128.46 54.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.562 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.66 133.59 48.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.585 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -61.06 -7.3 2.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.618 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 45.0 t0 -73.51 -95.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.656 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 177.07 -92.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.234 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.68 121.31 29.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.319 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.86 155.75 37.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.785 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.78 146.32 52.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.263 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -130.89 162.12 23.47 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.12 114.64 22.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.707 0.289 . . . . 0.0 110.356 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.607 HD11 HG23 ' A' ' 67' ' ' ILE . 1.1 tt -133.33 140.38 47.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.706 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.6 p -142.21 146.8 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.584 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -129.85 144.32 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.664 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -125.7 76.84 1.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.498 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.96 160.9 13.26 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.555 ' O ' ' O ' ' A' ' 107' ' ' SER . 1.4 m-20 -79.47 13.58 1.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.743 0.306 . . . . 0.0 110.494 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.555 ' O ' ' O ' ' A' ' 106' ' ' ASN . 25.3 p -48.54 -170.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.578 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -104.35 -15.03 15.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.553 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.0 t -168.78 122.36 0.84 Allowed 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.982 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 126' ' ' SER . 11.2 mt -125.93 138.62 53.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.724 0.297 . . . . 0.0 110.49 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.7 160.38 31.01 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 31.8 p -118.52 155.08 31.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 0.0 110.678 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.31 144.51 22.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.662 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.641 ' CG2' HD11 ' A' ' 53' ' ' LEU . 2.3 mt -138.31 114.95 10.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.389 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.71 140.78 49.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.723 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.7 p -145.76 150.09 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.476 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.6 10.99 2.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.483 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 83.64 -3.48 85.07 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.453 ' HB3' ' NH2' ' A' ' 121' ' ' ARG . 13.8 tptm -121.21 137.33 54.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.775 0.321 . . . . 0.0 110.569 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.452 ' H ' HG13 ' A' ' 120' ' ' VAL . 1.2 m -73.96 143.77 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.539 ' HE ' ' CA ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -111.7 -60.09 1.9 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.383 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.5 126.94 5.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.249 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -151.69 129.33 11.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.83 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.484 ' HA ' ' HE ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -98.02 115.71 28.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.326 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 74.2 t -114.99 117.55 56.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.687 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 110' ' ' ILE . 16.6 m -131.88 132.61 43.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.621 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.28 138.17 32.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.24 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -150.21 130.76 13.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.934 0.397 . . . . 0.0 110.831 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.629 HG12 ' OD1' ' A' ' 130' ' ' ASN . 2.0 t -93.71 122.03 44.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.432 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.629 ' OD1' HG12 ' A' ' 129' ' ' VAL . 0.4 OUTLIER 70.9 39.86 0.99 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.685 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.362 179.874 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.5 mtp . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -91.1 128.15 36.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.22 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 97' ' ' VAL . 35.7 tp -97.5 114.9 26.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.814 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.4 t -127.78 133.41 49.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.533 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.572 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -121.8 149.47 43.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 0.0 110.461 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.736 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -155.52 143.66 20.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.808 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.6 HG22 ' N ' ' A' ' 58' ' ' PHE . 42.9 mm -111.22 167.81 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.917 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.6 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -129.42 173.57 10.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.013 0.435 . . . . 0.0 110.989 -179.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.47 157.57 10.4 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -43.64 155.58 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.495 2.13 . . . . 0.0 112.034 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -66.94 117.9 5.14 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.844 2.363 . . . . 0.0 112.27 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.85 3.78 58.04 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.866 HG23 HD21 ' A' ' 106' ' ' ASN . 98.9 m -86.77 139.94 30.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 0.0 110.739 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.464 HG11 ' HA2' ' A' ' 81' ' ' GLY . 2.4 m -106.78 131.41 56.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.389 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.94 149.34 50.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.649 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 104' ' ' GLN . 0.0 OUTLIER -99.14 121.8 41.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.44 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.524 HD12 ' N ' ' A' ' 67' ' ' ILE . 2.1 mp -108.14 125.78 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.566 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.5 t -127.62 116.26 20.05 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.032 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -151.38 170.85 18.54 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.806 0.336 . . . . 0.0 110.636 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.486 ' CE1' ' O ' ' A' ' 71' ' ' ASP . 52.1 t80 -84.19 133.11 34.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.737 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.486 ' O ' ' CE1' ' A' ' 70' ' ' PHE . 21.1 t0 -104.44 149.6 25.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.555 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.82 -33.76 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.684 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -80.47 11.35 3.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.632 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.58 47.55 10.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.503 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.421 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 66.8 mt-10 -149.38 96.8 3.62 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.45 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.25 139.61 90.89 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.453 2.102 . . . . 0.0 111.893 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 67' ' ' ILE . 11.9 mt-30 -107.84 132.09 53.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.755 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 -131.84 129.39 40.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.345 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.7 m -120.3 136.64 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.857 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.9 143.62 51.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.343 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.464 ' HA2' HG11 ' A' ' 64' ' ' VAL . . . 58.95 13.61 20.07 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.21 147.53 31.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.758 0.314 . . . . 0.0 110.642 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.565 ' O ' ' O ' ' A' ' 84' ' ' LEU . 4.1 p -52.25 165.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.424 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.565 ' O ' ' O ' ' A' ' 83' ' ' VAL . 0.3 OUTLIER -27.49 149.46 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.941 0.4 . . . . 0.0 110.813 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.59 141.01 94.11 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.902 2.401 . . . . 0.0 112.251 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -113.17 -168.88 1.39 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.547 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.736 ' OG ' ' HB2' ' A' ' 56' ' ' GLU . 59.6 m -115.34 155.44 27.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.008 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.405 ' C ' ' ND1' ' A' ' 89' ' ' HIS . 0.7 OUTLIER -135.21 151.24 50.44 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.22 178.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.759 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -125.61 127.35 46.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.006 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mt -130.81 134.58 61.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.343 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 m -120.96 131.5 54.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.498 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.542 ' O ' ' C ' ' A' ' 93' ' ' ASN . 91.8 m -117.14 135.06 54.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.529 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.542 ' C ' ' O ' ' A' ' 92' ' ' THR . 73.0 m-80 28.05 -93.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.641 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 92' ' ' THR . 11.1 t70 -172.33 76.25 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.688 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -171.62 167.09 6.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.6 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.648 ' HB1' HG21 ' A' ' 116' ' ' VAL . . . -69.67 151.1 46.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.293 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.411 ' O ' HD13 ' A' ' 53' ' ' LEU . 93.0 t -153.12 151.21 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.0 0.428 . . . . 0.0 110.937 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -120.05 173.25 7.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.891 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.4 142.76 8.55 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.587 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -104.11 116.38 32.11 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.28 140.29 48.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.98 0.419 . . . . 0.0 111.039 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.1 148.99 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.263 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.412 ' O ' HG21 ' A' ' 110' ' ' ILE . . . -135.83 135.02 39.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 110.696 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.418 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 7.6 mt-30 -127.77 83.95 2.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.608 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.62 163.91 14.92 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.866 HD21 HG23 ' A' ' 63' ' ' THR . 0.0 OUTLIER -78.71 49.6 0.91 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.854 0.359 . . . . 0.0 110.418 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.48 ' OG ' ' N ' ' A' ' 108' ' ' ASP . 28.9 t -92.94 -172.37 2.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.515 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.48 ' N ' ' OG ' ' A' ' 107' ' ' SER . 4.8 m-20 -97.62 -38.35 9.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.535 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.539 ' HB2' HD21 ' A' ' 127' ' ' ASN . 44.2 t -141.01 112.04 7.2 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.987 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 126' ' ' SER . 5.4 mt -112.63 123.02 67.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.856 0.36 . . . . 0.0 110.677 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -150.51 173.5 30.1 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 11.8 p -127.9 165.98 19.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.743 0.306 . . . . 0.0 110.494 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 113' ' ' ARG . 18.4 mtm-85 -151.32 144.04 24.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.489 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.4 mm -127.79 115.97 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.568 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 81.8 p -122.0 122.01 38.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.465 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.648 HG21 ' HB1' ' A' ' 96' ' ' ALA . 3.5 p -145.65 150.86 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.764 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.9 t70 58.54 16.86 4.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.647 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.91 -1.6 10.03 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -117.52 137.86 52.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.596 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.413 ' O ' ' CG1' ' A' ' 120' ' ' VAL . 2.0 p -78.75 132.28 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.615 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.4 mtm-85 -123.46 -47.03 2.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.711 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -145.09 128.82 17.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.783 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -149.73 128.39 12.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.414 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.443 ' HG2' HH11 ' A' ' 124' ' ' ARG . 5.3 tpp85 -116.24 116.29 27.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.71 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.2 122.53 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.358 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 110' ' ' ILE . 65.6 m -126.53 124.63 40.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.733 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.539 HD21 ' HB2' ' A' ' 109' ' ' SER . 0.1 OUTLIER -95.65 131.61 41.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.465 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 108' ' ' ASP . 78.2 tt0 -153.73 134.2 13.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.572 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.4 t -93.13 123.39 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.549 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.72 44.77 10.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.46 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.463 -179.903 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.2 mmt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -114.91 125.33 53.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.546 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.66 117.24 34.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.397 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 t -126.2 142.13 51.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.009 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.63 148.49 43.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.023 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.474 ' C ' ' CD ' ' A' ' 56' ' ' GLU . 8.0 tm-20 -156.48 134.42 11.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.868 0.366 . . . . 0.0 111.047 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.63 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 9.7 tt -116.53 139.07 44.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.943 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.88 172.3 10.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.748 0.308 . . . . 0.0 110.766 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.41 -81.97 0.2 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.46 109.34 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.896 2.397 . . . . 0.0 111.97 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.8 96.39 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.531 2.154 . . . . 0.0 111.896 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.28 -16.7 16.02 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.05 152.0 46.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.766 0.317 . . . . 0.0 110.401 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 64' ' ' VAL . 17.0 m -101.21 123.58 54.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.818 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.21 155.54 46.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.335 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -95.29 121.9 37.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.75 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.52 138.0 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.333 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.2 t -134.15 125.96 29.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.965 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.601 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 12.6 t80 -137.45 152.74 49.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.848 0.356 . . . . 0.0 110.603 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.601 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 83.9 t80 -83.58 126.5 32.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.649 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.09 154.06 22.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.536 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.0 p -72.34 -32.03 40.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.799 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.58 ' O ' ' CB ' ' A' ' 74' ' ' SER . 1.8 p-10 -81.63 -7.4 59.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.945 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.58 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.5 t 86.58 86.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.822 0.344 . . . . 0.0 110.373 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 171.24 92.55 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.323 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -59.4 139.97 92.1 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.716 2.277 . . . . 0.0 112.147 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -106.06 140.56 38.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.417 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.8 ttp-105 -141.48 132.49 26.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.679 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.1 m -123.26 129.17 75.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.469 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -119.62 127.74 53.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.736 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.55 13.05 79.22 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.7 137.02 33.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 0.0 110.608 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.584 ' O ' ' O ' ' A' ' 84' ' ' LEU . 4.2 m -59.48 -167.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.442 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.584 ' O ' ' O ' ' A' ' 83' ' ' VAL . 0.3 OUTLIER -32.22 156.94 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.533 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.63 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 10.7 Cg_endo -56.84 159.43 14.38 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 123.006 2.471 . . . . 0.0 112.301 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -125.09 -164.23 1.27 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.531 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 99.1 p -135.43 153.78 51.67 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.962 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.2 mp -129.7 155.43 45.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.715 0.293 . . . . 0.0 110.583 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -109.84 120.23 41.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.636 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.6 mt -128.75 133.64 65.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.526 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.8 p -118.21 124.34 47.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.463 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.45 ' C ' ' H ' ' A' ' 94' ' ' ASP . 3.1 m -116.25 135.19 54.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.628 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -72.64 39.83 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.58 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 92' ' ' THR . 33.2 t0 -122.16 -97.15 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.616 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 176.28 -78.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.582 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -102.14 125.57 48.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.404 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 98' ' ' MET . 93.5 t -148.63 155.58 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.419 . . . . 0.0 110.827 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.464 ' N ' HG12 ' A' ' 97' ' ' VAL . 7.8 mtt -127.59 179.25 5.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.315 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -158.87 153.79 24.9 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -113.07 121.84 45.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.748 0.309 . . . . 0.0 110.355 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.49 ' O ' HG23 ' A' ' 101' ' ' ILE . 9.7 tt -133.13 128.93 56.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.711 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.9 t -127.15 145.22 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.41 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.484 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -127.74 156.74 41.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.704 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -119.43 66.45 0.8 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.579 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 131' ' ' ALA . . . -119.1 157.93 15.12 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -93.45 83.01 4.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.808 0.337 . . . . 0.0 110.595 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.7 p -115.56 -166.93 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.406 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -124.55 10.2 8.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.593 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.5 p -170.72 105.0 0.26 Allowed 'General case' 0 C--O 1.242 0.71 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.867 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.55 ' O ' ' O ' ' A' ' 126' ' ' SER . 5.4 tt -132.09 136.63 56.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 120.683 0.278 . . . . 0.0 110.378 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.55 176.77 41.03 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 32.0 m -120.46 149.55 42.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.793 0.33 . . . . 0.0 110.391 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.413 ' HB3' ' NH1' ' A' ' 113' ' ' ARG . 19.2 mtp-105 -144.37 146.19 32.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.754 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.41 122.97 58.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.236 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 115' ' ' THR . 9.1 t -118.36 126.12 51.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.954 0.407 . . . . 0.0 110.787 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.9 p -136.48 138.99 46.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.333 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.2 t0 48.1 22.99 0.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.525 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.9 -7.42 9.53 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.6 mttp -99.84 133.08 44.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.871 0.367 . . . . 0.0 110.651 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 p -67.36 141.34 17.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.418 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -118.02 -75.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.588 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -150.67 128.55 11.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.481 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -150.95 160.17 44.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.611 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -121.05 124.67 45.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.561 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.33 117.28 52.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.57 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.55 ' O ' ' O ' ' A' ' 110' ' ' ILE . 48.1 p -132.22 120.94 22.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.583 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.804 HD22 ' H ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -100.18 129.88 46.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.505 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.45 162.12 31.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.463 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.6 p -102.31 -8.49 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.561 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 130' ' ' ASN . 21.8 p30 -164.83 63.24 0.13 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.499 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 105' ' ' GLY . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.528 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.449 ' N ' ' HA ' ' A' ' 117' ' ' ASP . 4.6 ttt . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.92 128.82 56.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.293 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.836 HD13 ' C ' ' A' ' 53' ' ' LEU . 3.1 tm? -95.72 115.27 27.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 0.0 110.203 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.604 ' N ' HD13 ' A' ' 53' ' ' LEU . 18.6 p -127.33 131.99 50.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.583 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -125.84 149.48 48.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.218 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -155.5 142.42 19.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.918 0.39 . . . . 0.0 110.845 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.588 HG22 ' N ' ' A' ' 58' ' ' PHE . 48.1 mm -109.6 165.78 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.187 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.69 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -143.77 149.34 36.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.9 0.381 . . . . 0.0 110.349 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.45 163.34 33.94 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -41.68 145.82 0.62 Allowed 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.685 2.257 . . . . 0.0 111.724 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.53 115.96 3.99 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.636 2.224 . . . . 0.0 112.294 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.35 2.66 50.84 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.56 ' O ' ' O ' ' A' ' 83' ' ' VAL . 7.9 m -86.54 141.21 29.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.788 0.327 . . . . 0.0 110.949 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 64' ' ' VAL . 35.2 m -104.25 127.16 58.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.202 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.67 154.7 48.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.913 0.387 . . . . 0.0 110.889 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -107.81 121.54 44.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.578 HG23 HD11 ' A' ' 101' ' ' ILE . 42.7 mt -108.52 131.59 58.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.744 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.3 t -134.75 119.72 18.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.026 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.464 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 69.6 t80 -132.19 162.17 31.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.831 0.348 . . . . 0.0 110.724 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.464 ' O ' ' CE2' ' A' ' 69' ' ' TYR . 51.2 t80 -88.89 126.4 35.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.662 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -84.46 141.29 30.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.44 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.19 -23.94 29.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.712 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.629 ' O ' ' CB ' ' A' ' 74' ' ' SER . 7.2 t-20 -85.0 -13.35 50.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.762 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.629 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 6.0 p 92.18 15.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.64 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -125.08 78.89 66.18 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.411 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.3 139.06 20.67 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.507 2.138 . . . . 0.0 112.454 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -108.46 158.61 17.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.146 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -130.36 136.97 49.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.869 0.366 . . . . 0.0 110.83 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.602 ' O ' HG13 ' A' ' 79' ' ' VAL . 14.7 p -119.28 118.13 56.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.18 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.16 136.16 54.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.585 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.44 7.95 61.5 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.87 139.0 55.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.748 0.308 . . . . 0.0 110.562 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.56 ' O ' ' O ' ' A' ' 63' ' ' THR . 2.1 t -70.94 -53.1 22.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.293 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.87 154.13 80.25 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.609 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -66.24 155.08 71.59 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 122.91 2.407 . . . . 0.0 112.101 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.553 ' CG ' ' N ' ' A' ' 87' ' ' SER . 43.1 t-105 -123.54 -161.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.265 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.553 ' N ' ' CG ' ' A' ' 86' ' ' TRP . 99.7 p -139.69 150.82 45.33 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 120.604 0.24 . . . . 0.0 110.993 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.5 tp -128.16 147.06 50.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.219 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.484 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -108.62 120.26 41.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.804 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.0 mt -130.53 128.93 64.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.6 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.5 m -111.06 122.87 48.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.283 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.538 ' O ' ' C ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -124.7 130.62 52.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.816 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.538 ' C ' ' O ' ' A' ' 92' ' ' THR . 1.3 p30 24.31 -120.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.89 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -163.36 88.41 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.469 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -174.44 -159.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.549 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.418 ' HA ' HG11 ' A' ' 116' ' ' VAL . . . -83.57 119.56 24.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.374 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.2 t -114.39 142.19 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.796 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.4 ptp -128.29 166.02 19.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.005 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.94 145.77 12.62 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -116.08 115.11 25.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.349 . . . . 0.0 110.261 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.578 HD11 HG23 ' A' ' 67' ' ' ILE . 1.9 tt -132.41 135.28 58.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.61 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 93.7 t -128.03 150.24 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.463 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -122.81 140.93 52.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.39 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -118.93 77.74 1.21 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.667 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.01 159.66 23.1 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -82.16 46.6 1.04 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.85 0.357 . . . . 0.0 110.497 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.402 ' OG ' HD11 ' A' ' 110' ' ' ILE . 72.4 p -80.01 -174.66 4.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.577 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -124.77 9.97 8.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.59 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.1 t -171.09 122.48 0.57 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.936 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.583 ' O ' ' O ' ' A' ' 126' ' ' SER . 15.6 mt -142.23 152.47 18.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 120.824 0.345 . . . . 0.0 110.404 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.402 ' N ' ' CG2' ' A' ' 110' ' ' ILE . . . -176.59 158.68 25.01 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.648 ' SG ' ' O ' ' A' ' 124' ' ' ARG . 0.5 OUTLIER -118.03 167.76 11.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 0.0 110.674 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.403 ' O ' HD13 ' A' ' 114' ' ' ILE . 21.6 ttm180 -159.39 123.95 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.312 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 113' ' ' ARG . 3.3 mm -125.37 112.61 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.926 0.393 . . . . 0.0 110.782 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.78 135.62 55.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.458 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' A' ' 96' ' ' ALA . 31.0 t -118.79 150.8 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.559 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.449 ' HA ' ' N ' ' A' ' 51' ' ' MET . 37.4 t70 51.88 24.21 2.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.585 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.27 4.99 39.76 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -110.4 138.84 46.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.875 0.369 . . . . 0.0 110.69 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 120' ' ' VAL . 7.4 p -86.17 119.34 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.502 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.5 -35.85 2.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.304 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.81 127.04 5.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.499 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -151.56 145.66 25.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.439 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.648 ' O ' ' SG ' ' A' ' 112' ' ' CYS . 1.8 ttt180 -116.36 123.44 47.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.699 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 125' ' ' VAL . 3.0 p -138.95 116.25 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.619 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.583 ' O ' ' O ' ' A' ' 110' ' ' ILE . 51.4 m -133.81 121.74 22.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.443 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.95 137.32 36.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 110.773 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -155.01 134.02 12.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.333 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.2 t -68.1 129.52 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.559 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 40.32 69.78 0.29 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.402 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.488 -179.919 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 12.4 mtm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -96.86 127.62 43.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.407 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.616 HD13 ' O ' ' A' ' 97' ' ' VAL . 2.1 tt -96.84 115.79 28.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.594 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.93 137.23 53.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.674 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.442 ' OH ' ' CD2' ' A' ' 69' ' ' TYR . 23.8 p90 -120.07 149.56 42.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.979 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.658 ' C ' HD13 ' A' ' 57' ' ' ILE . 26.0 tt0 -155.59 156.03 34.35 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.34 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.857 HD11 HD13 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -115.85 175.74 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.956 179.296 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.63 145.61 36.85 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.028 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -168.66 160.45 33.95 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -43.48 155.59 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.707 2.272 . . . . 0.0 112.147 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.0 114.51 3.41 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.729 2.286 . . . . 0.0 112.053 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.02 15.49 30.72 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.3 m -79.31 139.06 37.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.829 0.347 . . . . 0.0 110.638 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.525 ' O ' HG23 ' A' ' 64' ' ' VAL . 31.2 m -109.76 123.06 65.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.447 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.46 154.22 44.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.786 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.28 115.59 27.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.374 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.467 HG23 HD11 ' A' ' 101' ' ' ILE . 5.3 mm -102.05 121.59 53.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.587 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.3 t -135.59 120.3 18.36 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.916 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.442 ' CD2' ' OH ' ' A' ' 55' ' ' TYR . 22.7 p90 -141.26 158.05 44.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.869 0.366 . . . . 0.0 110.7 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -83.5 136.57 34.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.27 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.18 137.71 41.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.579 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.8 t -62.34 -18.69 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.4 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.515 ' O ' ' OG ' ' A' ' 74' ' ' SER . 3.0 m-20 -89.31 -0.19 57.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.696 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' A' ' 73' ' ' ASN . 7.9 p 73.44 40.82 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.573 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -154.05 91.35 3.17 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.48 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.94 141.55 15.06 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.749 2.299 . . . . 0.0 112.315 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -107.24 147.97 29.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.478 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.421 ' NH1' ' HG3' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -135.91 133.09 37.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.676 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.7 t -112.88 118.87 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.66 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.1 116.61 32.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.376 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.27 20.87 16.56 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.43 153.86 25.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.368 . . . . 0.0 110.617 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.18 -39.49 8.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.374 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.63 152.48 28.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.5 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.485 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 19.8 Cg_endo -61.42 150.45 85.0 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.943 2.429 . . . . 0.0 112.363 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -128.75 -172.45 2.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.458 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.637 ' C ' HD12 ' A' ' 88' ' ' LEU . 97.3 p -127.81 155.04 44.72 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.041 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.637 HD12 ' C ' ' A' ' 87' ' ' SER . 6.8 mp -130.99 148.19 52.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.859 0.361 . . . . 0.0 110.942 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' A' ' 89' ' ' HIS . 6.5 p80 -110.16 124.23 51.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.017 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.9 mt -129.01 134.79 63.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.926 0.394 . . . . 0.0 110.932 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.17 122.95 46.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.322 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.591 ' O ' ' N ' ' A' ' 94' ' ' ASP . 2.2 m -126.96 128.16 45.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.768 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.526 ' C ' ' O ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -29.2 -37.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.555 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 92' ' ' THR . 1.6 m-20 -66.03 -135.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.684 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.45 -35.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.385 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.72 137.45 52.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.558 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.616 ' O ' HD13 ' A' ' 53' ' ' LEU . 21.0 t -150.09 124.28 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.581 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 5.5 mtt -96.55 131.31 43.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.605 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.23 146.79 18.88 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.505 ' O ' ' CG ' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -102.79 116.51 32.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.791 0.329 . . . . 0.0 110.453 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.857 HD13 HD11 ' A' ' 57' ' ' ILE . 17.0 tt -133.12 136.89 54.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.641 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.7 t -139.75 149.29 22.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.433 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -126.77 148.22 49.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.639 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -133.51 46.16 2.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.537 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -99.3 163.81 20.1 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.87 36.58 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.745 0.307 . . . . 0.0 110.535 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.417 ' OG ' HD11 ' A' ' 110' ' ' ILE . 0.8 OUTLIER -65.25 -167.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.646 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -122.78 -25.15 4.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.582 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.8 t -144.5 88.26 1.92 Allowed 'General case' 0 C--O 1.243 0.752 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.026 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.417 HD11 ' OG ' ' A' ' 107' ' ' SER . 6.1 mt -100.6 149.2 6.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 120.833 0.349 . . . . 0.0 110.486 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.84 164.32 29.98 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 9.3 p -125.82 152.87 44.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.78 0.324 . . . . 0.0 110.698 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.06 141.11 24.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.491 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.468 ' CG2' HD11 ' A' ' 53' ' ' LEU . 6.9 mm -115.76 133.01 63.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.717 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.3 p -122.67 121.08 35.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.471 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.97 129.05 75.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.666 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.24 17.29 1.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.404 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 88.1 -8.57 77.87 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -101.45 147.5 26.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.322 . . . . 0.0 110.68 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.29 128.5 37.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.624 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.46 HH11 ' HB3' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -107.66 -65.53 1.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.401 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -149.34 127.28 11.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.042 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.31 130.27 12.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.036 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -111.97 115.6 29.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.918 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.58 124.93 72.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.054 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.4 m -127.6 126.28 41.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.04 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.09 129.22 40.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.008 0.432 . . . . 0.0 110.837 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -157.32 130.57 7.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.231 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.49 116.3 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.452 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.508 ' CG ' ' O ' ' A' ' 130' ' ' ASN . 4.7 t30 59.94 69.72 0.68 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.417 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.596 -179.817 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.405 ' HG3' ' CD2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.405 ' CD2' ' HG3' ' A' ' 51' ' ' MET . 25.4 m-70 -116.0 128.79 56.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.341 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.734 HD12 ' O ' ' A' ' 53' ' ' LEU . 3.3 pp -96.27 120.51 36.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.928 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.58 133.95 50.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.68 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -120.86 149.59 42.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.378 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.756 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 1.8 tm-20 -155.4 144.68 20.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.97 0.414 . . . . 0.0 110.923 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 57' ' ' ILE . 34.6 mm -116.11 153.39 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.11 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -140.22 163.68 32.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.05 0.452 . . . . 0.0 111.04 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.34 171.23 43.49 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.505 ' O ' ' OG1' ' A' ' 63' ' ' THR . 53.9 Cg_exo -46.91 153.43 1.4 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.654 2.236 . . . . 0.0 111.985 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -64.68 119.59 6.66 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.721 2.281 . . . . 0.0 112.039 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.24 5.34 62.21 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 33.0 m -69.37 144.66 53.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 0.0 110.604 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 p -119.49 122.1 68.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.48 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.408 ' HB1' ' HB1' ' A' ' 103' ' ' ALA . . . -143.11 155.31 44.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.705 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.72 115.22 30.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.115 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 mp -90.36 127.7 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.829 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.4 t -128.13 116.06 19.36 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.021 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.512 ' CZ ' ' OD1' ' A' ' 71' ' ' ASP . 2.9 p90 -146.04 148.8 33.07 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.236 0.335 . . . . 0.0 110.413 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -88.13 121.37 30.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.379 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.512 ' OD1' ' CZ ' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -82.93 144.81 29.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.541 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.5 p -55.47 -11.02 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.95 0.405 . . . . 0.0 110.177 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 74' ' ' SER . 35.4 t30 -92.54 -8.97 42.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.417 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.563 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.5 p 85.24 3.74 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.423 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -114.29 95.82 40.51 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.52 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -79.38 139.54 14.68 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.552 2.168 . . . . 0.0 112.072 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -107.93 151.06 26.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -128.82 134.03 48.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.467 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.0 m -105.96 129.43 59.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.587 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 5.8 p-10 -111.98 132.88 54.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.697 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.16 28.65 63.82 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.51 147.63 52.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.799 0.333 . . . . 0.0 110.673 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.0 p -100.3 -30.8 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.503 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tp -170.26 114.76 0.48 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.415 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -55.75 162.25 6.97 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.095 1.863 . . . . 0.0 111.895 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.465 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 7.1 m-90 -126.09 -150.7 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.558 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.756 ' OG ' ' HB2' ' A' ' 56' ' ' GLU . 59.1 m -121.87 165.5 15.81 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.004 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.78 150.18 35.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.783 0.325 . . . . 0.0 110.821 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -110.16 119.54 39.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.375 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.1 mt -126.57 135.53 63.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.627 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.41 123.41 48.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.598 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.55 ' O ' ' C ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -132.3 155.58 48.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.399 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.55 ' C ' ' O ' ' A' ' 92' ' ' THR . 3.4 p30 -26.73 124.06 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.668 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.605 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.3 OUTLIER -32.08 98.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.449 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.605 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 167.35 143.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.361 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.4 126.38 29.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.703 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.98 131.57 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.416 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.569 ' SD ' ' CB ' ' A' ' 122' ' ' ALA . 6.3 mtm -96.37 137.17 35.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.651 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.29 162.45 19.91 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -111.63 115.81 29.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.312 . . . . 0.0 110.64 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.1 tt -132.82 141.41 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.445 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.2 155.97 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 110.753 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.408 ' HB1' ' HB1' ' A' ' 65' ' ' ALA . . . -136.52 146.46 46.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.322 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -120.31 31.99 6.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.738 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.59 156.6 26.89 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -85.89 78.58 9.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.773 0.321 . . . . 0.0 110.405 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.6 m -107.5 179.18 4.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.637 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.56 -12.03 15.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.685 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.9 p -167.55 100.0 0.49 Allowed 'General case' 0 C--O 1.243 0.721 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.005 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' A' ' 110' ' ' ILE . 12.5 tt -132.36 132.27 60.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.846 0.355 . . . . 0.0 110.696 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -153.29 175.89 31.54 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 1.7 p -124.32 156.75 36.44 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.725 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -160.95 139.58 10.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.428 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.5 mp -126.94 118.0 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.906 0.384 . . . . 0.0 110.765 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.7 t -116.83 128.3 55.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.3 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.9 t -121.0 155.81 24.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.818 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 58.44 14.34 2.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.597 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.5 9.47 78.03 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -116.51 140.07 49.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.774 0.321 . . . . 0.0 110.56 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.89 132.41 33.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.43 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -129.33 -74.94 0.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.573 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.569 ' CB ' ' SD ' ' A' ' 98' ' ' MET . . . -125.47 129.0 48.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.679 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -149.49 133.06 16.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.637 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.9 mmt-85 -105.97 119.93 40.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.481 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 84.9 t -113.05 116.24 52.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.73 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.7 m -133.94 117.04 16.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.144 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.444 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -114.53 129.55 56.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.838 0.352 . . . . 0.0 110.877 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -154.97 130.62 9.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.42 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.7 t -85.56 139.26 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.756 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 60.76 42.52 13.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.697 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.491 179.8 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -97.41 118.24 33.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.214 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.903 HD21 HG23 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -96.0 115.2 27.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.767 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.705 ' N ' HD13 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -127.32 130.48 49.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.493 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.5 ' OH ' ' CZ ' ' A' ' 69' ' ' TYR . 33.0 p90 -119.97 148.71 43.2 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.274 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.58 ' HG3' ' OG ' ' A' ' 87' ' ' SER . 1.7 tm-20 -156.05 136.43 13.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.9 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.589 HG22 ' N ' ' A' ' 58' ' ' PHE . 4.2 mp -99.15 167.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.745 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.589 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -132.79 163.65 28.59 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.145 -179.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.98 142.65 4.98 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -41.79 155.92 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.513 2.142 . . . . 0.0 112.202 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.07 134.77 28.1 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.76 2.306 . . . . 0.0 112.188 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.84 -4.16 71.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.56 ' O ' ' O ' ' A' ' 83' ' ' VAL . 15.7 m -86.64 130.84 34.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.0 110.723 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 64' ' ' VAL . 7.7 p -105.36 126.11 60.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.428 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -136.72 152.85 50.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.661 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -106.45 116.56 32.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.361 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 mp -96.3 131.7 42.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.5 t -134.69 123.84 24.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.003 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.5 ' CZ ' ' OH ' ' A' ' 55' ' ' TYR . 37.3 p90 -151.48 170.76 18.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.909 0.385 . . . . 0.0 110.624 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.64 ' CE1' ' O ' ' A' ' 74' ' ' SER . 27.3 t80 -88.74 134.55 33.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.29 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.436 ' C ' ' N ' ' A' ' 73' ' ' ASN . 0.9 OUTLIER -109.48 141.57 41.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.831 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.451 ' O ' HG12 ' A' ' 72' ' ' VAL . 17.2 t -52.73 -11.44 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.328 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.629 ' O ' ' CB ' ' A' ' 74' ' ' SER . 49.8 m-80 -83.86 1.26 44.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.461 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.64 ' O ' ' CE1' ' A' ' 70' ' ' PHE . 0.9 OUTLIER 92.27 -75.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.763 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.85 135.34 86.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.583 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.15 143.57 28.75 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.554 2.169 . . . . 0.0 112.133 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.471 HE21 HG13 ' A' ' 79' ' ' VAL . 14.1 tt0 -104.12 135.97 44.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.392 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.8 125.93 24.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.861 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.471 HG13 HE21 ' A' ' 77' ' ' GLN . 28.2 m -109.07 127.14 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.425 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.664 ' OD1' ' N ' ' A' ' 81' ' ' GLY . 13.1 t0 -126.39 150.35 48.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.866 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.664 ' N ' ' OD1' ' A' ' 80' ' ' ASP . . . 85.21 12.19 74.08 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.37 140.63 30.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.746 0.308 . . . . 0.0 110.632 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.786 HG13 ' HG ' ' A' ' 84' ' ' LEU . 1.5 p -81.66 -33.77 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.473 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.786 ' HG ' HG13 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -141.25 152.51 64.53 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.479 179.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.513 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 20.5 Cg_endo -62.41 160.48 31.35 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.888 2.392 . . . . 0.0 112.066 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.573 ' CD1' ' N ' ' A' ' 86' ' ' TRP . 10.5 m95 -123.6 172.65 8.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.395 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.58 ' OG ' ' HG3' ' A' ' 56' ' ' GLU . 70.5 m -114.83 144.8 42.94 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.032 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.604 HD23 ' N ' ' A' ' 89' ' ' HIS . 0.6 OUTLIER -131.35 141.02 49.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.853 0.358 . . . . 0.0 110.778 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.613 ' H ' ' CD2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -108.59 123.29 48.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.305 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.3 mt -129.35 124.17 59.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.932 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.21 123.27 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.212 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.6 m -126.38 133.67 51.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 110.98 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.558 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 26.0 t-20 39.69 32.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.983 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.536 ' C ' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER 28.8 59.68 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.612 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.45 -146.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.385 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -119.47 123.29 43.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.5 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.2 p -159.71 139.7 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.645 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.617 ' HB3' HG21 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -96.51 177.66 5.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.649 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -138.14 162.73 25.68 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.527 ' N ' ' ND2' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -118.81 116.51 26.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.699 0.285 . . . . 0.0 110.561 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -133.33 142.54 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.805 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 98.5 t -121.97 146.66 26.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.206 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -140.08 138.86 35.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.959 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -131.39 102.28 5.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.208 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -131.04 163.83 23.42 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -78.97 19.69 0.52 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.853 0.359 . . . . 0.0 110.274 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 105' ' ' GLY . 6.1 p -69.04 -171.72 0.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.64 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.83 8.23 12.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.675 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.0 p -172.79 104.84 0.15 Allowed 'General case' 0 C--O 1.242 0.686 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 126' ' ' SER . 2.9 mt -126.55 136.93 59.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 120.807 0.337 . . . . 0.0 110.341 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.54 175.98 41.8 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -126.18 167.54 15.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.762 0.315 . . . . 0.0 110.603 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -157.43 140.36 15.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.437 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.903 HG23 HD21 ' A' ' 53' ' ' LEU . 3.6 mp -124.42 114.99 43.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.689 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.54 123.88 41.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.429 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.573 ' C ' ' H ' ' A' ' 118' ' ' GLY . 10.8 p -135.15 151.22 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.706 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 117' ' ' ASP . 13.2 t70 53.03 2.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.579 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.573 ' H ' ' C ' ' A' ' 116' ' ' VAL . . . 88.53 9.37 69.29 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -123.77 127.92 48.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.723 0.297 . . . . 0.0 110.629 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.5 p -80.03 136.47 23.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.425 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.38 -52.91 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.877 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -150.86 128.31 11.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.602 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.74 126.79 9.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.806 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -96.0 118.87 33.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.406 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.0 t -121.0 116.59 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.83 0.348 . . . . 0.0 110.885 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.609 ' C ' HD22 ' A' ' 127' ' ' ASN . 0.3 OUTLIER -134.03 116.09 15.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.456 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.781 HD22 ' N ' ' A' ' 127' ' ' ASN . 0.6 OUTLIER -100.16 132.51 45.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.569 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -136.25 138.66 42.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.502 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 26.4 m -68.22 -6.14 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.588 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -161.6 92.64 0.88 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.615 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.489 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.6 mtt . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.417 ' CD2' HG22 ' A' ' 91' ' ' THR . 34.0 m170 -92.76 129.03 38.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.461 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.422 ' O ' HD23 ' A' ' 53' ' ' LEU . 2.7 tt -95.63 118.02 31.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.513 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.3 135.08 51.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.596 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.537 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 1.2 p90 -120.34 148.62 43.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.409 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.562 ' C ' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -156.38 138.58 14.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.8 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.767 HD11 HD13 ' A' ' 101' ' ' ILE . 1.3 mm -105.95 174.73 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.905 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -133.36 171.94 13.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.991 0.424 . . . . 0.0 110.963 -179.591 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.86 147.13 5.07 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -39.16 152.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.758 2.306 . . . . 0.0 112.171 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -67.18 123.86 11.43 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.781 2.321 . . . . 0.0 112.151 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.87 -7.76 60.99 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -69.99 134.89 48.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.743 0.306 . . . . 0.0 110.493 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.9 t -111.7 125.71 69.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.632 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -141.13 155.37 46.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.371 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -98.9 123.15 42.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.717 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 52.2 mt -102.74 124.15 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.433 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 42.1 t -122.32 117.51 26.26 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.059 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.597 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 35.9 t80 -143.35 158.31 43.75 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.79 0.329 . . . . 0.0 110.489 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.597 ' O ' ' CE2' ' A' ' 69' ' ' TYR . 68.1 t80 -85.31 134.68 34.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.572 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -103.94 126.12 50.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.611 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 72' ' ' VAL . 60.5 t -62.29 -5.49 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.687 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.647 ' O ' ' CB ' ' A' ' 74' ' ' SER . 63.3 m-20 -85.72 -22.32 27.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.615 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.647 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 2.3 p 146.24 -99.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.547 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 75' ' ' GLU . 0.7 OUTLIER -64.99 147.64 98.35 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.65 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.58 154.9 50.06 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.719 2.28 . . . . 0.0 112.152 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -90.25 149.37 22.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.396 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ttp85 -152.59 133.17 13.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.737 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.05 136.66 52.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.414 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.537 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 1.0 OUTLIER -127.36 121.62 31.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.709 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.36 26.78 32.26 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.33 128.31 34.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.752 0.311 . . . . 0.0 110.626 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.4 t -67.87 -31.56 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.496 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.507 ' O ' HD12 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -161.54 156.5 20.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.491 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.449 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 11.6 Cg_endo -57.01 149.17 63.93 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.893 2.396 . . . . 0.0 112.282 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -120.6 -178.0 3.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.29 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.9 m -120.49 141.7 49.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.005 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.37 139.61 52.29 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.607 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 2.1 p-80 -114.83 127.79 55.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 0.0 110.963 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.4 mt -127.62 134.48 65.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.155 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.417 HG22 ' CD2' ' A' ' 52' ' ' HIS . 12.0 p -103.69 122.74 45.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.601 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.621 ' C ' ' H ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER -127.83 135.12 49.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.665 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 93' ' ' ASN . 0.5 OUTLIER -67.94 24.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.296 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.621 ' H ' ' C ' ' A' ' 92' ' ' THR . 2.2 t70 -114.07 0.87 14.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.536 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 60.7 -84.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.632 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.03 113.5 21.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.501 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.61 160.59 24.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.679 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.443 ' CG ' ' N ' ' A' ' 99' ' ' GLY . 4.3 ttt -130.15 158.21 40.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.381 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.443 ' N ' ' CG ' ' A' ' 98' ' ' MET . . . -156.38 152.3 23.7 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -110.47 117.46 33.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.864 0.364 . . . . 0.0 110.445 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.767 HD13 HD11 ' A' ' 57' ' ' ILE . 9.9 tt -132.08 137.48 54.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.535 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.2 t -138.05 149.93 24.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.554 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -120.79 150.24 41.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.58 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -135.59 79.46 1.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.646 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -131.64 161.24 23.69 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.582 ' N ' ' ND2' ' A' ' 106' ' ' ASN . 0.4 OUTLIER -79.07 28.57 0.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.84 0.352 . . . . 0.0 110.405 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -62.96 -166.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.598 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 108' ' ' ASP . 1.4 m-20 -114.75 -28.25 7.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.668 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.4 t -141.74 126.68 18.26 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.898 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.509 ' O ' ' O ' ' A' ' 126' ' ' SER . 23.0 mt -135.67 154.1 34.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.412 ' N ' ' CG2' ' A' ' 110' ' ' ILE . . . 174.69 159.23 20.59 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 5.7 p -117.93 161.46 19.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.766 0.317 . . . . 0.0 110.339 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 113' ' ' ARG . 2.8 ptp180 -161.3 136.87 7.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.664 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.1 mt -127.5 122.77 60.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.416 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.45 139.6 51.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.53 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.541 HG21 ' NH1' ' A' ' 121' ' ' ARG . 19.6 m -133.06 135.27 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.682 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 53.23 30.65 10.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.67 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.98 -1.58 23.22 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -109.31 136.01 49.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.331 . . . . 0.0 110.556 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.9 t -77.54 128.7 38.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.779 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.541 ' NH1' HG21 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -116.95 -63.91 1.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.379 179.773 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.93 127.21 45.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -149.38 131.83 15.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.993 0.425 . . . . 0.0 111.066 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -121.48 115.52 23.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.897 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.524 ' O ' ' CG2' ' A' ' 125' ' ' VAL . 1.1 m -111.16 125.59 68.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.907 0.384 . . . . 0.0 111.025 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.7 OUTLIER -131.46 115.93 16.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.016 179.473 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -101.81 131.01 48.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.885 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -156.63 136.64 12.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.613 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 20.4 t -88.99 140.95 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.568 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 46.02 53.75 8.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.272 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.631 -179.935 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.3 mtm . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -114.88 128.74 56.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.465 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.931 HD22 ' O ' ' A' ' 97' ' ' VAL . 14.5 tp -96.13 114.86 26.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.449 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.5 p -127.78 129.95 47.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.563 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.456 ' CD1' ' C ' ' A' ' 55' ' ' TYR . 26.0 p90 -123.47 148.33 46.31 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.474 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.457 ' HG3' ' OG ' ' A' ' 87' ' ' SER . 10.4 tt0 -156.65 133.53 10.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.777 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.9 mp -98.76 158.31 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.854 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.49 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -132.3 166.26 22.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.912 0.387 . . . . 0.0 110.781 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.66 163.16 19.88 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.06 109.61 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.655 2.237 . . . . 0.0 112.119 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -45.79 141.87 8.17 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.517 2.145 . . . . 0.0 112.008 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.53 -13.31 56.75 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.6 p -83.03 137.76 34.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.716 0.293 . . . . 0.0 110.56 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 64' ' ' VAL . 20.9 m -103.31 132.37 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.739 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.49 153.83 43.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.306 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -97.27 114.88 26.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.623 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 67' ' ' ILE . 1.8 mp -87.71 122.67 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.583 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.4 t -130.26 116.28 18.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.98 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.61 ' CZ ' ' O ' ' A' ' 70' ' ' PHE . 16.3 t80 -149.86 149.43 30.47 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.822 0.344 . . . . 0.0 110.575 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.61 ' O ' ' CZ ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -84.71 130.53 34.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.389 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.67 ' OD1' ' N ' ' A' ' 72' ' ' VAL . 67.9 t0 -93.87 146.38 23.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.802 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.67 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 89.7 t -69.59 -34.3 60.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.46 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -81.01 11.76 3.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.761 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.9 m 61.49 71.4 0.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.61 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.524 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 3.2 tt0 -178.66 77.73 0.22 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.379 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.66 144.25 99.47 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.96 2.44 . . . . 0.0 112.177 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -107.66 134.85 50.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.382 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 mtm-85 -134.08 126.92 31.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.922 0.391 . . . . 0.0 110.656 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 t -115.94 119.77 62.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.513 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -108.51 121.6 45.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.566 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.21 15.38 38.68 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.72 130.59 43.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 0.0 110.648 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.3 t -73.47 -35.17 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.294 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.61 ' H ' HD12 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -149.76 157.36 38.35 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.507 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.563 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 18.6 Cg_endo -61.33 157.08 42.3 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.989 2.459 . . . . 0.0 112.107 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -129.26 176.93 7.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.356 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.457 ' OG ' ' HG3' ' A' ' 56' ' ' GLU . 59.7 m -114.19 161.58 17.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.98 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.0 tp -147.98 134.97 20.24 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.244 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -109.15 126.36 53.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.841 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 90' ' ' ILE . 4.6 mp -130.46 136.79 57.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.388 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.6 p -122.63 130.03 52.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.524 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.676 ' O ' ' N ' ' A' ' 94' ' ' ASP . 2.0 m -113.3 156.11 23.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.696 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.551 ' O ' ' C ' ' A' ' 94' ' ' ASP . 11.2 t30 -28.59 84.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.786 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.676 ' N ' ' O ' ' A' ' 92' ' ' THR . 10.3 m-20 23.6 92.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.707 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 172.06 140.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.652 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.5 140.01 33.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.234 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.931 ' O ' HD22 ' A' ' 53' ' ' LEU . 9.2 p -150.86 142.97 16.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 110.888 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.547 ' N ' ' SD ' ' A' ' 98' ' ' MET . 3.1 mmt -93.31 161.13 14.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.129 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.43 154.7 20.99 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.383 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.454 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.5 m-80 -109.92 115.38 29.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.681 0.277 . . . . 0.0 110.263 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.4 tt -131.96 142.38 43.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.957 0.408 . . . . 0.0 110.981 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.0 t -139.98 145.82 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.357 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -143.51 151.73 40.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.763 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.46 103.89 7.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.529 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.58 161.71 23.7 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.556 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.8 OUTLIER -82.87 54.92 2.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 0.0 110.574 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.27 -167.13 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.45 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -118.24 -10.94 10.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.618 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 t -154.84 102.41 2.35 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.56 ' O ' ' O ' ' A' ' 126' ' ' SER . 3.7 mt -127.23 127.06 68.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.854 0.359 . . . . 0.0 110.3 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.04 172.26 33.95 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.564 ' O ' ' O ' ' A' ' 124' ' ' ARG . 31.6 p -125.08 161.53 26.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.768 0.318 . . . . 0.0 110.694 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.793 ' C ' HD12 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -156.41 147.04 21.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.496 179.799 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.793 HD12 ' C ' ' A' ' 113' ' ' ARG . 1.8 mp -121.57 117.18 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 110.82 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.78 129.4 51.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.284 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 118' ' ' GLY . 27.3 m -136.5 144.49 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.917 0.389 . . . . 0.0 110.969 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' A' ' 117' ' ' ASP . 21.7 t0 44.93 13.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.84 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 116' ' ' VAL . . . 83.64 -2.25 87.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 116' ' ' VAL . 4.6 ttmt -102.99 126.07 50.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.387 . . . . 0.0 110.396 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 20.9 t -80.86 140.33 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.631 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.423 ' NH1' ' HG3' ' A' ' 121' ' ' ARG . 1.7 mmm-85 -128.87 -48.94 1.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.497 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.91 135.99 9.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.535 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -149.54 155.9 41.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.502 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.564 ' O ' ' O ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -124.61 116.13 21.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.517 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.5 t -121.26 117.25 52.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.567 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.56 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.6 OUTLIER -130.54 121.75 26.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.588 -179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.565 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -94.53 129.84 41.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.241 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -132.25 139.98 48.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.812 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.25 -8.98 12.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.413 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 178.93 82.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.41 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.675 -179.799 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.616 ' SD ' ' OD1' ' A' ' 117' ' ' ASP . 41.7 mtm . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.17 129.14 55.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.453 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.699 ' C ' HD23 ' A' ' 53' ' ' LEU . 7.0 tt -95.52 114.79 26.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.962 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.433 ' N ' HD23 ' A' ' 53' ' ' LEU . 0.7 OUTLIER -127.33 135.76 50.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 55' ' ' TYR . 26.8 p90 -130.13 149.3 51.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.096 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.981 ' OE1' ' OG ' ' A' ' 87' ' ' SER . 15.5 tt0 -155.64 150.72 26.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.963 0.411 . . . . 0.0 111.079 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.488 HD11 HG23 ' A' ' 110' ' ' ILE . 7.1 tt -112.1 163.21 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.887 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.642 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -139.96 165.08 28.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 110.993 -179.469 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.6 171.37 44.33 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -47.85 112.74 0.61 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.716 2.277 . . . . 0.0 111.976 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -44.62 146.79 2.01 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.431 2.087 . . . . 0.0 112.267 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.78 -10.7 59.2 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.1 m -79.37 139.18 37.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 110.661 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.7 t -102.48 122.95 55.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.496 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.87 140.96 36.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.695 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -101.04 116.07 31.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.31 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.9 tt -102.06 138.4 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.81 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.2 t -124.48 118.67 27.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.949 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -128.19 167.12 17.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.756 0.312 . . . . 0.0 110.55 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.4 ' CE1' ' HA ' ' A' ' 74' ' ' SER . 55.7 t80 -99.62 134.83 41.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.313 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -95.75 139.14 32.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.68 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -54.91 -29.77 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.549 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.591 HD22 ' N ' ' A' ' 73' ' ' ASN . 1.6 m120 -84.19 2.93 37.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.523 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 0.7 OUTLIER 76.99 10.1 2.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.508 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -110.43 91.39 11.78 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.401 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.92 139.83 17.73 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.624 2.216 . . . . 0.0 112.309 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -107.83 158.35 17.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.592 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -145.58 126.35 14.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.624 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.0 m -108.21 135.57 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.499 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -128.96 132.96 47.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.74 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.31 17.65 42.02 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.87 149.44 36.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.837 0.351 . . . . 0.0 110.754 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.556 HG23 ' CD1' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -88.35 -42.43 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.302 179.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.556 ' CD1' HG23 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -144.49 154.07 56.1 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.187 179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.28 147.37 47.39 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 122.96 2.44 . . . . 0.0 112.266 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.534 ' CD1' ' N ' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -114.23 -162.75 0.83 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.256 179.709 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.981 ' OG ' ' OE1' ' A' ' 56' ' ' GLU . 70.3 m -116.59 153.53 32.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.986 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 mt -128.23 141.74 51.37 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.737 0.303 . . . . 0.0 110.506 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.34 119.92 40.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.509 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.444 ' HA ' HD13 ' A' ' 90' ' ' ILE . 26.2 mm -126.7 121.55 58.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.75 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 p -105.38 122.48 46.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.344 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.2 m -122.08 149.25 43.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.716 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -86.83 31.31 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.454 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.538 ' C ' ' H ' ' A' ' 96' ' ' ALA . 32.8 m-20 -114.52 -4.07 12.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.548 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 94' ' ' ASP . . . 70.77 -28.52 0.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.713 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.538 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -156.62 138.15 14.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.701 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.3 p -174.9 144.7 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.429 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -104.3 154.3 19.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.777 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -122.02 159.03 16.7 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.25 122.13 46.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.719 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.8 pt -132.53 139.52 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.531 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 103' ' ' ALA . 75.0 t -123.43 159.31 28.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.349 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.517 ' N ' HG12 ' A' ' 102' ' ' VAL . . . -131.05 152.08 50.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.982 0.42 . . . . 0.0 110.612 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.91 64.05 1.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.328 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -130.97 163.99 23.35 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.7 20.39 0.45 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 0.0 110.558 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.603 ' OG ' ' N ' ' A' ' 108' ' ' ASP . 6.0 t -53.47 -173.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.626 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.603 ' N ' ' OG ' ' A' ' 107' ' ' SER . 37.4 t0 -119.61 -73.44 0.64 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.615 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.691 ' OG ' ' ND2' ' A' ' 127' ' ' ASN . 30.1 t -89.21 122.12 32.18 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.975 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.488 HG23 HD11 ' A' ' 57' ' ' ILE . 12.7 mt -130.46 139.44 51.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.828 0.347 . . . . 0.0 110.5 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.17 144.36 7.98 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 10.7 p -117.96 156.91 27.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.73 0.3 . . . . 0.0 110.476 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.766 ' C ' HD12 ' A' ' 114' ' ' ILE . 13.8 ptm180 -159.96 146.04 15.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.766 HD12 ' C ' ' A' ' 113' ' ' ARG . 3.8 mp -131.83 122.05 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.368 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.0 t -118.68 140.94 49.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.679 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.454 ' C ' ' H ' ' A' ' 118' ' ' GLY . 31.1 m -124.17 144.72 32.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.559 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.616 ' OD1' ' SD ' ' A' ' 51' ' ' MET . 0.5 OUTLIER 52.94 9.77 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.575 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 116' ' ' VAL . . . 88.02 5.6 76.75 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.6 mtmt -106.44 127.33 53.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.748 0.309 . . . . 0.0 110.512 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.486 ' O ' HG23 ' A' ' 120' ' ' VAL . 26.5 m -70.9 118.84 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.74 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -103.44 -72.94 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.479 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -135.31 128.09 31.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.315 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -146.9 123.85 11.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.0 mtt-85 -100.61 115.46 30.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.286 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.9 t -123.98 117.25 50.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.61 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.2 OUTLIER -132.99 122.67 24.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.406 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.691 ' ND2' ' OG ' ' A' ' 109' ' ' SER . 11.3 m120 -94.2 129.74 40.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.342 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -152.85 130.74 11.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.718 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.72 ' O ' HG13 ' A' ' 129' ' ' VAL . 13.7 p -65.06 104.36 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.554 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.589 ' N ' HD22 ' A' ' 130' ' ' ASN . 1.0 OUTLIER 66.79 81.76 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.56 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.606 -179.882 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -114.24 128.0 56.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.445 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 53' ' ' LEU . 2.2 pp -95.9 116.06 28.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.334 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.9 t -123.76 144.8 49.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.77 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.4 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -119.48 149.41 41.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.013 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.492 ' OE1' ' C ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -155.76 136.88 13.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.946 0.403 . . . . 0.0 111.087 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.519 HG22 ' N ' ' A' ' 58' ' ' PHE . 21.0 mt -116.31 161.81 14.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.002 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.519 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -141.32 151.02 43.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.018 0.437 . . . . 0.0 110.662 -179.878 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -165.93 168.83 39.93 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -46.11 144.72 6.06 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.651 2.234 . . . . 0.0 111.781 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -64.29 120.48 7.82 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.592 2.195 . . . . 0.0 112.17 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.09 2.94 59.13 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.579 ' O ' ' O ' ' A' ' 83' ' ' VAL . 6.7 t -78.71 141.48 37.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.861 0.363 . . . . 0.0 110.665 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 64' ' ' VAL . 33.8 m -101.79 128.2 54.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.621 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.35 144.73 33.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.839 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.45 116.32 32.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.247 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.699 HG23 HD11 ' A' ' 101' ' ' ILE . 23.7 mt -101.03 124.71 54.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.023 0.439 . . . . 0.0 111.006 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.5 t -135.63 124.35 23.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.992 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' A' ' 69' ' ' TYR . 23.9 p90 -147.94 169.01 20.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.909 0.385 . . . . 0.0 110.965 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -87.35 125.7 34.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.455 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -90.95 155.07 19.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.632 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 73' ' ' ASN . 5.3 p -51.77 -37.07 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.495 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 74' ' ' SER . 0.9 OUTLIER -85.16 11.75 9.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.473 179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.516 ' O ' ' C ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER 81.19 -68.03 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.313 -179.729 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.516 ' C ' ' O ' ' A' ' 74' ' ' SER . 5.6 tt0 -31.91 104.14 0.22 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.136 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -76.7 139.86 20.43 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.317 2.011 . . . . 0.0 112.318 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.79 147.66 24.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.498 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 78' ' ' ARG . 14.8 mtp180 -144.73 130.01 18.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.465 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.9 m -109.8 124.5 66.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.411 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.01 117.99 31.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.73 16.73 27.93 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.86 135.66 48.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.774 0.321 . . . . 0.0 110.5 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.579 ' O ' ' O ' ' A' ' 63' ' ' THR . 0.5 OUTLIER -81.17 -38.68 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.659 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.407 ' CD1' HG23 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -148.16 157.06 43.24 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.119 0.485 . . . . 0.0 110.578 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.492 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 38.0 Cg_endo -68.82 160.31 50.19 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.867 2.378 . . . . 0.0 112.227 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.93 -169.65 2.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.498 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.5 m -133.83 144.98 49.3 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.952 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.3 tp -138.32 155.64 48.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.627 0.251 . . . . 0.0 110.398 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -115.82 135.37 54.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 110.984 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.7 mt -129.23 130.32 67.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.249 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 91' ' ' THR . 5.4 t -115.35 129.21 56.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.771 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.557 ' O ' ' C ' ' A' ' 93' ' ' ASN . 14.0 m -129.97 125.42 35.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.226 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.557 ' C ' ' O ' ' A' ' 92' ' ' THR . 1.9 m120 26.26 -104.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.544 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 94' ' ' ASP . 4.8 p-10 -160.05 81.23 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.484 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -167.43 147.41 5.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.664 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.36 127.21 33.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.361 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -140.56 150.07 21.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -102.39 172.59 6.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.208 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -138.44 161.8 25.72 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.534 ' C ' ' OD1' ' A' ' 100' ' ' ASN . 16.2 t-20 -114.96 115.22 26.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 0.0 110.498 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.699 HD11 HG23 ' A' ' 67' ' ' ILE . 18.7 tt -130.98 141.42 46.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.505 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 103' ' ' ALA . 77.8 t -129.36 155.43 41.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.879 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.465 ' HB3' HG12 ' A' ' 110' ' ' ILE . . . -121.31 147.24 45.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.562 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.49 54.26 1.95 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.812 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.65 162.97 20.72 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.98 89.83 4.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.853 0.359 . . . . 0.0 110.448 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.2 p -117.82 177.7 4.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.774 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -116.91 -0.01 12.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.439 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.1 p -170.46 84.52 0.11 Allowed 'General case' 0 C--O 1.245 0.853 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.047 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.468 ' O ' ' CG2' ' A' ' 110' ' ' ILE . 0.4 OUTLIER -109.96 128.97 65.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 120.9 0.381 . . . . 0.0 110.774 -179.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -152.86 164.41 30.78 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 20.3 m -125.0 153.24 43.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.928 0.394 . . . . 0.0 110.727 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -159.87 144.89 15.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.309 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -126.56 133.67 68.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.833 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.8 m -122.79 124.02 42.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.432 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.444 ' C ' ' N ' ' A' ' 118' ' ' GLY . 0.5 OUTLIER -131.84 148.78 32.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.556 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.0 t0 49.87 13.46 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.691 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.444 ' N ' ' C ' ' A' ' 116' ' ' VAL . . . 84.64 -0.14 89.22 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.62 138.34 50.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.717 0.294 . . . . 0.0 110.586 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.3 t -85.41 118.67 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.53 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -90.37 -62.09 1.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.5 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -114.7 131.75 56.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.449 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -129.52 121.75 27.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.773 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.457 ' O ' ' CG ' ' A' ' 124' ' ' ARG . 11.8 ptm180 -128.49 123.19 32.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.293 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.8 t -122.5 120.25 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.63 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.42 115.94 18.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.637 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -95.08 130.18 41.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.211 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -150.4 130.57 13.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.761 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.07 18.34 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.993 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.412 ' CG ' ' O ' ' A' ' 130' ' ' ASN . 2.4 t-20 -179.09 65.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.409 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.627 -179.889 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.66 127.85 54.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.481 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.453 ' CD1' ' O ' ' A' ' 97' ' ' VAL . 1.5 tt -96.12 115.72 27.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.416 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.62 130.95 51.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.667 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -119.98 149.01 42.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.2 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 2.6 tm-20 -156.03 146.76 21.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.984 0.421 . . . . 0.0 111.002 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 58' ' ' PHE . 74.7 mt -114.73 159.96 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.761 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.672 ' CE2' HD11 ' A' ' 84' ' ' LEU . 11.8 t80 -140.28 156.86 46.3 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.245 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.589 ' N ' ' CD1' ' A' ' 58' ' ' PHE . . . -160.72 175.04 37.45 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -50.93 157.98 3.44 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.623 2.216 . . . . 0.0 111.979 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -75.27 118.66 5.27 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.803 2.335 . . . . 0.0 112.187 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.03 9.9 55.5 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.77 150.67 25.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.785 0.326 . . . . 0.0 110.442 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 64' ' ' VAL . 7.6 p -126.06 121.98 60.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.569 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.38 153.55 42.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.529 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.92 115.71 27.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.401 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.499 ' CD1' HD12 ' A' ' 57' ' ' ILE . 4.1 mm -93.24 132.73 36.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.853 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.5 t -135.8 127.54 29.15 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.909 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.454 ' CG ' ' N ' ' A' ' 70' ' ' PHE . 40.1 t80 -150.46 157.34 42.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.801 0.334 . . . . 0.0 110.678 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 12.9 t80 -87.44 124.35 33.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.439 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.83 156.81 22.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.483 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.29 -30.84 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.473 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 74' ' ' SER . 34.9 m120 -95.72 11.6 32.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.31 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.63 ' OG ' ' N ' ' A' ' 75' ' ' GLU . 1.1 p 85.19 -69.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.379 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.63 ' N ' ' OG ' ' A' ' 74' ' ' SER . 11.4 pt-20 -29.63 94.86 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.495 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.498 ' N ' ' O ' ' A' ' 74' ' ' SER . 51.3 Cg_endo -77.01 141.6 21.2 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.506 2.137 . . . . 0.0 111.978 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.452 ' HG2' ' N ' ' A' ' 78' ' ' ARG . 1.4 tt0 -107.58 140.83 39.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.987 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.452 ' N ' ' HG2' ' A' ' 77' ' ' GLN . 4.4 mtt-85 -135.9 133.5 37.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.165 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 m -99.35 136.56 29.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.72 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -113.09 103.67 11.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.64 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.32 33.46 5.4 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.31 148.11 50.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.789 0.328 . . . . 0.0 110.559 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.5 m -107.56 -20.03 6.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.395 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.672 HD11 ' CE2' ' A' ' 58' ' ' PHE . 5.3 tt -174.99 115.17 0.29 Allowed Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.222 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.567 ' N ' HD23 ' A' ' 84' ' ' LEU . 27.4 Cg_exo -55.63 144.19 76.08 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.897 1.731 . . . . 0.0 111.803 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.526 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 4.4 m-90 -111.5 -144.54 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.528 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.707 ' O ' HD22 ' A' ' 88' ' ' LEU . 97.0 p -134.17 155.21 50.52 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.977 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.707 HD22 ' O ' ' A' ' 87' ' ' SER . 1.5 mm? -129.1 151.84 49.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.786 0.327 . . . . 0.0 110.492 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.594 ' N ' ' CD2' ' A' ' 89' ' ' HIS . 0.4 OUTLIER -105.86 119.05 38.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.629 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.433 HD13 ' O ' ' A' ' 89' ' ' HIS . 50.3 mm -126.41 138.25 55.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.456 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 91' ' ' THR . 12.0 t -103.76 130.44 51.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.649 ' O ' ' N ' ' A' ' 94' ' ' ASP . 17.4 p -116.75 140.34 49.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.737 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.524 ' CG ' ' O ' ' A' ' 93' ' ' ASN . 1.8 t30 -49.5 79.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.59 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 92' ' ' THR . 21.9 m-20 34.08 79.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.55 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -169.41 145.79 3.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.508 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.432 ' CB ' HG11 ' A' ' 116' ' ' VAL . . . -108.5 113.6 26.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.439 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.453 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 7.7 p -133.91 156.78 41.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.674 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.444 ' HA ' HG21 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -108.07 117.26 33.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.533 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.38 161.87 54.39 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -112.9 115.39 28.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 0.0 110.595 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.4 tt -131.08 139.25 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.643 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 103' ' ' ALA . 8.2 t -130.39 155.16 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.397 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.451 ' N ' ' CG1' ' A' ' 102' ' ' VAL . . . -140.72 157.16 45.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.737 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -136.83 73.71 1.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.586 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -128.8 163.51 22.18 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -79.18 106.74 11.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.868 0.366 . . . . 0.0 110.516 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.0 p -140.9 -170.83 3.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.622 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 108' ' ' ASP . 2.3 t70 -134.15 4.93 3.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.5 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.8 p -174.73 62.46 0.02 OUTLIER 'General case' 0 C--O 1.245 0.847 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.959 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.504 ' O ' ' O ' ' A' ' 126' ' ' SER . 4.2 tt -98.99 129.52 49.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 O-C-N 123.16 0.288 . . . . 0.0 110.424 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -149.42 172.4 29.45 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.569 ' O ' ' O ' ' A' ' 124' ' ' ARG . 0.9 OUTLIER -118.99 157.32 27.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.765 0.317 . . . . 0.0 110.28 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.511 ' NH2' ' OE1' ' A' ' 56' ' ' GLU . 15.1 ptt-85 -161.41 141.78 10.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.642 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 113' ' ' ARG . 20.1 mm -117.71 131.37 70.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.615 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.1 p -110.3 132.88 53.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.429 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.432 HG11 ' CB ' ' A' ' 96' ' ' ALA . 24.5 t -142.05 150.08 19.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.598 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 50.99 19.24 0.63 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.653 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.38 -4.73 24.9 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -120.94 132.03 54.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.797 0.332 . . . . 0.0 110.557 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.3 t -74.63 134.53 29.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.46 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.03 -46.82 2.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.789 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.64 129.73 14.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.69 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -150.19 155.73 40.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.576 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.569 ' O ' ' O ' ' A' ' 112' ' ' CYS . 25.8 mtt-85 -116.22 116.0 27.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.608 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.7 p -124.31 128.82 74.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.527 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 110' ' ' ILE . 4.7 m -128.71 130.46 47.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.534 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -99.41 137.92 37.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.517 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -145.64 166.47 25.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.459 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.424 ' C ' ' CG ' ' A' ' 130' ' ' ASN . 5.2 t -97.59 -3.37 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.443 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.424 ' CG ' ' C ' ' A' ' 129' ' ' VAL . 0.1 OUTLIER 172.33 79.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.354 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.513 -179.83 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.7 mpt? . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -113.13 128.59 56.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.604 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.649 HD11 ' CG2' ' A' ' 114' ' ' ILE . 39.1 tp -95.79 115.76 27.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.087 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.1 p -126.45 131.77 51.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 88' ' ' LEU . 26.1 p90 -119.77 148.88 42.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.832 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.46 ' O ' HD13 ' A' ' 57' ' ' ILE . 2.2 tm-20 -155.81 144.88 20.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.901 0.382 . . . . 0.0 110.919 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.554 HG22 ' N ' ' A' ' 58' ' ' PHE . 31.4 mm -116.11 165.59 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.901 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.686 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -133.01 165.42 24.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.023 0.44 . . . . 0.0 110.952 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.76 170.56 37.33 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.559 ' O ' ' OG1' ' A' ' 63' ' ' THR . 17.9 Cg_endo -64.82 161.2 37.25 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.518 2.146 . . . . 0.0 112.016 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -72.51 119.52 6.17 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.868 2.379 . . . . 0.0 112.163 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.69 7.31 45.24 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.559 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -82.92 136.02 34.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.809 0.338 . . . . 0.0 110.653 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -114.53 122.63 69.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.615 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.61 151.53 44.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.503 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.497 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 9.2 p30 -96.24 116.0 28.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.635 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 mt -96.83 130.45 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.572 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.4 t -134.19 126.06 29.14 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.02 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.657 ' CZ ' ' O ' ' A' ' 70' ' ' PHE . 11.0 t80 -151.38 152.64 33.39 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.876 0.369 . . . . 0.0 110.63 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.657 ' O ' ' CZ ' ' A' ' 69' ' ' TYR . 49.7 t80 -84.75 121.53 27.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.494 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.448 ' HB2' ' H ' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -81.52 151.18 27.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.627 -179.84 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.5 t -64.72 -35.27 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.604 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -89.7 10.24 24.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.657 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 70.52 79.56 0.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.582 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.448 ' H ' ' HB2' ' A' ' 71' ' ' ASP . 2.7 tt0 -170.77 85.17 0.52 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.469 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -59.31 139.95 92.31 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.859 2.373 . . . . 0.0 112.197 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -106.04 132.67 51.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.56 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.1 mtm-85 -140.43 126.22 19.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.468 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.3 m -121.31 136.97 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.735 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -129.95 126.2 37.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.516 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.68 23.96 17.03 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.98 153.36 22.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 110.467 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.472 HG23 ' CD1' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -92.93 -39.82 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.615 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.608 ' CD1' ' CH2' ' A' ' 86' ' ' TRP . 0.2 OUTLIER -147.83 157.8 43.33 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.976 0.417 . . . . 0.0 110.628 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.73 162.49 39.45 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.87 2.38 . . . . 0.0 112.268 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.608 ' CH2' ' CD1' ' A' ' 84' ' ' LEU . 2.1 m95 -132.86 -156.49 0.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.332 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.606 ' O ' HD22 ' A' ' 88' ' ' LEU . 96.7 p -130.49 161.22 31.92 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.946 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.606 HD22 ' O ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -132.47 155.42 48.59 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.405 178.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.533 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.2 OUTLIER -116.2 120.61 39.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.668 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 53' ' ' LEU . 3.8 mp -124.15 129.79 73.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.656 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.01 129.86 53.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.302 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.563 ' O ' ' O ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -125.79 157.97 36.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.659 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.563 ' O ' ' O ' ' A' ' 92' ' ' THR . 5.1 m120 -34.76 -100.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.618 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.8 72.59 0.33 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.587 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -169.68 166.06 9.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.745 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.56 128.89 34.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.518 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 95' ' ' ALA . 0.7 OUTLIER -133.44 147.74 31.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.718 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.409 ' SD ' ' HB3' ' A' ' 122' ' ' ALA . 23.0 mtm -149.19 150.25 32.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.309 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.17 162.16 23.59 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -105.23 117.08 33.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.892 0.377 . . . . 0.0 110.589 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 tp -132.88 133.66 58.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.532 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.0 m -130.59 165.32 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.217 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -139.62 142.22 37.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.759 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -132.96 75.98 1.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.383 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -125.52 164.43 19.1 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.631 ' ND2' ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -78.02 48.86 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.108 0.48 . . . . 0.0 110.458 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.8 173.23 7.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.613 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.603 ' N ' ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -101.61 -17.07 16.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.418 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.9 t -146.54 115.98 7.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.0 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 131' ' ' ALA . 3.4 mt -137.64 125.96 32.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.834 0.35 . . . . 0.0 110.51 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -154.83 175.27 32.95 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -120.23 169.62 10.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.687 0.279 . . . . 0.0 110.519 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.94 144.99 13.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.81 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.649 ' CG2' HD11 ' A' ' 53' ' ' LEU . 4.4 mt -140.74 122.97 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.579 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.0 p -122.72 122.29 38.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.371 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.594 ' O ' ' N ' ' A' ' 118' ' ' GLY . 55.9 t -122.12 157.74 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.857 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.494 ' N ' HG12 ' A' ' 116' ' ' VAL . 80.9 m-20 39.22 20.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.807 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 116' ' ' VAL . . . 70.44 0.95 33.46 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 116' ' ' VAL . 4.6 tttp -113.65 143.46 44.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 110.57 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 120' ' ' VAL . 14.4 p -71.56 124.23 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.784 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.443 ' HG2' ' NH1' ' A' ' 121' ' ' ARG . 26.9 mtt-85 -125.38 -41.4 2.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.175 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.409 ' HB3' ' SD ' ' A' ' 98' ' ' MET . . . -152.78 128.22 9.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.134 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -149.16 131.74 15.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.786 0.326 . . . . 0.0 111.026 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.0 119.06 28.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.351 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.649 ' O ' HG13 ' A' ' 125' ' ' VAL . 7.5 p -122.25 118.53 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.726 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.3 OUTLIER -115.35 127.16 55.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.538 179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -95.6 133.15 39.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.714 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.573 ' O ' ' O ' ' A' ' 108' ' ' ASP . 9.6 mt-10 -148.97 130.51 14.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.355 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.01 -11.02 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.605 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 132' ' ' TYR . 9.7 m120 -164.38 72.03 0.22 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.35 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.56 ' HB3' HD12 ' A' ' 110' ' ' ILE . . . -66.49 71.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.669 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.56 ' O ' ' CE1' ' A' ' 134' ' ' TYR . 38.3 t80 -157.99 6.18 0.13 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.447 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.592 ' C ' ' H ' ' A' ' 135' ' ' CYS . 68.1 p -90.39 -16.66 28.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.621 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 134' ' ' TYR . 0.4 OUTLIER 67.8 -33.79 0.23 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.466 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . 0.592 ' H ' ' C ' ' A' ' 133' ' ' THR . 0.5 OUTLIER 178.23 98.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.474 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.3 tp -156.64 90.3 1.15 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.716 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.545 ' O ' ' C ' ' A' ' 138' ' ' LYS . 16.9 t -84.4 124.45 39.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.416 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.545 ' C ' ' O ' ' A' ' 137' ' ' VAL . 3.5 tppt? -27.32 128.29 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.815 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.84 -16.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.575 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.617 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.9 ptp . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -116.22 119.27 35.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.512 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.524 ' O ' HD23 ' A' ' 53' ' ' LEU . 6.3 tt -98.5 115.2 28.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.026 0.441 . . . . 0.0 110.703 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -127.51 129.71 47.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.052 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -119.96 148.54 43.4 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.732 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.705 ' OE1' ' OG ' ' A' ' 87' ' ' SER . 6.0 tt0 -156.8 131.93 9.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.705 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.581 HG22 ' N ' ' A' ' 58' ' ' PHE . 4.6 mm -91.36 167.95 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.581 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -132.41 145.49 51.25 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.885 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.07 156.66 28.09 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -50.33 161.63 1.1 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.923 2.415 . . . . 0.0 111.987 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -76.95 133.74 14.02 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.953 2.435 . . . . 0.0 112.279 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.94 -9.92 67.37 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.6 m -81.68 130.23 34.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.841 0.353 . . . . 0.0 110.496 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.9 m -101.9 127.39 55.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.579 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.35 155.48 49.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.557 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.503 ' OD1' ' C ' ' A' ' 66' ' ' ASP . 44.2 t0 -103.18 129.15 50.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.555 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.497 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 2.9 mt -118.73 126.46 75.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.62 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 39.9 t -113.27 117.87 33.04 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.067 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.593 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 33.9 t80 -139.96 145.93 38.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.702 0.287 . . . . 0.0 110.538 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.593 ' O ' ' CE2' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -83.24 134.48 34.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.207 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -94.21 153.32 18.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.92 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 73' ' ' ASN . 12.2 p -48.84 -39.09 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.635 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.514 ' O ' ' CB ' ' A' ' 74' ' ' SER . 0.3 OUTLIER -87.71 11.75 14.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.409 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.68 ' OG ' ' N ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER 82.15 -71.65 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.507 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.68 ' N ' ' OG ' ' A' ' 74' ' ' SER . 1.1 tp10 -26.12 88.75 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.701 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.588 ' N ' ' O ' ' A' ' 74' ' ' SER . 14.8 Cg_exo -65.08 144.57 82.39 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.932 2.421 . . . . 0.0 112.083 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -107.72 150.07 27.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.285 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -138.24 129.92 28.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.787 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.2 m -102.46 123.54 55.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.476 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 0.5 OUTLIER -120.97 108.74 14.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.686 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.69 29.03 7.56 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.45 132.86 34.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 0.0 110.578 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.08 -76.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.607 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.756 ' H ' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -118.17 156.73 50.25 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.588 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.516 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 25.6 Cg_endo -64.1 151.33 85.78 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.904 2.403 . . . . 0.0 112.339 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -114.31 -171.2 1.87 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.396 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.705 ' OG ' ' OE1' ' A' ' 56' ' ' GLU . 70.9 m -125.03 151.54 45.46 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.044 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 88' ' ' LEU . 8.1 tp -130.73 154.6 47.8 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.863 0.363 . . . . 0.0 110.5 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -123.57 120.65 33.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.404 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.7 mt -130.9 132.09 64.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.571 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.77 126.03 51.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.569 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.507 ' O ' ' C ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -130.24 156.39 44.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.585 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.623 ' OD1' ' N ' ' A' ' 93' ' ' ASN . 0.4 OUTLIER -30.78 120.13 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.478 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -42.51 92.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.568 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 93' ' ' ASN . . . -175.03 -171.92 0.56 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.446 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.68 113.15 8.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.452 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 t -107.26 152.36 8.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.192 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.5 ttt -148.48 137.48 21.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 0.0 111.015 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.64 156.99 18.85 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -118.73 115.39 24.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.812 0.339 . . . . 0.0 110.794 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.9 140.5 49.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.609 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 89.1 t -127.19 147.64 32.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.465 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -139.41 140.37 37.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.746 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -139.05 78.89 1.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.587 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.56 163.8 23.63 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -78.77 52.13 1.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.8 0.333 . . . . 0.0 110.483 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 129' ' ' VAL . 70.9 m -100.49 175.05 5.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.554 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 109' ' ' SER . 6.9 t70 -104.59 128.52 52.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.505 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 108' ' ' ASP . 47.0 t 44.02 93.52 0.01 OUTLIER 'General case' 0 C--O 1.24 0.599 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.971 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.498 ' CG2' ' OD1' ' A' ' 127' ' ' ASN . 15.9 tt -124.56 127.1 72.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 120.793 0.33 . . . . 0.0 110.461 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 125' ' ' VAL . . . -147.22 172.09 27.73 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.675 ' SG ' ' N ' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -118.75 162.66 18.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.675 ' N ' ' SG ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -158.76 143.72 16.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.923 0.392 . . . . 0.0 110.887 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.539 HD12 ' C ' ' A' ' 113' ' ' ARG . 1.9 mp -118.72 124.95 73.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.306 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.88 127.69 54.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.765 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.67 136.59 31.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.462 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.515 ' OD1' ' O ' ' A' ' 117' ' ' ASP . 57.7 t0 65.55 9.45 5.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.449 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.13 -5.98 57.77 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -101.13 139.3 37.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.812 0.339 . . . . 0.0 110.579 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 m -78.24 142.51 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.602 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -168.14 24.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.573 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -123.67 152.85 41.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.772 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.1 147.55 23.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.263 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.0 ptt85 -127.78 135.41 50.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.767 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.415 ' O ' ' CA ' ' A' ' 111' ' ' GLY . 2.1 t -103.08 134.64 43.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.165 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.667 ' C ' HD22 ' A' ' 127' ' ' ASN . 46.7 m -102.63 116.45 32.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.942 0.401 . . . . 0.0 110.901 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.69 ' N ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -128.34 135.19 49.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.449 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.601 ' N ' ' OE1' ' A' ' 128' ' ' GLU . 1.1 pm0 -104.36 174.6 5.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.746 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.656 ' O ' HG22 ' A' ' 129' ' ' VAL . 1.8 p -55.35 1.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.752 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.596 ' H ' ' C ' ' A' ' 128' ' ' GLU . 25.3 m-80 -112.84 -5.5 13.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.59 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.41 73.98 6.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.454 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -128.55 -171.3 2.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.509 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.4 m -59.14 97.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.57 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -174.41 102.88 0.1 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.682 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 1.3 m -109.37 121.23 44.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.451 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.481 ' O ' ' C ' ' A' ' 137' ' ' VAL . 3.5 mt -80.05 -91.14 0.05 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.79 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.481 ' C ' ' O ' ' A' ' 136' ' ' LEU . 41.2 t -33.42 95.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.695 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -75.07 -27.99 60.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.559 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.434 ' N ' ' HG2' ' A' ' 138' ' ' LYS . 1.2 m -63.19 147.99 49.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.585 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.564 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.545 ' N ' ' H ' ' A' ' 117' ' ' ASP . 9.2 mtt . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.437 ' O ' ' CG ' ' A' ' 52' ' ' HIS . 1.5 p-80 -109.36 125.81 52.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.308 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.733 ' C ' HD23 ' A' ' 53' ' ' LEU . 5.5 tt -96.1 115.87 28.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.785 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.635 ' N ' HD23 ' A' ' 53' ' ' LEU . 23.7 p -126.28 130.12 50.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.496 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.554 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 1.8 p90 -122.69 149.94 43.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.517 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.426 ' HG2' ' N ' ' A' ' 57' ' ' ILE . 17.0 tt0 -155.36 148.09 24.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.956 0.408 . . . . 0.0 111.042 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.522 HD11 HD13 ' A' ' 101' ' ' ILE . 1.6 mm -112.88 163.59 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.971 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.5 156.71 44.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.905 0.384 . . . . 0.0 110.698 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.65 170.21 42.93 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -47.56 152.87 2.38 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.854 2.369 . . . . 0.0 112.229 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -67.04 119.66 6.69 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.825 2.35 . . . . 0.0 111.933 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.99 -0.03 62.22 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.4 t -74.85 144.06 43.59 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.878 0.371 . . . . 0.0 110.559 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 64' ' ' VAL . 7.2 p -115.87 128.83 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.508 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.47 151.49 41.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.806 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.67 124.81 49.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.206 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.442 HG23 HD11 ' A' ' 101' ' ' ILE . 10.9 mt -111.17 133.64 56.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.017 0.437 . . . . 0.0 111.013 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.5 t -132.35 131.05 41.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.957 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.679 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 11.2 t80 -150.98 156.49 41.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.895 0.379 . . . . 0.0 110.986 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.679 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 10.0 t80 -83.76 119.63 25.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.282 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 75' ' ' GLU . 32.6 t70 -89.42 146.08 24.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.841 0.353 . . . . 0.0 110.775 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.482 HG13 ' OD1' ' A' ' 73' ' ' ASN . 4.5 p -53.99 -24.2 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.605 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.482 ' OD1' HG13 ' A' ' 72' ' ' VAL . 2.9 m-20 -86.55 -3.87 59.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.64 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.3 m 78.55 34.21 0.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.526 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.445 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 3.2 mm-40 -135.87 104.27 9.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.408 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -77.74 140.14 18.37 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.284 1.99 . . . . 0.0 112.086 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -107.42 148.11 29.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.563 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 75.4 mtm-85 -139.26 131.62 28.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.622 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.3 m -114.21 118.98 60.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.608 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -112.6 145.74 39.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.481 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.32 5.81 44.48 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.15 137.75 58.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.809 0.338 . . . . 0.0 110.413 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.45 -44.24 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.54 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.431 ' H ' HD12 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -147.55 155.27 45.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.109 0.48 . . . . 0.0 110.774 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.83 159.44 52.79 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 123.208 2.605 . . . . 0.0 112.533 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -129.13 -179.26 5.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.215 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 92.8 p -112.27 164.53 13.11 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.323 0.582 . . . . 0.0 111.004 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.88 145.8 33.46 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.937 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.508 ' CG ' ' O ' ' A' ' 89' ' ' HIS . 19.8 p80 -121.52 123.53 42.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 110.851 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.3 mt -128.51 121.3 54.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.513 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.4 m -104.14 122.47 45.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.548 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.553 ' O ' ' C ' ' A' ' 93' ' ' ASN . 1.9 m -129.19 158.33 39.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.536 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.553 ' C ' ' O ' ' A' ' 92' ' ' THR . 41.9 m-20 -25.54 91.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.713 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.658 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -31.47 124.98 0.24 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.566 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 163.75 -71.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.595 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -156.25 120.42 4.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.447 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 t -127.81 147.26 32.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.711 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.6 ttm -151.51 159.42 44.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.517 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -153.46 156.26 26.65 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.564 HD21 ' NH2' ' A' ' 124' ' ' ARG . 0.8 OUTLIER -119.19 115.83 25.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.327 . . . . 0.0 110.611 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.522 HD13 HD11 ' A' ' 57' ' ' ILE . 11.9 tt -130.95 137.26 56.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.71 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.34 145.52 33.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.536 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -123.84 158.84 30.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.702 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -143.79 76.16 1.5 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.386 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -116.79 163.61 12.47 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.763 HD22 ' N ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -79.28 28.44 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.572 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.418 ' H ' ' C ' ' A' ' 105' ' ' GLY . 2.0 p -73.05 -174.41 1.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.538 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' A' ' 128' ' ' GLU . 3.0 m-20 -113.25 -24.9 9.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.716 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 t -151.21 101.52 2.86 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.959 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.539 ' O ' ' O ' ' A' ' 126' ' ' SER . 15.6 tt -138.39 135.6 44.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.896 0.379 . . . . 0.0 110.577 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.73 173.1 35.67 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 1.4 p -124.93 162.31 24.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.821 0.343 . . . . 0.0 110.771 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -149.07 158.25 44.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.457 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.9 mm -126.56 127.68 70.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.634 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.57 132.4 53.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.567 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.455 ' C ' ' N ' ' A' ' 118' ' ' GLY . 7.6 p -143.14 149.65 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.571 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.545 ' H ' ' N ' ' A' ' 51' ' ' MET . 5.9 m-20 48.89 15.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.391 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.455 ' N ' ' C ' ' A' ' 116' ' ' VAL . . . 77.69 1.42 77.46 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -116.79 126.88 53.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.731 0.3 . . . . 0.0 110.607 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.0 t -74.88 136.51 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.475 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -129.13 -33.59 1.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.841 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.06 129.53 14.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.486 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -151.58 126.73 9.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.807 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.564 ' NH2' HD21 ' A' ' 100' ' ' ASN . 0.2 OUTLIER -113.6 115.73 28.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.238 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.7 m -114.97 133.21 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.696 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.5 OUTLIER -132.61 115.88 15.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.454 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -97.81 130.03 44.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.393 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.517 ' O ' ' O ' ' A' ' 108' ' ' ASP . 3.9 mm-40 -138.68 130.77 28.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.908 0.385 . . . . 0.0 110.806 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.9 m -73.4 -4.04 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.266 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.2 73.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.059 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -73.31 100.86 3.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.659 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -138.34 22.64 2.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.445 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.4 p -58.22 174.43 0.29 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.644 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.57 ' O ' ' O ' ' A' ' 135' ' ' CYS . 1.2 m-85 -118.83 40.44 3.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.676 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . 0.57 ' O ' ' O ' ' A' ' 134' ' ' TYR . 0.1 OUTLIER 34.34 101.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.815 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' A' ' 136' ' ' LEU . 27.9 mt -49.5 131.38 20.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.506 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.7 p -177.21 -26.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.816 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -82.77 141.73 32.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.529 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.76 -38.66 91.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.514 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.584 179.983 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -112.57 126.16 55.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.558 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.45 HD13 HG23 ' A' ' 114' ' ' ILE . 11.6 tp -97.32 115.28 27.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.56 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.438 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -127.14 142.85 51.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.509 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -126.0 148.43 49.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.42 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.716 ' OE1' ' OG ' ' A' ' 87' ' ' SER . 11.7 tt0 -156.7 134.4 10.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.979 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.569 HG22 ' H ' ' A' ' 58' ' ' PHE . 20.7 mm -101.98 170.57 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.569 ' H ' HG22 ' A' ' 57' ' ' ILE . 29.5 m-85 -132.19 173.04 11.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 111.085 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.21 151.51 6.15 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -40.16 139.16 1.07 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.586 2.191 . . . . 0.0 111.938 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.75 135.56 36.02 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.588 2.192 . . . . 0.0 112.22 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.6 -0.89 58.22 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.7 m -86.21 139.37 31.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.792 0.33 . . . . 0.0 110.645 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 p -111.55 123.4 67.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.384 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -137.45 156.71 47.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.537 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.15 115.17 27.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.331 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.454 HG23 HD11 ' A' ' 101' ' ' ILE . 72.7 mt -105.34 131.18 55.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.708 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.5 t -134.74 125.94 27.99 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.952 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.661 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 42.7 t80 -145.87 158.98 43.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.834 0.35 . . . . 0.0 110.647 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.661 ' O ' ' CE2' ' A' ' 69' ' ' TYR . 4.6 t80 -88.83 136.72 32.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.679 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.32 116.71 32.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.36 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 72' ' ' VAL . 18.0 t -75.5 -5.81 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.758 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.92 -17.98 25.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.593 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.6 t -176.72 -127.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.714 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -94.52 150.95 38.89 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.515 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.37 139.69 90.91 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.53 2.153 . . . . 0.0 111.871 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.58 156.84 17.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.697 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.7 ttm-85 -141.52 125.12 16.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.515 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.31 118.44 58.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.513 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 0.9 OUTLIER -115.74 133.62 55.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.658 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.55 31.37 8.89 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.57 148.98 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.863 0.363 . . . . 0.0 110.455 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.5 t -81.62 -53.35 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.301 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.528 ' O ' ' NE1' ' A' ' 86' ' ' TRP . 0.2 OUTLIER -140.67 151.89 64.51 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.209 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.516 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 11.5 Cg_endo -57.15 158.17 18.84 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.8 2.333 . . . . 0.0 112.071 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.528 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 37.4 m95 -130.15 -160.6 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.485 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.716 ' OG ' ' OE1' ' A' ' 56' ' ' GLU . 71.2 m -132.86 144.98 50.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.016 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.564 HD23 ' H ' ' A' ' 89' ' ' HIS . 0.4 OUTLIER -128.48 144.1 51.09 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 178.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.762 ' H ' ' CD2' ' A' ' 89' ' ' HIS . 0.7 OUTLIER -108.29 124.87 50.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.919 0.39 . . . . 0.0 110.943 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.6 mt -130.58 128.58 63.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.087 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.26 122.54 47.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.858 0.361 . . . . 0.0 110.934 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.537 ' O ' ' C ' ' A' ' 93' ' ' ASN . 5.3 m -126.14 125.57 42.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.236 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.537 ' C ' ' O ' ' A' ' 92' ' ' THR . 1.2 m-20 28.77 -134.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.494 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -139.41 98.74 3.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.563 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 168.35 -171.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.573 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -91.24 135.96 33.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.62 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.92 159.42 36.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.452 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.03 146.55 51.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.746 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.77 151.54 18.35 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -112.12 114.99 28.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.723 0.297 . . . . 0.0 110.596 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.454 HD11 HG23 ' A' ' 67' ' ' ILE . 0.8 OUTLIER -133.29 139.13 49.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.515 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 103' ' ' ALA . 2.3 t -131.96 165.14 32.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.519 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.404 ' H ' HG12 ' A' ' 102' ' ' VAL . . . -143.61 148.13 35.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.447 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.46 63.97 1.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.175 0.512 . . . . 0.0 110.359 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -118.16 163.53 12.93 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.43 52.42 2.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.733 0.301 . . . . 0.0 110.636 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.1 m -88.98 -167.82 2.0 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.388 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -112.26 -42.42 3.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.805 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.3 t -128.01 128.06 44.31 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.99 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.537 ' O ' ' O ' ' A' ' 126' ' ' SER . 7.5 mt -141.75 148.08 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.706 0.289 . . . . 0.0 110.307 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 177.8 163.86 30.21 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -117.83 160.14 21.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 0.0 110.611 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -151.3 155.48 38.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.635 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.45 HG23 HD13 ' A' ' 53' ' ' LEU . 4.4 mt -138.32 114.93 10.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.424 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.9 p -117.24 126.81 53.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.619 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 t -125.46 134.62 66.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.27 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 52.0 23.25 2.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.476 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.6 8.37 87.16 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -119.06 126.18 51.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.631 0.253 . . . . 0.0 110.399 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.2 p -74.26 138.72 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.769 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -115.35 -68.22 0.94 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.278 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -142.79 126.98 17.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.276 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -148.28 129.23 14.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.89 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -95.36 127.44 41.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.374 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 125' ' ' VAL . 10.8 p -117.45 117.31 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.806 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.6 OUTLIER -126.82 115.97 20.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.377 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 128' ' ' GLU . 54.9 t-20 -96.98 130.21 44.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.642 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.416 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 14.5 mt-10 -141.72 130.45 22.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.36 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 130' ' ' ASN . 0.3 OUTLIER -82.74 92.56 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.655 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.569 ' O ' ' N ' ' A' ' 132' ' ' TYR . 1.0 OUTLIER 83.3 62.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.529 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.3 71.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.08 0.467 . . . . 0.0 110.572 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.569 ' N ' ' O ' ' A' ' 130' ' ' ASN . 3.8 t80 -126.03 42.64 3.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.41 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.558 ' O ' ' O ' ' A' ' 132' ' ' TYR . 0.7 OUTLIER -39.58 171.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.91 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.454 ' O ' ' SG ' ' A' ' 135' ' ' CYS . 41.7 t80 62.08 146.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.676 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 134' ' ' TYR . 1.4 m -168.86 144.53 3.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.463 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 81.6 mt -100.53 102.53 13.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.507 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 137' ' ' VAL . 14.6 p -147.14 -0.22 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.74 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.544 ' O ' ' O ' ' A' ' 137' ' ' VAL . 17.7 tttt 46.97 106.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.598 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 140' ' ' ALA . 5.4 m -77.81 -66.81 0.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.732 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 139' ' ' SER . . . . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.514 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.443 ' SD ' ' OD1' ' A' ' 117' ' ' ASP . 17.2 mmt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.95 117.65 33.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.439 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.57 114.85 26.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.39 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.5 t -127.47 140.82 51.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.786 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.454 ' HE2' HD11 ' A' ' 90' ' ' ILE . 37.4 p90 -127.57 149.34 50.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.282 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -155.66 154.75 32.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 0.0 110.931 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.595 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 4.9 mm -116.51 161.38 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.294 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.535 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 7.9 m-85 -134.96 158.6 43.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.709 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.37 167.95 36.41 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -46.65 148.77 3.4 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.737 2.291 . . . . 0.0 112.08 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -70.29 134.7 27.47 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.703 2.268 . . . . 0.0 112.091 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.61 1.39 71.26 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 95.9 m -81.25 135.53 35.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.908 0.385 . . . . 0.0 110.44 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.0 t -113.33 123.44 68.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.491 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.07 153.13 43.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.778 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.22 121.36 40.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.366 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.485 HD12 ' N ' ' A' ' 67' ' ' ILE . 1.9 mp -98.81 131.2 46.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.766 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.3 t -129.62 119.2 23.18 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.019 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.6 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 2.6 p90 -142.23 171.34 14.19 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.631 0.253 . . . . 0.0 110.443 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.636 ' CD1' ' O ' ' A' ' 70' ' ' PHE . 0.6 OUTLIER -87.57 130.68 34.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.492 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 72' ' ' VAL . 33.3 t0 -88.83 139.1 30.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.519 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.557 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 6.2 p -54.56 -25.93 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.805 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.31 8.94 25.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.74 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.5 m 69.6 62.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.523 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.425 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 21.0 tt0 -170.43 92.26 0.48 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.263 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -58.84 139.82 92.47 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.712 2.275 . . . . 0.0 112.342 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -108.23 155.61 20.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.732 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -137.37 125.58 23.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.265 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.5 m -106.69 120.91 58.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.844 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.69 129.05 53.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.385 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.07 13.8 58.47 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.79 128.03 34.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.742 0.306 . . . . 0.0 110.618 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.42 HG12 ' HG ' ' A' ' 84' ' ' LEU . 58.4 t -61.35 -96.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.307 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.507 ' CD1' ' H ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -90.0 158.42 44.44 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.924 0.392 . . . . 0.0 110.453 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.595 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 17.4 Cg_endo -60.41 154.87 50.28 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.992 2.462 . . . . 0.0 112.194 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.9 175.42 6.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.429 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.0 m -113.21 152.35 29.86 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.946 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tp -129.67 151.72 49.96 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.041 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.594 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -112.32 126.0 54.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 0.0 110.898 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.454 HD11 ' HE2' ' A' ' 55' ' ' TYR . 21.5 mt -131.09 132.46 63.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.48 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.85 129.3 56.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.541 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 p -122.61 140.62 52.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.627 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.546 ' O ' ' C ' ' A' ' 94' ' ' ASP . 3.3 p30 -74.89 108.61 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.801 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.546 ' C ' ' O ' ' A' ' 93' ' ' ASN . 1.4 t70 26.39 83.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.642 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 177.59 139.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.549 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.02 125.01 42.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.718 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.1 t -141.38 123.73 14.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.503 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.85 136.0 33.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.499 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.41 148.7 20.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -102.87 115.59 30.89 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.5 tt -130.18 142.07 44.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.892 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 103' ' ' ALA . 69.4 t -136.7 162.64 34.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.224 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.561 ' N ' HG12 ' A' ' 102' ' ' VAL . . . -142.98 144.83 32.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.698 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.602 ' OE1' ' CZ ' ' A' ' 132' ' ' TYR . 3.2 mt-30 -120.52 42.75 2.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.401 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -96.32 157.82 21.53 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.408 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 4.9 p30 -79.3 26.79 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.743 0.306 . . . . 0.0 110.536 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.564 ' OG ' ' N ' ' A' ' 108' ' ' ASP . 12.3 t -63.97 -173.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.483 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.564 ' N ' ' OG ' ' A' ' 107' ' ' SER . 12.8 t0 -119.45 -58.85 1.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.778 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.2 t -99.96 98.25 9.03 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.987 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 6.9 mt -117.02 149.37 19.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.74 0.305 . . . . 0.0 110.341 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.9 161.59 26.83 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.592 ' SG ' ' N ' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -118.74 157.55 27.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 110.95 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.719 ' C ' HD12 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -151.3 138.24 19.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.342 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.719 HD12 ' C ' ' A' ' 113' ' ' ARG . 1.7 mp -125.7 125.71 68.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.719 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 p -123.54 129.23 50.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.38 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.2 p -126.53 126.04 68.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.594 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.443 ' OD1' ' SD ' ' A' ' 51' ' ' MET . 4.0 t70 65.13 12.23 7.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.559 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.73 -4.53 84.62 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -96.61 132.43 42.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.861 0.362 . . . . 0.0 110.46 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 120' ' ' VAL . 7.3 p -84.69 125.09 40.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.566 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.9 mmt85 -127.28 -53.99 1.37 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.612 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -119.46 129.17 54.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.502 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -151.59 122.86 7.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.37 118.93 33.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.261 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.3 t -127.46 118.99 51.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.069 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -133.17 116.98 16.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.323 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.23 128.78 40.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.909 0.385 . . . . 0.0 110.859 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.587 ' C ' ' H ' ' A' ' 130' ' ' ASN . 0.8 OUTLIER -157.9 130.35 7.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.381 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 129' ' ' VAL . 74.0 t -63.17 6.27 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.034 0.445 . . . . 0.0 110.163 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.587 ' H ' ' C ' ' A' ' 128' ' ' GLU . 0.7 OUTLIER -167.31 66.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.161 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.68 38.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.751 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.602 ' CZ ' ' OE1' ' A' ' 104' ' ' GLN . 28.0 t80 -177.15 111.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.529 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.558 ' O ' ' C ' ' A' ' 134' ' ' TYR . 0.2 OUTLIER -116.94 95.99 5.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.806 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.558 ' C ' ' O ' ' A' ' 133' ' ' THR . 2.0 m-85 23.38 -138.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.093 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -168.03 111.62 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.523 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -55.92 -178.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.636 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.52 105.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.514 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -125.03 -61.56 1.29 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.49 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.06 83.58 0.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.477 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.534 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.682 -179.895 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.44 ' O ' ' CG ' ' A' ' 52' ' ' HIS . 9.7 p-80 -105.96 128.44 53.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.401 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.578 ' CD1' ' O ' ' A' ' 97' ' ' VAL . 1.6 tt -97.01 115.52 27.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.618 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.03 139.53 52.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.642 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.468 ' CE1' HG21 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -121.37 148.52 44.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.243 179.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -156.25 144.01 19.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.932 0.396 . . . . 0.0 111.087 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.597 HG22 ' N ' ' A' ' 58' ' ' PHE . 6.1 mm -115.23 167.47 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.483 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.597 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -140.97 163.87 31.8 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.524 -0.471 . . . . 0.0 111.172 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.62 165.39 37.84 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.584 ' O ' ' OG1' ' A' ' 63' ' ' THR . 71.3 Cg_exo -41.71 166.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.882 2.388 . . . . 0.0 111.985 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -80.14 116.64 3.4 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.723 2.282 . . . . 0.0 112.283 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.08 12.9 62.89 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.584 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -86.22 148.84 25.46 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.46 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 64' ' ' VAL . 11.4 m -112.32 122.69 67.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.549 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.21 143.56 32.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.463 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.75 126.97 40.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.535 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.459 ' H ' HG13 ' A' ' 79' ' ' VAL . 3.7 mp -107.81 126.57 64.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.503 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.4 t -130.71 125.49 34.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.921 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.774 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 31.2 p90 -146.42 169.97 17.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.727 0.299 . . . . 0.0 110.561 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -85.98 119.19 26.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.579 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 73' ' ' ASN . 4.2 t0 -90.97 105.9 18.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.507 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 72' ' ' VAL . 61.6 t -59.1 -5.07 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.659 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.516 ' O ' ' CB ' ' A' ' 74' ' ' SER . 0.3 OUTLIER -77.58 -21.5 52.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.726 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.7 t 159.56 -93.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.715 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.497 ' N ' ' OG ' ' A' ' 74' ' ' SER . 8.1 pt-20 -100.91 148.92 35.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.616 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.29 145.69 49.1 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.759 2.306 . . . . 0.0 112.339 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.774 ' NE2' ' CE1' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -107.69 154.76 21.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.599 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 -132.08 135.08 46.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.579 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.459 HG13 ' H ' ' A' ' 67' ' ' ILE . 1.7 p -116.96 125.51 73.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.59 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -136.87 134.2 36.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.489 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.03 7.66 59.54 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.81 153.26 35.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.733 0.301 . . . . 0.0 110.604 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.805 HG13 ' HG ' ' A' ' 84' ' ' LEU . 3.0 p -90.86 -30.47 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.449 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.805 ' HG ' HG13 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -156.92 154.3 26.14 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 110.733 179.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.569 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 18.7 Cg_endo -61.64 158.47 36.97 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.873 2.382 . . . . 0.0 112.111 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -121.42 -160.13 0.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.54 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.1 t -136.3 138.24 41.52 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.969 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.487 HD23 ' H ' ' A' ' 89' ' ' HIS . 0.5 OUTLIER -128.21 143.45 51.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.728 0.299 . . . . 0.0 110.29 179.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.646 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -105.94 121.07 43.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.771 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.1 mp -121.47 130.63 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.567 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.9 p -112.69 131.61 55.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.495 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.57 157.57 21.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.553 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -52.94 -16.37 1.02 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.418 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -103.37 -115.94 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.538 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -166.33 -56.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.698 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.31 121.77 37.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.576 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.578 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 39.9 t -150.69 160.92 3.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.537 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.527 ' N ' ' CG1' ' A' ' 97' ' ' VAL . 4.8 mtt -121.62 157.45 30.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.408 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -142.96 148.31 20.01 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -102.96 118.28 36.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.796 0.331 . . . . 0.0 110.479 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.468 HG21 ' CE1' ' A' ' 55' ' ' TYR . 14.9 tt -133.19 142.13 42.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.546 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 103' ' ' ALA . 38.5 t -140.68 163.73 22.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.662 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.574 ' N ' HG12 ' A' ' 102' ' ' VAL . . . -138.42 158.68 43.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.408 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -135.64 75.74 1.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.73 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.23 155.23 19.25 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.0 55.2 1.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 110.359 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.649 ' OG ' ' N ' ' A' ' 108' ' ' ASP . 6.3 t -85.48 -167.56 1.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.712 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.649 ' N ' ' OG ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -119.84 -14.21 9.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.594 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.9 t -159.24 125.39 4.44 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.971 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.577 ' O ' ' O ' ' A' ' 126' ' ' SER . 26.1 mt -138.03 158.16 32.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.728 0.299 . . . . 0.0 110.514 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.489 ' N ' ' CG2' ' A' ' 110' ' ' ILE . . . -177.2 156.74 20.93 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.532 ' O ' ' O ' ' A' ' 124' ' ' ARG . 3.8 p -122.57 151.73 41.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.659 0.266 . . . . 0.0 110.449 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -160.01 148.22 16.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.663 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.68 123.22 56.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.802 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 72.5 p -119.16 136.53 54.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.333 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.417 ' C ' ' H ' ' A' ' 118' ' ' GLY . 84.9 t -132.44 149.09 31.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.792 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 55.39 8.88 0.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.58 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 116' ' ' VAL . . . 79.81 11.02 85.07 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -116.8 135.24 53.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.769 0.319 . . . . 0.0 110.546 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 71.9 t -70.08 120.57 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.616 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.424 ' NH1' ' HB3' ' A' ' 121' ' ' ARG . 4.0 mtp-105 -116.53 -72.26 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.655 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.22 134.92 46.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.676 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -149.65 157.19 43.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.489 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.532 ' O ' ' O ' ' A' ' 112' ' ' CYS . 7.5 ttt85 -123.52 130.14 52.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.646 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 54.6 t -114.03 118.52 58.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.527 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.577 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.7 OUTLIER -132.77 121.93 23.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.509 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -106.34 129.63 54.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.7 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 131' ' ' ALA . 3.9 mt-10 -157.35 133.88 9.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.496 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' A' ' 130' ' ' ASN . 4.2 m -82.64 135.88 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.433 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 107' ' ' SER . 1.7 m-80 36.26 53.36 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.443 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . . . -63.34 95.08 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.722 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.513 ' O ' ' CG ' ' A' ' 132' ' ' TYR . 1.9 p90 -131.79 22.26 4.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.319 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 69.9 p -67.01 117.79 9.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.682 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.45 ' O ' ' CB ' ' A' ' 135' ' ' CYS . 2.7 t80 -100.39 66.31 1.26 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.642 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . 0.45 ' CB ' ' O ' ' A' ' 134' ' ' TYR . 0.1 OUTLIER 77.71 25.73 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.595 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.443 ' N ' ' CD2' ' A' ' 136' ' ' LEU . 3.8 mm? -73.12 128.87 36.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.613 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.903 HG23 ' H ' ' A' ' 138' ' ' LYS . 16.1 m -130.82 -65.06 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.78 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.903 ' H ' HG23 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -53.56 -60.41 3.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.614 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.0 t 70.11 -76.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.606 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.373 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.55 179.975 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 30.8 mtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -110.95 123.68 50.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.326 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.661 ' C ' HD23 ' A' ' 53' ' ' LEU . 6.9 tt -95.84 114.58 26.33 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.286 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.423 ' N ' HD23 ' A' ' 53' ' ' LEU . 10.7 p -127.34 132.85 50.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.771 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 13.0 p90 -123.69 148.17 46.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.373 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.53 149.48 23.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.658 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.555 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -109.19 175.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.104 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -139.96 147.67 40.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.724 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.32 157.97 29.64 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -42.19 161.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.88 2.386 . . . . 0.0 112.164 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.41 122.77 7.21 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.933 2.422 . . . . 0.0 112.293 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.43 11.18 59.85 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.5 m -83.28 130.81 35.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 0.0 110.549 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -113.94 121.73 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.577 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.42 155.73 44.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.661 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -95.44 115.8 27.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.105 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.453 HD12 ' H ' ' A' ' 67' ' ' ILE . 3.3 mp -99.95 134.72 38.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.739 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.5 t -135.58 132.39 37.11 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.974 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 77' ' ' GLN . 24.1 p90 -145.31 164.7 30.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.766 0.317 . . . . 0.0 110.531 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.14 135.44 33.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.484 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -98.65 152.38 19.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.588 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 p -63.84 -31.23 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.549 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.629 ' O ' ' CB ' ' A' ' 74' ' ' SER . 18.3 m-20 -75.78 2.84 11.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.494 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.629 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.0 OUTLIER 91.34 -52.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.281 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -60.0 113.98 8.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.13 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -74.5 141.28 28.03 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.245 1.964 . . . . 0.0 112.25 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 69' ' ' TYR . 24.5 tt0 -107.14 145.61 32.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.621 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -139.4 130.45 26.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.536 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.8 t -105.05 123.22 59.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.549 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 81' ' ' GLY . 19.5 t0 -121.96 134.71 54.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.675 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.488 ' N ' ' OD1' ' A' ' 80' ' ' ASP . . . 94.17 18.35 36.93 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.31 128.53 35.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.761 0.315 . . . . 0.0 110.563 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.818 HG13 ' HG ' ' A' ' 84' ' ' LEU . 2.2 p -76.78 -14.63 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.519 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.818 ' HG ' HG13 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -159.72 155.96 23.69 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.562 179.664 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.555 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 11.7 Cg_endo -57.08 152.95 41.39 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.989 2.46 . . . . 0.0 112.273 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.64 162.17 18.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.413 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 72.6 m -110.29 139.13 45.77 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.988 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 tp -130.41 140.46 50.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.767 0.318 . . . . 0.0 110.438 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.529 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 1.0 OUTLIER -110.73 119.27 38.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.621 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 64.0 mt -129.07 130.02 68.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.324 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.61 123.66 47.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.864 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.62 ' C ' ' H ' ' A' ' 94' ' ' ASP . 0.2 OUTLIER -99.35 153.34 19.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.247 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -60.31 7.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.621 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.62 ' H ' ' C ' ' A' ' 92' ' ' THR . 11.1 t0 -123.26 -103.28 0.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.489 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 168.81 -56.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.686 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -88.55 114.65 25.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.548 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.408 ' O ' HD11 ' A' ' 53' ' ' LEU . 13.8 p -168.47 144.74 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.936 0.398 . . . . 0.0 110.835 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -121.13 143.21 49.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.354 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.595 ' C ' HD22 ' A' ' 100' ' ' ASN . . . -111.09 162.6 12.43 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.595 HD22 ' C ' ' A' ' 99' ' ' GLY . 1.0 OUTLIER -104.89 117.94 35.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.754 0.311 . . . . 0.0 110.519 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 101' ' ' ILE . 13.2 tt -131.18 131.75 63.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.698 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.15 147.61 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.483 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -128.8 138.38 52.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.662 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.638 ' NE2' ' OG1' ' A' ' 133' ' ' THR . 10.5 mm100 -122.56 73.17 1.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.452 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.73 163.37 20.67 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.62 ' OD1' ' ND2' ' A' ' 130' ' ' ASN . 24.9 t30 -84.0 37.89 0.62 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.749 0.309 . . . . 0.0 110.767 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.74 ' OG ' HD11 ' A' ' 110' ' ' ILE . 4.5 p -70.23 -177.68 1.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.531 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.49 -40.13 5.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.632 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.5 t -137.0 115.91 12.28 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.981 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.74 HD11 ' OG ' ' A' ' 107' ' ' SER . 10.3 mt -117.55 159.82 17.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.844 0.354 . . . . 0.0 110.529 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.547 ' N ' HG22 ' A' ' 110' ' ' ILE . . . 174.8 149.24 7.08 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.524 ' O ' ' O ' ' A' ' 124' ' ' ARG . 11.7 p -117.92 151.88 36.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.735 0.302 . . . . 0.0 110.587 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -154.31 154.85 34.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.507 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.639 ' O ' HG23 ' A' ' 120' ' ' VAL . 4.0 mp -137.54 124.4 28.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.581 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.3 p -122.35 141.17 51.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.686 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 119' ' ' LYS . 15.6 m -146.0 149.27 16.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.521 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 t0 49.41 17.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.639 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.411 ' N ' ' C ' ' A' ' 116' ' ' VAL . . . 84.87 -9.59 65.32 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 116' ' ' VAL . 15.9 mttm -112.07 124.72 53.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 0.0 110.539 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 114' ' ' ILE . 6.1 p -82.24 124.65 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.575 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -94.27 -34.91 12.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.531 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -141.05 141.28 34.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.505 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -148.99 122.47 9.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.783 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.524 ' O ' ' O ' ' A' ' 112' ' ' CYS . 27.2 mtt85 -127.29 115.87 19.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.205 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.25 118.23 54.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.001 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.9 OUTLIER -120.1 118.57 30.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.153 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.491 ' O ' ' OE1' ' A' ' 128' ' ' GLU . 2.7 m120 -94.23 129.9 40.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.842 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 131' ' ' ALA . 0.3 OUTLIER -151.21 136.55 17.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.383 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 52.2 t -95.98 128.61 47.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.779 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.62 ' ND2' ' OD1' ' A' ' 106' ' ' ASN . 7.8 m120 60.89 35.75 19.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.911 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.597 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . . . -62.11 124.16 20.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.338 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.647 ' O ' ' CD2' ' A' ' 132' ' ' TYR . 88.9 t80 -154.85 22.89 0.45 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.695 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.638 ' OG1' ' NE2' ' A' ' 104' ' ' GLN . 0.2 OUTLIER 81.39 115.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.571 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -72.46 -134.21 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.623 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . 0.511 ' O ' ' N ' ' A' ' 137' ' ' VAL . 7.6 t -148.01 -80.91 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.425 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.792 HD22 ' H ' ' A' ' 136' ' ' LEU . 3.5 mm? 33.7 -94.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.435 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.538 ' O ' ' C ' ' A' ' 138' ' ' LYS . 14.8 m -62.98 145.94 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.586 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.573 ' O ' ' O ' ' A' ' 139' ' ' SER . 15.4 pttt 27.81 -124.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.526 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.573 ' O ' ' O ' ' A' ' 138' ' ' LYS . 46.1 t 47.0 173.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.43 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.52 ' O ' ' O ' ' A' ' 139' ' ' SER . . . . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.597 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -102.48 120.0 39.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.453 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.835 ' C ' HD23 ' A' ' 53' ' ' LEU . 5.9 tt -96.19 115.87 28.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.743 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.627 ' N ' HD23 ' A' ' 53' ' ' LEU . 1.1 t -126.71 132.55 51.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.348 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -120.08 149.75 41.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.849 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.424 ' OE1' ' CD2' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -155.66 141.76 18.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.671 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.563 HD11 HG21 ' A' ' 101' ' ' ILE . 4.5 mp -112.12 157.76 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.188 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.656 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -133.07 170.83 14.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.98 0.419 . . . . 0.0 111.047 -179.606 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.24 179.97 39.99 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -47.44 158.66 0.58 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.648 2.232 . . . . 0.0 112.062 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.0 110.95 3.05 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.77 2.313 . . . . 0.0 112.159 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.51 8.91 57.1 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -85.2 141.19 30.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.742 0.306 . . . . 0.0 110.527 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.45 130.67 59.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.307 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -135.67 155.7 50.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.637 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.599 ' OD2' ' NE2' ' A' ' 104' ' ' GLN . 11.6 p-10 -97.96 127.6 44.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.445 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.69 HG23 HD11 ' A' ' 101' ' ' ILE . 3.4 mp -99.31 120.73 49.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.638 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.1 t -135.65 117.04 14.67 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.987 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -143.83 171.11 14.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.768 0.318 . . . . 0.0 110.431 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -83.96 128.25 34.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.551 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' A' ' 72' ' ' VAL . 15.3 t0 -91.3 142.9 27.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.607 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.567 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 1.0 OUTLIER -63.68 -25.03 37.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.554 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.427 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 0.9 OUTLIER -96.36 11.43 34.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.454 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 70.26 15.75 7.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.345 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 71' ' ' ASP . 1.9 tt0 -118.52 93.03 44.99 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.295 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -77.43 139.64 18.59 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.463 2.109 . . . . 0.0 112.333 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.435 ' HG2' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -107.67 143.34 36.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.572 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.435 ' N ' ' HG2' ' A' ' 77' ' ' GLN . 14.4 mtp-105 -139.65 125.35 19.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.536 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.7 m -107.66 134.5 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.621 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.632 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -104.91 142.46 34.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.451 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.54 31.81 81.03 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.52 131.26 34.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.842 0.353 . . . . 0.0 110.524 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.418 ' H ' HG12 ' A' ' 83' ' ' VAL . 1.8 p -87.05 113.5 24.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.514 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tp 60.51 118.34 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.462 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -55.24 160.96 7.62 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.953 1.769 . . . . 0.0 111.844 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.584 ' CD1' ' C ' ' A' ' 86' ' ' TRP . 0.1 OUTLIER -112.14 -172.69 2.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.655 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 92.1 p -111.19 155.46 22.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 89' ' ' HIS . 6.3 tp -140.25 143.77 36.13 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.495 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.573 ' N ' ' CD2' ' A' ' 89' ' ' HIS . 0.2 OUTLIER -107.6 128.1 54.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.765 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.5 mt -125.55 130.83 72.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.487 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -122.95 122.76 39.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.747 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.553 ' O ' ' C ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -117.58 156.82 27.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.465 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.553 ' C ' ' O ' ' A' ' 92' ' ' THR . 4.4 m-20 -24.15 -60.13 0.05 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.841 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.447 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 0.3 OUTLIER 165.51 92.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.546 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -175.33 133.94 0.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.53 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.55 116.17 15.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.614 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.5 p -139.26 138.26 40.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.426 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.42 165.26 12.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.684 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -127.45 144.24 14.96 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -103.46 119.77 39.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.75 0.31 . . . . 0.0 110.736 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.69 HD11 HG23 ' A' ' 67' ' ' ILE . 7.5 tt -133.02 136.63 55.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.698 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.0 t -127.85 149.34 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.308 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -120.8 148.63 43.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 0.0 110.76 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.599 ' NE2' ' OD2' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -119.32 51.38 1.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.576 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -112.16 159.47 13.7 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -81.95 62.23 5.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.771 0.319 . . . . 0.0 110.62 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.444 ' OG ' ' CD1' ' A' ' 110' ' ' ILE . 77.4 p -93.95 -172.84 2.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.504 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 109' ' ' SER . 26.6 m-20 -131.65 20.78 4.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.619 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 87.8 p 177.4 91.42 0.01 OUTLIER 'General case' 0 C--O 1.244 0.787 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.983 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.567 ' O ' ' O ' ' A' ' 126' ' ' SER . 12.0 mt -115.96 128.43 73.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 120.772 0.32 . . . . 0.0 110.325 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -152.48 173.34 31.56 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -119.9 165.14 15.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.713 0.292 . . . . 0.0 110.475 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.656 ' NH1' ' OE1' ' A' ' 123' ' ' GLU . 5.6 ttm-85 -154.46 139.49 17.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.588 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.423 ' H ' ' HB3' ' A' ' 123' ' ' GLU . 4.4 mm -134.07 114.02 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.517 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.7 m -117.93 138.0 52.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.656 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 119' ' ' LYS . 30.4 m -140.62 148.78 21.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.732 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.425 ' C ' ' H ' ' A' ' 119' ' ' LYS . 34.1 m-20 44.97 26.57 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.73 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.99 -9.66 5.04 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 116' ' ' VAL . 14.1 mttp -106.28 127.37 53.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.751 0.31 . . . . 0.0 110.363 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.76 130.95 32.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.929 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -105.85 -67.78 0.91 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.419 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -150.47 132.33 15.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.364 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.656 ' OE1' ' NH1' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -150.67 146.88 26.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.585 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -109.74 121.77 45.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.576 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.63 ' O ' HG23 ' A' ' 125' ' ' VAL . 16.3 m -114.54 118.24 58.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.546 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.567 ' O ' ' O ' ' A' ' 110' ' ' ILE . 24.3 p -124.37 117.62 24.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.513 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' A' ' 127' ' ' ASN . 0.8 OUTLIER -99.57 129.85 45.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.414 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.05 145.09 21.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.681 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.402 ' H ' HG13 ' A' ' 129' ' ' VAL . 2.2 m -70.3 -17.8 21.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.625 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -167.55 98.57 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.407 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.78 166.79 23.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.422 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 30.1 t80 66.26 69.47 0.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.463 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.7 m -160.91 -19.84 0.05 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.559 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -51.09 111.01 0.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.543 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . 0.568 ' SG ' ' N ' ' A' ' 136' ' ' LEU . 2.8 t -136.93 158.04 45.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.459 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.568 ' N ' ' SG ' ' A' ' 135' ' ' CYS . 1.8 mp -99.45 -122.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.592 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.13 34.29 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.526 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -144.71 175.02 10.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.681 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 m -101.86 -9.72 20.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.544 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.064 -0.969 . . . . 0.0 110.547 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 27.3 mmm . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -110.18 123.12 49.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.45 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.757 ' C ' HD23 ' A' ' 53' ' ' LEU . 5.8 tt -95.79 115.79 27.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.214 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.657 ' N ' HD23 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -126.33 139.52 53.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.704 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -119.82 149.83 41.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.018 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.79 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 0.3 OUTLIER -154.44 134.75 13.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.983 0.421 . . . . 0.0 110.954 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.572 HG22 ' H ' ' A' ' 58' ' ' PHE . 4.5 mm -97.76 170.32 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.587 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.572 ' H ' HG22 ' A' ' 57' ' ' ILE . 4.9 t80 -142.6 154.38 44.36 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.782 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.498 ' N ' ' CD1' ' A' ' 58' ' ' PHE . . . -168.48 173.97 43.19 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.559 ' C ' ' HG1' ' A' ' 63' ' ' THR . 1.3 Cg_endo -47.02 167.79 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 122.793 2.328 . . . . 0.0 111.936 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.33 117.63 5.18 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.857 2.371 . . . . 0.0 112.265 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.2 18.21 67.52 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.559 ' HG1' ' C ' ' A' ' 60' ' ' PRO . 4.0 m -72.31 132.0 43.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.807 0.337 . . . . 0.0 110.607 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 64' ' ' VAL . 5.2 m -108.03 122.93 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.578 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -141.34 155.92 45.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.295 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.45 126.98 42.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.621 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.607 HG23 HD11 ' A' ' 101' ' ' ILE . 2.6 mp -108.3 136.68 43.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.582 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.4 t -134.33 116.84 15.71 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.973 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.533 ' CG ' ' N ' ' A' ' 70' ' ' PHE . 50.5 t80 -143.96 165.08 28.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.753 0.311 . . . . 0.0 110.508 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.533 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 29.4 t80 -84.89 120.37 26.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.608 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -84.69 135.5 34.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.559 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.7 p -70.04 -15.25 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.69 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.643 ' O ' ' CB ' ' A' ' 74' ' ' SER . 3.9 t30 -78.81 -21.99 46.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.698 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.643 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 2.0 t 149.79 -104.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.567 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.617 ' N ' ' OG ' ' A' ' 74' ' ' SER . 0.4 OUTLIER -62.78 152.92 81.09 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.756 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -72.09 145.41 44.39 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.877 2.385 . . . . 0.0 112.289 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -102.74 144.48 31.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.32 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -144.87 138.37 26.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.952 0.406 . . . . 0.0 110.963 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.8 m -115.39 131.86 66.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.209 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.67 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -121.45 149.31 43.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.922 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 61.69 -6.59 0.21 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.551 ' H ' ' C ' ' A' ' 80' ' ' ASP . . . -63.94 134.42 55.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 0.0 110.573 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.536 ' O ' ' C ' ' A' ' 84' ' ' LEU . 3.6 m -47.5 -176.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.55 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.639 ' N ' HD23 ' A' ' 84' ' ' LEU . 1.8 pt? -28.46 148.04 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.62 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -56.15 146.51 70.47 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.757 2.305 . . . . 0.0 112.233 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -112.29 -166.52 1.09 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.556 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.79 ' OG ' ' HB2' ' A' ' 56' ' ' GLU . 59.2 m -117.85 165.1 14.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.959 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.59 HD23 ' H ' ' A' ' 89' ' ' HIS . 0.4 OUTLIER -135.79 155.19 50.74 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.627 178.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.59 ' H ' HD23 ' A' ' 88' ' ' LEU . 7.4 m80 -114.12 124.34 51.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.598 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.513 HD13 ' O ' ' A' ' 89' ' ' HIS . 3.0 mm -129.57 124.72 60.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.445 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 p -119.38 128.46 54.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.562 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.66 133.59 48.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.585 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -61.06 -7.3 2.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.618 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 45.0 t0 -73.51 -95.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.656 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 177.07 -92.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.234 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.68 121.31 29.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.319 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.86 155.75 37.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.785 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.78 146.32 52.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.263 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -130.89 162.12 23.47 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.12 114.64 22.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.707 0.289 . . . . 0.0 110.356 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.607 HD11 HG23 ' A' ' 67' ' ' ILE . 1.1 tt -133.33 140.38 47.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.706 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.6 p -142.21 146.8 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.584 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -129.85 144.32 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.664 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -125.7 76.84 1.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.498 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.96 160.9 13.26 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.555 ' O ' ' O ' ' A' ' 107' ' ' SER . 1.4 m-20 -79.47 13.58 1.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.743 0.306 . . . . 0.0 110.494 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.555 ' O ' ' O ' ' A' ' 106' ' ' ASN . 25.3 p -48.54 -170.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.578 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -104.35 -15.03 15.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.553 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.0 t -168.78 122.36 0.84 Allowed 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.982 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 126' ' ' SER . 11.2 mt -125.93 138.62 53.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.724 0.297 . . . . 0.0 110.49 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.7 160.38 31.01 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 31.8 p -118.52 155.08 31.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 0.0 110.678 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.31 144.51 22.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.662 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.641 ' CG2' HD11 ' A' ' 53' ' ' LEU . 2.3 mt -138.31 114.95 10.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.389 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.71 140.78 49.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.723 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.7 p -145.76 150.09 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.476 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.6 10.99 2.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.483 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 83.64 -3.48 85.07 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.453 ' HB3' ' NH2' ' A' ' 121' ' ' ARG . 13.8 tptm -121.21 137.33 54.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.775 0.321 . . . . 0.0 110.569 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.452 ' H ' HG13 ' A' ' 120' ' ' VAL . 1.2 m -73.96 143.77 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.539 ' HE ' ' CA ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -111.7 -60.09 1.9 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.383 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.5 126.94 5.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.249 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -151.69 129.33 11.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.83 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.484 ' HA ' ' HE ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -98.02 115.71 28.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.326 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 74.2 t -114.99 117.55 56.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.687 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 110' ' ' ILE . 16.6 m -131.88 132.61 43.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.621 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.28 138.17 32.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.24 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -150.21 130.76 13.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.934 0.397 . . . . 0.0 110.831 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.629 HG12 ' OD1' ' A' ' 130' ' ' ASN . 2.0 t -93.71 122.03 44.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.432 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.629 ' OD1' HG12 ' A' ' 129' ' ' VAL . 0.4 OUTLIER 70.9 39.86 0.99 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.685 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.14 67.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.362 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.678 ' CG ' ' O ' ' A' ' 132' ' ' TYR . 37.1 t80 -139.91 21.53 2.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.539 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 73.4 p -152.73 -124.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.654 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -110.91 80.4 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.588 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 1.5 t -51.74 104.36 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.537 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 60.2 mt -76.21 100.83 5.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.595 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -113.16 23.09 5.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.471 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 29.1 mttm -77.88 76.58 4.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.615 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.573 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -63.83 112.95 3.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.498 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.573 ' O ' ' O ' ' A' ' 139' ' ' SER . . . . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.604 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.5 mtp . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -91.1 128.15 36.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.22 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 97' ' ' VAL . 35.7 tp -97.5 114.9 26.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.814 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.4 t -127.78 133.41 49.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.533 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.572 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -121.8 149.47 43.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 0.0 110.461 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.736 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -155.52 143.66 20.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.808 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.6 HG22 ' N ' ' A' ' 58' ' ' PHE . 42.9 mm -111.22 167.81 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.917 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.6 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -129.42 173.57 10.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.013 0.435 . . . . 0.0 110.989 -179.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.47 157.57 10.4 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -43.64 155.58 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.495 2.13 . . . . 0.0 112.034 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -66.94 117.9 5.14 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.844 2.363 . . . . 0.0 112.27 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.85 3.78 58.04 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.866 HG23 HD21 ' A' ' 106' ' ' ASN . 98.9 m -86.77 139.94 30.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 0.0 110.739 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.464 HG11 ' HA2' ' A' ' 81' ' ' GLY . 2.4 m -106.78 131.41 56.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.389 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.94 149.34 50.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.649 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 104' ' ' GLN . 0.0 OUTLIER -99.14 121.8 41.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.44 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.524 HD12 ' N ' ' A' ' 67' ' ' ILE . 2.1 mp -108.14 125.78 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.566 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.5 t -127.62 116.26 20.05 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.032 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -151.38 170.85 18.54 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.806 0.336 . . . . 0.0 110.636 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.486 ' CE1' ' O ' ' A' ' 71' ' ' ASP . 52.1 t80 -84.19 133.11 34.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.737 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.486 ' O ' ' CE1' ' A' ' 70' ' ' PHE . 21.1 t0 -104.44 149.6 25.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.555 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.82 -33.76 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.684 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -80.47 11.35 3.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.632 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.58 47.55 10.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.503 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.421 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 66.8 mt-10 -149.38 96.8 3.62 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.45 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.25 139.61 90.89 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.453 2.102 . . . . 0.0 111.893 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 67' ' ' ILE . 11.9 mt-30 -107.84 132.09 53.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.755 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 -131.84 129.39 40.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.345 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.7 m -120.3 136.64 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.857 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.9 143.62 51.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.343 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.464 ' HA2' HG11 ' A' ' 64' ' ' VAL . . . 58.95 13.61 20.07 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.21 147.53 31.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.758 0.314 . . . . 0.0 110.642 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.565 ' O ' ' O ' ' A' ' 84' ' ' LEU . 4.1 p -52.25 165.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.424 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.565 ' O ' ' O ' ' A' ' 83' ' ' VAL . 0.3 OUTLIER -27.49 149.46 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.941 0.4 . . . . 0.0 110.813 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.59 141.01 94.11 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.902 2.401 . . . . 0.0 112.251 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -113.17 -168.88 1.39 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.547 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.736 ' OG ' ' HB2' ' A' ' 56' ' ' GLU . 59.6 m -115.34 155.44 27.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.008 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.405 ' C ' ' ND1' ' A' ' 89' ' ' HIS . 0.7 OUTLIER -135.21 151.24 50.44 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.22 178.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.759 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -125.61 127.35 46.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.006 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mt -130.81 134.58 61.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.343 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 m -120.96 131.5 54.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.498 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.542 ' O ' ' C ' ' A' ' 93' ' ' ASN . 91.8 m -117.14 135.06 54.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.529 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.542 ' C ' ' O ' ' A' ' 92' ' ' THR . 73.0 m-80 28.05 -93.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.641 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 92' ' ' THR . 11.1 t70 -172.33 76.25 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.688 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -171.62 167.09 6.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.6 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.648 ' HB1' HG21 ' A' ' 116' ' ' VAL . . . -69.67 151.1 46.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.293 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.411 ' O ' HD13 ' A' ' 53' ' ' LEU . 93.0 t -153.12 151.21 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.0 0.428 . . . . 0.0 110.937 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -120.05 173.25 7.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.891 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.4 142.76 8.55 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.587 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -104.11 116.38 32.11 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.28 140.29 48.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.98 0.419 . . . . 0.0 111.039 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.1 148.99 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.263 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.412 ' O ' HG21 ' A' ' 110' ' ' ILE . . . -135.83 135.02 39.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 110.696 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.418 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 7.6 mt-30 -127.77 83.95 2.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.608 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.62 163.91 14.92 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.866 HD21 HG23 ' A' ' 63' ' ' THR . 0.0 OUTLIER -78.71 49.6 0.91 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.854 0.359 . . . . 0.0 110.418 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.48 ' OG ' ' N ' ' A' ' 108' ' ' ASP . 28.9 t -92.94 -172.37 2.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.515 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.48 ' N ' ' OG ' ' A' ' 107' ' ' SER . 4.8 m-20 -97.62 -38.35 9.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.535 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.539 ' HB2' HD21 ' A' ' 127' ' ' ASN . 44.2 t -141.01 112.04 7.2 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.987 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 126' ' ' SER . 5.4 mt -112.63 123.02 67.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.856 0.36 . . . . 0.0 110.677 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -150.51 173.5 30.1 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 11.8 p -127.9 165.98 19.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.743 0.306 . . . . 0.0 110.494 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 113' ' ' ARG . 18.4 mtm-85 -151.32 144.04 24.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.489 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.4 mm -127.79 115.97 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.568 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 81.8 p -122.0 122.01 38.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.465 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.648 HG21 ' HB1' ' A' ' 96' ' ' ALA . 3.5 p -145.65 150.86 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.764 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.9 t70 58.54 16.86 4.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.647 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.91 -1.6 10.03 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -117.52 137.86 52.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.596 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.413 ' O ' ' CG1' ' A' ' 120' ' ' VAL . 2.0 p -78.75 132.28 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.615 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.4 mtm-85 -123.46 -47.03 2.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.711 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -145.09 128.82 17.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.783 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -149.73 128.39 12.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.414 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.443 ' HG2' HH11 ' A' ' 124' ' ' ARG . 5.3 tpp85 -116.24 116.29 27.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.71 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.2 122.53 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.358 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 110' ' ' ILE . 65.6 m -126.53 124.63 40.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.733 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.539 HD21 ' HB2' ' A' ' 109' ' ' SER . 0.1 OUTLIER -95.65 131.61 41.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.465 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 108' ' ' ASP . 78.2 tt0 -153.73 134.2 13.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.572 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.4 t -93.13 123.39 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.549 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 132' ' ' TYR . 0.8 OUTLIER 60.72 44.77 10.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.46 -179.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.35 71.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.463 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.573 ' N ' ' O ' ' A' ' 130' ' ' ASN . 57.6 t80 -88.77 127.29 35.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.403 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.546 ' C ' ' O ' ' A' ' 132' ' ' TYR . 29.6 p -26.28 111.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.832 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -86.48 172.39 10.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.576 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -57.94 167.81 1.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.467 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 137' ' ' VAL . 87.3 mt -120.65 -2.04 9.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.664 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.502 ' O ' ' O ' ' A' ' 136' ' ' LEU . 62.5 t 57.26 145.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.479 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.456 ' CG ' ' H ' ' A' ' 139' ' ' SER . 9.5 pttm -91.73 -108.15 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.673 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.456 ' H ' ' CG ' ' A' ' 138' ' ' LYS . 2.5 t 179.7 -78.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.601 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.442 179.986 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.2 mmt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -114.91 125.33 53.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.546 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.66 117.24 34.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.397 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 t -126.2 142.13 51.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.009 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.63 148.49 43.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.023 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.474 ' C ' ' CD ' ' A' ' 56' ' ' GLU . 8.0 tm-20 -156.48 134.42 11.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.868 0.366 . . . . 0.0 111.047 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.63 ' O ' ' CG ' ' A' ' 85' ' ' PRO . 9.7 tt -116.53 139.07 44.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.943 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.88 172.3 10.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.748 0.308 . . . . 0.0 110.766 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.41 -81.97 0.2 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.46 109.34 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.896 2.397 . . . . 0.0 111.97 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.8 96.39 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.531 2.154 . . . . 0.0 111.896 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.28 -16.7 16.02 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.05 152.0 46.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.766 0.317 . . . . 0.0 110.401 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 64' ' ' VAL . 17.0 m -101.21 123.58 54.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.818 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -130.21 155.54 46.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.335 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -95.29 121.9 37.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.75 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.52 138.0 46.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.333 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.2 t -134.15 125.96 29.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.965 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.601 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 12.6 t80 -137.45 152.74 49.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.848 0.356 . . . . 0.0 110.603 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.601 ' N ' ' CD1' ' A' ' 69' ' ' TYR . 83.9 t80 -83.58 126.5 32.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.649 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.09 154.06 22.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.536 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.0 p -72.34 -32.03 40.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.799 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.58 ' O ' ' CB ' ' A' ' 74' ' ' SER . 1.8 p-10 -81.63 -7.4 59.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.945 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.58 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.5 t 86.58 86.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.822 0.344 . . . . 0.0 110.373 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 171.24 92.55 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.323 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -59.4 139.97 92.1 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.716 2.277 . . . . 0.0 112.147 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -106.06 140.56 38.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.417 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.8 ttp-105 -141.48 132.49 26.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.679 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.1 m -123.26 129.17 75.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.469 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -119.62 127.74 53.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.736 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.55 13.05 79.22 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.7 137.02 33.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 0.0 110.608 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.584 ' O ' ' O ' ' A' ' 84' ' ' LEU . 4.2 m -59.48 -167.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.442 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.584 ' O ' ' O ' ' A' ' 83' ' ' VAL . 0.3 OUTLIER -32.22 156.94 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.533 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.63 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 10.7 Cg_endo -56.84 159.43 14.38 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 123.006 2.471 . . . . 0.0 112.301 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -125.09 -164.23 1.27 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.531 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 99.1 p -135.43 153.78 51.67 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.962 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.2 mp -129.7 155.43 45.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.715 0.293 . . . . 0.0 110.583 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -109.84 120.23 41.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.636 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.6 mt -128.75 133.64 65.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.526 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.8 p -118.21 124.34 47.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.463 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.45 ' C ' ' H ' ' A' ' 94' ' ' ASP . 3.1 m -116.25 135.19 54.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.628 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -72.64 39.83 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.58 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 92' ' ' THR . 33.2 t0 -122.16 -97.15 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.616 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 176.28 -78.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.582 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -102.14 125.57 48.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.404 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 98' ' ' MET . 93.5 t -148.63 155.58 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.419 . . . . 0.0 110.827 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.464 ' N ' HG12 ' A' ' 97' ' ' VAL . 7.8 mtt -127.59 179.25 5.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.315 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -158.87 153.79 24.9 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -113.07 121.84 45.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.748 0.309 . . . . 0.0 110.355 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.49 ' O ' HG23 ' A' ' 101' ' ' ILE . 9.7 tt -133.13 128.93 56.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.711 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.9 t -127.15 145.22 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.41 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.484 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -127.74 156.74 41.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.704 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -119.43 66.45 0.8 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.579 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 131' ' ' ALA . . . -119.1 157.93 15.12 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -93.45 83.01 4.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.808 0.337 . . . . 0.0 110.595 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.7 p -115.56 -166.93 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.406 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -124.55 10.2 8.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.593 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.5 p -170.72 105.0 0.26 Allowed 'General case' 0 C--O 1.242 0.71 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.867 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.55 ' O ' ' O ' ' A' ' 126' ' ' SER . 5.4 tt -132.09 136.63 56.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 120.683 0.278 . . . . 0.0 110.378 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.55 176.77 41.03 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 32.0 m -120.46 149.55 42.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.793 0.33 . . . . 0.0 110.391 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.413 ' HB3' ' NH1' ' A' ' 113' ' ' ARG . 19.2 mtp-105 -144.37 146.19 32.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.754 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.41 122.97 58.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.236 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 115' ' ' THR . 9.1 t -118.36 126.12 51.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.954 0.407 . . . . 0.0 110.787 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.9 p -136.48 138.99 46.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.333 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.2 t0 48.1 22.99 0.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.525 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.9 -7.42 9.53 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.6 mttp -99.84 133.08 44.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.871 0.367 . . . . 0.0 110.651 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 p -67.36 141.34 17.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.418 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -118.02 -75.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.588 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -150.67 128.55 11.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.481 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -150.95 160.17 44.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.611 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -121.05 124.67 45.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.561 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.33 117.28 52.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.57 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.55 ' O ' ' O ' ' A' ' 110' ' ' ILE . 48.1 p -132.22 120.94 22.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.583 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.804 HD22 ' H ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -100.18 129.88 46.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.505 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.45 162.12 31.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.463 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.6 p -102.31 -8.49 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.561 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 130' ' ' ASN . 21.8 p30 -164.83 63.24 0.13 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.499 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 105' ' ' GLY . . . -61.3 98.24 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.528 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -161.24 -20.66 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.43 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.5 m -73.31 78.71 1.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.42 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -44.21 -69.91 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.632 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 72.3 m -93.65 130.4 39.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.69 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.1 96.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.537 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.8 p -171.76 149.51 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.646 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.482 ' O ' ' C ' ' A' ' 139' ' ' SER . 3.7 ptpt -151.17 -174.44 4.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.479 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.514 ' O ' ' C ' ' A' ' 140' ' ' ALA . 10.8 p 32.76 63.49 0.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.557 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.514 ' C ' ' O ' ' A' ' 139' ' ' SER . . . . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.659 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.449 ' N ' ' HA ' ' A' ' 117' ' ' ASP . 4.6 ttt . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.92 128.82 56.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.293 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.836 HD13 ' C ' ' A' ' 53' ' ' LEU . 3.1 tm? -95.72 115.27 27.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 0.0 110.203 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.604 ' N ' HD13 ' A' ' 53' ' ' LEU . 18.6 p -127.33 131.99 50.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.583 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -125.84 149.48 48.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.218 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -155.5 142.42 19.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.918 0.39 . . . . 0.0 110.845 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.588 HG22 ' N ' ' A' ' 58' ' ' PHE . 48.1 mm -109.6 165.78 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.187 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.69 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -143.77 149.34 36.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.9 0.381 . . . . 0.0 110.349 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.45 163.34 33.94 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -41.68 145.82 0.62 Allowed 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.685 2.257 . . . . 0.0 111.724 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.53 115.96 3.99 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.636 2.224 . . . . 0.0 112.294 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.35 2.66 50.84 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.56 ' O ' ' O ' ' A' ' 83' ' ' VAL . 7.9 m -86.54 141.21 29.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.788 0.327 . . . . 0.0 110.949 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 64' ' ' VAL . 35.2 m -104.25 127.16 58.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.202 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.67 154.7 48.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.913 0.387 . . . . 0.0 110.889 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -107.81 121.54 44.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.578 HG23 HD11 ' A' ' 101' ' ' ILE . 42.7 mt -108.52 131.59 58.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.744 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.3 t -134.75 119.72 18.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.026 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.464 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 69.6 t80 -132.19 162.17 31.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.831 0.348 . . . . 0.0 110.724 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.464 ' O ' ' CE2' ' A' ' 69' ' ' TYR . 51.2 t80 -88.89 126.4 35.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.662 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -84.46 141.29 30.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.44 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.19 -23.94 29.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.712 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.629 ' O ' ' CB ' ' A' ' 74' ' ' SER . 7.2 t-20 -85.0 -13.35 50.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.762 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.629 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 6.0 p 92.18 15.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.64 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -125.08 78.89 66.18 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.411 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.3 139.06 20.67 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.507 2.138 . . . . 0.0 112.454 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -108.46 158.61 17.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.146 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -130.36 136.97 49.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.869 0.366 . . . . 0.0 110.83 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.602 ' O ' HG13 ' A' ' 79' ' ' VAL . 14.7 p -119.28 118.13 56.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.18 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.16 136.16 54.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.585 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.44 7.95 61.5 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.87 139.0 55.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.748 0.308 . . . . 0.0 110.562 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.56 ' O ' ' O ' ' A' ' 63' ' ' THR . 2.1 t -70.94 -53.1 22.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.293 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.87 154.13 80.25 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.609 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -66.24 155.08 71.59 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 122.91 2.407 . . . . 0.0 112.101 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.553 ' CG ' ' N ' ' A' ' 87' ' ' SER . 43.1 t-105 -123.54 -161.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.265 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.553 ' N ' ' CG ' ' A' ' 86' ' ' TRP . 99.7 p -139.69 150.82 45.33 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 120.604 0.24 . . . . 0.0 110.993 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.5 tp -128.16 147.06 50.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.219 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.484 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -108.62 120.26 41.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.804 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.0 mt -130.53 128.93 64.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.6 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.5 m -111.06 122.87 48.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.283 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.538 ' O ' ' C ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -124.7 130.62 52.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.816 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.538 ' C ' ' O ' ' A' ' 92' ' ' THR . 1.3 p30 24.31 -120.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.89 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -163.36 88.41 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.469 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -174.44 -159.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.549 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.418 ' HA ' HG11 ' A' ' 116' ' ' VAL . . . -83.57 119.56 24.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.374 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.2 t -114.39 142.19 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.796 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.4 ptp -128.29 166.02 19.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.005 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.94 145.77 12.62 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -116.08 115.11 25.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.349 . . . . 0.0 110.261 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.578 HD11 HG23 ' A' ' 67' ' ' ILE . 1.9 tt -132.41 135.28 58.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.61 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 93.7 t -128.03 150.24 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.463 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -122.81 140.93 52.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.39 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -118.93 77.74 1.21 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.667 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.01 159.66 23.1 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -82.16 46.6 1.04 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.85 0.357 . . . . 0.0 110.497 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.402 ' OG ' HD11 ' A' ' 110' ' ' ILE . 72.4 p -80.01 -174.66 4.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.577 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -124.77 9.97 8.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.59 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.1 t -171.09 122.48 0.57 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.936 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.583 ' O ' ' O ' ' A' ' 126' ' ' SER . 15.6 mt -142.23 152.47 18.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 120.824 0.345 . . . . 0.0 110.404 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.402 ' N ' ' CG2' ' A' ' 110' ' ' ILE . . . -176.59 158.68 25.01 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.648 ' SG ' ' O ' ' A' ' 124' ' ' ARG . 0.5 OUTLIER -118.03 167.76 11.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 0.0 110.674 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.403 ' O ' HD13 ' A' ' 114' ' ' ILE . 21.6 ttm180 -159.39 123.95 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.312 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 113' ' ' ARG . 3.3 mm -125.37 112.61 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.926 0.393 . . . . 0.0 110.782 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.78 135.62 55.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.458 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' A' ' 96' ' ' ALA . 31.0 t -118.79 150.8 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.559 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.449 ' HA ' ' N ' ' A' ' 51' ' ' MET . 37.4 t70 51.88 24.21 2.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.585 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.27 4.99 39.76 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -110.4 138.84 46.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.875 0.369 . . . . 0.0 110.69 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 120' ' ' VAL . 7.4 p -86.17 119.34 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.502 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.5 -35.85 2.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.304 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.81 127.04 5.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.499 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -151.56 145.66 25.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.439 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.648 ' O ' ' SG ' ' A' ' 112' ' ' CYS . 1.8 ttt180 -116.36 123.44 47.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.699 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 125' ' ' VAL . 3.0 p -138.95 116.25 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.619 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.583 ' O ' ' O ' ' A' ' 110' ' ' ILE . 51.4 m -133.81 121.74 22.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.443 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.95 137.32 36.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 110.773 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -155.01 134.02 12.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.333 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.2 t -68.1 129.52 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.559 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 40.32 69.78 0.29 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.402 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.21 89.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.488 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.65 93.8 1.51 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.737 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.757 HG22 ' O ' ' A' ' 133' ' ' THR . 89.6 m 58.61 52.3 7.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.958 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.422 ' CB ' ' O ' ' A' ' 133' ' ' THR . 1.4 t80 74.47 -167.86 0.1 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.889 0.376 . . . . 0.0 110.741 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . 0.647 ' O ' ' N ' ' A' ' 137' ' ' VAL . 0.8 OUTLIER -148.63 -58.1 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.501 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.544 HD23 ' H ' ' A' ' 138' ' ' LYS . 0.7 OUTLIER 54.53 -73.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.412 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.647 ' N ' ' O ' ' A' ' 135' ' ' CYS . 14.8 t 41.3 60.39 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.683 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.544 ' H ' HD23 ' A' ' 136' ' ' LEU . 29.5 tttt -123.42 -10.42 7.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.474 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.7 p -46.7 97.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.561 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.544 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.445 179.936 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 12.4 mtm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -96.86 127.62 43.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.407 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.616 HD13 ' O ' ' A' ' 97' ' ' VAL . 2.1 tt -96.84 115.79 28.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.594 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.93 137.23 53.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.674 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.442 ' OH ' ' CD2' ' A' ' 69' ' ' TYR . 23.8 p90 -120.07 149.56 42.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.979 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.658 ' C ' HD13 ' A' ' 57' ' ' ILE . 26.0 tt0 -155.59 156.03 34.35 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.34 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.857 HD11 HD13 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -115.85 175.74 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.956 179.296 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.63 145.61 36.85 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.028 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -168.66 160.45 33.95 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -43.48 155.59 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.707 2.272 . . . . 0.0 112.147 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.0 114.51 3.41 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.729 2.286 . . . . 0.0 112.053 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.02 15.49 30.72 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.3 m -79.31 139.06 37.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.829 0.347 . . . . 0.0 110.638 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.525 ' O ' HG23 ' A' ' 64' ' ' VAL . 31.2 m -109.76 123.06 65.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.447 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.46 154.22 44.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.786 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.28 115.59 27.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.374 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.467 HG23 HD11 ' A' ' 101' ' ' ILE . 5.3 mm -102.05 121.59 53.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.587 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.3 t -135.59 120.3 18.36 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.916 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.442 ' CD2' ' OH ' ' A' ' 55' ' ' TYR . 22.7 p90 -141.26 158.05 44.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.869 0.366 . . . . 0.0 110.7 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -83.5 136.57 34.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.27 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.18 137.71 41.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.579 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.8 t -62.34 -18.69 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.4 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.515 ' O ' ' OG ' ' A' ' 74' ' ' SER . 3.0 m-20 -89.31 -0.19 57.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.696 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' A' ' 73' ' ' ASN . 7.9 p 73.44 40.82 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.573 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -154.05 91.35 3.17 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.48 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.94 141.55 15.06 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.749 2.299 . . . . 0.0 112.315 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -107.24 147.97 29.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.478 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.421 ' NH1' ' HG3' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -135.91 133.09 37.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.676 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.7 t -112.88 118.87 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.66 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.1 116.61 32.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.376 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.27 20.87 16.56 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.43 153.86 25.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.368 . . . . 0.0 110.617 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.18 -39.49 8.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.374 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.63 152.48 28.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.5 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.485 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 19.8 Cg_endo -61.42 150.45 85.0 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.943 2.429 . . . . 0.0 112.363 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -128.75 -172.45 2.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.458 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.637 ' C ' HD12 ' A' ' 88' ' ' LEU . 97.3 p -127.81 155.04 44.72 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.041 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.637 HD12 ' C ' ' A' ' 87' ' ' SER . 6.8 mp -130.99 148.19 52.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.859 0.361 . . . . 0.0 110.942 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' A' ' 89' ' ' HIS . 6.5 p80 -110.16 124.23 51.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.017 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.9 mt -129.01 134.79 63.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.926 0.394 . . . . 0.0 110.932 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.17 122.95 46.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.322 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.591 ' O ' ' N ' ' A' ' 94' ' ' ASP . 2.2 m -126.96 128.16 45.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.768 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.526 ' C ' ' O ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -29.2 -37.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.555 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 92' ' ' THR . 1.6 m-20 -66.03 -135.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.684 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.45 -35.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.385 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.72 137.45 52.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.558 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.616 ' O ' HD13 ' A' ' 53' ' ' LEU . 21.0 t -150.09 124.28 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.581 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 5.5 mtt -96.55 131.31 43.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.605 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.23 146.79 18.88 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.505 ' O ' ' CG ' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -102.79 116.51 32.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.791 0.329 . . . . 0.0 110.453 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.857 HD13 HD11 ' A' ' 57' ' ' ILE . 17.0 tt -133.12 136.89 54.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.641 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.7 t -139.75 149.29 22.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.433 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -126.77 148.22 49.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.639 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -133.51 46.16 2.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.537 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -99.3 163.81 20.1 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.87 36.58 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.745 0.307 . . . . 0.0 110.535 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.417 ' OG ' HD11 ' A' ' 110' ' ' ILE . 0.8 OUTLIER -65.25 -167.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.646 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -122.78 -25.15 4.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.582 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.8 t -144.5 88.26 1.92 Allowed 'General case' 0 C--O 1.243 0.752 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.026 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.417 HD11 ' OG ' ' A' ' 107' ' ' SER . 6.1 mt -100.6 149.2 6.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 120.833 0.349 . . . . 0.0 110.486 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.84 164.32 29.98 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 9.3 p -125.82 152.87 44.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.78 0.324 . . . . 0.0 110.698 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.06 141.11 24.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.491 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.468 ' CG2' HD11 ' A' ' 53' ' ' LEU . 6.9 mm -115.76 133.01 63.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.717 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.3 p -122.67 121.08 35.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.471 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.97 129.05 75.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.666 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.24 17.29 1.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.404 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 88.1 -8.57 77.87 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -101.45 147.5 26.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.322 . . . . 0.0 110.68 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.29 128.5 37.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.624 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.46 HH11 ' HB3' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -107.66 -65.53 1.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.401 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -149.34 127.28 11.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.042 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.31 130.27 12.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.036 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -111.97 115.6 29.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.918 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.58 124.93 72.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.054 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.4 m -127.6 126.28 41.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.04 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.09 129.22 40.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.008 0.432 . . . . 0.0 110.837 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -157.32 130.57 7.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.231 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.49 116.3 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.452 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.508 ' CG ' ' O ' ' A' ' 130' ' ' ASN . 4.7 t30 59.94 69.72 0.68 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.417 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.1 48.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.596 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.457 ' O ' ' C ' ' A' ' 133' ' ' THR . 54.4 t80 -140.25 10.0 2.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.529 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 134' ' ' TYR . 5.9 p 34.97 -125.87 0.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.787 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.598 ' N ' ' OG1' ' A' ' 133' ' ' THR . 23.4 m-85 -127.84 -168.62 1.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.625 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -158.48 173.81 16.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.417 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.405 ' CB ' ' O ' ' A' ' 135' ' ' CYS . 1.2 tt 74.89 -78.37 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.492 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.3 t 64.52 118.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.448 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 139' ' ' SER . 1.5 pttp -54.95 123.5 13.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.65 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.9 OUTLIER 60.44 138.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.647 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.551 179.942 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.405 ' HG3' ' CD2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.405 ' CD2' ' HG3' ' A' ' 51' ' ' MET . 25.4 m-70 -116.0 128.79 56.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.341 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.734 HD12 ' O ' ' A' ' 53' ' ' LEU . 3.3 pp -96.27 120.51 36.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.928 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.58 133.95 50.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.68 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -120.86 149.59 42.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.378 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.756 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 1.8 tm-20 -155.4 144.68 20.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.97 0.414 . . . . 0.0 110.923 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 57' ' ' ILE . 34.6 mm -116.11 153.39 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.11 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -140.22 163.68 32.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.05 0.452 . . . . 0.0 111.04 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.34 171.23 43.49 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.505 ' O ' ' OG1' ' A' ' 63' ' ' THR . 53.9 Cg_exo -46.91 153.43 1.4 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.654 2.236 . . . . 0.0 111.985 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -64.68 119.59 6.66 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.721 2.281 . . . . 0.0 112.039 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.24 5.34 62.21 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 33.0 m -69.37 144.66 53.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 0.0 110.604 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 p -119.49 122.1 68.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.48 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.408 ' HB1' ' HB1' ' A' ' 103' ' ' ALA . . . -143.11 155.31 44.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.705 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.72 115.22 30.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.115 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 mp -90.36 127.7 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.829 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.4 t -128.13 116.06 19.36 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.021 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.512 ' CZ ' ' OD1' ' A' ' 71' ' ' ASP . 2.9 p90 -146.04 148.8 33.07 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.236 0.335 . . . . 0.0 110.413 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -88.13 121.37 30.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.379 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.512 ' OD1' ' CZ ' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -82.93 144.81 29.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.541 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.5 p -55.47 -11.02 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.95 0.405 . . . . 0.0 110.177 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 74' ' ' SER . 35.4 t30 -92.54 -8.97 42.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.417 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.563 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.5 p 85.24 3.74 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.423 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -114.29 95.82 40.51 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.52 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -79.38 139.54 14.68 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.552 2.168 . . . . 0.0 112.072 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -107.93 151.06 26.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -128.82 134.03 48.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.467 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.0 m -105.96 129.43 59.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.587 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 5.8 p-10 -111.98 132.88 54.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.697 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.16 28.65 63.82 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.51 147.63 52.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.799 0.333 . . . . 0.0 110.673 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.0 p -100.3 -30.8 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.503 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tp -170.26 114.76 0.48 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.415 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -55.75 162.25 6.97 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.095 1.863 . . . . 0.0 111.895 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.465 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 7.1 m-90 -126.09 -150.7 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.558 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.756 ' OG ' ' HB2' ' A' ' 56' ' ' GLU . 59.1 m -121.87 165.5 15.81 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.004 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.78 150.18 35.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.783 0.325 . . . . 0.0 110.821 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -110.16 119.54 39.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.375 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.1 mt -126.57 135.53 63.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.627 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.41 123.41 48.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.598 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.55 ' O ' ' C ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -132.3 155.58 48.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.399 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.55 ' C ' ' O ' ' A' ' 92' ' ' THR . 3.4 p30 -26.73 124.06 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.668 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.605 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.3 OUTLIER -32.08 98.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.449 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.605 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 167.35 143.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.361 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.4 126.38 29.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.703 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.98 131.57 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.416 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.569 ' SD ' ' CB ' ' A' ' 122' ' ' ALA . 6.3 mtm -96.37 137.17 35.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.651 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.29 162.45 19.91 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -111.63 115.81 29.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.312 . . . . 0.0 110.64 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.1 tt -132.82 141.41 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.445 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.2 155.97 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 110.753 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.408 ' HB1' ' HB1' ' A' ' 65' ' ' ALA . . . -136.52 146.46 46.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.322 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -120.31 31.99 6.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.738 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.59 156.6 26.89 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -85.89 78.58 9.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.773 0.321 . . . . 0.0 110.405 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.6 m -107.5 179.18 4.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.637 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.56 -12.03 15.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.685 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.9 p -167.55 100.0 0.49 Allowed 'General case' 0 C--O 1.243 0.721 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.005 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' A' ' 110' ' ' ILE . 12.5 tt -132.36 132.27 60.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.846 0.355 . . . . 0.0 110.696 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -153.29 175.89 31.54 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 1.7 p -124.32 156.75 36.44 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.725 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -160.95 139.58 10.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.428 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.5 mp -126.94 118.0 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.906 0.384 . . . . 0.0 110.765 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.7 t -116.83 128.3 55.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.3 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.9 t -121.0 155.81 24.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.818 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 58.44 14.34 2.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.597 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.5 9.47 78.03 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -116.51 140.07 49.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.774 0.321 . . . . 0.0 110.56 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.89 132.41 33.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.43 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -129.33 -74.94 0.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.573 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.569 ' CB ' ' SD ' ' A' ' 98' ' ' MET . . . -125.47 129.0 48.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.679 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -149.49 133.06 16.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.637 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.9 mmt-85 -105.97 119.93 40.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.481 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 84.9 t -113.05 116.24 52.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.73 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.7 m -133.94 117.04 16.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.144 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.444 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -114.53 129.55 56.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.838 0.352 . . . . 0.0 110.877 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -154.97 130.62 9.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.42 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.7 t -85.56 139.26 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.756 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 60.76 42.52 13.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.697 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.25 151.95 34.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.491 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 53.98 103.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.558 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 134' ' ' TYR . 90.4 m -164.25 -71.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.565 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.453 ' O ' ' CB ' ' A' ' 135' ' ' CYS . 0.4 OUTLIER 47.97 -177.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.671 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . 0.471 ' O ' ' O ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER 77.81 16.11 1.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.773 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 135' ' ' CYS . 0.5 OUTLIER 39.51 95.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.509 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.656 ' O ' ' N ' ' A' ' 139' ' ' SER . 3.2 m -144.5 5.26 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.945 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.24 -70.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.419 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.656 ' N ' ' O ' ' A' ' 137' ' ' VAL . 8.3 p -133.39 -174.07 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.368 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 139' ' ' SER . . . . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.543 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -97.41 118.24 33.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.214 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.903 HD21 HG23 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -96.0 115.2 27.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.767 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.705 ' N ' HD13 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -127.32 130.48 49.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.493 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.5 ' OH ' ' CZ ' ' A' ' 69' ' ' TYR . 33.0 p90 -119.97 148.71 43.2 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.274 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.58 ' HG3' ' OG ' ' A' ' 87' ' ' SER . 1.7 tm-20 -156.05 136.43 13.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.9 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.589 HG22 ' N ' ' A' ' 58' ' ' PHE . 4.2 mp -99.15 167.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.745 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.589 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -132.79 163.65 28.59 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.145 -179.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.98 142.65 4.98 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -41.79 155.92 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.513 2.142 . . . . 0.0 112.202 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.07 134.77 28.1 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.76 2.306 . . . . 0.0 112.188 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.84 -4.16 71.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.56 ' O ' ' O ' ' A' ' 83' ' ' VAL . 15.7 m -86.64 130.84 34.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.0 110.723 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 64' ' ' VAL . 7.7 p -105.36 126.11 60.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.428 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -136.72 152.85 50.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.661 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -106.45 116.56 32.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.361 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 mp -96.3 131.7 42.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.5 t -134.69 123.84 24.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.003 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.5 ' CZ ' ' OH ' ' A' ' 55' ' ' TYR . 37.3 p90 -151.48 170.76 18.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.909 0.385 . . . . 0.0 110.624 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.64 ' CE1' ' O ' ' A' ' 74' ' ' SER . 27.3 t80 -88.74 134.55 33.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.29 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.436 ' C ' ' N ' ' A' ' 73' ' ' ASN . 0.9 OUTLIER -109.48 141.57 41.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.831 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.451 ' O ' HG12 ' A' ' 72' ' ' VAL . 17.2 t -52.73 -11.44 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.328 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.629 ' O ' ' CB ' ' A' ' 74' ' ' SER . 49.8 m-80 -83.86 1.26 44.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.461 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.64 ' O ' ' CE1' ' A' ' 70' ' ' PHE . 0.9 OUTLIER 92.27 -75.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.763 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.85 135.34 86.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.583 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.15 143.57 28.75 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.554 2.169 . . . . 0.0 112.133 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.471 HE21 HG13 ' A' ' 79' ' ' VAL . 14.1 tt0 -104.12 135.97 44.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.392 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.8 125.93 24.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.861 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.471 HG13 HE21 ' A' ' 77' ' ' GLN . 28.2 m -109.07 127.14 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.425 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.664 ' OD1' ' N ' ' A' ' 81' ' ' GLY . 13.1 t0 -126.39 150.35 48.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.866 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.664 ' N ' ' OD1' ' A' ' 80' ' ' ASP . . . 85.21 12.19 74.08 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.37 140.63 30.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.746 0.308 . . . . 0.0 110.632 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.786 HG13 ' HG ' ' A' ' 84' ' ' LEU . 1.5 p -81.66 -33.77 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.473 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.786 ' HG ' HG13 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -141.25 152.51 64.53 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.479 179.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.513 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 20.5 Cg_endo -62.41 160.48 31.35 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.888 2.392 . . . . 0.0 112.066 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.573 ' CD1' ' N ' ' A' ' 86' ' ' TRP . 10.5 m95 -123.6 172.65 8.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.395 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.58 ' OG ' ' HG3' ' A' ' 56' ' ' GLU . 70.5 m -114.83 144.8 42.94 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.032 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.604 HD23 ' N ' ' A' ' 89' ' ' HIS . 0.6 OUTLIER -131.35 141.02 49.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.853 0.358 . . . . 0.0 110.778 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.613 ' H ' ' CD2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -108.59 123.29 48.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.305 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.3 mt -129.35 124.17 59.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.932 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.21 123.27 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.212 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.6 m -126.38 133.67 51.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 110.98 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.558 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 26.0 t-20 39.69 32.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.983 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.536 ' C ' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER 28.8 59.68 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.612 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.45 -146.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.385 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -119.47 123.29 43.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.5 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.2 p -159.71 139.7 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.645 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.617 ' HB3' HG21 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -96.51 177.66 5.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.649 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -138.14 162.73 25.68 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.527 ' N ' ' ND2' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -118.81 116.51 26.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.699 0.285 . . . . 0.0 110.561 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -133.33 142.54 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.805 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 98.5 t -121.97 146.66 26.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.206 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -140.08 138.86 35.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.959 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -131.39 102.28 5.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.208 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -131.04 163.83 23.42 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -78.97 19.69 0.52 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.853 0.359 . . . . 0.0 110.274 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 105' ' ' GLY . 6.1 p -69.04 -171.72 0.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.64 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.83 8.23 12.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.675 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.0 p -172.79 104.84 0.15 Allowed 'General case' 0 C--O 1.242 0.686 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 126' ' ' SER . 2.9 mt -126.55 136.93 59.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 120.807 0.337 . . . . 0.0 110.341 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.54 175.98 41.8 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -126.18 167.54 15.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.762 0.315 . . . . 0.0 110.603 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -157.43 140.36 15.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.437 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.903 HG23 HD21 ' A' ' 53' ' ' LEU . 3.6 mp -124.42 114.99 43.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.689 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.54 123.88 41.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.429 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.573 ' C ' ' H ' ' A' ' 118' ' ' GLY . 10.8 p -135.15 151.22 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.706 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 117' ' ' ASP . 13.2 t70 53.03 2.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.579 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.573 ' H ' ' C ' ' A' ' 116' ' ' VAL . . . 88.53 9.37 69.29 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -123.77 127.92 48.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.723 0.297 . . . . 0.0 110.629 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.5 p -80.03 136.47 23.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.425 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.38 -52.91 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.877 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -150.86 128.31 11.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.602 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.74 126.79 9.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.806 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -96.0 118.87 33.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.406 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.0 t -121.0 116.59 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.83 0.348 . . . . 0.0 110.885 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.609 ' C ' HD22 ' A' ' 127' ' ' ASN . 0.3 OUTLIER -134.03 116.09 15.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.456 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.781 HD22 ' N ' ' A' ' 127' ' ' ASN . 0.6 OUTLIER -100.16 132.51 45.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.569 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -136.25 138.66 42.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.502 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 26.4 m -68.22 -6.14 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.588 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -161.6 92.64 0.88 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.615 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -86.49 -37.55 18.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.489 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.688 ' CG ' ' N ' ' A' ' 133' ' ' THR . 51.0 t80 -73.99 -178.11 3.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.516 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.688 ' N ' ' CG ' ' A' ' 132' ' ' TYR . 65.0 p -133.4 -115.83 0.21 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.628 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -166.59 -24.69 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.523 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.58 118.15 3.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.802 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.0 mt -143.01 -173.34 3.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.553 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 138' ' ' LYS . 2.3 t -149.35 -15.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.602 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.542 ' O ' ' O ' ' A' ' 139' ' ' SER . 0.0 OUTLIER -37.24 105.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.436 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.542 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.6 OUTLIER 45.33 104.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.451 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.641 -179.923 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.6 mtt . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.417 ' CD2' HG22 ' A' ' 91' ' ' THR . 34.0 m170 -92.76 129.03 38.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.461 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.422 ' O ' HD23 ' A' ' 53' ' ' LEU . 2.7 tt -95.63 118.02 31.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.513 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.3 135.08 51.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.596 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.537 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 1.2 p90 -120.34 148.62 43.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.409 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.562 ' C ' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -156.38 138.58 14.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.8 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.767 HD11 HD13 ' A' ' 101' ' ' ILE . 1.3 mm -105.95 174.73 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.905 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -133.36 171.94 13.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.991 0.424 . . . . 0.0 110.963 -179.591 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.86 147.13 5.07 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -39.16 152.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.758 2.306 . . . . 0.0 112.171 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -67.18 123.86 11.43 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.781 2.321 . . . . 0.0 112.151 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.87 -7.76 60.99 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -69.99 134.89 48.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.743 0.306 . . . . 0.0 110.493 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.9 t -111.7 125.71 69.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.632 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -141.13 155.37 46.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.371 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -98.9 123.15 42.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.717 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 52.2 mt -102.74 124.15 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.433 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 42.1 t -122.32 117.51 26.26 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.059 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.597 ' CE2' ' O ' ' A' ' 70' ' ' PHE . 35.9 t80 -143.35 158.31 43.75 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.79 0.329 . . . . 0.0 110.489 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.597 ' O ' ' CE2' ' A' ' 69' ' ' TYR . 68.1 t80 -85.31 134.68 34.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.572 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -103.94 126.12 50.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.611 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 72' ' ' VAL . 60.5 t -62.29 -5.49 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.687 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.647 ' O ' ' CB ' ' A' ' 74' ' ' SER . 63.3 m-20 -85.72 -22.32 27.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.615 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.647 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 2.3 p 146.24 -99.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.547 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 75' ' ' GLU . 0.7 OUTLIER -64.99 147.64 98.35 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.65 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.58 154.9 50.06 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.719 2.28 . . . . 0.0 112.152 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -90.25 149.37 22.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.396 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ttp85 -152.59 133.17 13.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.737 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.05 136.66 52.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.414 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.537 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 1.0 OUTLIER -127.36 121.62 31.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.709 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.36 26.78 32.26 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.33 128.31 34.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.752 0.311 . . . . 0.0 110.626 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.4 t -67.87 -31.56 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.496 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.507 ' O ' HD12 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -161.54 156.5 20.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.491 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.449 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 11.6 Cg_endo -57.01 149.17 63.93 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.893 2.396 . . . . 0.0 112.282 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -120.6 -178.0 3.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.29 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.9 m -120.49 141.7 49.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.005 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.37 139.61 52.29 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.607 ' ND1' ' N ' ' A' ' 89' ' ' HIS . 2.1 p-80 -114.83 127.79 55.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 0.0 110.963 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.4 mt -127.62 134.48 65.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.155 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.417 HG22 ' CD2' ' A' ' 52' ' ' HIS . 12.0 p -103.69 122.74 45.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.601 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.621 ' C ' ' H ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER -127.83 135.12 49.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.665 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 93' ' ' ASN . 0.5 OUTLIER -67.94 24.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.296 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.621 ' H ' ' C ' ' A' ' 92' ' ' THR . 2.2 t70 -114.07 0.87 14.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.536 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 60.7 -84.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.632 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.03 113.5 21.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.501 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.61 160.59 24.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.679 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.443 ' CG ' ' N ' ' A' ' 99' ' ' GLY . 4.3 ttt -130.15 158.21 40.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.381 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.443 ' N ' ' CG ' ' A' ' 98' ' ' MET . . . -156.38 152.3 23.7 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -110.47 117.46 33.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.864 0.364 . . . . 0.0 110.445 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.767 HD13 HD11 ' A' ' 57' ' ' ILE . 9.9 tt -132.08 137.48 54.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.535 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.2 t -138.05 149.93 24.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.554 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -120.79 150.24 41.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.58 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -135.59 79.46 1.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.646 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -131.64 161.24 23.69 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.582 ' N ' ' ND2' ' A' ' 106' ' ' ASN . 0.4 OUTLIER -79.07 28.57 0.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.84 0.352 . . . . 0.0 110.405 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -62.96 -166.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.598 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 108' ' ' ASP . 1.4 m-20 -114.75 -28.25 7.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.668 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.4 t -141.74 126.68 18.26 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.898 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.509 ' O ' ' O ' ' A' ' 126' ' ' SER . 23.0 mt -135.67 154.1 34.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.412 ' N ' ' CG2' ' A' ' 110' ' ' ILE . . . 174.69 159.23 20.59 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 5.7 p -117.93 161.46 19.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.766 0.317 . . . . 0.0 110.339 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 113' ' ' ARG . 2.8 ptp180 -161.3 136.87 7.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.664 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.1 mt -127.5 122.77 60.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.416 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.45 139.6 51.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.53 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.541 HG21 ' NH1' ' A' ' 121' ' ' ARG . 19.6 m -133.06 135.27 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.682 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 53.23 30.65 10.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.67 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.98 -1.58 23.22 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -109.31 136.01 49.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.331 . . . . 0.0 110.556 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.9 t -77.54 128.7 38.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.779 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.541 ' NH1' HG21 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -116.95 -63.91 1.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.379 179.773 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.93 127.21 45.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -149.38 131.83 15.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.993 0.425 . . . . 0.0 111.066 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -121.48 115.52 23.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.897 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.524 ' O ' ' CG2' ' A' ' 125' ' ' VAL . 1.1 m -111.16 125.59 68.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.907 0.384 . . . . 0.0 111.025 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.7 OUTLIER -131.46 115.93 16.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.016 179.473 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -101.81 131.01 48.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.885 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -156.63 136.64 12.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.613 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 20.4 t -88.99 140.95 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.568 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 46.02 53.75 8.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.272 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.42 113.02 4.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.631 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 65.75 115.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.522 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -133.94 169.4 17.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.287 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -171.52 73.58 0.05 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.998 0.428 . . . . 0.0 110.635 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . 0.701 ' SG ' ' N ' ' A' ' 136' ' ' LEU . 0.1 OUTLIER -129.72 163.99 24.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.448 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.701 ' N ' ' SG ' ' A' ' 135' ' ' CYS . 0.3 OUTLIER -110.59 105.62 14.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.684 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 140' ' ' ALA . 18.7 m -107.8 -176.09 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.485 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.462 ' O ' ' C ' ' A' ' 139' ' ' SER . 32.7 mtmt -120.01 -66.31 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.551 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.462 ' C ' ' O ' ' A' ' 138' ' ' LYS . 31.3 t -35.49 -74.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.528 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 139' ' ' SER . . . . . . . . 0 C--O 1.218 -0.561 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.587 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.3 mtm . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -114.88 128.74 56.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.465 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.931 HD22 ' O ' ' A' ' 97' ' ' VAL . 14.5 tp -96.13 114.86 26.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.449 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.5 p -127.78 129.95 47.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.563 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.456 ' CD1' ' C ' ' A' ' 55' ' ' TYR . 26.0 p90 -123.47 148.33 46.31 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.474 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.457 ' HG3' ' OG ' ' A' ' 87' ' ' SER . 10.4 tt0 -156.65 133.53 10.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.777 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.9 mp -98.76 158.31 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.854 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.49 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -132.3 166.26 22.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.912 0.387 . . . . 0.0 110.781 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.66 163.16 19.88 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.06 109.61 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.655 2.237 . . . . 0.0 112.119 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -45.79 141.87 8.17 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.517 2.145 . . . . 0.0 112.008 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.53 -13.31 56.75 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.6 p -83.03 137.76 34.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.716 0.293 . . . . 0.0 110.56 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 64' ' ' VAL . 20.9 m -103.31 132.37 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.739 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.49 153.83 43.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.306 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -97.27 114.88 26.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.623 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 67' ' ' ILE . 1.8 mp -87.71 122.67 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.583 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.4 t -130.26 116.28 18.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.98 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.61 ' CZ ' ' O ' ' A' ' 70' ' ' PHE . 16.3 t80 -149.86 149.43 30.47 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.822 0.344 . . . . 0.0 110.575 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.61 ' O ' ' CZ ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -84.71 130.53 34.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.389 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.67 ' OD1' ' N ' ' A' ' 72' ' ' VAL . 67.9 t0 -93.87 146.38 23.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.802 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.67 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 89.7 t -69.59 -34.3 60.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.46 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -81.01 11.76 3.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.761 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.9 m 61.49 71.4 0.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.61 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.524 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 3.2 tt0 -178.66 77.73 0.22 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.379 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.66 144.25 99.47 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.96 2.44 . . . . 0.0 112.177 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -107.66 134.85 50.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.382 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 mtm-85 -134.08 126.92 31.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.922 0.391 . . . . 0.0 110.656 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 t -115.94 119.77 62.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.513 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -108.51 121.6 45.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.566 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.21 15.38 38.68 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.72 130.59 43.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 0.0 110.648 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.3 t -73.47 -35.17 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.294 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.61 ' H ' HD12 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -149.76 157.36 38.35 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.507 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.563 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 18.6 Cg_endo -61.33 157.08 42.3 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.989 2.459 . . . . 0.0 112.107 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -129.26 176.93 7.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.356 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.457 ' OG ' ' HG3' ' A' ' 56' ' ' GLU . 59.7 m -114.19 161.58 17.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.98 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.0 tp -147.98 134.97 20.24 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.244 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -109.15 126.36 53.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.841 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 90' ' ' ILE . 4.6 mp -130.46 136.79 57.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.388 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.6 p -122.63 130.03 52.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.524 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.676 ' O ' ' N ' ' A' ' 94' ' ' ASP . 2.0 m -113.3 156.11 23.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.696 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.551 ' O ' ' C ' ' A' ' 94' ' ' ASP . 11.2 t30 -28.59 84.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.786 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.676 ' N ' ' O ' ' A' ' 92' ' ' THR . 10.3 m-20 23.6 92.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.707 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 94' ' ' ASP . . . 172.06 140.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.652 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.5 140.01 33.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.234 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.931 ' O ' HD22 ' A' ' 53' ' ' LEU . 9.2 p -150.86 142.97 16.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 110.888 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.547 ' N ' ' SD ' ' A' ' 98' ' ' MET . 3.1 mmt -93.31 161.13 14.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.129 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.43 154.7 20.99 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.383 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.454 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.5 m-80 -109.92 115.38 29.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.681 0.277 . . . . 0.0 110.263 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.4 tt -131.96 142.38 43.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.957 0.408 . . . . 0.0 110.981 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.0 t -139.98 145.82 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.357 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -143.51 151.73 40.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.763 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.46 103.89 7.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.529 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.58 161.71 23.7 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.556 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.8 OUTLIER -82.87 54.92 2.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 0.0 110.574 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.27 -167.13 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.45 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -118.24 -10.94 10.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.618 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 t -154.84 102.41 2.35 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.56 ' O ' ' O ' ' A' ' 126' ' ' SER . 3.7 mt -127.23 127.06 68.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.854 0.359 . . . . 0.0 110.3 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.04 172.26 33.95 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.564 ' O ' ' O ' ' A' ' 124' ' ' ARG . 31.6 p -125.08 161.53 26.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.768 0.318 . . . . 0.0 110.694 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.793 ' C ' HD12 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -156.41 147.04 21.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.496 179.799 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.793 HD12 ' C ' ' A' ' 113' ' ' ARG . 1.8 mp -121.57 117.18 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 110.82 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.78 129.4 51.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.284 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 118' ' ' GLY . 27.3 m -136.5 144.49 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.917 0.389 . . . . 0.0 110.969 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' A' ' 117' ' ' ASP . 21.7 t0 44.93 13.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.84 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 116' ' ' VAL . . . 83.64 -2.25 87.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 116' ' ' VAL . 4.6 ttmt -102.99 126.07 50.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.387 . . . . 0.0 110.396 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 20.9 t -80.86 140.33 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.631 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.423 ' NH1' ' HG3' ' A' ' 121' ' ' ARG . 1.7 mmm-85 -128.87 -48.94 1.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.497 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.91 135.99 9.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.535 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -149.54 155.9 41.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.502 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.564 ' O ' ' O ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -124.61 116.13 21.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.517 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.5 t -121.26 117.25 52.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.567 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.56 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.6 OUTLIER -130.54 121.75 26.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.588 -179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.565 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -94.53 129.84 41.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.241 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -132.25 139.98 48.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.812 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.25 -8.98 12.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.413 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 132' ' ' TYR . 0.4 OUTLIER 178.93 82.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.41 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.82 71.25 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.675 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 130' ' ' ASN . 81.5 t80 -172.43 117.72 0.35 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.583 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.1 161.0 36.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.64 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.492 ' O ' ' O ' ' A' ' 135' ' ' CYS . 0.1 OUTLIER -65.06 91.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.394 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . 0.492 ' O ' ' O ' ' A' ' 134' ' ' TYR . 34.1 m -48.57 -174.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.7 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 45.34 88.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.759 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.35 84.5 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.491 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.43 94.88 5.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.55 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.1 t -171.18 56.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.435 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.53 -179.844 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.616 ' SD ' ' OD1' ' A' ' 117' ' ' ASP . 41.7 mtm . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.17 129.14 55.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.453 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.699 ' C ' HD23 ' A' ' 53' ' ' LEU . 7.0 tt -95.52 114.79 26.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.962 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.433 ' N ' HD23 ' A' ' 53' ' ' LEU . 0.7 OUTLIER -127.33 135.76 50.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 55' ' ' TYR . 26.8 p90 -130.13 149.3 51.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.096 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.981 ' OE1' ' OG ' ' A' ' 87' ' ' SER . 15.5 tt0 -155.64 150.72 26.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.963 0.411 . . . . 0.0 111.079 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.488 HD11 HG23 ' A' ' 110' ' ' ILE . 7.1 tt -112.1 163.21 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.887 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.642 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -139.96 165.08 28.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 110.993 -179.469 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.6 171.37 44.33 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -47.85 112.74 0.61 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.716 2.277 . . . . 0.0 111.976 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -44.62 146.79 2.01 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.431 2.087 . . . . 0.0 112.267 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.78 -10.7 59.2 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.1 m -79.37 139.18 37.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 110.661 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.7 t -102.48 122.95 55.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.496 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.87 140.96 36.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.695 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -101.04 116.07 31.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.31 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.9 tt -102.06 138.4 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.81 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.2 t -124.48 118.67 27.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.949 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -128.19 167.12 17.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.756 0.312 . . . . 0.0 110.55 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.4 ' CE1' ' HA ' ' A' ' 74' ' ' SER . 55.7 t80 -99.62 134.83 41.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.313 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -95.75 139.14 32.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.68 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -54.91 -29.77 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.549 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.591 HD22 ' N ' ' A' ' 73' ' ' ASN . 1.6 m120 -84.19 2.93 37.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.523 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 0.7 OUTLIER 76.99 10.1 2.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.508 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -110.43 91.39 11.78 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.401 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.92 139.83 17.73 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.624 2.216 . . . . 0.0 112.309 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -107.83 158.35 17.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.592 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -145.58 126.35 14.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.624 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.0 m -108.21 135.57 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.499 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -128.96 132.96 47.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.74 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.31 17.65 42.02 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.87 149.44 36.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.837 0.351 . . . . 0.0 110.754 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.556 HG23 ' CD1' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -88.35 -42.43 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.302 179.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.556 ' CD1' HG23 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -144.49 154.07 56.1 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.187 179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.28 147.37 47.39 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 122.96 2.44 . . . . 0.0 112.266 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.534 ' CD1' ' N ' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -114.23 -162.75 0.83 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.256 179.709 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.981 ' OG ' ' OE1' ' A' ' 56' ' ' GLU . 70.3 m -116.59 153.53 32.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.986 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 mt -128.23 141.74 51.37 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.737 0.303 . . . . 0.0 110.506 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.34 119.92 40.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.509 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.444 ' HA ' HD13 ' A' ' 90' ' ' ILE . 26.2 mm -126.7 121.55 58.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.75 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 p -105.38 122.48 46.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.344 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.2 m -122.08 149.25 43.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.716 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -86.83 31.31 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.454 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.538 ' C ' ' H ' ' A' ' 96' ' ' ALA . 32.8 m-20 -114.52 -4.07 12.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.548 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 94' ' ' ASP . . . 70.77 -28.52 0.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.713 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.538 ' H ' ' C ' ' A' ' 94' ' ' ASP . . . -156.62 138.15 14.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.701 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.3 p -174.9 144.7 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.429 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -104.3 154.3 19.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.777 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -122.02 159.03 16.7 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.25 122.13 46.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.719 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.8 pt -132.53 139.52 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.531 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 103' ' ' ALA . 75.0 t -123.43 159.31 28.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.349 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.517 ' N ' HG12 ' A' ' 102' ' ' VAL . . . -131.05 152.08 50.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.982 0.42 . . . . 0.0 110.612 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.91 64.05 1.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.328 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 107' ' ' SER . . . -130.97 163.99 23.35 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.7 20.39 0.45 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 0.0 110.558 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.603 ' OG ' ' N ' ' A' ' 108' ' ' ASP . 6.0 t -53.47 -173.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.626 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.603 ' N ' ' OG ' ' A' ' 107' ' ' SER . 37.4 t0 -119.61 -73.44 0.64 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.615 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.691 ' OG ' ' ND2' ' A' ' 127' ' ' ASN . 30.1 t -89.21 122.12 32.18 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.975 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.488 HG23 HD11 ' A' ' 57' ' ' ILE . 12.7 mt -130.46 139.44 51.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.828 0.347 . . . . 0.0 110.5 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.17 144.36 7.98 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 10.7 p -117.96 156.91 27.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.73 0.3 . . . . 0.0 110.476 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.766 ' C ' HD12 ' A' ' 114' ' ' ILE . 13.8 ptm180 -159.96 146.04 15.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.766 HD12 ' C ' ' A' ' 113' ' ' ARG . 3.8 mp -131.83 122.05 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.368 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.0 t -118.68 140.94 49.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.679 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.454 ' C ' ' H ' ' A' ' 118' ' ' GLY . 31.1 m -124.17 144.72 32.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.559 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.616 ' OD1' ' SD ' ' A' ' 51' ' ' MET . 0.5 OUTLIER 52.94 9.77 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.575 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 116' ' ' VAL . . . 88.02 5.6 76.75 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.6 mtmt -106.44 127.33 53.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.748 0.309 . . . . 0.0 110.512 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.486 ' O ' HG23 ' A' ' 120' ' ' VAL . 26.5 m -70.9 118.84 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.74 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -103.44 -72.94 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.479 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -135.31 128.09 31.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.315 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -146.9 123.85 11.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.0 mtt-85 -100.61 115.46 30.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.286 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.9 t -123.98 117.25 50.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.61 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 110' ' ' ILE . 0.2 OUTLIER -132.99 122.67 24.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.406 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.691 ' ND2' ' OG ' ' A' ' 109' ' ' SER . 11.3 m120 -94.2 129.74 40.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.342 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -152.85 130.74 11.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.718 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.72 ' O ' HG13 ' A' ' 129' ' ' VAL . 13.7 p -65.06 104.36 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.554 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.589 ' N ' HD22 ' A' ' 130' ' ' ASN . 1.0 OUTLIER 66.79 81.76 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.56 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.11 157.51 28.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.606 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.405 ' O ' ' C ' ' A' ' 133' ' ' THR . 4.4 m-85 59.84 -87.41 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.56 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 132' ' ' TYR . 0.8 OUTLIER -38.82 134.1 1.02 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.604 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.49 ' O ' ' O ' ' A' ' 135' ' ' CYS . 0.2 OUTLIER -125.32 -30.26 3.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.511 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 134' ' ' TYR . 0.0 OUTLIER -54.92 -157.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.44 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.86 -9.67 1.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.648 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 138' ' ' LYS . 79.4 t -147.3 132.72 11.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.754 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 137' ' ' VAL . 4.9 tttm 76.88 -177.26 0.12 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.727 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.3 t -128.89 6.07 5.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.515 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.56 -179.951 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -114.24 128.0 56.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.445 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 53' ' ' LEU . 2.2 pp -95.9 116.06 28.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.334 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.9 t -123.76 144.8 49.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.77 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.4 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -119.48 149.41 41.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.013 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.492 ' OE1' ' C ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -155.76 136.88 13.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.946 0.403 . . . . 0.0 111.087 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.519 HG22 ' N ' ' A' ' 58' ' ' PHE . 21.0 mt -116.31 161.81 14.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.002 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.519 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -141.32 151.02 43.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.018 0.437 . . . . 0.0 110.662 -179.878 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -165.93 168.83 39.93 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -46.11 144.72 6.06 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.651 2.234 . . . . 0.0 111.781 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -64.29 120.48 7.82 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.592 2.195 . . . . 0.0 112.17 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.09 2.94 59.13 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.579 ' O ' ' O ' ' A' ' 83' ' ' VAL . 6.7 t -78.71 141.48 37.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.861 0.363 . . . . 0.0 110.665 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 64' ' ' VAL . 33.8 m -101.79 128.2 54.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.621 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.35 144.73 33.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.839 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.45 116.32 32.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.247 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.699 HG23 HD11 ' A' ' 101' ' ' ILE . 23.7 mt -101.03 124.71 54.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.023 0.439 . . . . 0.0 111.006 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.5 t -135.63 124.35 23.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.992 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' A' ' 69' ' ' TYR . 23.9 p90 -147.94 169.01 20.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.909 0.385 . . . . 0.0 110.965 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -87.35 125.7 34.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.455 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -90.95 155.07 19.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.632 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 73' ' ' ASN . 5.3 p -51.77 -37.07 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.495 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 74' ' ' SER . 0.9 OUTLIER -85.16 11.75 9.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.473 179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.516 ' O ' ' C ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER 81.19 -68.03 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.313 -179.729 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.516 ' C ' ' O ' ' A' ' 74' ' ' SER . 5.6 tt0 -31.91 104.14 0.22 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.136 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -76.7 139.86 20.43 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.317 2.011 . . . . 0.0 112.318 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.79 147.66 24.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.498 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 78' ' ' ARG . 14.8 mtp180 -144.73 130.01 18.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.465 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.9 m -109.8 124.5 66.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.411 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.01 117.99 31.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.73 16.73 27.93 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.86 135.66 48.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.774 0.321 . . . . 0.0 110.5 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.579 ' O ' ' O ' ' A' ' 63' ' ' THR . 0.5 OUTLIER -81.17 -38.68 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.659 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.407 ' CD1' HG23 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -148.16 157.06 43.24 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.119 0.485 . . . . 0.0 110.578 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.492 ' CG ' ' O ' ' A' ' 57' ' ' ILE . 38.0 Cg_endo -68.82 160.31 50.19 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.867 2.378 . . . . 0.0 112.227 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.93 -169.65 2.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.498 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.5 m -133.83 144.98 49.3 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.952 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.3 tp -138.32 155.64 48.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.627 0.251 . . . . 0.0 110.398 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -115.82 135.37 54.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 110.984 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.7 mt -129.23 130.32 67.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.249 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 91' ' ' THR . 5.4 t -115.35 129.21 56.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.771 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.557 ' O ' ' C ' ' A' ' 93' ' ' ASN . 14.0 m -129.97 125.42 35.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.226 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.557 ' C ' ' O ' ' A' ' 92' ' ' THR . 1.9 m120 26.26 -104.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.544 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 94' ' ' ASP . 4.8 p-10 -160.05 81.23 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.484 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -167.43 147.41 5.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.664 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.36 127.21 33.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.361 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -140.56 150.07 21.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -102.39 172.59 6.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.208 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -138.44 161.8 25.72 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.534 ' C ' ' OD1' ' A' ' 100' ' ' ASN . 16.2 t-20 -114.96 115.22 26.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 0.0 110.498 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.699 HD11 HG23 ' A' ' 67' ' ' ILE . 18.7 tt -130.98 141.42 46.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.505 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 103' ' ' ALA . 77.8 t -129.36 155.43 41.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.879 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.465 ' HB3' HG12 ' A' ' 110' ' ' ILE . . . -121.31 147.24 45.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.562 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.49 54.26 1.95 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.812 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.65 162.97 20.72 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.98 89.83 4.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.853 0.359 . . . . 0.0 110.448 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.2 p -117.82 177.7 4.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.774 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -116.91 -0.01 12.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.439 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.1 p -170.46 84.52 0.11 Allowed 'General case' 0 C--O 1.245 0.853 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.047 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.468 ' O ' ' CG2' ' A' ' 110' ' ' ILE . 0.4 OUTLIER -109.96 128.97 65.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 120.9 0.381 . . . . 0.0 110.774 -179.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -152.86 164.41 30.78 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 20.3 m -125.0 153.24 43.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.928 0.394 . . . . 0.0 110.727 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -159.87 144.89 15.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.309 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -126.56 133.67 68.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.833 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.8 m -122.79 124.02 42.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.432 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.444 ' C ' ' N ' ' A' ' 118' ' ' GLY . 0.5 OUTLIER -131.84 148.78 32.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.556 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.0 t0 49.87 13.46 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.691 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.444 ' N ' ' C ' ' A' ' 116' ' ' VAL . . . 84.64 -0.14 89.22 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.62 138.34 50.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.717 0.294 . . . . 0.0 110.586 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.3 t -85.41 118.67 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.53 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -90.37 -62.09 1.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.5 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -114.7 131.75 56.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.449 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -129.52 121.75 27.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.773 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.457 ' O ' ' CG ' ' A' ' 124' ' ' ARG . 11.8 ptm180 -128.49 123.19 32.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.293 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.8 t -122.5 120.25 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.63 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.42 115.94 18.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.637 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -95.08 130.18 41.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.211 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -150.4 130.57 13.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.761 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.07 18.34 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.993 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.412 ' CG ' ' O ' ' A' ' 130' ' ' ASN . 2.4 t-20 -179.09 65.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.409 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.46 124.0 26.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.627 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.667 ' CD1' ' O ' ' A' ' 132' ' ' TYR . 1.5 t80 -165.89 -25.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.425 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 30.7 p -101.57 -163.75 1.04 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.634 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.565 ' O ' ' N ' ' A' ' 136' ' ' LEU . 0.9 OUTLIER -111.58 44.25 1.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.669 -179.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . 0.433 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -51.62 84.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.434 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' A' ' 134' ' ' TYR . 4.8 mt -66.65 82.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.532 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 135' ' ' CYS . 1.6 t -132.35 155.32 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.433 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -87.49 -50.92 6.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.676 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.0 m -151.35 -136.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.538 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.574 -179.888 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.66 127.85 54.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.481 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.453 ' CD1' ' O ' ' A' ' 97' ' ' VAL . 1.5 tt -96.12 115.72 27.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.416 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.62 130.95 51.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.667 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -119.98 149.01 42.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.2 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 2.6 tm-20 -156.03 146.76 21.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.984 0.421 . . . . 0.0 111.002 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 58' ' ' PHE . 74.7 mt -114.73 159.96 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.761 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.672 ' CE2' HD11 ' A' ' 84' ' ' LEU . 11.8 t80 -140.28 156.86 46.3 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.245 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.589 ' N ' ' CD1' ' A' ' 58' ' ' PHE . . . -160.72 175.04 37.45 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -50.93 157.98 3.44 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.623 2.216 . . . . 0.0 111.979 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -75.27 118.66 5.27 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.803 2.335 . . . . 0.0 112.187 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.03 9.9 55.5 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.77 150.67 25.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.785 0.326 . . . . 0.0 110.442 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 64' ' ' VAL . 7.6 p -126.06 121.98 60.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.569 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.38 153.55 42.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.529 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.92 115.71 27.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.401 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.499 ' CD1' HD12 ' A' ' 57' ' ' ILE . 4.1 mm -93.24 132.73 36.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.853 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.5 t -135.8 127.54 29.15 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.909 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.454 ' CG ' ' N ' ' A' ' 70' ' ' PHE . 40.1 t80 -150.46 157.34 42.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.801 0.334 . . . . 0.0 110.678 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' A' ' 69' ' ' TYR . 12.9 t80 -87.44 124.35 33.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.439 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.83 156.81 22.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.483 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.29 -30.84 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.473 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 74' ' ' SER . 34.9 m120 -95.72 11.6 32.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.31 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.63 ' OG ' ' N ' ' A' ' 75' ' ' GLU . 1.1 p 85.19 -69.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.379 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.63 ' N ' ' OG ' ' A' ' 74' ' ' SER . 11.4 pt-20 -29.63 94.86 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.495 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.498 ' N ' ' O ' ' A' ' 74' ' ' SER . 51.3 Cg_endo -77.01 141.6 21.2 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.506 2.137 . . . . 0.0 111.978 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.452 ' HG2' ' N ' ' A' ' 78' ' ' ARG . 1.4 tt0 -107.58 140.83 39.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.987 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.452 ' N ' ' HG2' ' A' ' 77' ' ' GLN . 4.4 mtt-85 -135.9 133.5 37.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.165 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 m -99.35 136.56 29.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.72 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -113.09 103.67 11.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.64 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.32 33.46 5.4 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.31 148.11 50.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.789 0.328 . . . . 0.0 110.559 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.5 m -107.56 -20.03 6.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.395 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.672 HD11 ' CE2' ' A' ' 58' ' ' PHE . 5.3 tt -174.99 115.17 0.29 Allowed Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.222 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.567 ' N ' HD23 ' A' ' 84' ' ' LEU . 27.4 Cg_exo -55.63 144.19 76.08 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.897 1.731 . . . . 0.0 111.803 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.526 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 4.4 m-90 -111.5 -144.54 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.528 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.707 ' O ' HD22 ' A' ' 88' ' ' LEU . 97.0 p -134.17 155.21 50.52 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.977 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.707 HD22 ' O ' ' A' ' 87' ' ' SER . 1.5 mm? -129.1 151.84 49.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.786 0.327 . . . . 0.0 110.492 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.594 ' N ' ' CD2' ' A' ' 89' ' ' HIS . 0.4 OUTLIER -105.86 119.05 38.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.629 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.433 HD13 ' O ' ' A' ' 89' ' ' HIS . 50.3 mm -126.41 138.25 55.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.456 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 91' ' ' THR . 12.0 t -103.76 130.44 51.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.649 ' O ' ' N ' ' A' ' 94' ' ' ASP . 17.4 p -116.75 140.34 49.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.737 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.524 ' CG ' ' O ' ' A' ' 93' ' ' ASN . 1.8 t30 -49.5 79.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.59 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 92' ' ' THR . 21.9 m-20 34.08 79.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.55 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -169.41 145.79 3.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.508 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.432 ' CB ' HG11 ' A' ' 116' ' ' VAL . . . -108.5 113.6 26.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.439 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.453 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 7.7 p -133.91 156.78 41.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.674 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.444 ' HA ' HG21 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -108.07 117.26 33.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.533 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.38 161.87 54.39 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -112.9 115.39 28.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 0.0 110.595 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.4 tt -131.08 139.25 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.643 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 103' ' ' ALA . 8.2 t -130.39 155.16 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.397 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.451 ' N ' ' CG1' ' A' ' 102' ' ' VAL . . . -140.72 157.16 45.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.737 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -136.83 73.71 1.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.586 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -128.8 163.51 22.18 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -79.18 106.74 11.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.868 0.366 . . . . 0.0 110.516 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.0 p -140.9 -170.83 3.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.622 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 108' ' ' ASP . 2.3 t70 -134.15 4.93 3.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.5 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.8 p -174.73 62.46 0.02 OUTLIER 'General case' 0 C--O 1.245 0.847 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.959 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.504 ' O ' ' O ' ' A' ' 126' ' ' SER . 4.2 tt -98.99 129.52 49.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 O-C-N 123.16 0.288 . . . . 0.0 110.424 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -149.42 172.4 29.45 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.569 ' O ' ' O ' ' A' ' 124' ' ' ARG . 0.9 OUTLIER -118.99 157.32 27.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.765 0.317 . . . . 0.0 110.28 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.511 ' NH2' ' OE1' ' A' ' 56' ' ' GLU . 15.1 ptt-85 -161.41 141.78 10.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.642 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 113' ' ' ARG . 20.1 mm -117.71 131.37 70.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.615 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.1 p -110.3 132.88 53.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.429 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.432 HG11 ' CB ' ' A' ' 96' ' ' ALA . 24.5 t -142.05 150.08 19.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.598 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 50.99 19.24 0.63 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.653 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.38 -4.73 24.9 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -120.94 132.03 54.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.797 0.332 . . . . 0.0 110.557 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.3 t -74.63 134.53 29.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.46 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.03 -46.82 2.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.789 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.64 129.73 14.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.69 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -150.19 155.73 40.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.576 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.569 ' O ' ' O ' ' A' ' 112' ' ' CYS . 25.8 mtt-85 -116.22 116.0 27.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.608 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.7 p -124.31 128.82 74.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.527 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 110' ' ' ILE . 4.7 m -128.71 130.46 47.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.534 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -99.41 137.92 37.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.517 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -145.64 166.47 25.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.459 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.424 ' C ' ' CG ' ' A' ' 130' ' ' ASN . 5.2 t -97.59 -3.37 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.443 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 132' ' ' TYR . 0.1 OUTLIER 172.33 79.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.354 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.72 76.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.513 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.448 ' N ' ' O ' ' A' ' 130' ' ' ASN . 2.3 t80 -117.99 -70.16 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.511 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 134' ' ' TYR . 1.3 t -56.57 -27.79 58.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.539 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.572 ' O ' ' N ' ' A' ' 136' ' ' LEU . 5.1 t80 58.62 130.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.702 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 17.7 t -53.69 80.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.613 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.572 ' N ' ' O ' ' A' ' 134' ' ' TYR . 8.3 tp -107.16 21.4 17.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.593 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.416 HG23 ' C ' ' A' ' 136' ' ' LEU . 2.4 t 64.72 156.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.674 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.3 tttp 74.15 -168.71 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.63 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.5 m 70.7 12.85 7.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.554 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.613 -179.924 . . . . . . . . 0 0 . 1 stop_ save_